FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Pascon, T
   Barbosa, AMP
   Cordeiro, RCL
   Bussaneli, DG
   Prudencio, CB
   Nunes, SK
   Pinheiro, FA
   Bossolan, G
   Oliveira, LG
   Calderon, IMP
   Marini, G
   Rudge, MVC
AF Pascon, Tawana
   Barbosa, Angelica M. P.
   Cordeiro, Rita C. L.
   Bussaneli, Diego G.
   Prudencio, Caroline B.
   Nunes, Sthefanie K.
   Pinheiro, Fabiane A.
   Bossolan, Grasiela
   Oliveira, Leandro G.
   Calderon, Iracema M. P.
   Marini, Gabriela
   Rudge, Marilza V. C.
TI Prenatal exposure to gestational diabetes mellitus increases
   developmental defects in the enamel of offspring
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE STRESS; TOOTH ERUPTION; CHILDREN; EXPRESSION; RISK;
   SUPPLEMENTATION; POPULATION; INFANTS; MOTHERS; OBESITY
AB Background and objective
   Gestational diabetes mellitus (GDM) is associated with short- and long-term maternal and perinatal repercussions. Our objective was to evaluate the long-term consequences of intrauterine exposure to hyperglycemia on Developmental Defects of Enamel (DDE) in offspring.
   Results
   Overall, 50 children of women with GDM and 250 children of normoglycemic women participated, the latter serving as controls. Children were examined at the age between 3 and 12 years. In addition to physical examination, two independent observers examined and rated photographs to identify specific types of DDE in a blinded fashion. Among offspring of mothers with GDM, rates of DDE (all types combined) and hypoplasia (specific type) were significantly higher (p < 0.001, p = 0.04), in comparison to offspring of normoglycemic mothers. Considering only the affected teeth (1060 in GDM category; 5499 in controls), rates of DDE (all types combined) were significantly higher for total teeth (p < 0.001) and deciduous teeth (p < 0.001), but not permanent teeth. In specific types of DDE involving deciduous teeth, rates of demarcate opacity were significantly higher (p < 0.001; canine and 2nd mandibular molars) and hypoplasia (p < 0.001; 2nd maxillary molars and 2nd mandibular molars). In permanent teeth, the rate of diffuse opacity in association with GDM was significantly higher (p < 0.001; maxillary central incisors and 1st maxillary molars).
   Conclusion
   GDM was associated with the adverse effects of DDE on offspring. This study lays the foundation for future studies to determine the impact of GDM on long-term risk of DDE.
C1 [Pascon, Tawana; Barbosa, Angelica M. P.; Prudencio, Caroline B.; Nunes, Sthefanie K.; Pinheiro, Fabiane A.; Bossolan, Grasiela; Oliveira, Leandro G.; Calderon, Iracema M. P.; Rudge, Marilza V. C.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil.
   [Barbosa, Angelica M. P.] Sao Paulo State Univ UNESP, Dept Physiotherapy & Occupat Therapy, Sch Philosophy & Sci, Marilia, SP, Brazil.
   [Cordeiro, Rita C. L.; Bussaneli, Diego G.] Sao Paulo State Univ UNESP, Dept Pediat Dent & Orthodont, Araraquara Sch Dent, Araraquara, SP, Brazil.
   [Marini, Gabriela] Univ Sacred Heart USC, Hlth Sci Ctr, Bauru, SP, Brazil.
RP Barbosa, AMP (reprint author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil.; Barbosa, AMP (reprint author), Sao Paulo State Univ UNESP, Dept Physiotherapy & Occupat Therapy, Sch Philosophy & Sci, Marilia, SP, Brazil.
EM angelicapascon@gmail.com
RI Girotto Bussaneli, Diego/F-4022-2014
OI Girotto Bussaneli, Diego/0000-0001-9078-7385
CR Afshar H., 2002, J DENT, V14, P25
   Amaral ACS, 2012, REV MED MINAS GER S5, V22, pS40, DOI [10.1891/0730-0832.20.6.17, DOI 10.1891/0730-0832.20.6.17]
   Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc12-s064]
   [Anonymous], 1992, Int Dent J, V42, P411
   Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x
   Asemi Z, 2014, DIABETOLOGIA, V57, P1798, DOI 10.1007/s00125-014-3293-x
   Bronckers ALJJ, 2015, J DENT RES, V94, P1740, DOI 10.1177/0022034515606900
   Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531
   Burguet A, 2010, DIABETES METAB, V36, P682, DOI 10.1016/j.diabet.2010.11.018
   Caixeta Fabíola Ferreira, 2005, Rev. Assoc. Med. Bras., V51, P195, DOI 10.1590/S0104-42302005000400014
   Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790
   Chen GQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40762
   Collodel A, 2015, REV ASS PAUL CIR DEN, V69, P412
   Crombie FA, 2013, J DENT, V41, P611, DOI 10.1016/j.jdent.2013.05.002
   Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201
   DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668
   Dummer P M, 1990, Community Dent Health, V7, P369
   Fleiss IL, 1981, STAT METHODS RATES P, P212
   Frias JL, 2007, AM J MED GENET A, V143A, P2904, DOI 10.1002/ajmg.a.32071
   Garot E, 2018, J DENT, V72, P8, DOI 10.1016/j.jdent.2018.03.005
   Ghanim A, 2017, EUR ARCH PAEDIATR DE, V18, P225, DOI 10.1007/s40368-017-0293-9
   Ghapanchi J, 2015, BRIT J MED MED RES, V10, P1
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Hoffmann HS, DEFEITOS ESMALTE SUA
   Hong L, 2009, CARIES RES, V43, P345, DOI 10.1159/000231571
   Hu P, 2012, CELLS TISSUES ORGANS, V196, P501, DOI 10.1159/000337493
   Jalevik B, 2000, Int J Paediatr Dent, V10, P278, DOI 10.1046/j.1365-263x.2000.00210.x
   Jones C W, 2001, Neonatal Netw, V20, P17
   Kanchan Tanuj, 2015, Indian J Dent, V6, P99, DOI 10.4103/0975-962X.155887
   Karamali M, 2016, PUBLIC HEALTH NUTR, V19, P156, DOI 10.1017/S1368980015000609
   Lal S, 2008, PEDIATRICS, V121, pE1139, DOI 10.1542/peds.2007-1486
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lunardelli Sandra Espíndola, 2005, Braz. oral res., V19, P144, DOI 10.1590/S1806-83242005000200013
   Maganha CA, 1990, REV GINECOL OBSTET, V23, P158
   McHugh ML, 2012, BIOCHEM MEDICA, V22, P276
   Meneses J, 1999, PEDIATRIA SAO PAULO, P30
   Mitanchez D, 2014, J PEDIATR-US, V164, P445, DOI 10.1016/j.jpeds.2013.10.076
   Monte-Santo AS, 2018, INT J PAEDIATR DENT, V28, P595, DOI 10.1111/ipd.12416
   NEEDLEMAN H L, 1992, Pediatric Dentistry, V14, P158
   NOREN JG, 1983, ACTA ODONTOL SCAND, V41, P355, DOI 10.3109/00016358309162347
   Oliveira AFB, 2006, CARIES RES, V40, P296, DOI 10.1159/000093188
   Pinho J, 2011, REV BRAS ODONTOL, V68
   Rudge M, 2005, REV BRAS GINECOL OBS, V27
   Sabokseir A, 2016, PEERJ, V4, DOI 10.7717/peerj.1745
   SEOW W K, 1989, Pediatric Dentistry, V11, P297
   SEOW W K, 1987, Pediatric Dentistry, V9, P221
   Seow W K, 1984, Pediatr Dent, V6, P28
   Seow WK, 2011, PEDIATR DENT, V33, P207
   SEOW WK, 1991, J DENT CHILD, V58, P441
   Silva-Sousa Yara Teresinha Corrêa, 2003, Braz. Dent. J., V14, P162, DOI 10.1590/S0103-64402003000300004
   Silva-Sousa Yara Teresinha Corrêa, 2003, Braz. Dent. J., V14, P87, DOI 10.1590/S0103-64402003000200003
   Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400
   Vello MA, 2010, ORAL DIS, V16, P257, DOI 10.1111/j.1601-0825.2009.01629.x
   Villarino ME, 2005, PEDIATR RES, V58, P695, DOI 10.1203/01.PDR.0000180599.54807.24
   Vrachnis N, 2012, EXP DIABETES RES, DOI 10.1155/2012/538474
   Wei D, 2014, DIABETES, V63, P3512, DOI 10.2337/db14-0231
   Weinert Leticia S, 2010, Diabetes Care, V33, pe98, DOI 10.2337/dc10-0544
   Wen X, 2014, EUR J ORAL SCI, V122, P21, DOI 10.1111/eos.12106
   Wong HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109351
   Wong HM, 2014, COMMUNITY DENT ORAL, V42, P61, DOI 10.1111/cdoe.12064
   World Health Organization, 1997, ORAL HLTH SURVEYS BA
   Wren C, 2003, HEART, V89, P1217, DOI 10.1136/heart.89.10.1217
   Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036727
   Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598
   Yin KF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144703
   Yogev Y, 2009, SEMIN FETAL NEONAT M, V14, P77, DOI 10.1016/j.siny.2008.09.002
   2015, DIABETES CARE S1, V38, pS4, DOI DOI 10.2337/DC15-S003
NR 67
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2019
VL 14
IS 2
AR e0211771
DI 10.1371/journal.pone.0211771
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM9LQ
UT WOS:000459806400033
PM 30811464
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tonin, FS
   Borba, HH
   Mendes, AM
   Wiens, A
   Fernandez-Llimos, F
   Pontarolo, R
AF Tonin, Fernanda S.
   Borba, Helena H.
   Mendes, Antonio M.
   Wiens, Astrid
   Fernandez-Llimos, Fernando
   Pontarolo, Roberto
TI Description of network meta-analysis geometry: A metrics design study
SO PLOS ONE
LA English
DT Article
ID SYSTEMATIC REVIEWS; PRISMA EXTENSION; ISSUES; PLOT; CARE
AB Background
   The conduction and report of network meta-analysis (NMA), including the presentation of the network-plot, should be transparent. We aimed to propose metrics adapted from graph theory and social network-analysis literature to numerically describe NMA geometry.
   Methods
   A previous systematic review of NMAs of pharmacological interventions was performed. Data on the graph's presentation were collected. Network-plots were reproduced using Gephi 0.9.1. Eleven geometric metrics were tested. The Spearman test for non-parametric correlation analyses and the Bland-Altman and Lin's Concordance tests were performed (IBM SPSS Statistics 24.0).
   Results
   From the 477 identified NMAs only 167 graphs could be reproduced because they provided enough information on the plot characteristics. The median nodes and edges were 8 (IQR 6-11) and 10 (IQR 6-16), respectively, with 22 included studies (IQR 13-35). Metrics such as density (median 0.39, ranged 0.07-1.00), median thickness (2.0, IQR 1.0-3.0), percentages of common comparators (median 68%), and strong edges (median 53%) were found to contribute to the description of NMA geometry. Mean thickness, average weighted degree and average path length produced similar results than other metrics, but they can lead to misleading conclusions.
   Conclusions
   We suggest the incorporation of seven simple metrics to report NMA geometry. Editors and peer-reviews should ensure that guidelines for NMA report are strictly followed before publication.
C1 [Tonin, Fernanda S.; Mendes, Antonio M.] Univ Fed Parana, Pharmaceut Sci Postgrad Programme, Curitiba, Parana, Brazil.
   [Tonin, Fernanda S.; Fernandez-Llimos, Fernando] Univ Lisbon, Res Inst Med iMed ULisboa, Lisbon, Portugal.
   [Borba, Helena H.; Wiens, Astrid; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil.
   [Fernandez-Llimos, Fernando] Univ Lisbon, Dept Social Pharm, Fac Pharm, Lisbon, Portugal.
RP Fernandez-Llimos, F (reprint author), Univ Lisbon, Res Inst Med iMed ULisboa, Lisbon, Portugal.; Pontarolo, R (reprint author), Univ Fed Parana, Dept Pharm, Curitiba, Parana, Brazil.; Fernandez-Llimos, F (reprint author), Univ Lisbon, Dept Social Pharm, Fac Pharm, Lisbon, Portugal.
EM f-llimos@ff.ul.pt; pontarolo@ufpr.br
OI Fernandez-Llimos, Fernando/0000-0002-8529-9595; Matoso Mendes, Antonio
   Eduardo/0000-0002-5752-349X
FU Brazilian National Council of Technological and Scientific Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
   (CAPES)
FX FST was supported by the Brazilian National Council of Technological and
   Scientific Development (CNPq), and the Coordination for the Improvement
   of Higher Education Personnel (CAPES). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Al Wattar Bassel H, 2017, Evid Based Med, V22, P12, DOI 10.1136/ebmed-2016-110599
   Anzures-Cabrera J, 2010, RES SYNTH METHODS, V1, P66, DOI 10.1002/jrsm.6
   Arif T., 2015, INT J COMPUT APPL TE, V4, P889
   Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741
   Batson S, 2017, J CLIN EPIDEMIOL, V86, P182, DOI 10.1016/j.jclinepi.2017.03.008
   Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340
   Bhatnagar Nidhi, 2014, Perspect Clin Res, V5, P154, DOI 10.4103/2229-3485.140550
   BLAND JM, 1986, LANCET, V1, P307
   Brignardello-Petersen R, 2019, J CLIN EPIDEMIOL, V105, P60, DOI 10.1016/j.jclinepi.2018.08.022
   Brown S, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-110
   Carroll K, 2016, PHARM STAT, V15, P135, DOI 10.1002/pst.1733
   Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654
   Chung HJ, 2008, CLIN TRIALS, V5, P301, DOI 10.1177/1740774508093614
   Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008
   Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001
   Cornell JE, 2015, ANN INTERN MED, V162, P797, DOI 10.7326/M15-0930
   Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767
   Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724
   Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085
   Dunn AG, 2011, SOC SCI MED, V72, P1064, DOI 10.1016/j.socscimed.2011.01.029
   Franchini AJ, 2012, RES SYNTH METHODS, V3, P142, DOI 10.1002/jrsm.1049
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI DOI 10.1002/9780470712184
   Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385
   Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508
   Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159
   Jia YT, 2008, IEEE T VIS COMPUT GR, V14, P1285, DOI 10.1109/TVCG.2008.151
   Kanters S, 2016, B WORLD HEALTH ORGAN, V94, P782, DOI 10.2471/BLT.16.174326
   Konig J, 2013, STAT MED, V32, P5414, DOI 10.1002/sim.6001
   Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35
   Lewis S, 2001, BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Mavridis D, 2015, EVID-BASED MENT HEAL, V18, P40, DOI 10.1136/eb-2015-102088
   Mbuagbaw L, 2017, SYST REV, V6, DOI 10.1186/s13643-017-0473-z
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Neupane B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115065
   Nooraie RY, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2067-9
   Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006
   Otte E, 2002, J INFORM SCI, V28, P441, DOI 10.1177/016555102762202123
   Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630
   Rucker G, 2016, RES SYNTH METHODS, V7, P94, DOI 10.1002/jrsm.1143
   Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058
   Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011
   Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682
   Scott J., 2013, SOCIAL NETWORK ANAL
   Senn S, 2013, STAT METHODS MED RES, V22, P169, DOI 10.1177/0962280211432220
   Sturtz S, 2012, RES SYNTH METHODS, V3, P300, DOI 10.1002/jrsm.1057
   Sullivan SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113277
   Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006
   Tonin Fernanda S, 2018, Int J Epidemiol, DOI 10.1093/ije/dyy197
   Tonin Fernanda S., 2017, Pharmacy Pract (Granada), V15, P943, DOI [10.18549/PharmPract.2017.01.943, 10.18549/pharmpract.2017.01.943]
   Veroniki AA, 2016, J CLIN EPIDEMIOL, V76, P193, DOI 10.1016/j.jclinepi.2016.02.016
   Wang EK, 2014, SCI WORLD J, DOI 10.1155/2014/930314
   Wasserman S., 1994, SOCIAL NETWORK ANAL
   Zarin W, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0764-6
   Zhang P, 2013, HDB GRAPH THEORY
NR 56
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 20
PY 2019
VL 14
IS 2
AR e0212650
DI 10.1371/journal.pone.0212650
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM2OT
UT WOS:000459307000081
PM 30785955
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kirsch, K
   Detilleux, J
   Serteyn, D
   Sandersen, C
AF Kirsch, Katharina
   Detilleux, Johann
   Serteyn, Didier
   Sandersen, Charlotte
TI Comparison of two portable clinical analyzers to one stationary analyzer
   for the determination of blood gas partial pressures and blood
   electrolyte concentrations in horses
SO PLOS ONE
LA English
DT Article
ID ACID-BASE; STATISTICAL-METHODS; HEMOGLOBIN; AGREEMENT; INTERFERENCE;
   POTASSIUM; PRECISION
AB Portable blood gas analyzers are used to facilitate diagnosis and treatment of disorders related to disturbances of acid-base and electrolyte balance in the ambulatory care of equine patients. The aim of this study was to determine whether 2 portable analyzers produce results in agreement with a stationary analyzer. Blood samples from 23 horses hospitalized for various medical reasons were included in this prospective study. Blood gas analysis and electrolyte concentrations measured by the portable analyzers VetStat and epoc were compared to those produced by the cobas b 123 analyzer via concordance analysis, Passing-Bablok regression and Bland-Altman analysis. Limits of agreement indicated relevant bias between the VetStat and cobas b 123 for partial pressure of oxygen (pO(2); 27.5-33.8 mmHg), sodium ([Na+]; 4.3-21.6 mmol/L) and chloride concentration ([CI-]; 0.3-7.9 mmol/L) and between the epoc and cobas b 123 for pH (0.070-0.022), partial pressure of carbon dioxide (pCO(2); 3.6-7.3 mmHg), pO(2) (36.2-32.7 mmHg) and [Na+] (0.38.1 mmol/L). The VetStat analyzer yielded results that were in agreement with the cobas b 123 analyzer for determination of pH, pCO(2), bicarbonate ([HCO3-]) and potassium concentration [K+], while the epoc analyzer achieved acceptable agreement for [HCO3] and [K+]. The VetStat analyzer may be useful in performing blood gas analysis in equine samples but analysis of [Na+], [Cl-] and pO(2) should be interpreted with caution. The epoc delivered reliable results for [HCO3] and [K+], while results for pH, pCO(2), pO(2) and [Na+] should be interpreted with caution.
C1 [Kirsch, Katharina; Serteyn, Didier; Sandersen, Charlotte] Univ Liege, Fac Vet Med, Dept Compan Anim & Equids, Equine Clin, Liege, Belgium.
   [Detilleux, Johann] Univ Liege, Fac Vet Med, Dept Quantitat Genet, Liege, Belgium.
RP Sandersen, C (reprint author), Univ Liege, Fac Vet Med, Dept Compan Anim & Equids, Equine Clin, Liege, Belgium.
EM charlotte.sandersen@uliege.be
CR Aguilera-Tejero JC, 2002, RES VET SCI, V68, P103
   Andrews F M, 1995, Equine Vet J Suppl, P57
   Bardell D, 2017, VET ANAESTH ANALG, V44, P77, DOI 10.1111/vaa.12392
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   BLAND JM, 1986, LANCET, V1, P307
   Blikslager AT, 1998, EQUINE INTERNAL MED, P922
   Briggs C, 2014, INT J LAB HEMATOL, V36, P613, DOI 10.1111/ijlh.12201
   Center for Disease Control and Prevention (CDC) Centers for Medicare and Medical Services (CMS) HHS, 2003, FED REGISTER, V68, P3640
   CORNBLEET PJ, 1979, CLIN CHEM, V25, P432
   Dimeski G, 2010, CLIN CHIM ACTA, V411, P309, DOI 10.1016/j.cca.2009.12.005
   Elmeshreghi TN, 2018, VET CLIN PATH, V47, P415, DOI 10.1111/vcp.12635
   Foreman J. H., 2004, Equine and Comparative Exercise Physiology, V1, P99, DOI 10.1079/ECEP200310
   Gourlain H, 1997, CLIN CHEM, V43, P1078
   Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI [10.1097/01.AACN.0000318125.41512.a3, 10.4037/15597768-2008-2015]
   Hinchcliff K W, 1995, Equine Vet J Suppl, P105
   JOHNSON PJ, 1995, VET CLIN N AM-EQUINE, V11, P491, DOI 10.1016/S0749-0739(17)30312-7
   KOCH TR, 1990, CLIN CHEM, V36, P807
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lindinger M. I., 2004, Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, P872, DOI 10.1016/B978-0-7020-2671-3.50043-X
   Lippi G, 2013, CLIN CHEM LAB MED, V51, P1651, DOI 10.1515/cclm-2012-0802
   McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x
   McBride GB, HAM2005062 NIWA
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Roels E, 2016, J VET EMERG CRIT CAR, V26, P352, DOI 10.1111/vec.12469
   ROSE RJ, 1980, EQUINE VET J, V12, P132, DOI 10.1111/j.2042-3306.1980.tb03401.x
   ROSE RJ, 1979, EQUINE VET J, V11, P56, DOI 10.1111/j.2042-3306.1979.tb01300.x
   Saini N, 2015, TRANSFUS APHER SCI, V52, P319, DOI 10.1016/j.transci.2015.01.009
   SEHGAL LR, 1984, CRIT CARE MED, V12, P907, DOI 10.1097/00003246-198410000-00015
   Smith BP, 2014, LARGE ANIMAL INTERNA, P362
   Southwood LL, 2015, EQUINE EMERGENCY CRI, P635
   Viu J, 2010, EQUINE VET J, V42, P76, DOI 10.1111/j.2042-3306.2010.00213.x
   West E, 2014, J SMALL ANIM PRACT, V55, P139, DOI 10.1111/jsap.12177
   WESTGARD JO, 1974, CLIN CHEM, V20, P825
   Westgard JO, MINIMUM OPTIMAL DESI
   Williamson L H, 1996, Equine Vet J Suppl, P92
NR 35
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 15
PY 2019
VL 14
IS 2
AR e0211104
DI 10.1371/journal.pone.0211104
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HL5KT
UT WOS:000458766300004
PM 30768603
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de Knegt, MC
   Haugen, M
   Linde, JJ
   Kuhl, JT
   Nordestgaard, BG
   Kober, LV
   Hove, JD
   Kofoed, KF
AF de Knegt, Martina C.
   Haugen, Morten
   Linde, Jesper J.
   Kuhl, Jorgen Tobias
   Nordestgaard, Borge G.
   Kober, Lars, V
   Hove, Jens D.
   Kofoed, Klaus F.
TI Reproducibility of quantitative coronary computed tomography angiography
   in asymptomatic individuals and patients with acute chest pain
SO PLOS ONE
LA English
DT Article
ID ARTERY-DISEASE; CT ANGIOGRAPHY; PLAQUE BURDEN; HIGH-RISK;
   QUANTIFICATION; AGREEMENT; SOFTWARE; LESIONS
AB Purpose
   Quantitative computed tomography (QCT) provides important prognostic information of coronary atherosclerosis. We investigated intraobserver and interobserver QCT reproducibility in asymptomatic individuals, patients with acute chest pain without acute coronary syndrome (ACS), and patients with acute chest pain and ACS.
   Methods
   Fifty patients from each cohort, scanned between 01/02/2010-14/11/2013 and matched according to age and gender, were retrospectively assessed for inclusion. Patients with no coronary artery disease, previous coronary artery bypass graft surgery, and poor image quality were excluded. Coronary atherosclerosis was measured semi-automatically by 2 readers. Reproducibility of minimal lumen area (MLA), minimal lumen diameter (MLD), area stenosis, diameter stenosis, vessel remodeling, plaque eccentricity, plaque burden, and plaque volumes was assessed using concordance correlation coefficient (CCC), Bland-Altman, coefficient of variation, and Cohen's kappa.
   Results
   A total of 84 patients (63 matched) were included. Intraobserver and interobserver reproducibility estimates were acceptable for MLA (CCC = 0.94 and CCC = 0.91, respectively), MLD (CCC = 0.92 and CCC = 0.86, respectively), plaque burden (CCC = 0.86 and CCC = 0.80, respectively), and plaque volume (CCC = 0.97 and CCC = 0.95, respectively). QCT detected area and diameter stenosis >= 50%, positive remodeling, and eccentric plaque with moderate-good intraobserver and interobserver reproducibility (kappa: 0.64-0.66, 0.69-0.76, 0.46-0.48, and 0.41-0.62, respectively). Reproducibility of plaque composition decreased with decreasing plaque density (intraobserver and interobserver CCC for dense calcium (>0.99; 0.98), fibrotic (0.96; 0.93), fibro-fatty (0.95; 0.91), and necrotic core tissue (0.89; 0.84). Reproducibility generally decreased with worsening clinical risk profile.
   Conclusions
   Semi-automated QCT of coronary plaque morphology is reproducible, albeit with some decline in reproducibility with worsening patient risk profile.
C1 [de Knegt, Martina C.; Haugen, Morten; Linde, Jesper J.; Kuhl, Jorgen Tobias; Kober, Lars, V; Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark.
   [de Knegt, Martina C.; Hove, Jens D.] Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark.
   [Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark.
   [Kofoed, Klaus F.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Radiol, Copenhagen, Denmark.
RP de Knegt, MC (reprint author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Dept Cardiol, Copenhagen, Denmark.; de Knegt, MC (reprint author), Univ Copenhagen, Fac Hlth Sci, Dept Cardiol, Hvidovre Hosp, Copenhagen, Denmark.
EM martinadeknegt@gmail.com
OI Kofoed, Klaus/0000-0001-9742-1554; de Knegt, Martina/0000-0001-7668-0338
FU Department of Cardiology, Hvidovre Hospital, Copenhagen, Denmark; Danish
   Agency for Science, Technology and Innovation by The Danish Council for
   Strategic Research [09-066994]
FX This study was funded by Department of Cardiology, Hvidovre Hospital,
   Copenhagen, Denmark and Danish Agency for Science, Technology and
   Innovation by The Danish Council for Strategic Research (EDITORS:
   Eastern Denmark initiative to improve Revascularization Strategies,
   Grant 09-066994). These funding sources had no involvement in study
   design; in the collection, analysis and interpretation of data; in the
   writing of the report; or in the decision to submit the article for
   publication.
CR Arbab-Zadeh A, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.118.007992
   Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041
   Blackmon KN, 2009, J THORAC IMAG, V24, P96, DOI 10.1097/RTI.0b013e31819b674b
   BLAND JM, 1986, LANCET, V1, P307
   Boogers MJ, 2012, EUR HEART J, V33, P1007, DOI 10.1093/eurheartj/ehr465
   Broersen A, 2016, INT J CARDIOVAS IMAG, V32, P543, DOI 10.1007/s10554-015-0820-x
   Cho IJ, 2018, J AM COLL CARDIOL, V71, P1998, DOI [10.1016/S0735-1097(18)32539-7, 10.1016/j.jacc.2018.02.079]
   Colak Y, 2015, AM J RESP CRIT CARE, V192, P172, DOI 10.1164/rccm.201502-0302OC
   Dalager MG, 2011, INT J CARDIOVAS IMAG, V27, P593, DOI 10.1007/s10554-010-9695-z
   de Graaf MA, 2013, INT J CARDIOVAS IMAG, V29, P1177, DOI 10.1007/s10554-013-0194-x
   de Knegt Martina C, 2018, Eur Heart J Cardiovasc Imaging, DOI 10.1093/ehjci/jey146
   de Knegt MC, 2016, INT J CARDIOVAS IMAG, V32, P1555, DOI 10.1007/s10554-016-0932-y
   Dey D, 2014, J CARDIOVASC COMPUT, V8, P368, DOI 10.1016/j.jcct.2014.07.007
   Ferencik M, 2015, J CARDIOVASC COMPUT, V9, P538, DOI 10.1016/j.jcct.2015.07.003
   Kang DK, 2011, EUR RADIOL, V21, P712, DOI 10.1007/s00330-010-1970-9
   Kristensen TS, 2011, J AM COLL CARDIOL, V58, P502, DOI 10.1016/j.jacc.2011.01.058
   Kuhl JT, 2017, SCAND CARDIOVASC J, V51, P28, DOI 10.1080/14017431.2016.1207799
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Laqmani A, 2016, ROFO-FORTSCHR RONTG, V188, P933, DOI 10.1055/s-0042-110099
   Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Linde JJ, 2013, INT J CARDIOL, V168, P5257, DOI 10.1016/j.ijcard.2013.08.020
   Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044
   Ovrehus KA, 2016, J CARDIOVASC COMPUT, V10, P114, DOI 10.1016/j.jcct.2015.11.003
   Papadopoulou SL, 2013, INT J CARDIOVAS IMAG, V29, P1095, DOI 10.1007/s10554-012-0167-5
   Rinehart S, 2011, J CARDIOVASC COMPUT, V5, P35, DOI 10.1016/j.jcct.2010.09.006
   Szilveszter B, 2016, INT J CARDIOVAS IMAG, V32, P161, DOI 10.1007/s10554-015-0741-8
   Versteylen MO, 2013, J AM COLL CARDIOL, V61, P2296, DOI 10.1016/j.jacc.2013.02.065
   Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2
NR 29
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2018
VL 13
IS 12
AR e0207980
DI 10.1371/journal.pone.0207980
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HE3IQ
UT WOS:000453248000012
PM 30550593
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Serrano, NC
   Quintero-Lesmes, DC
   Becerra-Bayona, S
   Guio, E
   Beltran, M
   Paez, MC
   Ortiz, R
   Saldarriaga, W
   Diaz, LA
   Monterrosa, A
   Miranda, J
   Mesa, CM
   Sanin, JE
   Monsalve, G
   Dudbridge, F
   Hingorani, AD
   Casas, JP
AF Serrano, Norma C.
   Cristina Quintero-Lesmes, Doris
   Becerra-Bayona, Silvia
   Guio, Elizabeth
   Beltran, Monica
   Paez, Maria C.
   Ortiz, Ricardo
   Saldarriaga, Wilmar
   Diaz, Luis A.
   Monterrosa, Alvaro
   Miranda, Jezid
   Mesa, Clara M.
   Sanin, Jose E.
   Monsalve, German
   Dudbridge, Frank
   Hingorani, Aroon D.
   Casas, Juan P.
TI Association of pre-eclampsia risk with maternal levels of folate,
   homocysteine and vitamin B12 in Colombia: A case-control study
SO PLOS ONE
LA English
DT Article
ID FOLIC-ACID SUPPLEMENTATION; PERICONCEPTIONAL MULTIVITAMIN USE;
   GESTATIONAL HYPERTENSION; EARLY-PREGNANCY; DIETARY-FOLATE; WOMEN
AB Background
   Maternal serum concentrations of folate, homocysteine, and vitamin B12 have been associated with pre-eclampsia. Nevertheless, reported studies involve limited number of cases to reliably assess the nature of these associations. Our aim was to examine the relation of these three biomarkers with pre-eclampsia risk in a large Colombian population.
   Materials and methods
   Design: A case-control study.
   Setting: Cases of pre-eclampsia and healthy pregnant controls were recruited at the time of delivery from eight different Colombian cities between 2000 and 2012.
   Population or Sample: 2978 cases and 4096 controls were studied. Maternal serum concentrations of folate, homocysteine, and vitamin B12 were determined in 1148 (43.6%) cases and 1300 (31.7%) controls. Also, self-reported folic acid supplementation was recorded for 2563 (84%) cases and 3155 (84%) controls.
   Analysis: Adjusted odds ratios (OR) for pre-eclampsia were estimated for one standard deviation (1SD) increase in log-transformed biomarkers. Furthermore, we conducted analyses to compare women that reported taking folic acid supplementation for different periods during pregnancy.
   Main Outcomes Measures: Odds ratio for pre-eclampsia.
   Results
   After adjusting for potential confounders in logistic regression models, the OR for preeclampsia was 0.80 (95% CI: 0.72, 0.90) for 1SD increase in log-folate, 1.16 (95%CI: 1.05, 1.27) for 1SD increase in log-homocysteine, and 1.10 (95%CI: 0.99, 1.22) for 1SD increase in log-vitamin B12. No interactions among the biomarkers were identified. Women who self-reported consumption of folic acid (1 mg/day) throughout their pregnancy had an adjusted OR for pre-eclampsia of 0.86 (95%CI: 0.67, 1.09) compared to women that reported no consumption of folic acid at any point during pregnancy.
   Conclusions
   Maternal serum concentrations of folate were associated as a protective factor for pre-eclampsia while concentrations of homocysteine were associated as a risk factor. No association between maternal vitamin B12 concentrations and preeclampsia was found.
C1 [Serrano, Norma C.; Cristina Quintero-Lesmes, Doris; Guio, Elizabeth] Fdn Cardiovasc Colombia, Floridablanca, Colombia.
   [Serrano, Norma C.; Cristina Quintero-Lesmes, Doris] Hosp Int Colombia, Piedecuesta, Colombia.
   [Serrano, Norma C.; Becerra-Bayona, Silvia; Beltran, Monica; Paez, Maria C.; Ortiz, Ricardo] Univ Autonoma Bucaramanga, Bucaramanga, Colombia.
   [Beltran, Monica; Diaz, Luis A.] Univ Ind Santander, Bucaramanga, Colombia.
   [Saldarriaga, Wilmar] Univ Valle, Fac Salud, Dept Ginecol & Obstet, Dept Morfol, Cali, Colombia.
   [Monterrosa, Alvaro; Miranda, Jezid] Univ Cartagena, Cartagena, Colombia.
   [Mesa, Clara M.] Univ CES, Medellin, Colombia.
   [Sanin, Jose E.; Monsalve, German] Univ Pontificia Bolivariana, Bucaramanga, Colombia.
   [Dudbridge, Frank] Univ Leicester, Ctr Med, Dept Hlth Sci, Leicester, Leics, England.
   [Hingorani, Aroon D.; Casas, Juan P.] UCL, Farr Inst Hlth Informat, London, England.
RP Serrano, NC (reprint author), Fdn Cardiovasc Colombia, Floridablanca, Colombia.; Serrano, NC (reprint author), Hosp Int Colombia, Piedecuesta, Colombia.; Serrano, NC (reprint author), Univ Autonoma Bucaramanga, Bucaramanga, Colombia.
EM normaserrano@fcv.org
OI Miranda, Jezid/0000-0003-0372-8374; Serrano Diaz, Norma
   Cecilia/0000-0003-3532-2002; Quintero Lesmes, Doris
   Cristina/0000-0001-8875-0110; Hingorani, Aroon/0000-0001-8365-0081
FU COLCIENCIAS - Colombia [295-2007]
FX This project was funded by COLCIENCIAS - Colombia (grant code No.
   295-2007).
CR ACOG practice bulletin, 2002, OBSTET GYNECOL, V99, P159, DOI DOI 10.1016/S0029-7844(01)01747-1
   Agrawal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119120
   Almeida LC, 2010, CAD SAUDE PUBLICA, V26, P2011, DOI 10.1590/S0102-311X2010001100003
   Atkinson KR, 2009, J LIPID RES, V50, P71, DOI 10.1194/jlr.M800296-JLR200
   Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x
   Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218
   Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009
   Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052
   Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177
   Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348
   De Stavola BL, 2006, AM J EPIDEMIOL, V163, P84, DOI 10.1093/aje/kwj003
   Di Simone N, 2004, MOL HUM REPROD, V10, P665, DOI 10.1093/molehr/gah091
   Di Simone N, 2003, BIOL REPROD, V69, P1129, DOI 10.1095/biolreprod.103.015800
   Eddib A, 2009, CLIN MED WOMENS HLTH, V2, pS2385
   GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80
   Guo YanFang, 2012, Fetal and Maternal Medicine Review, V23, P131, DOI 10.1017/S096553951200006X
   Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129
   Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6
   Kamudhamas A, 2004, AM J OBSTET GYNECOL, V191, P563, DOI 10.1016/j.ajog.2004.01.037
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Kim MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097273
   Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009
   Leanos-Miranda A, 2015, J RHEUMATOL, V42, P1141, DOI 10.3899/jrheum.141571
   Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199
   Manizheh SM, 2009, SAUDI MED J, V30, P88
   Mignini LE, 2005, OBSTET GYNECOL, V105, P411, DOI 10.1097/01.AOG.0000151117.52952.b6
   Neyman J, 1928, BIOMETRIKA, V20A, P175, DOI 10.2307/2331945
   Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7
   Salehi-Pourmehr Hanieh, 2012, Iran J Nurs Midwifery Res, V17, P461
   Serrano NC, 2018, PREGNANCY HYPERTENS
   Serrano NC, 2018, ATHEROSCLEROSIS, V276, P189, DOI 10.1016/j.atherosclerosis.2018.05.051
   Shenoy V, 2010, TRENDS ENDOCRIN MET, V21, P529, DOI 10.1016/j.tem.2010.05.002
   Singh MD, 2015, NUTR REV, V73, P694, DOI 10.1093/nutrit/nuv028
   Steegers-Theunissen RPM, 2000, BRIT J OBSTET GYNAEC, V107, P1513, DOI 10.1111/j.1471-0528.2000.tb11677.x
   Thangaratinam S, 2011, BEST PRACT RES CL OB, V25, P419, DOI 10.1016/j.bpobgyn.2011.02.008
   Theriault S, 2013, OBSTET GYNECOL, V122, P345, DOI 10.1097/AOG.0b013e31829b2f7c
   Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002
   Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59
   Wang Y, 2015, EUR J CLIN NUTR, V69, P1145, DOI 10.1038/ejcn.2014.295
   Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x
   Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067
NR 43
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 6
PY 2018
VL 13
IS 12
AR e0208137
DI 10.1371/journal.pone.0208137
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HD1YF
UT WOS:000452307600028
PM 30521542
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Milanes-Guisado, Y
   Gutierrez-Valencia, A
   Trujillo-Rodriguez, M
   Espinosa, N
   Viciana, P
   Lopez-Cortes, LF
AF Milanes-Guisado, Yusnelkis
   Gutierrez-Valencia, Alicia
   Trujillo-Rodriguez, Maria
   Espinosa, Nuria
   Viciana, Pompeyo
   Fernando Lopez-Cortes, Luis
TI Absolute CD4(+) T cell count overstate immune recovery assessed by
   CD4(+)/CD8(+) ratio in HIV-infected patients on treatment
SO PLOS ONE
LA English
DT Article
ID COMBINATION ANTIRETROVIRAL THERAPY; VIRAL LOAD SUPPRESSION; CD4/CD8
   RATIO; OBSERVATIONAL COHORT; NORMALIZATION; INDIVIDUALS; PERCENTAGE;
   ACHIEVE; IMPACT; ADULTS
AB Objectives
   To analyse the correlation and concordance between aCD4, CD4%, CD4/CD8, their intrapatient variability, and to compare the immune recovery (IR) rates based on the three parameters in HIV-infected patients after starting antiretroviral therapy.
   Methods
   From a prospectively followed cohort, patients who maintained HIV-RNA suppression in >= 95% of the determinations throughout the follow-up were selected. IR was defined as aCD4 >650/mu l, CD4% >= 38% or CD4/CD8 >= 1.
   Results
   A total of 1164 patients with a median follow-up of 5 years were analysed. The increases in aCD4, CD4% and CD4/CD8 were highest during the first year and considerably lower there-after regardless of baseline aCD4. The annual increases in aCD4 showed poor correlations with those of CD4% (r = 0.143-0.250) and CD4/CD8 (r = 0.101-0.192) but were high between CD4% and CD4/CD8 (r = 0.765-0.844; p<0.001). The median intra-annual coefficients of variation for aCD4, CD4/CD8 and CD4% were 12.5, 8.5 and 6.6, respectively. After five years, 66.7%, 41.6% and 42.1% of the patients reached aCD4 >650/mu l, CD4% >= 38%, and CD4/CD8 >= 1, respectively, while only 31% achieved both aCD4 and CD4/CD8 target values.
   Conclusions
   The increases in aCD4 poorly correlate with those of CD4% and CD4/CD8. IR rates based on aCD4 significantly overstate those obtained by CD4% and CD4/CD8. CD4% and CD4/CD8 are more stable markers than aCD4 and should be taken into account to monitor the IR after treatment initiation.
C1 [Milanes-Guisado, Yusnelkis; Gutierrez-Valencia, Alicia; Trujillo-Rodriguez, Maria; Espinosa, Nuria; Viciana, Pompeyo; Fernando Lopez-Cortes, Luis] Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen Rocio,Enfermedades Infecciosas M, Seville, Spain.
RP Lopez-Cortes, LF (reprint author), Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen Rocio,Enfermedades Infecciosas M, Seville, Spain.
EM luisfernando@lopezcorets.net
OI Lopez.Cortes, Luis Fernando/0000-0002-3804-3458
FU Red de Investigacion en SIDA (RIS) [RD16/0025/0020-ISCIII-FEDER]; Red de
   Investigacion en SIDA [RD16/0025/0020-ISCIII-FEDER]
FX This work was supported by Red de Investigacion en SIDA (RIS)
   RD16/0025/0020-ISCIII-FEDER to LFLC.; This work was supported by Red de
   Investigacion en SIDA RD16/0025/0020-ISCIII-FEDER. We are indebted to
   Karin Neukam, PhD, for her assistance with the final English version of
   the manuscript.
CR [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   [Anonymous], 2017, GUIDELINES USE ANTIR, P1
   Caby F, 2016, CLIN INFECT DIS, V62, P1297, DOI 10.1093/cid/ciw076
   Campbell PJ, 1997, INT J STD AIDS, V8, P423, DOI 10.1258/0956462971920460
   Cao W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20697
   Castilho JL, 2016, AIDS, V30, P899, DOI 10.1097/QAD.0000000000001005
   De Biasi S, 2016, AIDS, V30, P2599, DOI 10.1097/QAD.0000000000001247
   Fogli M, 2014, NEW MICROBIOL, V37, P75
   Gordon CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125248
   Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b
   Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3
   He L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148915
   Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669
   Hema MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161594
   HUGHES MD, 1994, J INFECT DIS, V169, P28, DOI 10.1093/infdis/169.1.28
   Hughes RA, 2011, HIV MED, V12, P583, DOI 10.1111/j.1468-1293.2011.00929.x
   Kelly C, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0156099, 10.1371/journal.pone]
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d
   Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9
   Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5
   O'Connor JL, 2014, AIDS, V28, P919, DOI 10.1097/QAD.0000000000000165
   Peeling RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115019
   Perez-Santiago J, 2016, AIDS, V30, P2275, DOI 10.1097/QAD.0000000000001205
   Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72
   Seng Remonie, 2015, AIDS, V29, P595, DOI 10.1097/QAD.0000000000000571
   Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078
   Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075
   Smith DM, 2016, CLIN INFECT DIS, V63, P1517, DOI 10.1093/cid/ciw612
   STEIN DS, 1992, J INFECT DIS, V165, P352, DOI 10.1093/infdis/165.2.352
   TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114
   Tinago W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097011
   Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x
   Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556
   Wolbers M, 2007, ANTIVIR THER, V12, P889
NR 35
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 22
PY 2018
VL 13
IS 10
AR e0205777
DI 10.1371/journal.pone.0205777
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX7HS
UT WOS:000447938400017
PM 30346965
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pelizzo, G
   Guazzotti, M
   Klersy, C
   Nakib, G
   Costanzo, F
   Andreatta, E
   Bassotti, G
   Calcaterra, V
AF Pelizzo, Gloria
   Guazzotti, Marinella
   Klersy, Catherine
   Nakib, Ghassan
   Costanzo, Federico
   Andreatta, Erika
   Bassotti, Gabrio
   Calcaterra, Valeria
TI Spleen size evaluation in children: Time to define splenomegaly for
   pediatric surgeons and pediatricians
SO PLOS ONE
LA English
DT Article
ID CONVENTIONAL LAPAROSCOPIC SPLENECTOMY; SCHOOL-AGE-CHILDREN; SOUTH-EAST
   NIGERIA; NORMAL VALUES; SONOGRAPHIC ASSESSMENT; COMPUTED-TOMOGRAPHY;
   KIDNEY DIMENSIONS; NORMAL LIMITS; INFANTS; LIVER
AB Background
   We determined the range of normal spleen dimensions evaluated by ultrasonography (US) in children according to sex and age and the relationship between splenic measurements, auxological data and body proportions, in order to define splenomegaly parameters in support of the surgical mini-invasive approaches in pediatrics.
   Methods
   We prospectively examined 317 caucasian children of both sexes. The patients were divided into three groups: 0-3 years; 4-10 years; 11-18 years. Sex, weight, height/length, body mass index (BMI), waist circumference and xipho-pubic distance were determined for each child. US spleen evaluation included longitudinal/antero-posterior/transverse diameters, transverse area and volume. Spleen volume/abdominal volume, longitudinal spleen diameter/longitudinal left kidney diameter and longitudinal spleen diameter/xipho-pubic distance ratios were also calculated.
   Results
   For caucasian subjects, in different age groups spleen volume, transverse area and diameter increased while the spleen/abdominal volume ratio decreased significantly (p<0.001). A significant (p<0.001) decrease in longitudinal spleen diameter/xipho-pubic distance ratio was noted between the 0-3 years group and both 4-10 and 11-18 years group. Age and auxological data, except BMI, showed a high correlation with spleen dimension (r >= 0.8).
   Conclusions
   The current concept of splenomegaly is not applicable in pediatric surgery. A dedicated classification of splenomegaly is needed for children and would improve the safety and feasibility of treatment.
C1 [Pelizzo, Gloria] Childrens Hosp, Pediat Surg Unit, Ist Mediterraneo Eccellenza Pediat, Palermo, Italy.
   [Guazzotti, Marinella; Costanzo, Federico; Andreatta, Erika] Fdn IRCCS Policlin San Matteo, Pediat Surg Unit, Dept Mother & Child Hlth, Pavia, Italy.
   [Klersy, Catherine] Fdn IRCCS Policlin San Matteo, Sci Direct, Biometry & Clin Epidemiol, Pavia, Italy.
   [Nakib, Ghassan] Mediclin City Hosp, Dept Paediat Surg, Medclin Middle East, Dubai, U Arab Emirates.
   [Bassotti, Gabrio] Univ Perugia, Med Sch, Dept Med, Gastroenterol Sect, Perugia, Italy.
   [Calcaterra, Valeria] Univ Pavia, Pediat Unit, Dept Mother & Child Hlth, Fdn IRCCS Policlin San Matteo, Pavia, Italy.
   [Calcaterra, Valeria] Univ Pavia, Dept Internal Med, Pavia, Italy.
RP Pelizzo, G (reprint author), Childrens Hosp, Pediat Surg Unit, Ist Mediterraneo Eccellenza Pediat, Palermo, Italy.
EM gloria.pelizzo@gmail.com
OI CALCATERRA, VALERIA/0000-0002-2137-5974; Pelizzo,
   Gloria/0000-0002-5253-8828
FU Association "4CHILDREN CC Onlus"
FX The authors would thank Dr. Elisa Zambaiti for support in the
   acquisition of data; Dr. L. Kelly for English revision of the
   manuscript; Prof. L. Cavallo for your expertise; the Association
   "4CHILDREN C&C Onlus" for supporting research in our Pediatric Surgery
   Unit.
CR al-Imam O, 2000, East Mediterr Health J, V6, P514
   Al-Salem AH, 2016, J PEDIAT HEMATOL ONC, V38, P1, DOI 10.1097/MPH.0000000000000121
   Benter T, 2011, J ULTRAS MED, V30, P1281
   BLAND JM, 1986, LANCET, V1, P307
   BURDI AR, 1969, AM J ANAT, V125, P113, DOI 10.1002/aja.1001250106
   Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156
   Chiorean L, 2014, MED ULTRASON, V16, P48, DOI 10.11152/mu.2014.2066.161.lc1mz2
   Chow KU, 2016, RADIOLOGY, V279, P306, DOI 10.1148/radiol.2015150887
   Coquet B, 2010, SURG RADIOL ANAT, V32, P25, DOI 10.1007/s00276-009-0535-6
   Corcione F, 2012, SURG ENDOSC, V26, P2870, DOI 10.1007/s00464-012-2272-x
   Deng XG, 2012, PEDIATR SURG INT, V28, P1201, DOI 10.1007/s00383-012-3215-2
   Dhingra B, 2010, INDIAN PEDIATR, V47, P487, DOI 10.1007/s13312-010-0090-6
   DITTRICH M, 1983, PEDIATR RADIOL, V13, P206, DOI 10.1007/BF00973157
   Esposito C, 2001, J PEDIATR SURG, V36, P309, DOI 10.1053/jpsu.2001.20703
   Eze CU, 2014, AFR HEALTH SCI, V14, P246, DOI 10.4314/ahs.v14i1.38
   Eze CU, 2013, AFR HEALTH SCI, V13, P384, DOI 10.4314/ahs.v13i2.27
   Ezeofor SN, 2014, NIGER J CLIN PRACT, V17, P484, DOI 10.4103/1119-3077.134046
   French J, 1996, NELSON TXB PEDIAT, P1439
   GAIRDNER D, 1971, ARCH DIS CHILD, V46, P783, DOI 10.1136/adc.46.250.783
   GOERG C, 1990, J CLIN ULTRASOUND, V18, P569, DOI 10.1002/jcu.1870180708
   Habermalz B, 2008, SURG ENDOSC, V22, P821, DOI 10.1007/s00464-007-9735-5
   Hassan ME, 2014, JSLS, V18
   Kebede Tesfaye, 2009, Ethiop Med J, V47, P49
   Kim DJ, 2014, ANN SURG TREAT RES, V86, P314, DOI 10.4174/astr.2014.86.6.314
   Konus OL, 1998, AM J ROENTGENOL, V171, P1693, DOI 10.2214/ajr.171.6.9843315
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Monclova JL, 2013, SURG ENDOSC, V27, P895, DOI 10.1007/s00464-012-2530-y
   Mahon D, 2003, ANN ROY COLL SURG, V85, P248, DOI 10.1308/003588403766274953
   Megremis SD, 2004, RADIOLOGY, V231, P129, DOI 10.1148/radiol.2311020963
   Megremis S, 2007, J ULTRAS MED, V26, P329, DOI 10.7863/jum.2007.26.3.329
   MIMOUNI F, 1985, CLIN PEDIATR, V24, P197, DOI 10.1177/000992288502400403
   MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098
   Park A, 2000, SURG ENDOSC-ULTRAS, V14, P527, DOI 10.1007/s004640000152
   Qian DH, 2014, ANZ J SURG, V84, P915, DOI 10.1111/ans.12597
   Robertson F, 2001, EUR RADIOL, V11, P80, DOI 10.1007/s003300000528
   ROCHE AF, 1986, HUM BIOL, V58, P893
   Safak AA, 2005, J ULTRAS MED, V24, P1359, DOI 10.7863/jum.2005.24.10.1359
   Sauerbrei EE, 1987, PRACTICAL GUIDE ULTR, P15
   Skeete D, 2008, SAGES MANUAL STRATEG, P387
   Tan M, 2003, WORLD J GASTROENTERO, V9, P1086
   Van Der Veken E, 2016, SURG ENDOSC, V30, P4962, DOI 10.1007/s00464-016-4838-5
   Vecchio R, 2013, UPDATES SURG-ITALY, V65, P337, DOI 10.1007/s13304-012-0186-8
   WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2
   WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P118, DOI 10.1597/1545-1569(1992)029<0118:CSMBOC>2.3.CO;2
   Walsh RM, 2004, SURG ENDOSC, V18, P272, DOI 10.1007/s00464-003-8916-0
   Wright E, 1996, STATA TECH B, V34, P24
   Wright EM, 1999, STAT METHODS MED RES, V8, P93, DOI 10.1191/096228099672225506
   ZHANG B, 1989, CLIN LAB HAEMATOL, V11, P7, DOI 10.1111/j.1365-2257.1989.tb00168.x
NR 48
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 23
PY 2018
VL 13
IS 8
AR e0202741
DI 10.1371/journal.pone.0202741
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR6TZ
UT WOS:000442800100114
PM 30138410
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Duchin, Y
   Shamir, RR
   Patriat, R
   Kim, J
   Vitek, JL
   Sapiro, G
   Harel, N
AF Duchin, Yuval
   Shamir, Reuben R.
   Patriat, Remi
   Kim, Jinyoung
   Vitek, Jerrold L.
   Sapiro, Guillermo
   Harel, Noam
TI Patient-specific anatomical model for deep brain stimulation based on 7
   Tesla MRI
SO PLOS ONE
LA English
DT Article
ID SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; SURGERY; SHIFT; ELECTRODES;
   ACCURACY; VOLUMES; AGE
AB Objective
   Deep brain stimulation (DBS) requires accurate localization of the anatomical target structure, and the precise placement of the DBS electrode within it. Ultra-high field 7 Tesla (T) MR images can be utilized to create patient-specific anatomical 3D models of the subthalamic nuclei (STN) to enhance pre-surgical DBS targeting as well as post-surgical visualization of the DBS lead position and orientation. We validated the accuracy of the 7T imaging-based patient-specific model of the STN and measured the variability of the location and dimensions across movement disorder patients.
   Methods
   72 patients who underwent DBS surgery were scanned preoperatively on 7T MRI. Segmentations and 3D volume rendering of the STN were generated for all patients. For 21 STNDBS cases, microelectrode recording (MER) was used to validate the segmentation. For 12 cases, we computed the correlation between the overlap of the STN and volume of tissue activated (VTA) and the monopolar review for a further validation of the model's accuracy and its clinical relevancy.
   Results
   We successfully reconstructed and visualized the STN in all patients. Significant variability was found across individuals regarding the location of the STN center of mass as well as its volume, length, depth and width. Significant correlations were found between MER and the 7T imaging-based model of the STN (r = 0.86) and VTA-STN overlap and the monopolar review outcome (r = 0.61).
   Conclusion
   The results suggest that an accurate visualization and localization of a patient-specific 3D model of the STN can be generated based on 7T MRI. The imaging-based 7T MRI STN model was validated using MER and patient's clinical outcomes. The significant variability observed in the STN location and shape based on a large number of patients emphasizes the importance of an accurate direct visualization of the STN for DBS targeting. An accurate STN localization can facilitate postoperative stimulation parameters for optimized patient outcome.
C1 [Duchin, Yuval; Patriat, Remi; Harel, Noam] Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.
   [Duchin, Yuval; Shamir, Reuben R.; Kim, Jinyoung] Surg Informat Sci, Minneapolis, MN USA.
   [Kim, Jinyoung; Sapiro, Guillermo] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA.
   [Kim, Jinyoung; Sapiro, Guillermo] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA.
   [Kim, Jinyoung; Sapiro, Guillermo] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Kim, Jinyoung; Sapiro, Guillermo] Duke Univ, Dept Math, Durham, NC 27706 USA.
   [Vitek, Jerrold L.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.
RP Harel, N (reprint author), Univ Minnesota, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA.
EM HAREL002@umn.edu
RI Harel, Noam/R-7391-2018
OI Harel, Noam/0000-0002-6034-3801; Patriat, Remi/0000-0003-2928-3772
FU NIH [R01-NS085188, P41 EB015894, P30 NS076408]; University of Minnesota
   Udall center [P50NS098573]
FX This study was supported by the NIH R01-NS085188; NIH P41 EB015894; P30
   NS076408 and the University of Minnesota Udall center P50NS098573. There
   was no additional external funding received for this study.
CR Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105
   Andrade-Souza Yuri M, 2005, Neurosurgery, V56, P360
   BALLESTER MAG, 2002, MED IMAGE ANAL, V6, P389
   Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059
   Colpan ME, 2010, PARKINSONISM RELAT D, V16, P398, DOI 10.1016/j.parkreldis.2010.03.008
   D'Haese PF, 2010, STEREOT FUNCT NEUROS, V88, P81, DOI 10.1159/000271823
   Daniluk S, 2010, ACTA NEUROCHIR, V152, P201, DOI 10.1007/s00701-009-0514-z
   Deuschl G, 2013, PARKINSONISM RELAT D, V19, P56, DOI 10.1016/j.parkreldis.2012.07.004
   Duchin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037328
   Elias WJ, 2007, J NEUROSURG, V107, P983, DOI 10.3171/JNS-07/11/0983
   Ellis TM, 2008, NEUROSURGERY, V63, P754, DOI 10.1227/01.NEU.0000325492.58799.35
   Gross RE, 2006, ELECTROPHYSIOLOGICAL, V21, pS259, DOI [/10.1002/mds.20960, DOI 10.1002/MDS.20960]
   Hamel W, 2017, WORLD NEUROSURG, V99, P41, DOI 10.1016/j.wneu.2016.11.012
   Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013
   Khan MF, 2008, STEREOT FUNCT NEUROS, V86, P44, DOI 10.1159/000108588
   Kim J, 2015, ROBUST PREDICTION CL, P587, DOI [10.1007/978-3-319-24571-3_70, DOI 10.1007/978-3-319-24571-3_70]
   Kim J, 2014, IEEE J BIOMED HEALTH, V18, P1678, DOI 10.1109/JBHI.2013.2292858
   Lau JC, 2018, NEUROIMAGE, V168, P141, DOI 10.1016/j.neuroimage.2016.12.066
   Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Madler B, 2012, AM J NEURORADIOL, V33, P1072, DOI 10.3174/ajnr.A2906
   Matplotlib, PYTH PLOTT MATPL 2 2
   Mavridis Ioannis, 2013, Anat Res Int, V2013, P319710, DOI 10.1155/2013/319710
   Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36
   Miyagi Y, 2007, J NEUROSURG, V107, P989, DOI 10.3171/JNS-07/11/0989
   Pallavaram S, 2015, NEUROSURGERY, V76, P756, DOI 10.1227/NEU.0000000000000714
   Pereira JLB, 2016, BASAL GANGLIA, V6, P83, DOI 10.1016/j.baga.2016.01.003
   Plantinga BR, 2018, NEUROIMAGE, V168, P403, DOI 10.1016/j.neuroimage.2016.09.023
   Python Software Foundation, PYTH LANG REF VERS 2
   Richter EO, 2004, J NEUROSURG, V100, P541, DOI 10.3171/jns.2004.100.3.0541
   Rodriguez RL, 2007, NEUROLOGIST, V13, P253, DOI 10.1097/NRL.0013018095a4d5
   Rolston JD, 2016, PARKINSONISM RELAT D, V33, P72, DOI 10.1016/j.parkreldis.2016.09.014
   Shamir RR, 2015, BRAIN STIMUL, V8, P1025, DOI 10.1016/j.brs.2015.06.003
   Sharma M, 2014, NEUROL INDIA, V62, P503, DOI 10.4103/0028-3886.144442
   StatsModels, STAT PYTH STATSM 0 9
   Todd MJ, 2007, DISCRETE APPL MATH, V155, P1731, DOI 10.1016/j.dam.2007.02.013
   Travis E. O, 2006, A GUIDE TO NUMPY
   Verhagen R, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/066009
   Wodarg F, 2012, MOVEMENT DISORD, V27, P874, DOI 10.1002/mds.25006
   Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037
   Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089
   Zaidel A, 2010, BRAIN, V133, P2007, DOI 10.1093/brain/awq144
   Zonenshayn M, 2000, NEUROSURGERY, V47, P282, DOI 10.1097/00006123-200008000-00005
NR 43
TC 4
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 22
PY 2018
VL 13
IS 8
AR e0201469
DI 10.1371/journal.pone.0201469
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR3NR
UT WOS:000442500400022
PM 30133472
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Jamnick, NA
   Botella, J
   Pyne, DB
   Bishop, DJ
AF Jamnick, Nicholas A.
   Botella, Javier
   Pyne, David B.
   Bishop, David J.
TI Manipulating graded exercise test variables affects the validity of the
   lactate threshold and (V) over dotO(2peak)
SO PLOS ONE
LA English
DT Article
ID STEADY-STATE; PHYSIOLOGICAL-RESPONSES; CYCLING PERFORMANCE; ANAEROBIC
   THRESHOLD; AEROBIC CAPACITY; SPORTS-MEDICINE; POWER OUTPUT; PEAK POWER;
   O-2 UPTAKE; INTENSITY
AB Background
   To determine the validity of the lactate threshold (LT) and maximal oxygen uptake ((V) over dotO(2max)) determined during graded exercise test (GXT) of different durations and using different LT calculations. Trained male cyclists (n = 17) completed five GXTs of varying stage length (1, 3, 4, 7 and 10 min) to establish the LT, and a series of 30-min constant power bouts to establish the maximal lactate steady state (MLSS). (V) over dotO(2) was assessed during each GXT and a subsequent verification exhaustive bout (VEB), and 14 different LTs were calculated from four of the GXTs (3, 4, 7 and 10 min)-yielding a total 56 LTs. Agreement was assessed between the highest (V) over dotO(2) measured during each GXT (V) over dotO(2peak) as well as between each LT and MLSS. (V) over dotO(2peak) and LT data were analysed using mean difference (MD) and intraclass correlation (ICC).
   Results
   The (V) over dotO(2peak) value from GXT(1) was 61.0 +/- 5.3 mL.kg(-1).min(-1) and the peak power 420 +/- 55W (mean +/- SD). The power at the MLSS was 264 +/- 39 W. (V) over dotO(2peak) from GXT(3, 4, 7, 10) underestimated (V) over dotO(2peak) by similar to 1 +/- 5 mL.kg(-1).min(-1). Many of the traditional LT methods were not valid and a newly developed Modified D-max method derived from GXT(4) provided the most valid estimate of the MLSS (MD = 1.1 W; ICC = 0.96).
   Conclusion
   The data highlight how GXT protocol design and data analysis influence the determination of both (V) over dotO(2peak) and LT. It is also apparent that (V) over dotO(2max) and LT cannot be determined in a single GXT, even with the inclusion of a VEB.
C1 [Jamnick, Nicholas A.; Botella, Javier; Bishop, David J.] Victoria Univ, Inst Hlth & Sport, Coll Sport & Exercise Sci, Melbourne, Vic, Australia.
   [Pyne, David B.] Australian Inst Sport, Canberra, ACT, Australia.
   [Pyne, David B.] Univ Canberra, Res Inst Sport & Exercise UCRISE, Canberra, ACT, Australia.
   [Bishop, David J.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia.
RP Jamnick, NA (reprint author), Victoria Univ, Inst Hlth & Sport, Coll Sport & Exercise Sci, Melbourne, Vic, Australia.
EM nicholas.jamnick@live.vu.edu.au
OI Bishop, David/0000-0002-6956-9188; Pyne, David/0000-0003-1555-5079
FU Graduate Research Office (PhD Student Budget) at Victoria University
FX Funding was provided by the Graduate Research Office (PhD Student
   Budget) at Victoria University. The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adami A, 2013, EUR J APPL PHYSIOL, V113, P2647, DOI 10.1007/s00421-013-2705-9
   Aldrich J, 1995, STAT SCI, V10, P364, DOI 10.1214/ss/1177009870
   Baldwin J, 2000, MED SCI SPORT EXER, V32, P1648
   BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020
   BEAVER WL, 1985, J APPL PHYSIOL, V59, P1936
   Beneke R, 2003, EUR J APPL PHYSIOL, V89, P95, DOI 10.1007/s00421-002-0783-1
   Bentley DJ, 2007, SPORTS MED, V37, P575, DOI 10.2165/00007256-200737070-00002
   Bentley DJ, 2001, EUR J APPL PHYSIOL, V85, P351, DOI 10.1007/s004210100452
   Berg A, 1990, Pneumologie, V44, P2
   Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003
   Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014
   Bishop D, 1998, J Sci Med Sport, V1, P171
   BLAND JM, 1986, LANCET, V1, P307
   BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558
   CAIOZZO VJ, 1982, J APPL PHYSIOL, V53, P1184
   CHENG B, 1992, INT J SPORTS MED, V13, P518, DOI 10.1055/s-2007-1021309
   COEN B, 1991, INT J SPORTS MED, V12, P519, DOI 10.1055/s-2007-1024727
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155
   Czuba M, 2009, J HUM KINET, V21, P49, DOI 10.2478/v10078-09-0006-5
   Denadai BS, 2004, BRAZ J MED BIOL RES, V37, P1551, DOI 10.1590/S0100-879X2004001000015
   Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003
   Foxdal P, 1996, INT J SPORTS MED, V17, P360, DOI 10.1055/s-2007-972861
   Gonzalez-Haro C, 2015, J STRENGTH COND RES, V29, P1040, DOI 10.1519/JSC.0000000000000741
   Granata C, 2018, SPORTS MED, P1
   Grossl T, 2012, EUR J SPORT SCI, V12, P161, DOI 10.1080/17461391.2010.551417
   Hauser T, 2014, INT J SPORTS MED, V35, P517, DOI 10.1055/s-0033-1353176
   Hauser T, 2013, INT J SPORTS MED, V34, P196, DOI 10.1055/s-0032-1321719
   HECK H, 1985, INT J SPORTS MED, V6, P117, DOI 10.1055/s-2008-1025824
   Hering GO, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00310
   Hill AV, 1924, P R SOC LOND B-CONTA, V97, P84, DOI 10.1098/rspb.1924.0045
   Hopkins W., 2015, ANAL VALIDITY LINEAR, V19, P36
   Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001
   Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278
   HUGHSON RL, 1987, J APPL PHYSIOL, V62, P1975
   IVY JL, 1980, J APPL PHYSIOL, V48, P523
   JACKSON AS, 1990, MED SCI SPORT EXER, V22, P863, DOI 10.1249/00005768-199012000-00021
   Jamnick NA, 2016, MED SCI SPORT EXER, V48, P254, DOI 10.1249/MSS.0000000000000763
   Keir DA, 2015, MED SCI SPORT EXER, V47, P1932, DOI 10.1249/MSS.0000000000000613
   Keir DA, 2014, EXP PHYSIOL, V99, P1511, DOI 10.1113/expphysiol.2014.080812
   KINDERMANN W, 1979, EUR J APPL PHYSIOL O, V42, P25, DOI 10.1007/BF00421101
   Kirkeberg JM, 2011, INT J SPORTS MED, V32, P266, DOI 10.1055/s-0030-1269914
   LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016
   Machado FA, 2012, J SPORT SCI, V30, P1267, DOI 10.1080/02640414.2012.702424
   Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x
   McNaughton LR, 2006, J STRENGTH COND RES, V20, P157
   Medicine ACoS, 2013, ACSMS GUIDELINES FOR
   Morton RH, 2012, BRIT J SPORT MED, V46, P64, DOI 10.1136/bjsm.2010.076380
   Pallares JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163389
   Pettitt RW, 2017, J APPL PHYSIOL, V123, P696, DOI 10.1152/japplphysiol.00338.2017
   Pettitt RW, 2013, J STRENGTH COND RES, V27, P549, DOI 10.1519/JSC.0b013e31825770d7
   Poole DC, 2017, J APPL PHYSIOL, V122, P997, DOI 10.1152/japplphysiol.01063.2016
   Riebe D, 2015, MED SCI SPORT EXER, V47, P2473, DOI 10.1249/MSS.0000000000000664
   SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285
   Smekal G, 2012, EUR J APPL PHYSIOL, V112, P3079, DOI 10.1007/s00421-011-2283-7
   Van Schuylenbergh R, 2004, INT J SPORTS MED, V25, P403, DOI 10.1055/s-2004-819942
   WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004
   WHIPP BJ, 1989, RESP PHYSIOL, V76, P357, DOI 10.1016/0034-5687(89)90076-5
   Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b013e318054e304
   ZOLADZ JA, 1995, J PHYSIOL-LONDON, V488, P211, DOI 10.1113/jphysiol.1995.sp020959
NR 61
TC 9
Z9 9
U1 2
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 30
PY 2018
VL 13
IS 7
AR e0199794
DI 10.1371/journal.pone.0199794
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO7MT
UT WOS:000440251600006
PM 30059543
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Achamrah, N
   Colange, G
   Delay, J
   Rimbert, A
   Folope, V
   Petit, A
   Grigioni, S
   Dechelotte, P
   Coeffier, M
AF Achamrah, Najate
   Colange, Guillaume
   Delay, Julie
   Rimbert, Agnes
   Folope, Vanessa
   Petit, Andre
   Grigioni, Sebastien
   Dechelotte, Pierre
   Coeffier, Moise
TI Comparison of body composition assessment by DXA and BIA according to
   the body mass index: A retrospective study on 3655 measures
SO PLOS ONE
LA English
DT Article
ID BIOELECTRICAL-IMPEDANCE ANALYSIS; X-RAY ABSORPTIOMETRY;
   ANOREXIA-NERVOSA; OBESE WOMEN; PHASE-ANGLE; WEIGHT-LOSS; BIOIMPEDANCE;
   WATER; OVERWEIGHT; PREDICTION
AB Background and aims
   Body composition assessment is often used in clinical practice for nutritional evaluation and monitoring. The standard method, dual-energy X-ray absorptiometry (DXA), is hardly feasible in routine clinical practice contrary to Bioelectrical Impedance Analysis (BIA) method. We thus aimed to compare body composition assessment by DXA and BIA according to the body mass index (BMI) in a large cohort.
   Methods
   Retrospectively, we analysed DXA and BIA measures in patients followed in a Nutrition Unit from 2010 to 2016. Body composition was assessed under standardized conditions in the morning, after a fasting period of 12 h, by DXA (Lunar Prodigy Advance) and BIA (Bodystat QuadScan 4000, Manufacturer's equation). Bland-Altman test was performed for each class of BMI (kg/m(2)) and fat mass and fat free mass values were compared using Kruskal-Wallis test. Pearson correlations were also performed and the concordance coefficient of Lin was calculated.
   Results
   Whatever the BMI, BIA and DXA methods reported higher concordance for values of FM than FFM. Body composition values were very closed for patients with BMI between 16 and 18,5 (difference < 1kg). For BMI > 18,5 and BMI < 40, BIA overestimated fat free mass from 3,38 to 8,28 kg, and underestimated fat mass from 2,51 to 5,67 kg compared with DXA method. For BMI >= 40, differences vary with BMI. For BMI < 16, BIA underestimated fat free mass by 2,25 kg, and overestimated fat mass by 2,57 kg. However, limits of agreement were very large either for FM and FFM values, irrespective of BMI.
   Conclusion
   The small bias, particularly in patients with BMI between 16 and 18, suggests that BIA and DXA methods are interchangeable at a population level. However, concordance between BIA and DXA methods at the individual level is lacking, irrespective of BMI.
C1 [Achamrah, Najate; Colange, Guillaume; Delay, Julie; Rimbert, Agnes; Folope, Vanessa; Petit, Andre; Grigioni, Sebastien; Dechelotte, Pierre; Coeffier, Moise] Rouen Univ, Nutr Dept, Hosp Ctr, Rouen, France.
   [Achamrah, Najate; Rimbert, Agnes; Folope, Vanessa; Petit, Andre; Grigioni, Sebastien; Dechelotte, Pierre; Coeffier, Moise] Normandie Univ, URN, Nutr Inflammat & Dysfonct Axe Intestin Cerveau, IRIB,INSERM,UMR 1073, Rouen, France.
   [Achamrah, Najate; Dechelotte, Pierre; Coeffier, Moise] INSERM, Clin Invest Ctr CIC 1404, Rouen, France.
   [Achamrah, Najate; Dechelotte, Pierre; Coeffier, Moise] Rouen Univ Hosp, Rouen, France.
RP Achamrah, N (reprint author), Rouen Univ, Nutr Dept, Hosp Ctr, Rouen, France.; Achamrah, N (reprint author), Normandie Univ, URN, Nutr Inflammat & Dysfonct Axe Intestin Cerveau, IRIB,INSERM,UMR 1073, Rouen, France.
EM najate.achamrah@chu-rouen.fr
CR Aguera Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143012
   Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7
   Battle DE, 2013, CODAS, V25, P191
   Bedogni G, 2003, EUR J CLIN NUTR, V57, P1068, DOI 10.1038/sj.ejcn.1601643
   Bosaeus M, 2014, CLIN NUTR, V33, P471, DOI 10.1016/j.clnu.2013.06.017
   Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5
   Demura S, 2005, J SPORT MED PHYS FIT, V45, P68
   DEURENBERG P, 1991, INT J OBESITY, V15, P17
   DEURENBERG P, 1995, BRIT J NUTR, V73, P349, DOI 10.1079/BJN19950038
   Deurenberg P, 1996, AM J CLIN NUTR, V64, P449
   dos Santos L, 2016, EUR J CLIN NUTR, V70, P1408, DOI 10.1038/ejcn.2016.124
   Ellegard L, 2016, EUR J CLIN NUTR, V70, P1181, DOI 10.1038/ejcn.2016.50
   Francis P, 2017, BIOGERONTOLOGY
   Gaba A, 2015, J HUM NUTR DIET, V28, P390, DOI 10.1111/jhn.12257
   Genton L, 2017, CLIN NUTR
   Gonzalez MC, 2016, AM J CLIN NUTR, V103, P712, DOI 10.3945/ajcn.115.116772
   Kent E, 2013, OBSTET GYNECOL, V121, P46, DOI [http://10.1097/AOG.0b013e31827a0052, 10.1097/AOG.0b013e31827a0052]
   Kohrt WM, 1998, J APPL PHYSIOL, V84, P372
   Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012
   Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004
   Leahy S, 2012, EUR J APPL PHYSIOL, V112, P589, DOI 10.1007/s00421-011-2010-4
   Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23
   Lemos T, 2017, CURR OPIN ENDOCRINOL, V24, P310, DOI 10.1097/MED.0000000000000360
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Marra M, 2009, EUR J CLIN NUTR, V63, P905, DOI 10.1038/ejcn.2008.54
   Marra M, 2017, CLIN NUTR
   Mattar L, 2011, CLIN NUTR, V30, P746, DOI 10.1016/j.clnu.2011.05.012
   Mattar L, 2011, NUTR RES REV, V24, P39, DOI 10.1017/S0954422410000284
   Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283
   Neovius M, 2006, OBESITY, V14, P1731, DOI 10.1038/oby.2006.199
   Panotopoulos G, 2001, MED SCI SPORT EXER, V33, P665
   Partik BL, 2002, INVEST RADIOL, V37, P489, DOI 10.1097/00004424-200209000-00003
   Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241
   Peterson SJ, 2016, NUTR CLIN PRACT, V31, P40, DOI 10.1177/0884533615622537
   Piccoli A, 2005, JPEN-PARENTER ENTER, V29, P148, DOI 10.1177/0148607105029003148
   Prior BM, 1997, J APPL PHYSIOL, V83, P623
   Raimann JG, 2014, KIDNEY INT, V85, P898, DOI 10.1038/ki.2013.358
   Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049
   Scalfi L, 1997, BRIT J NUTR, V78, P357, DOI 10.1079/BJN19970156
   Scalfi L, 1999, INT J OBESITY, V23, P133, DOI 10.1038/sj.ijo.0800780
   Shafer KJ, 2009, NUTRITION, V25, P25, DOI 10.1016/j.nut.2008.07.004
   STEWART SP, 1993, BRIT J NUTR, V69, P645, DOI 10.1079/BJN19930066
   Thomson R, 2007, CLIN NUTR, V26, P771, DOI 10.1016/j.clnu.2007.08.003
   Thurlow S, 2017, EUR J CLIN NUTR
   Vassilev G, 2017, OBES SURG, V27, P665, DOI 10.1007/s11695-016-2315-9
   Verdich C, 2011, DIABETES METAB, V37, P222, DOI 10.1016/j.diabet.2010.10.007
   WAKI M, 1991, AM J PHYSIOL, V261, pE199
NR 47
TC 5
Z9 5
U1 2
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 12
PY 2018
VL 13
IS 7
AR e0200465
DI 10.1371/journal.pone.0200465
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM8FT
UT WOS:000438457400061
PM 30001381
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Senaras, C
   Niazi, MKK
   Sahiner, B
   Pennell, MP
   Tozbikian, G
   Lozanski, G
   Gurcan, MN
AF Senaras, Caglar
   Niazi, Muhammad Khalid Khan
   Sahiner, Berkman
   Pennell, Michael P.
   Tozbikian, Gary
   Lozanski, Gerard
   Gurcan, Metin N.
TI Optimized generation of high-resolution phantom images using cGAN:
   Application to quantification of Ki67 breast cancer images
SO PLOS ONE
LA English
DT Article
AB In pathology, Immunohistochemical staining (IHC) of tissue sections is regularly used to diagnose and grade malignant tumors. Typically, IHC stain interpretation is rendered by a trained pathologist using a manual method, which consists of counting each positively- and negatively-stained cell under a microscope. The manual enumeration suffers from poor reproducibility even in the hands of expert pathologists. To facilitate this process, we propose a novel method to create artificial datasets with the known ground truth which allows us to analyze the recall, precision, accuracy, and intra- and inter-observer variability in a systematic manner, enabling us to compare different computer analysis approaches. Our method employs a conditional Generative Adversarial Network that uses a database of Ki67 stained tissues of breast cancer patients to generate synthetic digital slides. Our experiments show that synthetic images are indistinguishable from real images. Six readers (three pathologists and three image analysts) tried to differentiate 15 real from 15 synthetic images and the probability that the average reader would be able to correctly classify an image as synthetic or real more than 50% of the time was only 44.7%.
C1 [Senaras, Caglar; Niazi, Muhammad Khalid Khan; Gurcan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.
   [Sahiner, Berkman] US FDA, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.
   [Pennell, Michael P.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA.
   [Tozbikian, Gary; Lozanski, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.
RP Senaras, C (reprint author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.
EM csenaras@wakehealth.edu
RI Sahiner, Berkman/Z-1134-2018
OI senaras, caglar/0000-0003-4211-4367
FU National Cancer Institute [R01CA134451, U24CA199374]
FX The project described was supported in part by Awards Number R01CA134451
   (Pls: Gurcan, Lozanski), U24CA199374 (PI: Gurcan) from the National
   Cancer Institute. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Cancer Institute, the National Institute of Allergy and
   Infectious Diseases, or the National Institutes of Health.
CR BLAND JM, 1986, LANCET, V1, P307
   Bojarski Mariusz, 2016, ARXIV160407316
   Cheikh BB, 2017, SPIE MED IMAGING
   Di Cataldo S, 2010, COMPUT METH PROG BIO, V100, P1, DOI 10.1016/j.cmpb.2010.02.002
   Fauzi MFA, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0235-6
   Goodfellow I., 2014, ADV NEURAL INFORM PR
   Isola P., 2016, ARXIV161107004
   Kingma D., 2014, ARXIV14126980
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   loffe S., 2015, ARXIV150203167
   Maas A. L., 2013, P ICML
   Niazi K, NUCL IHC ENUMERATION
   Niazi M. K. K., 2017, INTERACTIVE IM UNPUB
   Niazi MKK, 2014, SPIE MED IMAGING
   Niazi MKK, 2013, SPIE MED IMAGING
   Reid MD, 2015, MODERN PATHOL, V28, P686, DOI 10.1038/modpathol.2014.156
   Ronneberger O., 2015, INT C MED IM COMP CO
   Shen D., 2017, ANN REV BIOMEDICAL E
   Szegedy C., 2016, P IEEE C COMP VIS PA
   Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x
   Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615
   Wang X., 2016, EUR C COMP VIS
   Zaha DC, 2014, WORLD J CLIN ONCOL, V5, P382, DOI 10.5306/wjco.v5.i3.382
NR 23
TC 0
Z9 0
U1 2
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2018
VL 13
IS 5
AR e0196846
DI 10.1371/journal.pone.0196846
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF2GV
UT WOS:000431757400045
PM 29742125
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Herrero-Huerta, M
   Lindenbergh, R
   Rodriguez-Gonzalvez, P
AF Herrero-Huerta, Monica
   Lindenbergh, Roderik
   Rodriguez-Gonzalvez, Pablo
TI Automatic tree parameter extraction by a Mobile LiDAR System in an urban
   context
SO PLOS ONE
LA English
DT Article
ID DIAMETER ESTIMATION; BASE HEIGHT; LASER; AIRBORNE; TOOL
AB In an urban context, tree data are used in city planning, in locating hazardous trees and in environmental monitoring. This study focuses on developing an innovative methodology to automatically estimate the most relevant individual structural parameters of urban trees sampled by a Mobile LiDAR System at city level. These parameters include the Diameter at Breast Height (DBH), which was estimated by circle fitting of the points belonging to different height bins using RANSAC. In the case of non-circular trees, DBH is calculated by the maximum distance between extreme points. Tree sizes were extracted through a connectivity analysis. Crown Base Height, defined as the length until the bottom of the live crown, was calculated by voxelization techniques. For estimating Canopy Volume, procedures of mesh generation and alpha-shape methods were implemented. Also, tree location coordinates were obtained by means of Principal Component Analysis. The workflow has been validated on 29 trees of different species sampling a stretch of road 750 m long in Delft (The Netherlands) and tested on a larger dataset containing 58 individual trees. The validation was done against field measurements. DBH parameter had a correlation R-2 value of 0.92 for the height bin of 20 cm which provided the best results. Moreover, the influence of the number of points used for DBH estimation, considering different height bins, was investigated. The assessment of the other inventory parameters yield correlation coefficients higher than 0.91. The quality of the results confirms the feasibility of the proposed methodology, providing scalability to a comprehensive analysis of urban trees.
C1 [Herrero-Huerta, Monica; Lindenbergh, Roderik] Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands.
   [Herrero-Huerta, Monica; Rodriguez-Gonzalvez, Pablo] Univ Salamanca, Higher Polytech Sch Avila, TIDOP Res Grp, Avila, Spain.
   [Herrero-Huerta, Monica] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.
   [Rodriguez-Gonzalvez, Pablo] Univ Leon, Dept Min Technol Topog & Struct, Ponferrada, Spain.
RP Herrero-Huerta, M (reprint author), Delft Univ Technol, Dept Geosci & Remote Sensing, Delft, Netherlands.; Herrero-Huerta, M (reprint author), Univ Salamanca, Higher Polytech Sch Avila, TIDOP Res Grp, Avila, Spain.; Herrero-Huerta, M (reprint author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.
EM monicaherrero@usal.es
RI Rodriguez-Gonzalvez, Pablo/H-8820-2015
OI Rodriguez-Gonzalvez, Pablo/0000-0002-2657-813X; Lindenbergh,
   Roderik/0000-0001-8655-5266; Herrero-Huerta, Monica/0000-0002-4134-557X
FU FP7 project IQmulus [FP7-ICT-2011-318787]
FX The research is partly funded by the FP7 project IQmulus
   (FP7-ICT-2011-318787), aiming at the design and implementation of a high
   volume fusion and analysis Platform for geospatial point clouds,
   coverages and volumetric data sets.
CR Aldoma A, 2012, IEEE ROBOT AUTOM MAG, V19, P80, DOI 10.1109/MRA.2012.2206675
   Attene M, 2010, VISUAL COMPUT, V26, P1393, DOI 10.1007/s00371-010-0416-3
   Barnhart HX, 2002, BIOMETRICS, V58, P1020, DOI 10.1111/j.0006-341X.2002.01020.x
   Bohm J, 2016, INT ARCH PHOTOGRAMM, V41, P301, DOI 10.5194/isprsarchives-XLI-B3-301-2016
   Branch J, 2007, THIRD INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P727
   Bucksch A, 2014, IEEE GEOSCI REMOTE S, V11, P1056, DOI 10.1109/LGRS.2013.2285471
   Chen CC, 2013, COMPUT STAT DATA AN, V60, P132, DOI 10.1016/j.csda.2012.11.004
   Cignoni P., 2008, ERCIM NEWS, V73, P45, DOI DOI 10.2312/L0CALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPC0NF2008/129-136
   EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635
   Evans DL, 2006, FOREST CHRON, V82, P211, DOI 10.5558/tfc82211-2
   Fan YZ, 2008, LINEAR MULTILINEAR A, V56, P381, DOI 10.1080/03081080701306589
   Fensham RJ, 2002, AUST J BOT, V50, P415, DOI 10.1071/BT01032
   Forsman M, 2016, FORESTS, V7, DOI 10.3390/f7090206
   Gel YR, 2008, ECON LETT, V99, P30, DOI 10.1016/j.econlet.2007.05.022
   Golias NA, 1997, FINITE ELEM ANAL DES, V25, P331, DOI 10.1016/S0168-874X(96)00054-6
   GREY G. M., 1978, URBAN FORESTRY
   Henning JG, 2006, PHOTOGRAMM ENG REM S, V72, P1349, DOI 10.14358/PERS.72.12.1349
   Holopainen M., 2011, REMOTE SENSING SPATI, V3812, P91, DOI DOI 10.5194/ISPRSARCHIVES-XXXVIII-5-W12-91-2011
   Holopainen M, 2011, SILVI LASER 2011
   Jolliffe I. T., 2002, PRINCIPAL COMPONENT, P78
   Jung SE, 2011, REMOTE SENS-BASEL, V3, P2346, DOI 10.3390/rs3112346
   Kauffman JB, 2016, PROTOCOLS MEASUREMEN
   Lauterbach HA, 2015, REMOTE SENS-BASEL, V7, P13753, DOI 10.3390/rs71013753
   Leica Geosystems, 2011, SPEC LEIC SCANSTATIO
   Liang XL, 2014, IEEE T GEOSCI REMOTE, V52, P1739, DOI 10.1109/TGRS.2013.2253783
   Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lindenbergh RC, 2015, INT ARCH PHOTOGRAMM, V40-3, P589, DOI 10.5194/isprsarchives-XL-3-W3-589-2015
   Maguya AS, 2015, REMOTE SENS-BASEL, V7, P8950, DOI [10.3390/rs70708950, 10.3390/rs7078950]
   Moskal LM, 2012, REMOTE SENS-BASEL, V4, P1, DOI 10.3390/rs4010001
   Nikolov N, 2003, ENVIRON POLLUT, V124, P231, DOI 10.1016/S0269-7491(02)00471-2
   Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142
   Pope A.J., 1976, NOAA TECH REP, P133
   Popescu SC, 2008, REMOTE SENS ENVIRON, V112, P767, DOI 10.1016/j.rse.2007.06.011
   Raumonen P, 2013, REMOTE SENS-BASEL, V5, P491, DOI 10.3390/rs5020491
   Roberts M, 2015, EVALUATING TREE GROW
   Rodriguez-Gonzalvez P, 2015, IET SCI MEAS TECHNOL, V9, P505, DOI 10.1049/iet-smt.2014.0053
   RODRIGUEZGONZALVEZ, 2015, 3D VIRT REC VIS, V40, P17, DOI DOI 10.5194/ISPRSARCHIVES-XL-5-W4-17-2015
   Rusu R. B., 2011, 2011 IEEE INT C ROB
   Schnabel R, 2007, COMPUT GRAPH FORUM, V26, P214, DOI 10.1111/j.1467-8659.2007.01016.x
   Srinivasan S, 2015, REMOTE SENS-BASEL, V7, P1877, DOI 10.3390/rs70201877
   Toschi I, 2015, INT ARCH PHOTOGRAMM, V40-5, P245, DOI 10.5194/isprsarchives-XL-5-W4-245-2015
   van Leeuwen M, 2010, EUR J FOREST RES, V129, P749, DOI 10.1007/s10342-010-0381-4
   Wang J., 2017, SCALABLE INFORM EXTR
   Wu B, 2013, REMOTE SENS-BASEL, V5, P584, DOI 10.3390/rs5020584
   Young M., 2000, OPTICS LASERS INCLUD
   Zhang CY, 2012, PHOTOGRAMM ENG REM S, V78, P1079, DOI 10.14358/PERS.78.10.1079
NR 47
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 24
PY 2018
VL 13
IS 4
AR e0196004
DI 10.1371/journal.pone.0196004
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD7GN
UT WOS:000430678800022
PM 29689076
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Simko, I
   Hayes, RJ
AF Simko, Ivan
   Hayes, Ryan J.
TI Accuracy, reliability, and timing of visual evaluations of decay in
   fresh-cut lettuce
SO PLOS ONE
LA English
DT Article
ID SHELF-LIFE; ROMAINE LETTUCE; ICEBERG LETTUCE; BREEDING LINES;
   RESISTANCE; SYMPTOMS; QUALITY; ASSESSMENTS; PERFORMANCE; SEVERITY
AB Visual assessments are used for evaluating the quality of food products, such as fresh-cut lettuce packaged in bags with modified atmosphere. We have compared the accuracy and the reliability of visual evaluations of decay on fresh-cut lettuce performed with experienced and inexperienced raters. In addition, we have analyzed decay data from over 4.5 thousand bags to determine the optimum timing for evaluations to detect differences among accessions. Lin's concordance coefficient (rho(c)) that takes into consideration both the closeness of the data and the conformance to the identity line showed high repeatability (intra-rater reliability, rho(c) = 0.97), reproducibility (inter-rater reliability, rho(c) = 0.92), and accuracy (rho(c) = 0.96) for experienced raters. Inexperienced raters did not perform as well and their ratings showed decreased repeatability (rho(c) = 0.93), but even larger reduction in reproducibility (rho(c) = 0.80) and accuracy (rho(c) = 0.90). We have detected that 5.3% of ratings were outside of the 95% limits of agreement. These under-or overestimates were predominantly found for bags with intermediate levels of decay, which corresponds to the middle of the rating scale. This occurs because intermediate amounts of decay are more difficult to discriminate than extremes. The frequencies of aberrant ratings for experienced raters ranged from 0.6% to 4.4% (mean = 2.1%), for inexperienced raters the frequencies were substantially higher, ranging from 6.1% to 15.6% (mean = 9.4%). Therefore, we recommend that new raters receive training that includes practical examples in this range of decay, use of standard area diagrams, and continuing interaction with experienced raters (consultation during actual rating). Very high agreement among experienced raters indicate that visual ratings can be successfully used for evaluations of decay, until a more objective, rapid, and affordable method is developed. We recommend evaluating samples at multiple time points until 42 days after processing (about 80% decay on average) and then combining these individual ratings into the area under the decay progress stairs (AUDePS) score. Applying this approach, experienced evaluators can accurately detect difference among lettuce accessions and identify lettuce cultivars with reduced decay.
C1 [Simko, Ivan] ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA.
   [Hayes, Ryan J.] USDA, Natl Forage Seed Prod Res Ctr, Corvallis, OR USA.
RP Simko, I (reprint author), ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA.
EM ivan.simko@ars.usda.gov
RI Simko, Ivan/N-4033-2019
OI Simko, Ivan/0000-0002-8769-8477
CR Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2
   [Anonymous], 2015, MONTEREY COUNTY CROP
   Bardsley SJ, 2013, PLANT PATHOL, V62, P460, DOI 10.1111/j.1365-3059.2012.02651.x
   Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122
   BLAND JM, 1986, LANCET, V1, P307
   Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285
   Bock CH, 2009, PLANT DIS, V93, P412, DOI 10.1094/PDIS-93-4-0412
   Everitt B. S., 2010, CAMBRIDGE DICT STAT
   Glaser L. K., 2001, AGR INFORM B, V767
   Hayes RJ, 2016, ACTA HORTIC, V1141, P65, DOI 10.17660/ActaHortic.2016.1141.7
   Hayes R. J., 2017, COMPENDIUM LETTUCE D, P1
   Hayes RJ, 2008, J AM SOC HORTIC SCI, V133, P228
   Hayes RJ, 2014, J AM SOC HORTIC SCI, V139, P388
   Hayes RJ, 2014, HORTSCIENCE, V49, P18
   Hayes RJ, 2011, HORTSCIENCE, V46, P501
   HORSFALL JG, 1945, PHYTOPATHOLOGY, V35, P655
   Kim JG, 2005, J SCI FOOD AGR, V85, P1622, DOI 10.1002/jsfa.2158
   Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Nita M, 2003, PHYTOPATHOLOGY, V93, P995, DOI 10.1094/PHYTO.2003.93.8.995
   NUTTER FW, 1993, PHYTOPATHOLOGY, V83, P806
   NUTTER FW, 1995, CAN J PLANT PATHOL, V17, P174, DOI 10.1080/07060669509500709
   Simko I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01985
   Simko I, 2015, POSTHARVEST BIOL TEC, V106, P44, DOI 10.1016/j.postharvbio.2015.04.007
   Simko I, 2014, CSSA SPEC PUBL, V33, P53, DOI 10.2135/cssaspecpub33.c4
   Simko I, 2014, HORTSCIENCE, V49, P679
   Simko I, 2012, CROP SCI, V52, P2131, DOI 10.2135/cropsci2012.02.0111
   Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216
   Simko I, 2010, HORTSCIENCE, V45, P670
   Smyth AB, 1998, J AGR FOOD CHEM, V46, P4556, DOI 10.1021/jf980208s
   Toivonen P. M. A., 2009, MODIFIED CONTROLLED, P463
   Tudela JA, 2016, POSTHARVEST BIOL TEC, V120, P36, DOI 10.1016/j.postharvbio.2016.05.009
   Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003
   Yadav NVS, 2013, PLANT PATHOL, V62, P325, DOI 10.1111/j.1365-3059.2012.02641.x
   Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908
   Zhang FZ, 2007, J EXP BOT, V58, P1433, DOI 10.1093/jxb/erm006
NR 36
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2018
VL 13
IS 4
AR e0194635
DI 10.1371/journal.pone.0194635
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD1LV
UT WOS:000430262300008
PM 29664945
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Weinstein, JR
   Thompson, LM
   Artiga, AD
   Bryan, JP
   Arriaga, WE
   Omer, SB
   McCracken, JP
AF Weinstein, John R.
   Thompson, Lisa M.
   Diaz Artiga, Anaite
   Bryan, Joe P.
   Arriaga, William E.
   Omer, Saad B.
   McCracken, John P.
TI Determining gestational age and preterm birth in rural Guatemala: A
   comparison of methods
SO PLOS ONE
LA English
DT Article
ID LAST MENSTRUAL PERIOD; ULTRASOUND; BORN; PREMATURE; SCORE
AB Background
   Preterm birth is the leading cause of death among children <5 years of age. Accurate determination of prematurity is necessary to provide appropriate neonatal care and guide preventive measures. To estimate the most accurate method to identify infants at risk for adverse outcomes, we assessed the validity of two widely available methods-last menstrual period (LMP) and the New Ballard (NB) neonatal assessment-against ultrasound in determining gestational age and preterm birth in highland Guatemala.
   Methods
   Pregnant women (n = 188) were recruited with a gestational age <20 weeks and followed until delivery. Ultrasound was performed by trained physicians and LMP was collected during recruitment. NB was performed on infants within 96 hours of birth by trained study nurses. LMP and NB accuracy at determining gestational age and identifying prematurity was assessed by comparing them to ultrasound.
   Results
   By ultrasound, infant mean gestational age at birth was 38.3 weeks (SD = 1.6) with 16% born at less than 37 gestation. LMP was more accurate than NB (mean difference of +0.13 weeks for LMP and +0.61 weeks for NB). However, LMP and NB estimates had low agreement with ultrasound-determined gestational age (Lin's concordance<0.48 for both methods) and preterm birth (kappa<0.29 for both methods). By LMP, 18% were judged premature compared with 6% by NB. LMP underestimated gestational age among women presenting later to prenatal care (0.18 weeks for each additional week). Gestational age for preterm infants was overestimated by nearly one week using LMP and nearly two weeks using NB. New Ballard neuromuscular measurements were more predictive of preterm birth than those measuring physical criteria.
   Conclusion
   In an indigenous population in highland Guatemala, LMP overestimated prematurity by 2% and NB underestimated prematurity by 10% compared with ultrasound estimates. New, simple and accurate methods are needed to identify preterm birth in resource-limited settings worldwide.
C1 [Weinstein, John R.; Thompson, Lisa M.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.
   [Diaz Artiga, Anaite; McCracken, John P.] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala.
   [Bryan, Joe P.] Ctr Dis Control & Prevent, Cent Amer Reg Off, Guatemala City, Guatemala.
   [Bryan, Joe P.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA.
   [Arriaga, William E.] Minist Salud Publ & Asistencia Social, Quetzaltenango, Guatemala.
   [Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Weinstein, John R.] Boston Univ, Sch Med, Boston, MA 02118 USA.
   [Thompson, Lisa M.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.
RP Thompson, LM (reprint author), Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.; Thompson, LM (reprint author), Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.
EM lisa.thompson@emory.edu
RI Thompson, Lisa/H-2059-2019
OI Thompson, Lisa/0000-0002-8001-2057; Weinstein, John/0000-0003-1349-5404
FU US Centers for Disease Control and Prevention [1U01GH001003]
FX This work was funded by the US Centers for Disease Control and
   Prevention through Cooperative Agreement 1U01GH001003.; This work was
   funded by the US Centers for Disease Control and Prevention through
   Cooperative Agreement 1U01GH001003 to SBO. The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be
   [Anonymous], 2015, TERRITORIAL EPIDEMIO, P2
   Ashish KC, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0361-4
   BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Bernart C, 2014, 63 ANN M AM SOC TROP
   BLAND JM, 1986, LANCET, V1, P307
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   COHEN J, 1986, 200 SOC BEHAV SCI, P18
   Dansereau E, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1018-5
   DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5
   Eregie CO, 2000, J TROP PEDIATRICS, V46, P140, DOI 10.1093/tropej/46.3.140
   Feresu S A, 2003, Cent Afr J Med, V49, P47
   Feresu S A, 2003, Cent Afr J Med, V49, P97
   Gernand AD, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0072-y
   Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X
   HENRIKSEN TB, 1995, EPIDEMIOLOGY, V6, P533, DOI 10.1097/00001648-199509000-00012
   Hoffman CS, 2008, PAEDIATR PERINAT EP, V22, P587, DOI 10.1111/j.1365-3016.2008.00965.x
   Howson C. P., 2012, BORN TOO SOON GLOBAL
   Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP DAT VIS
   Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030
   Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI [10.1186/1471-2393-S1-S1, 10.1186/1471-2393-10-S1-S1]
   Lee ACC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3303
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x
   Neufeld LM, 2006, PAEDIATR PERINAT EP, V20, P290, DOI 10.1111/j.1365-3016.2006.00741.x
   Noble KG, 2012, PEDIATRICS, V130, pE257, DOI 10.1542/peds.2011-2157
   Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448
   Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60
   Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332
   Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601
   Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504
   Sunjoh F, 2004, J TROP PEDIATRICS, V50, P285, DOI 10.1093/tropej/50.5.285
   Thawani R, 2013, J HEALTH POPUL NUTR, V31, P523
   Thompson LM, 2014, HEALTH CARE WOMEN IN, V35, P216, DOI 10.1080/07399332.2013.829066
   Word Health Organization. Media Centre, 2017, PRET BIRTH FACT SHEE
   Zhang X, 2009, J PEDIATR-US, V154, P358, DOI 10.1016/j.jpeds.2008.09.013
NR 38
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2018
VL 13
IS 3
AR e0193666
DI 10.1371/journal.pone.0193666
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ7QU
UT WOS:000427796800012
PM 29554145
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gomez-Campos, R
   Andruske, CL
   de Arruda, M
   Albornoz, CU
   Cossio-Bolanos, M
AF Gomez-Campos, Rossana
   Andruske, Cynthia Lee
   de Arruda, Miguel
   Albornoz, Camilo Urra
   Cossio-Bolanos, Marco
TI Proposed equations and reference values for calculating bone health in
   children and adolescent based on age and sex
SO PLOS ONE
LA English
DT Article
ID CONCORDANCE CORRELATION-COEFFICIENT; MINERAL DENSITY; BRAZILIAN
   CHILDREN; LUMBAR SPINE; PUBERTY; REGRESSION; CHILDHOOD; CURVES; GROWTH;
   MASS
AB Background
   The Dual Energy X-Ray Absorptiometry (DXA) is the gold standard for measuring BMD and bone mineral content (BMC). In general, DXA is ideal for pediatric use. However, the development of specific standards for particular geographic regions limits its use and application for certain socio-cultural contexts. Additionally, the anthropometry may be a low cost and easy to use alternative method in epidemiological contexts. The goal of our study was to develop regression equations for predicting bone health of children and adolescents based on anthropometric indicators to propose reference values based on age and sex.
   Methods
   3020 students (1567 males and 1453 females) ranging in ages 4.0 to 18.9 were studied from the Maule Region (Chile). Anthropometric variables evaluated included: weight, standing height, sitting height, forearm length, and femur diameter. A total body scan (without the head) was conducted by means of the Dual Energy X-Ray Absorptiometry. Bone mineral density (BMD) and the bone mineral content (BMC) were also determined. Calcium consumption was controlled for by recording the intake of the three last days prior to the evaluation. Body Mass Index (BMI) was calculated, and somatic maturation was determined by using the years of peak growth rate (APHV).
   Results
   Four regression models were generated to calculate bone health: for males BMD = (R-2 = 0.79) and BMC = (R-2 = 0.84) and for the females BMD = (R-2 = 0.76) and BMC = (R2 = 0.83). Percentiles were developed by using the LMS method (p3, p5, p15, p25, p50, p75, p85, p95 and p97).
   Conclusions
   Regression equations and reference curves were developed to assess the bone health of Chilean children and adolescents. These instruments help identify children with potential underlying problems in bone mineralization during the growth stage and biological maturation.
C1 [Gomez-Campos, Rossana; de Arruda, Miguel; Cossio-Bolanos, Marco] Univ Estadual Campinas, Fac Phys Educ, Campinas, Chile.
   [Gomez-Campos, Rossana] Univ Autonoma Chile, Talca, Chile.
   [Andruske, Cynthia Lee] Univ Talca, Escuela Pedagog Ingies, Fac Ciencias Educ, Campus Linares, Talca, Chile.
   [Andruske, Cynthia Lee] Res Network Human Biol Dev, Arequipa, Peru.
   [Albornoz, Camilo Urra] Univ Santo Tomas, Fac Salud, Escuela Kinesiol, Talca, Chile.
   [Cossio-Bolanos, Marco] Catholic Univ Maule, Dept Phys Activ Sci, Talca, Chile.
   [Cossio-Bolanos, Marco] Univ Nacl San Agustin, Arequipa, Peru.
RP Cossio-Bolanos, M (reprint author), Univ Estadual Campinas, Fac Phys Educ, Campinas, Chile.; Cossio-Bolanos, M (reprint author), Catholic Univ Maule, Dept Phys Activ Sci, Talca, Chile.; Cossio-Bolanos, M (reprint author), Univ Nacl San Agustin, Arequipa, Peru.
EM mcossio1972@hotmail.com
OI Andruske, Cynthia Lee/0000-0001-7762-0310; Cossio-Bolanos, Marco
   Antonio/0000-0001-7230-9996
FU Conycit [1141295]
FX This work was supported by Conycit 1141295.
CR ALWIS G, 2010, ACTA PAEDIATR, V99, DOI DOI 10.1111/J.1651-2227.2010.01713.X
   Ancao MS, 2002, PROGRAMA DE APOIO
   Bachrach LK, 2005, ENDOCRIN METAB CLIN, V34, P521, DOI 10.1016/j.ecl.2005.04.001
   Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002
   Barnhart HX, 2002, BIOMETRICS, V58, P1020, DOI 10.1111/j.0006-341X.2002.01020.x
   Baroncelli GI, 2000, HORM RES, V54, P2
   BLAND JM, 1986, LANCET, V1, P307
   Boot AM, 1997, J CLIN ENDOCR METAB, V82, P57, DOI 10.1210/jc.82.1.57
   Butte NF, 2007, J NUTR, V137, P153
   Cameron N, 2004, AM J CLIN NUTR, V80, P70
   Fonseca RMC, 2008, PEDIATR EXERC SCI, V20, P40, DOI 10.1123/pes.20.1.40
   COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005
   DELRIO LD, 1994, PEDIATR RES, V35, P362
   Faulkner RA, 1996, CALCIFIED TISSUE INT, V59, P344, DOI 10.1007/s002239900138
   Fonseca ASM, 2001, BRAZ J MED BIOL RES, V34, P347, DOI 10.1590/S0100-879X2001000300008
   Gartner A, 2004, EUR J CLIN NUTR, V58, P523, DOI 10.1038/sj.ejcn.1601839
   Goncalves EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127294
   Gordon CM, 2008, J CLIN DENSITOM, V11, P43, DOI 10.1016/j.jocd.2007.12.005
   Gordon CM, 2005, CURR OPIN ENDOCRINOL, V12
   Guo B, 2013, J BONE MINER METAB, V31, P304, DOI 10.1007/s00774-012-0401-1
   Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088
   Henderson RC, 2004, DEV MED CHILD NEUROL, V46, P416, DOI 10.1017/S0012162204000672
   Kalkwarf HJ, 2007, J CLIN ENDOCR METAB, V92, P2087, DOI 10.1210/jc.2006-2553
   Khadilkar AV, 2011, BONE, V48, P810, DOI 10.1016/j.bone.2010.12.013
   Kuczmarski RJ, 2000, ADV DATA VITAL HLTH, V314
   Lin L, 2000, BIOMETRICS, V56, P324, DOI DOI 10.1111/J.0006-341X.2000.00324.X
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MILLER JZ, 1991, BONE MINER, V14, P137, DOI 10.1016/0169-6009(91)90091-D
   Minghelli B, 2013, N AM J MED SCI, V5, P653, DOI 10.4103/1947-2714.122309
   Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020
   Molgaard C, 1997, ARCH DIS CHILD, V76, P9, DOI 10.1136/adc.76.1.9
   Nakavachara P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097218
   Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005
   Ross WD, 1991, HUMAN KINETICS, P223
   RUBIN K, 1993, J PEDIATR-US, V123, P863, DOI 10.1016/S0022-3476(05)80381-6
   Silva Carla C., 2006, Arq Bras Endocrinol Metab, V50, P105, DOI 10.1590/S0004-27302006000100015
   SLINKER BK, 1985, AM J PHYSIOL, V249, pR1
   Vargas Deisi M., 2003, J. Pediatr. (Rio J.), V79, P253, DOI 10.1590/S0021-75572003000300012
   Zemel BS, 2011, J CLIN ENDOCR METAB, V96, P3160, DOI 10.1210/jc.2011-1111
NR 39
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 31
PY 2017
VL 12
IS 7
AR e0181918
DI 10.1371/journal.pone.0181918
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC3TH
UT WOS:000406761600038
PM 28759569
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Oxford, JK
   Tiedtke, JM
   Ossmann, A
   Ozbe, D
   Schultheiss, OC
AF Oxford, Jon K.
   Tiedtke, Johanna M.
   Ossmann, Anna
   Oezbe, Dominik
   Schultheiss, Oliver C.
TI Endocrine and aggressive responses to competition are moderated by
   contest outcome, gender, individual versus team competition, and
   implicit motives
SO PLOS ONE
LA English
DT Article
ID POWER MOTIVATION; TESTOSTERONE CONCENTRATIONS; HORMONAL RESPONSE;
   CORTISOL RESPONSE; SALIVARY CORTISOL; BIOSOCIAL MODEL; SEX-DIFFERENCES;
   SOCIAL SUPPORT; BEHAVIOR; DOMINANCE
AB This study examined hormonal responses to competition in relation to gender, social context, and implicit motives. Participants (N = 326) were randomly assigned to win or lose in a 10-round, virtual face-to-face competition, in same-sex individual-and team-competition contexts. Saliva samples, taken before and twice after the competition, were assayed for testosterone (T), estradiol (E), progesterone (P), and cortisol (C). Implicit needs for power (nPower) and affiliation (nAffiliation) were assessed with a picture-story exercise before the competition. Aggression was measured via the volume at which participants set noise blasts for their opponents. Men competing individually and women competing as teams showed similar T increases after winning. C was differentially associated with outcome in the team matches, with higher post-match cortisol for winning women, and an opposite effect for male teams. Analyses including implicit motives indicated that situational variables interacted with motivational needs in shaping hormonal responses to competition: in naturally cycling women, nPower predicted T increases after winning and T and E decreases after losing. In men, nPower predicted T increases after losing and decreases after winning. In male teams, nPower predicted C increases after losing, but not after winning, whereas in individual competitions, nPower was a general negative predictor of C changes in women. nAffiliation predicted P increases for women competing as teams, and P decreases for women competing individually. Aggression was higher in men, losers, and teams than in women, winners, and individuals. High aggression was associated with high baseline C in women competing individually and with low baseline C and C decreases in women competing as teams and in men generally. Our findings suggest that while situational and gender factors play a role in hormonal responses to competition, they also depend on their interplay with motivational factors. They also suggest that while aggression is strongly affected by situational factors in the context of a competition, it has no direct association with motivational and hormonal correlates of dominance (nPower, T, E) and instead is associated with (mostly) low levels of C.
C1 [Oxford, Jon K.] Southern Arkansas Univ, Behav & Social Sci, Magnolia, AR USA.
   [Tiedtke, Johanna M.; Ossmann, Anna; Oezbe, Dominik; Schultheiss, Oliver C.] Friedrich Alexander Univ, Dept Psychol, Erlangen, Germany.
RP Schultheiss, OC (reprint author), Friedrich Alexander Univ, Dept Psychol, Erlangen, Germany.
EM oliver.schultheiss@fau.de
OI Schultheiss, Oliver C./0000-0002-7892-5228
FU Alexander-von-Humboldt Foundation
FX This work was supported by the Alexander-von-Humboldt Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ALBERT DJ, 1993, NEUROSCI BIOBEHAV R, V17, P405, DOI 10.1016/S0149-7634(05)80117-4
   Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251
   Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007
   Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291
   Bateup HS, 2002, EVOL HUM BEHAV, V23, P181, DOI 10.1016/S1090-5138(01)00100-3
   BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59
   Bettencourt BA, 1996, PSYCHOL BULL, V119, P422, DOI 10.1037/0033-2909.119.3.422
   Brown SL, 2009, HORM BEHAV, V56, P108, DOI 10.1016/j.yhbeh.2009.03.022
   Carre JM, 2015, NEUROSCIENCE, V286, P171, DOI 10.1016/j.neuroscience.2014.11.029
   Carre JM, 2011, AGGRESSIVE BEHAV, V37, P489, DOI 10.1002/ab.20407
   Carre JM, 2011, PSYCHONEUROENDOCRINO, V36, P935, DOI 10.1016/j.psyneuen.2011.02.001
   Carre JM, 2009, PSYCHONEUROENDOCRINO, V34, P561, DOI 10.1016/j.psyneuen.2008.10.018
   CASHDAN E, 1995, HORM BEHAV, V29, P354, DOI 10.1006/hbeh.1995.1025
   Casto KV, 2016, HORM BEHAV, V82, P21, DOI 10.1016/j.yhbeh.2016.04.004
   Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035
   Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355
   Dyer JL, 1984, HUMAN FACTORS REV, P285
   Edwards DA, 2006, PHYSIOL BEHAV, V87, P135, DOI 10.1016/j.physbeh.2005.09.007
   Edwards DA, 2013, HORM BEHAV, V64, P153, DOI 10.1016/j.yhbeh.2013.03.003
   Edwards DA, 2009, HORM BEHAV, V56, P195, DOI 10.1016/j.yhbeh.2009.01.008
   Flinn MV, 2012, HUM NATURE-INT BIOS, V23, P68, DOI 10.1007/s12110-012-9135-y
   Geniole SN, 2017, HORM BEHAV, V92, P37, DOI 10.1016/j.yhbeh.2016.10.002
   GLADUE BA, 1989, AGGRESSIVE BEHAV, V15, P409, DOI 10.1002/1098-2337(1989)15:6<409::AID-AB2480150602>3.0.CO;2-P
   Hamilton LD, 2015, ADAPT HUM BEHAV PHYS, V1, P202, DOI 10.1007/s40750-015-0025-5
   Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7
   Hofer J, 2011, J RES PERS, V45, P219, DOI 10.1016/j.jrp.2011.02.003
   Jimenez M, 2012, PSYCHONEUROENDOCRINO, V37, P1577, DOI 10.1016/j.psyneuen.2012.02.011
   Kalin NH, 1999, J CLIN PSYCHIAT S15, V60, P478
   Kaplan NM, 2000, TXB ENDOCRINE PHYSL, P328
   Kivlighan KT, 2005, PSYCHONEUROENDOCRINO, V30, P58, DOI 10.1016/j.psyneuen.2004.05.009
   Kollner MG, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00826
   Liening SH, 2010, PHYSIOL BEHAV, V99, P8, DOI 10.1016/j.physbeh.2009.10.001
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MASON A, 1987, J PERS SOC PSYCHOL, V52, P203, DOI 10.1037/0022-3514.52.1.203
   MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x
   MAZUR A, 1985, SOC FORCES, V64, P377
   Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228
   Mazur A., 2013, HDB NEUROSOCIOLOGY, P359
   Mazur A, 2015, EVOL PSYCHOL-SER, P303, DOI 10.1007/978-3-319-12697-5_24
   McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38
   MCCLELLAND DC, 1983, J PERS SOC PSYCHOL, V44, P564, DOI 10.1037/0022-3514.44.3.564
   MICHAEL RP, 1993, AM J PRIMATOL, V30, P213, DOI 10.1002/ajp.1350300306
   MULLEN B, 1986, PERS SOC PSYCHOL B, V12, P187, DOI 10.1177/0146167286122005
   Oliveira R., 2014, NEUROSCI NEUROECON, V3, P19, DOI DOI 10.2147/NAN.S55721
   Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006
   Oxford J, 2010, EVOL HUM BEHAV, V31, P201, DOI 10.1016/j.evolhumbehav.2009.07.002
   Packard MG, 1997, NEUROREPORT, V8, P3009, DOI 10.1097/00001756-199709290-00004
   Pajer K, 2001, ARCH GEN PSYCHIAT, V58, P297, DOI 10.1001/archpsyc.58.3.297
   Panksepp J., 1998, AFFECTIVE NEUROSCIEN
   Rawolle M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00923
   READ GF, 1990, ANN NY ACAD SCI, V595, P260, DOI 10.1111/j.1749-6632.1990.tb34300.x
   SAPOLSKY RM, 1986, ENDOCRINOLOGY, V118, P1630, DOI 10.1210/endo-118-4-1630
   SAPOLSKY RM, 1985, ENDOCRINOLOGY, V116, P2273, DOI 10.1210/endo-116-6-2273
   Sapolsky RM, 2002, BEHAV ENDOCRINOLOGY, P409
   Schultheiss O.C., 2007, SOCIAL NEUROSCIENCE, P176
   Schultheiss O. C, 2007, HDB RES METHODS PERS, P322
   Schultheiss O. C., 2009, METHODS SOCIAL NEURO, P17
   Schultheiss OC, 2003, HORM BEHAV, V43, P293, DOI 10.1016/S0018-506X(03)00003-5
   Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174
   Schultheiss OC, 1999, HORM BEHAV, V36, P234, DOI 10.1006/hbeh.1999.1542
   Schultheiss OC, 2002, HORM BEHAV, V41, P195, DOI 10.1006/hbeh.2001.1745
   Schultheiss OC, 2008, MOTIVATION ACTION, P247, DOI DOI 10.1017/CBO9780511499821.011
   Schultheiss OC, 2014, SOC PERSONAL PSYCHOL, V8, P1, DOI 10.1111/spc3.12082
   Schultheiss OC, 2013, SOC PERSONAL PSYCHOL, V7, P52, DOI 10.1111/spc3.12008
   Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632
   Stanton SJ, 2007, HORM BEHAV, V52, P571, DOI 10.1016/j.yhbeh.2007.07.002
   Stanton SJ, 2009, J RES PERS, V43, P1109, DOI 10.1016/j.jrp.2009.08.002
   Stanton SJ, 2009, J RES PERS, V43, P942, DOI 10.1016/j.jrp.2009.04.001
   Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x
   TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x
   Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488
   Vongas JG, HORM BEHAV
   Wagner JD, 2002, EVOL HUM BEHAV, V23, P437, DOI 10.1016/S1090-5138(02)00100-9
   Wiemers US, 2015, HORM BEHAV, V71, P69, DOI 10.1016/j.yhbeh.2015.04.007
   WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134
   Winter D. G., 2010, IMPLICIT MOTIVES, P407, DOI DOI 10.1093/ACPROF:OSO/9780195335156.003.0014
   Winter D. G., 1994, MANUAL SCORING UNPUB
   Winter D. G., 1996, PERSONALITY ANAL INT
   Wirth M. M, 2011, FRONTIERS ENDOCRINOL, V2, P1, DOI [10.3389/fendo.2011.00019, DOI 10.3389/FENDO.2011.00019]
   Wirth MM, 2006, HORM BEHAV, V50, P786, DOI 10.1016/j.yhbeh.2006.08.003
   Wirth MM, 2006, HORM BEHAV, V49, P346, DOI 10.1016/j.yhbeh.2005.08.013
   WRANGHAM RW, 1996, DEMONIC MALES APES O
   ZUMPE D, 1989, AM J PRIMATOL, V17, P287, DOI 10.1002/ajp.1350170404
NR 83
TC 2
Z9 2
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2017
VL 12
IS 7
AR e0181610
DI 10.1371/journal.pone.0181610
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FC1CT
UT WOS:000406575700064
PM 28750061
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Costa, MC
   Tozzi, G
   Cristofolini, L
   Danesi, V
   Viceconti, M
   Dall'Ara, E
AF Costa, Maria Cristiana
   Tozzi, Gianluca
   Cristofolini, Luca
   Danesi, Valentina
   Viceconti, Marco
   Dall'Ara, Enrico
TI Micro Finite Element models of the vertebral body: Validation of local
   displacement predictions
SO PLOS ONE
LA English
DT Article
ID DIGITAL VOLUME CORRELATION; HUMAN CANCELLOUS BONE; TRABECULAR BONE;
   CORTICAL BONE; MECHANICAL-PROPERTIES; AUGMENTED VERTEBRAE;
   COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; STRAIN; TISSUE
AB The estimation of local and structural mechanical properties of bones with micro Finite Element (microFE) models based on Micro Computed Tomography images depends on the quality bone geometry is captured, reconstructed and modelled. The aim of this study was to validate microFE models predictions of local displacements for vertebral bodies and to evaluate the effect of the elastic tissue modulus on model's predictions of axial forces. Four porcine thoracic vertebrae were axially compressed in situ, in a step-wise fashion and scanned at approximately 39 mu m resolution in preloaded and loaded conditions. A global digital volume correlation (DVC) approach was used to compute the full-field displacements. Homogeneous, isotropic and linear elastic microFE models were generated with boundary conditions assigned from the interpolated displacement field measured from the DVC. Measured and predicted local displacements were compared for the cortical and trabecular compartments in the middle of the specimens. Models were run with two different tissue moduli defined from microindentation data (12.0GPa) and a back-calculation procedure (4.6GPa). The predicted sum of axial reaction forces was compared to the experimental values for each specimen. MicroFE models predicted more than 87% of the variation in the displacement measurements (R-2 = 0.87-0.99). However, model predictions of axial forces were largely overestimated (80-369%) for a tissue modulus of 12.0GPa, whereas differences in the range 10-80% were found for a back-calculated tissue modulus. The specimen with the lowest density showed a large number of elements strained beyond yield and the highest predictive errors. This study shows that the simplest microFE models can accurately predict quantitatively the local displacements and qualitatively the strain distribution within the vertebral body, independently from the considered bone types.
C1 [Costa, Maria Cristiana; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.
   [Costa, Maria Cristiana; Viceconti, Marco; Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.
   [Tozzi, Gianluca] Univ Portsmouth, Zeiss Global Ctr, Sch Engn, Portsmouth, Hants, England.
   [Cristofolini, Luca; Danesi, Valentina] Alma Mater Studiorum Univ Bologna, Sch Engn & Architecture, Bologna, Italy.
   [Viceconti, Marco] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.
RP Dall'Ara, E (reprint author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Dall'Ara, E (reprint author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.
EM e.dallara@sheffield.ac.uk
OI Dall'Ara, Enrico/0000-0003-1471-5077
FU Sheffield Hospital Charity [141515-1]; Engineering and Physical Sciences
   Research Council (MultiSim project) [EP/K03877X/1]; Royal Society
   [RG130831, RG150012]; European Society of Biomechanics (ESB mobility
   award)
FX This study was partially supported by Sheffield Hospital Charity (grant
   number: 141515-1; ED, MV; http://www.sheffieldhospitalscharity.org.uk/),
   the Engineering and Physical Sciences Research Council (MultiSim
   project, grant number: EP/K03877X/1; MV; https://www.epsrc.ac.uk/), the
   Royal Society (grant number: RG130831, GT; grant number: RG150012, ED;
   https://royalsociety.org/), and the European Society of Biomechanics
   (ESB mobility award 2014; VD; https://esbiomech.org/). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bevill G, 2009, BONE, V44, P579, DOI 10.1016/j.bone.2008.11.020
   Chen Y, 2017, J MECH BEHAV BIOMED, V65, P644, DOI 10.1016/j.jmbbm.2016.09.014
   Chen Y, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028106
   Chevalier Y, 2007, J BIOMECH, V40, P3333, DOI 10.1016/j.jbiomech.2007.05.004
   Christen D, 2014, J MECH BEHAV BIOMED, V29, P500, DOI 10.1016/j.jmbbm.2013.10.010
   Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019
   Dall'Ara E, 2012, OSTEOPOROSIS INT, V23, P563, DOI 10.1007/s00198-011-1568-3
   Dall'Ara E, 2010, J BIOMECH, V43, P2374, DOI 10.1016/j.jbiomech.2010.04.023
   Danesi V, 2016, CLIN BIOMECH, V39, P14, DOI 10.1016/j.clinbiomech.2016.07.010
   Danesi V, 2014, J BIOMECH, V47, P313, DOI 10.1016/j.jbiomech.2013.10.005
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Feng L, 2012, J BIOMECH, V45, P1775, DOI 10.1016/j.jbiomech.2012.05.001
   Fox J, 1990, MODERN METHODS DATA
   Gillard F, 2014, J MECH BEHAV BIOMED, V29, P480, DOI 10.1016/j.jmbbm.2013.09.014
   Grassi L, 2015, J MECH BEHAV BIOMED, V50, P43, DOI 10.1016/j.jmbbm.2015.06.006
   Gross T, 2012, COMPUT METHOD BIOMEC, V15, P1137, DOI 10.1080/10255842.2011.581236
   Hambli R, 2013, BONE, V56, P363, DOI 10.1016/j.bone.2013.06.028
   Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2
   Hardisty MR, 2012, J ORTHOP RES, V30, P1032, DOI 10.1002/jor.22045
   Harrison NM, 2013, BIOMECH MODEL MECHAN, V12, P225, DOI 10.1007/s10237-012-0394-7
   Hojjat SP, 2012, J BIOMECH, V45, P2342, DOI 10.1016/j.jbiomech.2012.07.004
   Homminga J, 2004, BONE, V34, P510, DOI 10.1016/j.bone.2003.12.001
   Hou FJ, 1998, J BIOMECH, V31, P1009, DOI 10.1016/S0021-9290(98)00110-9
   Hussein AI, 2012, PROC IUTAM, V4, P116, DOI 10.1016/j.piutam.2012.05.013
   Jackman TM, 2016, J BIOMECH, V49, P267, DOI 10.1016/j.jbiomech.2015.12.004
   Jackman TM, 2015, J BONE MINER RES, P1
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Ladd AJC, 1998, J ORTHOP RES, V16, P622, DOI 10.1002/jor.1100160516
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017
   Manda K, 2017, BIOMECH MODEL MECHAN, V16, P173, DOI 10.1007/s10237-016-0809-y
   Mirzaali MJ, 2016, BONE, V93, P196, DOI 10.1016/j.bone.2015.11.018
   Morgan EF, 2001, J BIOMECH ENG-T ASME, V123, P1, DOI 10.1115/1.1338122
   Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x
   Niebur GL, 2000, J BIOMECH, V33, P1575, DOI 10.1016/S0021-9290(00)00149-4
   Niebur GL, 1999, J BIOMECH ENG-T ASME, V121, P629, DOI 10.1115/1.2800865
   Pahr DH, 2012, COMPUT METHOD BIOMEC, V15, P711, DOI 10.1080/10255842.2011.556627
   Palanca M, 2017, J BIOMECH IN PRESS
   Palanca M, 2016, J BIOMECH, V49, P3882, DOI 10.1016/j.jbiomech.2016.10.018
   Rietbergen V., 2000, COMPUT SIMUL MODEL M, V1, P98
   Roberts BC, 2014, J BIOMECH, V47, P923, DOI 10.1016/j.jbiomech.2014.01.001
   Sandino C, 2015, J MECH BEHAV BIOMED, V44, P1, DOI 10.1016/j.jmbbm.2014.12.018
   Schwiedrzik J, 2016, INT J NUMER METH BIO, V32, DOI 10.1002/cnm.2739
   Schwiedrzik JJ, 2014, EXPT THEORETICAL NUM
   Sutcliffe P, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17420
   Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202
   Tozzi G, 2017, J MECH BEHAV BIOMED, V67, P117, DOI 10.1016/j.jmbbm.2016.12.006
   Ulrich D, 1998, J BIOMECH, V31, P1187, DOI 10.1016/S0021-9290(98)00118-3
   Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI [10.2106/JBJS.I.00919, 10.2106/J8JS.I.00919]
   van Rietbergen B, 1998, Technol Health Care, V6, P413
   VANRIETBERGEN B, 1995, J BIOMECH, V28, P69
   Verhulp E, 2008, J BIOMECH, V41, P1479, DOI 10.1016/j.jbiomech.2008.02.032
   Viceconti M., 2016, CAN WE TRUST MICRO F, P1
   Wolfram U, 2010, J BIOMECH, V43, P1731, DOI 10.1016/j.jbiomech.2010.02.026
   Wolfram U, 2010, BONE, V46, P348, DOI 10.1016/j.bone.2009.09.035
   Zauel R, 2006, J BIOMECH ENG-T ASME, V128, P1, DOI 10.1115/1.2146001
NR 57
TC 14
Z9 14
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 11
PY 2017
VL 12
IS 7
AR e0180151
DI 10.1371/journal.pone.0180151
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FA7TI
UT WOS:000405649400009
PM 28700618
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Coutinho, E
   Schuller, B
AF Coutinho, Eduardo
   Schuller, Bjorn
TI Shared acoustic codes underlie emotional communication in music and
   speech-Evidence from deep transfer learning
SO PLOS ONE
LA English
DT Article
ID CLASSIFICATION; RECOGNITION; EXPRESSION; DATABASE; NETWORK
AB Music and speech exhibit striking similarities in the communication of emotions in the acoustic domain, in such a way that the communication of specific emotions is achieved, at least to a certain extent, by means of shared acoustic patterns. From an Affective Sciences points of view, determining the degree of overlap between both domains is fundamental to understand the shared mechanisms underlying such phenomenon. From a Machine learning perspective, the overlap between acoustic codes for emotional expression in music and speech opens new possibilities to enlarge the amount of data available to develop music and speech emotion recognition systems. In this article, we investigate time-continuous predictions of emotion (Arousal and Valence) in music and speech, and the Transfer Learning between these domains. We establish a comparative framework including intra- (i.e., models trained and tested on the same modality, either music or speech) and cross-domain experiments (i.e., models trained in one modality and tested on the other). In the cross domain context, we evaluated two strategies the direct transfer between domains, and the contribution of Transfer Learning techniques (feature-representation-transfer based on Denoising Auto Encoders) for reducing the gap in the feature space distributions. Our results demonstrate an excellent cross-domain generalisation performance with and without feature representation transfer in both directions. In the case of music, cross-domain approaches outperformed intra-domain models for Valence estimation, whereas for Speech intra-domain models achieve the best performance. This is the first demonstration of shared acoustic codes for emotional expression in music and speech in the time-continuous domain.
C1 [Coutinho, Eduardo] Univ Liverpool, Dept Mus, Liverpool, Merseyside, England.
   [Coutinho, Eduardo; Schuller, Bjorn] Imperial Coll London, Dept Comp, London, England.
RP Coutinho, E (reprint author), Univ Liverpool, Dept Mus, Liverpool, Merseyside, England.; Coutinho, E (reprint author), Imperial Coll London, Dept Comp, London, England.
EM e.coutinho@liverpool.ac.uk
RI Coutinho, Eduardo/K-1391-2019
OI Coutinho, Eduardo/0000-0001-5234-1497
FU European Union [645378]
FX This work was partially funded by European Union's Horizon 2020
   (blipe:/ec.europa.eu/programmestorizon2020/) research and innovation
   programme under grant agreement No. 645378 (ARIA-VALUSPA) awarded to
   Bjorn Schuller.
CR Alain G, 2014, J MACH LEARN RES, V15, P3563
   Aljanaki A, 2015, WORK NOT P MED 2015, V1436
   Aljanaki A, 2014, WORK NOT P MED 2014, V1263
   Arnold Andrew, 2007, 7 IEEE INT C DAT MIN, P77, DOI DOI 10.1109/ICDMW.2007.109
   Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x
   Balkwill LL, 1999, MUSIC PERCEPT, V17, P43
   Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50
   BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918
   Brown S, 2000, ORIGINS OF MUSIC, P271
   Coutinho E, 2014, WORK NOT P MED 2014, V1263, P5
   Coutinho E, 2017, MUSIC PERCEPT, V34, P371, DOI 10.1525/MP.2017.34.4.371
   Coutinho E, 2014, IEEE IJCNN, P3592, DOI 10.1109/IJCNN.2014.6889814
   Coutinho E, 2013, COGNITION EMOTION, V27, P658, DOI 10.1080/02699931.2012.732559
   Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700
   Coutinho E, 2009, MUSIC PERCEPT, V27, P1, DOI 10.1525/MP.2009.27.1.1
   Deng J, 2013, INT CONF AFFECT, P511, DOI 10.1109/ACII.2013.90
   Douglas-Cowie E, 2007, LECT NOTES COMPUT SC, V4738, P488
   ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1016/0364-0213(90)90002-E
   Eyben Florian, 2013, P 21 ACM INT C MULT, P835, DOI [10.1145/2502081.2502224, DOI 10.1145/2502081.2502224]
   Feng Y., 2003, P 26 ANN INT ACM SIG, P375, DOI DOI 10.1145/860500.860508
   Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058
   Gabrielsson A, 2010, HDB MUSIC EMOTION TH, P367, DOI DOI 10.1093/ACPROF:0S0/9780199230143.003.0014
   Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015
   Glorot X., 2011, P 28 INT C MACH LEAR, P513
   Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042
   Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI 10.1007/978-3-642-24797-2
   Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774
   Hunter PG, 2008, COGNITION EMOTION, V22, P327, DOI 10.1080/02699930701438145
   Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319
   Ilie G, 2011, MUSIC PERCEPT, V28, P247, DOI 10.1525/MP.2011.28.3.247
   Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293
   Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008
   Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770
   Kawakami A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00311
   KIVY P, 1980, PHILOS STUD, V38, P351, DOI 10.1007/BF00419335
   Korhonen M, 2004, MODELING CONTINUOUS
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lin YC, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037683
   McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20
   Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191
   Peretz I, 2001, ANN NY ACAD SCI, V930, P153, DOI 10.1111/j.1749-6632.2001.tb05731.x
   Ranzato M., 2007, ADV NEURAL INFORM PR, V19, P1137
   Ringeval F, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1335, DOI 10.1145/2733373.2806408
   Ringeval F, 2015, PATTERN RECOGN LETT, V66, P22, DOI 10.1016/j.patrec.2014.11.007
   Ringeval Fabien, 2013, AUT FAC GEST REC FG, P1, DOI DOI 10.1109/FG.2013.6553805
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   Scherer K. R., 2013, EMOTIONAL POWER MUSI, P121, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0010
   Scherer K. R., 2001, MUSIC EMOTION THEORY, P361
   SCHERER KR, 1995, J VOICE, V9, P235, DOI 10.1016/S0892-1997(05)80231-0
   Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561
   Schuller B, 2011, 2 LECT NOT COMP SCI, V6975
   Schuller B, 2013, INTERSPEECH, P148
   Schuller B, 2010, IEEE T AFFECT COMPUT, V1, P119, DOI 10.1109/T-AFFC.2010.8
   Schuller B, 2014, INTERSPEECH, P427
   Soleymani M., 2013, P 2 ACM INT WORKSH C, P1, DOI [10.1145/2506364.2506365, DOI 10.1145/2506364.2506365]
   Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017
   Vincent P., 2008, P 25 INT C MACH LEAR, P1096, DOI DOI 10.1145/1390156.1390294
   Vincent P, 2010, J MACH LEARN RES, V11, P3371
   Weninger F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00292
   Wollmer M, 2010, IEEE J-STSP, V4, P867, DOI 10.1109/JSTSP.2010.2057200
   Wollmer M, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P597
   Wollmer M, 2011, ACM T SPEECH LANGUAG, V7, P12
   Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494
NR 63
TC 4
Z9 4
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 28
PY 2017
VL 12
IS 6
AR e0179289
DI 10.1371/journal.pone.0179289
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EZ3JT
UT WOS:000404607900019
PM 28658285
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fu, XM
   Peng, C
   Li, Z
   Liu, S
   Tan, MM
   Song, JL
AF Fu, Xiaoming
   Peng, Chun
   Li, Zan
   Liu, Shan
   Tan, Minmin
   Song, Jinlin
TI The application of multi-baseline digital close-range photogrammetry in
   three-dimensional imaging and measurement of dental casts
SO PLOS ONE
LA English
DT Article
ID MODELS
AB Objective To explore a new technique for reconstructing and measuring three-dimensional (3D) models of orthodontic plaster casts using multi-baseline digital close-range photogrammetry (MBDCRP) with a single-lens reflex camera.
   Study design Thirty sets of orthodontic plaster casts that do not exhibit severe horizontal overlap (> 2 mm) between any two teeth were recorded by a single-lens reflex camera with 72 pictures taken in different directions. The 3D models of these casts were reconstructed and measured using the open source software MeshLab. These parameters, including mesio-distal crown diameter, arch width, and arch perimeter, were recorded six times on both the 3D digital models and on plaster casts by two examiners. Statistical analysis was carried out using the Bland-Altman method to measure agreement between the novel method and the traditional calliper method by calculating the differences between mean values.
   Results The average differences between the measurements of the photogrammetric 3D models and the plaster casts were 0.011-0.402mm. The mean differences between measurements obtained by the photogrammetric 3D models and the dental casts were not significant except for the lower arch perimeter (P> 0.05), and all the differences were regarded as clinically acceptable (< 0.5 mm).
   Conclusions Measurements obtained by MBDCRP are compared well with those obtained from plaster casts, indicating that MBDCRP is an alternate way to store and measure dental plaster casts without severe horizontal overlap between any two teeth.
C1 [Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China.
   [Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.
   [Fu, Xiaoming; Liu, Shan; Tan, Minmin; Song, Jinlin] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China.
   [Peng, Chun] Chongqing Med Univ, Yongchuan Hosp, Chongqing, Peoples R China.
   [Li, Zan] Chongqing Peoples Hosp, Dept Pathol, Chongqing, Peoples R China.
RP Song, JL (reprint author), Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China.; Song, JL (reprint author), Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.; Song, JL (reprint author), Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China.
EM soongjl@163.com
FU National Natural Science Foundation of China [81400572]; Medical
   Research Project of Chongqing [20142051]
FX Funded by National Natural Science Foundation of China (81400572),
   http://www.nsfc.gov.cn/; Medical Research Project of Chongqing
   (20142051), http://183.230.146.1:9117/kysystem/. XMF received the
   fundings, who had roles in study design, preparation of the manuscript.
CR Asquith J, 2007, EUR J ORTHODONT, V29, P517, DOI 10.1093/ejo/cjm044
   Bell A, 2003, J Orthod, V30, P219, DOI 10.1093/ortho/30.3.219
   BLAND JM, 1986, LANCET, V1, P307
   Correia Gabriele Dória Cabral, 2014, Dental Press J. Orthod., V19, P107, DOI 10.1590/2176-9451.19.4.107-113.oar
   Czarnota J, 2016, J OROFAC ORTHOP, V77, P22, DOI 10.1007/s00056-015-0004-2
   Fetic DJ, 2012, P 35 INT CONV MIPRO
   Gilson SJ, 2011, J NEUROSCI METH, V199, P328, DOI 10.1016/j.jneumeth.2011.05.011
   Hayashi K, 2015, AM J ORTHOD DENTOFAC, V147, P373, DOI 10.1016/j.ajodo.2014.11.015
   Hirogaki Y, 2001, IEEE T MED IMAGING, V20, P1093, DOI 10.1109/42.959306
   Im J, 2014, AM J ORTHOD DENTOFAC, V145, P434, DOI 10.1016/j.ajodo.2013.12.014
   Leifert MF, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2008.11.019
   Lemos LS, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140337
   Li LL, 2014, OPT EXPRESS, V22, P27707, DOI 10.1364/OE.22.027707
   Li WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117320
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lu M, 2014, SENSORS-BASEL, V14, P24156, DOI 10.3390/s141224156
   Machen DE, 1991, LEGAL ASPECTS ORTHOD
   Okunami TR, 2007, AM J ORTHOD DENTOFAC, V131, P51, DOI 10.1016/j.ajodo.2005.04.042
   Persson A, 2006, J PROSTHET DENT, V95, P194, DOI 10.1016/j.prosdent.2006.01.003
   Previtali M, 2011, 38 C INT ARCH PHOT R, P103
   Radeke J, 2014, J OROFAC ORTHOP, V75, P264, DOI 10.1007/s00056-014-0217-9
   Redlich M, 2008, ORTHOD CRANIOFAC RES, V11, P90, DOI 10.1111/j.1601-6343.2007.00417.x
   Remondino F, 2006, THESIS
   Schenk T, 2005, INTRO PHOTOGRAMMETRY
   Sokovic M, 2006, J MATER PROCESS TECH, V175, P398, DOI 10.1016/j.jmatprotec.2005.04.047
   Yau HT, 2014, COMPUT BIOL MED, V48, P8, DOI 10.1016/j.compbiomed.2014.02.001
   Yazdi B, 2014, ULTRASOUND OBST GYN, V43, P170, DOI 10.1002/uog.12509
   Zheng S., 2004, ISPRS 20 C COMM 5 GE, P70
NR 28
TC 5
Z9 5
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 22
PY 2017
VL 12
IS 6
AR e0178858
DI 10.1371/journal.pone.0178858
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EY6ZV
UT WOS:000404135800012
PM 28640827
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fisher, P
   Aumann, C
   Chia, K
   O'Halloran, N
   Chandra, S
AF Fisher, Peter
   Aumann, Colin
   Chia, Kohleth
   O'Halloran, Nick
   Chandra, Subhash
TI Adequacy of laser diffraction for soil particle size analysis
SO PLOS ONE
LA English
DT Article
ID SODIUM-HYPOCHLORITE; PLUMMET BALANCE; ORGANIC-MATTER; CLAY;
   DIFFRACTOMETRY; DISTRIBUTIONS; SENSITIVITY; INSTRUMENT; HYDROMETER;
   FRACTIONS
AB Sedimentation has been a standard methodology for particle size analysis since the early 1900s. In recent years laser diffraction is beginning to replace sedimentation as the prefered technique in some industries, such as marine sediment analysis. However, for the particle size analysis of soils, which have a diverse range of both particle size and shape, laser diffraction still requires evaluation of its reliability. In this study, the sedimentation based sieve plummet balance method and the laser diffraction method were used to measure the particle size distribution of 22 soil samples representing four contrasting Australian Soil Orders. Initially, a precise wet riffling methodology was developed capable of obtaining representative samples within the recommended obscuration range for laser diffraction. It was found that repeatable results were obtained even if measurements were made at the extreme ends of the manufacturer's recommended obscuration range. Results from statistical analysis suggested that the use of sample pretreatment to remove soil organic carbon ( and possible traces of calcium-carbonate content) made minor differences to the laser diffraction particle size distributions compared to no pretreatment. These differences were found to be marginally statistically significant in the Podosol topsoil and Vertosol subsoil. There are well known reasons why sedimentation methods may be considered to 'overestimate' plate-like clay particles, while laser diffraction will 'underestimate' the proportion of clay particles. In this study we used Lin's concordance correlation coefficient to determine the equivalence of laser diffraction and sieve plummet balance results. The results suggested that the laser diffraction equivalent thresholds corresponding to the sieve plummet balance cumulative particle sizes of < 2 mu m, < 20 mu m, and < 200 mu m, were < 9 mu m, < 26 mu m, < 275 mu m respectively. The many advantages of laser diffraction for soil particle size analysis, and the empirical results of this study, suggest that deployment of laser diffraction as a standard test procedure can provide reliable results, provided consistent sample preparation is used.
C1 [Fisher, Peter; Aumann, Colin; Chia, Kohleth; O'Halloran, Nick; Chandra, Subhash] Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia.
RP Fisher, P (reprint author), Dept Econ Dev Jobs Transport & Resources, Agr Res & Dev Div, Tatura, Vic, Australia.
EM peter.fisher@ecodev.vic.gov.au
FU Victorian Department of Economic Development, Jobs, Transport Resources
FX The research was undertaken with funding from the Victorian Department
   of Economic Development, Jobs, Transport & Resources. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aitchison J., 1986, STAT ANAL COMPOSITIO
   Allen T., 1997, POWDER SAMPLING PART
   Altman DG, 1990, PRACTICAL STAT MED R
   [Anonymous], 2002, D11277 ISO
   Arriaga FJ, 2006, SOIL SCI, V171, P663, DOI 10.1097/01.ss.0000228056.92839.88
   Blott SJ, 2006, SEDIMENTOLOGY, V53, P671, DOI 10.1111/j.1365-3091.2006.00786.x
   Buurman P, 2001, GEOL MIJNBOUW-N J G, V80, P49, DOI 10.1017/S0016774600022319
   Buurman P, 1997, SOIL SCI, V162, P211, DOI 10.1097/00010694-199703000-00007
   Cheshire MV, 2000, EUR J SOIL SCI, V51, P497, DOI 10.1046/j.1365-2389.2000.00325.x
   Di Stefano C, 2010, BIOSYST ENG, V106, P205, DOI 10.1016/j.biosystemseng.2010.03.013
   Emerson WW, 2000, AUST J SOIL RES, V38, P203, DOI 10.1071/SR97105
   Ernst MD, 2004, PERMUTATION METHODS, P676
   Eshel G, 2004, SOIL SCI SOC AM J, V68, P736
   Fedotov GN, 2007, EURASIAN SOIL SCI+, V40, P281, DOI 10.1134/S1064229307030064
   Galwey N. W., 2014, INTRO MIXED MODELLIN
   GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x
   Goossens D, 2008, SEDIMENTOLOGY, V55, P65, DOI 10.1111/j.1365-3091.2007.00893.x
   GUGGENHEIM S, 1995, CLAY CLAY MINER, V43, P255, DOI 10.1346/CCMN.1995.0430213
   Hall AD, 1904, J CHEM SOC, V85, P950, DOI 10.1039/ct9048500950
   Hutton JT, 1955, 11 CSIRO DIV SOILS
   Isbell R. F., 2002, AUSTR SOIL CLASSIFIC
   Kerry R, 2009, GEODERMA, V152, P324, DOI 10.1016/j.geoderma.2009.06.018
   Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x
   Kowalenko CG, 2013, GEODERMA, V193, P22, DOI 10.1016/j.geoderma.2012.09.006
   Lin L, 2000, BIOMETRICS, V56, P324, DOI DOI 10.1111/J.0006-341X.2000.00324.X
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lu N, 2000, GEOTECH TEST J, V23, P487
   Ma ZH, 2000, POWDER TECHNOL, V111, P66, DOI 10.1016/S0032-5910(00)00242-4
   MARSHALL T. J., 1956, AUSTRALIAN JOUR APPL SCI, V7, P142
   Mason C., 2011, NMBAQCS BEST PRACTIC
   Matthews MD., 1991, PRINCIPLES METHODS A
   Mcintyre D, 1974, METHODS ANAL IRRIGAT, V11
   MIKHAIL EH, 1978, AUST J SOIL RES, V16, P241, DOI 10.1071/SR9780241
   Mikutta R, 2005, SOIL SCI SOC AM J, V69, P120, DOI 10.2136/sssaj2005.0120
   Miller BA, 2012, SOIL SCI SOC AM J, V76, P1719, DOI 10.2136/sssaj2011.0303
   Miller W.P., 1988, J AGRON ED, V17, P24
   NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x
   OMUETI JAI, 1980, SOIL SCI SOC AM J, V44, P878, DOI 10.2136/sssaj1980.03615995004400040044x
   Ozer M, 2010, ENVIRON ENG GEOSCI, V16, P163, DOI 10.2113/gseegeosci.16.2.163
   Pabst W, 2000, J EUR CERAM SOC, V20, P1429, DOI 10.1016/S0955-2219(00)00016-9
   Payne R, 2016, GENSTAT WINDOWS INTR
   Pearson Karl, 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076
   Piper CS, 1942, SOIL PLANT ANAL LAB
   Rayment GE, 1992, AUSTR LAB HDB SOIL W
   Roberson S, 2014, SEDIMENTOLOGY, V61, P1157, DOI 10.1111/sed.12093
   Ryzak M, 2011, J PLANT NUTR SOIL SC, V174, P624, DOI 10.1002/jpln.201000255
   Scealy JL, 2014, AUST NZ J STAT, V56, P145, DOI 10.1111/anzs.12073
   Scott-Jackson JE, 2005, J ARCHAEOL SCI, V32, P969, DOI 10.1016/j.jas.2005.01.013
   SHELDRICK BH, 1976, CAN J SOIL SCI, V56, P55, DOI 10.4141/cjss76-008
   SLAGER S, 1964, SEDIMENTOLOGY, V3, P240, DOI 10.1111/j.1365-3091.1964.tb00463.x
   Snedecor G. W., 1967, STAT METHODS
   Sochan A, 2015, SOIL SCI SOC AM J, V79, P37, DOI 10.2136/sssaj2013.07.0308n
   Sperazza M, 2004, J SEDIMENT RES, V74, P736, DOI 10.1306/031104740736
   Standards Australia, 2003, 1289332003 AS
   Vdovic N, 2010, EUR J SOIL SCI, V61, P854, DOI 10.1111/j.1365-2389.2010.01298.x
   Watson D. F., 1989, MATH GEOL, V21, P233
   WEIPENG W, 2015, PLOS ONE, V0010
   Zobeck TM, 2004, APPL ENG AGRIC, V20, P633
NR 58
TC 16
Z9 17
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 4
PY 2017
VL 12
IS 5
AR e0176510
DI 10.1371/journal.pone.0176510
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET9SP
UT WOS:000400648500049
PM 28472043
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Straney, LD
   Udy, AA
   Burrell, A
   Bergmeir, C
   Huckson, S
   Cooper, DJ
   Pilcher, DV
AF Straney, Lahn D.
   Udy, Andrew A.
   Burrell, Aidan
   Bergmeir, Christoph
   Huckson, Sue
   Cooper, D. James
   Pilcher, David V.
TI Modelling risk-adjusted variation in length of stay among Australian and
   New Zealand ICUs
SO PLOS ONE
LA English
DT Article
ID INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; APACHE-III; BENCHMARKING;
   PREDICTION; OUTCOMES
AB Purpose
   Comparisons between institutions of intensive care unit (ICU) length of stay (LOS) are significantly confounded by individual patient characteristics, and currently there is a paucity of methods available to calculate risk-adjusted metrics.
   Methods
   We extracted de-identified data from the Australian and New Zealand Intensive Care Society (ANZICS) Adult Patient Database for admissions between January 1 2011 and December 31 2015. We used a mixed-effects log-normal regression model to predict LOS using patient and admission characteristics. We calculated a risk-adjusted LOS ratio (RALOSR) by dividing the geometric mean observed LOS by the exponent of the expected Ln-LOS for each site and year. The RALOSR is scaled such that values <1 indicate a LOS shorter than expected, while values >1 indicate a LOS longer than expected. Secondary mixed effects regression modelling was used to assess the stability of the estimate in units over time.
   Results
   During the study there were a total of 662,525 admissions to 168 units (median annual admissions = 767, IQR:426-1121). The mean observed LOS was 3.21 days (median = 1.79 IQR = 0.92-3.52) over the entire period, and declined on average 1.97 hours per year (95% CI:1.76-2.18) from 2011 to 2015. The RALOSR varied considerably between units, ranging from 0.35 to 2.34 indicating large differences after accounting for case-mix.
   Conclusions
   There are large disparities in risk-adjusted LOS among Australian and New Zealand ICU swhich may reflect differences in resource utilization.
C1 [Straney, Lahn D.; Udy, Andrew A.; Cooper, D. James; Pilcher, David V.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.
   [Udy, Andrew A.; Burrell, Aidan; Cooper, D. James; Pilcher, David V.] Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia.
   [Bergmeir, Christoph] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia.
   [Huckson, Sue; Pilcher, David V.] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia.
RP Pilcher, DV (reprint author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.; Pilcher, DV (reprint author), Alfred Hosp, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia.; Pilcher, DV (reprint author), Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia.
EM d.pilcher@alfred.org.au
RI Bergmeir, Christoph/Q-9911-2019; Udy, Andrew/G-2538-2010; Cooper, D.
   James/G-7961-2013
OI Pilcher, David/0000-0002-8939-7985; Udy, Andrew/0000-0002-6284-2022;
   Straney, Lahn/0000-0002-2615-2366; Cooper, D. James/0000-0002-5872-9051
FU Monash Institute of Medica lEngineering (MIME) [2016-37]
FX This research was funded in part by the Monash Institute of Medica
   lEngineering (MIME) under a MIME seed funding grant (2016-37). (LS, CB)
   [https://www.monash.edu/mime/seed]. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BECKER RB, 1995, J CARDIOVASC SURG, V36, P1
   Heidegger CP, 2005, INTENS CARE MED, V31, P1676, DOI 10.1007/s00134-005-2831-x
   KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480
   Paul E, 2016, CRIT CARE RESUSC, V18, P25
   Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058
   Power GS, 2014, CURR OPIN CRIT CARE, V20, P544, DOI 10.1097/MCC.0000000000000136
   Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007
   Strand K, 2010, CRIT CARE, V14, DOI 10.1186/cc9279
   Straney L, 2012, HEALTH SERV RES, V47, P2190, DOI 10.1111/j.1475-6773.2012.01421.x
   Straney L, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.028811
   Straney LD, 2010, INTENS CARE MED, V36, P1410, DOI 10.1007/s00134-010-1916-3
   Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118
   Vicente FG, 2004, INTENS CARE MED, V30, P655, DOI 10.1007/s00134-003-2139-7
   Zimmerman JE, 2006, CRIT CARE MED, V34, P2517, DOI 10.1097/01.CCM.0000240233.01711.D9
NR 16
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2017
VL 12
IS 5
AR e0176570
DI 10.1371/journal.pone.0176570
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET9RV
UT WOS:000400646300035
PM 28464035
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Aljanaki, A
   Yang, YH
   Soleymani, M
AF Aljanaki, Anna
   Yang, Yi-Hsuan
   Soleymani, Mohammad
TI Developing a benchmark for emotional analysis of music
SO PLOS ONE
LA English
DT Article
ID PERCEIVED EMOTION
AB Music emotion recognition (MER) field rapidly expanded in the last decade. Many new methods and new audio features are developed to improve the performance of MER algorithms. However, it is very difficult to compare the performance of the new methods because of the data representation diversity and scarcity of publicly available data. In this paper, we address these problems by creating a data set and a benchmark for MER. The data set that we release, a MediaEval Database for Emotional Analysis in Music (DEAM), is the largest available data set of dynamic annotations (valence and arousal annotations for 1,802 songs and song excerpts licensed under Creative Commons with 2Hz time resolution). Using DEAM, we organized the 'Emotion in Music'task at MediaEval Multimedia Evaluation Campaign from 2013 to 2015. The benchmark attracted, in total, 21 active teams to participate in the challenge. We analyze the results of the benchmark: the winning algorithms and feature-sets. We also describe the design of the benchmark, the evaluation procedures and the data cleaning and transformations that we suggest. The results from the benchmark suggest that the recurrent neural network based approaches combined with large feature-sets work best for dynamic MER.
C1 [Aljanaki, Anna] Univ Utrecht, Utrecht, Netherlands.
   [Aljanaki, Anna; Soleymani, Mohammad] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.
   [Yang, Yi-Hsuan] Acad Sinica, Taipei, Taiwan.
RP Aljanaki, A (reprint author), Univ Utrecht, Utrecht, Netherlands.; Aljanaki, A (reprint author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.
EM aljanaki@gmail.com
FU COMMIT/project; Ambizione program of the Swiss National Science
   Foundation [PZ00P2_154981]
FX AA's work was supported by COMMIT/project (commit-nl.nl). MS was
   supported by Ambizione program of the Swiss National Science Foundation
   (Grant number PZ00P2_154981).
CR Aljanaki A, 2013, P MEDIAEVAL 2013 WOR
   Aljanaki A, 2015, P MEDIAEVAL 2015 WOR
   Aljanaki A, 2015, P INT SOC MUS INF RE
   Aljanaki A, 2014, P MEDIAEVAL 2014 WOR
   Aljanaki A, 2016, INFORM PROCESS MANAG, V52, P115, DOI 10.1016/j.ipm.2015.03.004
   Aljanaki Anna, 2014, P 15 INT SOC MUS INF, P373
   Bachorik JP, 2009, MUSIC PERCEPT, V26, P355, DOI 10.1525/MP.2009.26.4.355
   Barthet Mathieu, 2012, P INT S COMP MUS MOD, P492
   Bittner R, 2014, P INT SOC MUS INF RE
   Cabrera D., 1999, P AUSTR AC SOC C, P47
   Cai K, 2015, P MEDIAEVAL 2015 WOR
   Chen YA, 2015, INT CONF ACOUST SPEE, P693, DOI 10.1109/ICASSP.2015.7178058
   Chmulik M, 2015, P MEDIAEVAL 2015 WOR
   Collier G., 2007, PSYCHOL MUSIC, V35, P110, DOI DOI 10.1177/0305735607068890
   Coutinho E, 2015, P MEDIAEVAL 2015 WOR
   Coutinho E, 2014, P MEDIAEVAL 2014 WOR
   Coutinho E, 2014, IEEE IJCNN, P3592, DOI 10.1109/IJCNN.2014.6889814
   Eerola T., 2014, P AES INT C
   Eyben Florian, 2013, P 21 ACM INT C MULT, P835, DOI [10.1145/2502081.2502224, DOI 10.1145/2502081.2502224]
   Fan Y, 2014, P MEDIAEVAL 2014 WOR
   Geringer JM, 2004, B COUN RES MUSIC ED, P1
   Gupta R, 2015, P MEDIAEVAL 2015 WOR
   He L., 2015, P 5 INT WORKSH AUD V, P73, DOI DOI 10.1145/2808196.2811641
   Hu X., 2008, P 9 INT C MUS INF RE, P462
   Hu X, 2017, IEEE T AFFECT COMPUT, V8, P228, DOI 10.1109/TAFFC.2016.2523503
   Huq A, 2010, J NEW MUSIC RES, V39, P227, DOI 10.1080/09298215.2010.513733
   Imbrasaite V, 2014, P IEEE INT C MULT EX
   Imbrasaite V., 2013, 2013 IEEE INT C MULT, P1
   Inskip C, 2012, INT J DIGIT LIBRARIE, V12, P137, DOI 10.1007/s00799-012-0084-1
   Kim YE, 2010, P INT SOC MUS INF RE, P255
   Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15
   Korhonen MD, 2006, IEEE T SYST MAN CY B, V36, P588, DOI 10.1109/TSMCB.2005.862491
   Kumar N, 2014, P MEDIAEVAL 2014 WOR
   Laurier C, 2007, MIREX TASK AUDIO MOO
   Laurier C, 2009, P 7 TRIENN C EUR SOC, P260
   Laurier C., 2009, P INT C MUS INF RETR, P381
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Liu Y, 2015, P MEDIAEVAL 2015 WOR
   Markov K, 2013, P MEDIAEVAL 2013 WOR
   Markov K, 2014, P MEDIAEVAL 2014 WOR
   McKeown G, 2012, IEEE T AFFECT COMPUT, V3, P5, DOI 10.1109/T-AFFC.2011.20
   McKeown GJ, 2014, PSYCHOL METHODS, V19, P155, DOI 10.1037/a0034282
   Morris JD, 1995, J ADVERTISING RES, V35, P63
   Nicolaou MA, 2011, IEEE T AFFECT COMPUT, V2, P92, DOI 10.1109/T-AFFC.2011.9
   Panda R, 2013, P INT S COMP MUS MOD
   Panda R, 2011, P 130 AUD ENG SOC CO
   Patra B. G., 2015, P MEDIAEVAL 2015 WOR
   Pellegrini T, 2015, P MEDIAEVAL 2015 WOR
   Ringeval F, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1335, DOI 10.1145/2733373.2806408
   Ringeval Fabien, 2013, AUT FAC GEST REC FG, P1, DOI DOI 10.1109/FG.2013.6553805
   RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714
   Schmidt E M, 2010, 2010 Ninth International Conference on Machine Learning and Applications (ICMLA 2010), P655, DOI 10.1109/ICMLA.2010.101
   Schmidt EM, 2011, P INT SOC MUS INF RE
   Schmidt EM, 2013, P INT SOC MUS INF RE
   Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561
   Schubert E, 2003, PERCEPT MOTOR SKILL, V96, P1117, DOI 10.2466/PMS.96.3.1117-1122
   Schubert E, 1996, P 4 INT C MUS PERC C, P263
   Schubert E, 2013, PSYCHOL MUSIC, V41, P350, DOI 10.1177/0305735611430079
   Schuller B, 2012, ICMI '12: PROCEEDINGS OF THE ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P449
   Schuller B, 2011, LECT NOTES COMPUT SC, V6975, P415, DOI 10.1007/978-3-642-24571-8_53
   Soleymani M, 2013, P MEDIAEVAL 2013 WOR
   Soleymani M, 2010, WORKSH CROWDS SEARCH
   Soleymani M, 2014, P ACM INT C MULT
   Soleymani M, 2014, IEEE T MULTIMEDIA, V16, P1075, DOI 10.1109/TMM.2014.2305573
   Speck JA, 2011, P INT SOC MUS INF RE
   Su D, 2012, P ACM INT WORKSH MUS, P51
   Thayer RE, 1989, BIOPSYCHOLOGY MOOD A
   Valstar M., 2014, P 4 INT WORKSH AUD V, V14, P3
   Valstar M., 2013, P 3 ACM INT WORKSH A, P3, DOI DOI 10.1145/2512530.2512533
   Vuoskoski JK, 2011, MUSIC SCI, V15, P159, DOI 10.1177/1029864911403367
   Wang J.-C., 2012, P ACM MULT, P89, DOI DOI 10.1145/2393347.2393367
   Wang JC, 2015, IEEE T AFFECT COMPUT, V6, P56, DOI 10.1109/TAFFC.2015.2397457
   Weber M, 2015, P MEDIAEVAL 2015 WOR
   Weninger F, 2013, P MEDIAEVAL 2013 WOR
   Xu M, 2015, P MEDIAEVAL 2015 WOR
   Yang W, 2014, P MEDIAEVAL 2014 WOR
   Yang YH, 2008, IEEE T AUDIO SPEECH, V16, P448, DOI 10.1109/TASL.2007.911513
   Yang YH, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168754
   Yu-An Chen, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P2149, DOI 10.1109/ICASSP.2014.6853979
NR 79
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 10
PY 2017
VL 12
IS 3
AR e73392
DI 10.1371/journal.pone.0173392
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN6CJ
UT WOS:000396091800035
PM 28282400
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Levy, TS
   Mendez-Gomez-Humaran, I
   Ruan, MDM
   Tapia, BM
   Hernandez, SV
   Avila, MH
AF Shamah Levy, Teresa
   Mendez-Gomez-Humaran, Ignacio
   Morales Ruan, Maria del Carmen
   Martinez Tapia, Brenda
   Villalpando Hernandez, Salvador
   Hernandez Avila, Mauricio
TI Validation of Masimo Pronto 7 and HemoCue 201 for hemoglobin
   determination in children from 1 to 5 years of age
SO PLOS ONE
LA English
DT Article
ID CAPILLARY; ACCURACY; DEVICE; ANEMIA; SYSTEM; BLOOD
AB Objective
   To evaluate the accuracy and precision of HemoCue 201 (HemoCue) and Masimo Pronto 7 (Masimo) devices for measuring hemoglobin (Hb) in epidemiological studies, having venous blood samples as a gold standard.
   Material and methods
   We measured Hb concentrations in a field sample of 148 children from one to five years of age. Masimo and HemoCue were used for capillary blood samples and an automatic analyzer for venous blood samples. Regression models with no intercept were constructed to measure precision and predictability, concordance correlations to measure accuracy and precision, and Bland-Altman limits of agreement as well as hierarchical linear models to estimate variance.
   Results
   Both HemoCue and Masimo underestimated Hb concentrations compared to the gold standard. They respectively yielded the following results: regression coefficients of 0.887 and 0.876 with 98.7% and 98.6% predictability; concordance correlation coefficients of 0.183 (p<0.001) and 0.166 (p<0.001); and Bland-Altman variances of -1.51 and -1.62. With regard to Masimo specifically, the three-level Hierarchical Linear Model showed that 57.9% of total variance stemmed from random errors in repeated measures from the same subject.
   Conclusions
   HemoCue and Masimo measure lower Hb concentrations than the gold standard. Their accuracy and precision levels are comparable. It is essential to ensure proper use of devices through enhanced training of field workers.
C1 [Shamah Levy, Teresa; Morales Ruan, Maria del Carmen; Martinez Tapia, Brenda; Villalpando Hernandez, Salvador; Hernandez Avila, Mauricio] Natl Publ Hlth Inst INSP, Cuernavaca, Morelos, Mexico.
   [Mendez-Gomez-Humaran, Ignacio] Ctr Res Math, Aguascalientes, Aguascalientes, Mexico.
RP Mendez-Gomez-Humaran, I (reprint author), Ctr Res Math, Aguascalientes, Aguascalientes, Mexico.
EM imendez@cimat.mx
RI MENDEZ GOMEZ HUMARAN, IGNACIO/S-7593-2018
OI MENDEZ GOMEZ HUMARAN, IGNACIO/0000-0002-3908-0867
FU Laboratorio Reactivos y Quimicos S.A. de C.V. from Mexico
FX The funds for this study were supported by the Laboratorio Reactivos y
   Quimicos S.A. de C.V. from Mexico. The grant was 10,000 USD. The funders
   had no role in study design, data collectionand analysis, decision to
   publish, or preparation of the manuscript.
CR Amano I, 2013, PEDIATR INT, V55, P803, DOI 10.1111/ped.12236
   [Anonymous], 2010, OPERATORS MANUAL
   Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Bridges N, 1987, AM CLIN PROD REV, V6, P22
   Bruells CS, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-159
   CHEN PP, 1992, ANAESTH INTENS CARE, V20, P497, DOI 10.1177/0310057X9202000419
   COHEN AR, 1988, AM J CLIN PATHOL, V90, P302, DOI 10.1093/ajcp/90.3.302
   Morales-Ruan MD, 2013, SALUD PUBLICA MEXICO, V55, pS199
   Giraud B, 2013, BRIT J ANAESTH, V111, P946, DOI 10.1093/bja/aet252
   Gutierrez JP, 2012, ENCUESTA NACL SALUDY
   Hiscock R, 2015, ANAESTH INTENS CARE, V43, P341, DOI 10.1177/0310057X1504300310
   International Committee for Standardization in Haematology, 1967, BRIT J HAEMATOL, V13, P71
   Lamhaut L, 2011, ANESTHESIOLOGY, V115, P548, DOI 10.1097/ALN.0b013e3182270c22
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Neufeld L, 2002, SALUD PUBLICA MEXICO, V44, P219, DOI 10.1590/s0036-36342002000300005
   NEVILLE RG, 1987, BRIT MED J, V294, P1263, DOI 10.1136/bmj.294.6582.1263
   Patel AJ, 2013, VOX SANG, V104, P317, DOI 10.1111/vox.12006
   VANKAMPEN E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0
   VONSCHENCK H, 1986, CLIN CHEM, V32, P526
   World Health Organization, 2011, HAEM CONC DIAGN AN A
   World Health Organization, 2014, GLOB NUTR TARG 2025
NR 22
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 7
PY 2017
VL 12
IS 2
AR e0170990
DI 10.1371/journal.pone.0170990
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EK1SG
UT WOS:000393705500016
PM 28170445
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lee, LW
   Liao, YS
   Lu, HK
   Hsiao, PL
   Chen, YY
   Chi, CC
   Hsieh, KC
AF Lee, Li-Wen
   Liao, Yu-San
   Lu, Hsueh-Kuan
   Hsiao, Pei-Lin
   Chen, Yu-Yawn
   Chi, Ching-Chi
   Hsieh, Kuen-Chang
TI Validation of two portable bioelectrical impedance analyses for the
   assessment of body composition in school age children
SO PLOS ONE
LA English
DT Article
ID X-RAY ABSORPTIOMETRY; SKELETAL-MUSCLE MASS; CORRELATION-COEFFICIENT;
   BIOIMPEDANCE ANALYSIS; ASSESSING AGREEMENT; RELIABILITY; ADOLESCENTS;
   PREDICTION; VALIDITY; BIA
AB Background
   Bioelectrical impedance analysis (BIA) is a convenient and child-friendly method for longitudinal analysis of changes in body composition. However, most validation studies of BIA have been performed on adult Caucasians. The present cross-sectional study investigated the validity of two portable BIA devices, the Inbody 230 (BIA(8MF)) and the Tanita BC-418 (BIA(8SF)), in healthy Taiwanese children.
   Methods
   Children aged 7-12 years (72 boys and 78 girls) were recruited. Body composition was measured by the BIA(8SF) and the BIA(8MF). Dual X-ray absorptiometry (DXA) was used as the reference method.
   Results
   There were strong linear correlations in body composition measurements between the BIA(8SF) and DXA and between the BIA(8MF) and DXA. Both BIAs underestimated fat mass (FM) and percentage body fat (%BF) relative to DXA in both genders The degree of agreement in lean body mass (LBM), FM, and %BF estimates was higher between BIA(8MF) and DXA than between BIA(8SF) and DXA. The Lin's concordance correlation coefficient (rho(c)) for LBM8MF met the criteria of substantial to perfect agreement whereas the rho(c) for FM8MF met the criteria of fair to substantial agreement. Bland-Altman analysis showed a clinically acceptable agreement between LBM measures by BIA(8MF) and DXA. The limit of agreement in %BF estimation by BIA and DXA were wide and the errors were clinically important. For the estimation of ALM, BIA(8SF) and BIA(8MF) both provided poor accuracy.
   Conclusions
   For all children, LBM measures were precise and accurate using the BIA(8MF) whereas clinically significant errors occurred in FM and %BF estimates. Both BIAs underestimated FM and %BF in children. Thus, the body composition results obtained using the inbuilt equations of the BIA(8SF) and BIA(8MF) should be interpreted with caution, and high quality validation studies for specific subgroups of children are required prior to field research.
C1 [Lee, Li-Wen; Liao, Yu-San; Hsiao, Pei-Lin] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan.
   [Lee, Li-Wen; Liao, Yu-San] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan.
   [Lu, Hsueh-Kuan] Natl Taiwan Univ Sport, Sport Sci Res Ctr, Taichung, Taiwan.
   [Chen, Yu-Yawn] Natl Taiwan Univ Sport, Dept Phys Educ, Taichung, Taiwan.
   [Chen, Yu-Yawn] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Yilan, Taiwan.
   [Chi, Ching-Chi] Chang Gung Mem Hosp, Dept Dermatol, Linkou, Taiwan.
   [Chi, Ching-Chi] Chang Gung Mem Hosp, Dept Dermatol, Chiayi, Taiwan.
   [Chi, Ching-Chi] Chang Gung Univ, Coll Med, Taoyuan, Taiwan.
   [Hsieh, Kuen-Chang] Natl Chung Hsing Univ, Off Phys Educ & Sport, Taichung, Taiwan.
   [Hsieh, Kuen-Chang] Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan.
RP Chi, CC (reprint author), Chang Gung Mem Hosp, Dept Dermatol, Linkou, Taiwan.; Chi, CC (reprint author), Chang Gung Mem Hosp, Dept Dermatol, Chiayi, Taiwan.; Chi, CC (reprint author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Hsieh, KC (reprint author), Natl Chung Hsing Univ, Off Phys Educ & Sport, Taichung, Taiwan.; Hsieh, KC (reprint author), Charder Elect Co Ltd, Res Ctr, Taichung, Taiwan.
EM chingchi@cgmh.org.tw; abaqus0927@yahoo.com.tw
OI Lee, Li-Wen/0000-0001-8019-1772
FU Chang Gung Memorial Hospital [CMRPG6D0353, CMRPG6C0052]
FX This study was funded by a single institution, the Chang Gung Memorial
   Hospital (grant number CMRPG6D0353, CCC and CMRPG6C0052, LWL). The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. One of the
   authors (KCH) is an employee of Charder Electronic Co, Ltd. This company
   did not provide KCH financial support in executing this study. Nor did
   the company have any additional role in the research funding, study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific roles of the author are
   articulated in the Author Contributions section.
CR [Anonymous], 1996, INBODY US MAN
   Barnhart HX, 2007, J BIOPHARM STAT, V17, P529, DOI 10.1080/10543400701376480
   BLAND JM, 1990, COMPUT BIOL MED, V20, P337, DOI 10.1016/0010-4825(90)90013-F
   BLAND JM, 1986, LANCET, V1, P307
   Clasey JL, 2011, OBESITY, V19, P1813, DOI 10.1038/oby.2011.158
   Dittmar M, 2001, AM J PHYSIOL-ENDOC M, V281, pE1005
   Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015
   Gudivaka R, 1985, J APPL PHYSIOL, V1999, P1087
   Haroun D, 2009, OBESITY, V17, P2245, DOI 10.1038/oby.2009.98
   Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460
   Khalil SF, 2014, SENSORS-BASEL, V14, P10895, DOI 10.3390/s140610895
   Kim J, 2002, AM J CLIN NUTR, V76, P378
   Kim J, 2006, AM J CLIN NUTR, V84, P1014
   Kriemler S, 2009, EUR J CLIN NUTR, V63, P619, DOI 10.1038/ejcn.2008.19
   KUSHNER RF, 1992, J AM COLL NUTR, V11, P199
   Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004
   Lewy VD, 1999, J PEDIATR ENDOCR MET, V12, P443
   Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x
   McBride GB, 2005, HAM2005062 NIWA
   ORGAN LW, 1994, J APPL PHYSIOL, V77, P98
   Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993
   Pietrobelli A, 1998, EUR J CLIN NUTR, V52, P507, DOI 10.1038/sj.ejcn.1600592
   Prins M, 2008, EUR J CLIN NUTR, V62, P1065, DOI 10.1038/sj.ejcn.1602830
   Shaikh MG, 2007, HORM RES, V68, P8, DOI 10.1159/000098481
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Silva AM, 2013, J OBES, DOI 10.1155/2013/148696
   Talma H, 2013, OBES REV, V14, P895, DOI 10.1111/obr.12061
   Wells JCK, 2006, ARCH DIS CHILD, V91, P612
   Wells JCK, 2005, ARCH DIS CHILD, V90, P965, DOI 10.1136/adc.2004.067538
   Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908
NR 32
TC 8
Z9 8
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
AR e0171568
DI 10.1371/journal.pone.0171568
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700101
PM 28158304
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Quintana, DS
   Elvsashagen, T
   Zak, N
   Norbom, LB
   Pedersen, PO
   Quraishi, SH
   Bjornerud, A
   Malt, UF
   Groote, IR
   Kaufmann, T
   Andreassen, OA
   Westlye, LT
AF Quintana, Daniel S.
   Elvsashagen, Torbjorn
   Zak, Nathalia
   Norbom, Linn B.
   Pedersen, Per O.
   Quraishi, Sophia H.
   Bjornerud, Atle
   Malt, Ulrik F.
   Groote, Inge R.
   Kaufmann, Tobias
   Andreassen, Ole A.
   Westlye, Lars T.
TI Diurnal Variation and Twenty-Four Hour Sleep Deprivation Do Not Alter
   Supine Heart Rate Variability in Healthy Male Young Adults
SO PLOS ONE
LA English
DT Article
ID AUTONOMIC NERVOUS-SYSTEM; CIRCADIAN-RHYTHM DISRUPTION;
   INSULIN-RESISTANCE; DECISION-MAKING; MODULATION; STABILITY; PRESSURE;
   DURATION; EMOTION; PHOTOPLETHYSMOGRAPHY
AB Heart rate variability (HRV) has become an increasingly popular index of cardiac autonomic control in the biobehavioral sciences due to its relationship with mental illness and cognitive traits. However, the intraindividual stability of HRV in response to sleep and diurnal disturbances, which are commonly reported in mental illness, and its relationship with executive function are not well understood. Here, in 40 healthy adult males we calculated high frequency HRV-D an index of parasympathetic nervous system (PNS) activity-D using pulse oximetry during brain imaging, and assessed attentional and executive function performance in a subsequent behavioral test session at three time points: morning, evening, and the following morning. Twenty participants were randomly selected for total sleep deprivation whereas the other 20 participants slept as normal. Sleep deprivation and morning-tonight variation did not influence high frequency HRV at either a group or individual level; however, sleep deprivation abolished the relationship between orienting attention performance and HRV. We conclude that a day of wake and a night of laboratory-induced sleep deprivation do not alter supine high frequency HRV in young healthy male adults.
C1 [Quintana, Daniel S.; Elvsashagen, Torbjorn; Zak, Nathalia; Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Univ Oslo, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, NORMENT, Oslo, Norway.
   [Quintana, Daniel S.; Elvsashagen, Torbjorn; Zak, Nathalia; Kaufmann, Tobias; Andreassen, Ole A.; Westlye, Lars T.] Oslo Univ Hosp, Oslo, Norway.
   [Elvsashagen, Torbjorn] Oslo Univ Hosp, Dept Neurol, Oslo, Norway.
   [Elvsashagen, Torbjorn; Zak, Nathalia; Pedersen, Per O.; Malt, Ulrik F.] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Norbom, Linn B.; Groote, Inge R.; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway.
   [Quraishi, Sophia H.] Columbia Univ, Barnard Coll, New York, NY USA.
   [Bjornerud, Atle; Groote, Inge R.] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway.
   [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway.
   [Malt, Ulrik F.] Oslo Univ Hosp, Div Clin Neurosci, Dept Res & Educ, Oslo, Norway.
RP Quintana, DS (reprint author), Univ Oslo, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, NORMENT, Oslo, Norway.; Quintana, DS (reprint author), Oslo Univ Hosp, Oslo, Norway.
EM daniel.quintana@medisin.uio.no
RI Kaufmann, Tobias/M-8972-2017; Quintana, Daniel S./H-2726-2019
OI Kaufmann, Tobias/0000-0002-4003-1018; Quintana, Daniel
   S./0000-0003-2876-0004; Norbom, Linn/0000-0001-7489-2724; Malt,
   Ulrik/0000-0002-9881-2511; Westlye, Lars T./0000-0001-8644-956X
FU Novo Nordisk Foundation [NNF160C0019856]
FX This work was supported by the Novo Nordisk Foundation (NNF160C0019856)
   to DSQ. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020
   AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241
   AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045
   Alvares GA, 2016, J PSYCHIATR NEUROSCI, V41, P89, DOI 10.1503/jpn.140217
   Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205
   Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3
   Beauchaine TP, 2015, INT J PSYCHOPHYSIOL
   BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x
   Bertsch K, 2012, PSYCHOPHYSIOLOGY, V49, P672, DOI 10.1111/j.1469-8986.2011.01341.x
   Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086
   Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048
   BROWN TE, 1993, J APPL PHYSIOL, V75, P2310
   Bruce EN, 1996, J APPL PHYSIOL, V80, P1079
   Burgess HJ, 1997, AM J PHYSIOL-HEART C, V273, pH1761
   Burgess HJ, 1996, J SLEEP RES, V5, P83, DOI 10.1046/j.1365-2869.1996.00016.x
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080
   Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126
   Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111
   Denver JW, 2007, BIOL PSYCHOL, V74, P286, DOI 10.1016/j.biopsycho.2005.09.005
   Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430
   Elvsashagen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127351
   Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886
   FURLAN R, 1990, CIRCULATION, V81, P537, DOI 10.1161/01.CIR.81.2.537
   Gil E, 2010, PHYSIOL MEAS, V31, P1271, DOI 10.1088/0967-3334/31/9/015
   Glos M, 2014, PHYSIOL BEHAV, V125, P45, DOI 10.1016/j.physbeh.2013.11.011
   Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410
   Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0
   Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4
   Hayley AC, 2015, J SLEEP RES, V24, P621, DOI 10.1111/jsr.12316
   Holmes AL, 2002, J APPL PHYSIOL, V92, P2578, DOI 10.1152/japplphysiol.01106.2001
   Hu K, 2011, CIRCULATION, V123, P961, DOI 10.1161/CIRCULATIONAHA.110.943019
   Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008
   Jeffreys H., 1998, THEORY PROBABILITY
   Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442
   Kato M, 2000, HYPERTENSION, V35, P1173, DOI 10.1161/01.HYP.35.5.1173
   Kaufmann T, 2016, NEUROIMAGE, V127, P324, DOI 10.1016/j.neuroimage.2015.12.028
   Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7
   Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.12.012, 10.1016/j.biopsych.2009.11.019]
   Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x
   Kirkpatrick B, 2013, SCHIZOPHRENIA BULL, V39, P1174, DOI 10.1093/schbul/sbt141
   Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x
   Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131
   Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lindmark S, 2003, DIABETIC MED, V20, P399, DOI 10.1046/j.1464-5491.2003.00920.x
   Love J, 2015, JASP
   Lu G., 2009, Journal of Medical Engineering & Technology, V33, P634, DOI 10.3109/03091900903150998
   Martinmaki K, 2006, AM J PHYSIOL-HEART C, V290, pH640, DOI 10.1152/ajpheart.00054.2005
   Masi A, 2015, MOL PSYCHIATR, V20, P440, DOI 10.1038/mp.2014.59
   McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019
   Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148
   Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003
   Pagani M, 2009, AUTON NEUROSCI-BASIC, V145, P76, DOI 10.1016/j.autneu.2008.10.009
   Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189
   Pinna GD, 2007, CLIN SCI, V113, P131, DOI 10.1042/CS20070055
   Porges S. W., 2011, POLYVAGAL THEORY NEU
   Posner MI, 2008, ANN NY ACAD SCI, V1129, P193, DOI 10.1196/annals.1417.011
   Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73
   Quintana DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00805
   Quintana DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37212
   Quintana DS, 2013, ALCOHOL CLIN EXP RES, V37, pE23, DOI 10.1111/j.1530-0277.2012.01913.x
   Quintana DS, 2012, INT J PSYCHOPHYSIOL, V86, P168, DOI 10.1016/j.ijpsycho.2012.08.012
   R Development Core team, 2014, R A LANGUAGE AND ENV
   Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001
   Sakakibara M, 1996, PSYCHOSOM MED, V58, P32, DOI 10.1097/00006842-199601000-00006
   Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009
   Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119
   Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004
   Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x
   Shea SA, 2011, CIRC RES, V108, P980, DOI 10.1161/CIRCRESAHA.110.233668
   Sinnreich R, 1998, HEART, V80, P156, DOI 10.1136/hrt.80.2.156
   SLOAN RP, 1995, PSYCHOPHYSIOLOGY, V32, P191, DOI 10.1111/j.1469-8986.1995.tb03311.x
   SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x
   Spengler CM, 2000, AM J RESP CRIT CARE, V161, P1124, DOI 10.1164/ajrccm.161.4.9906026
   Spiegelhalder K, 2013, CURR PSYCHIAT REP, V15, P1
   Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4
   Tsunoda M, 2001, PSYCHIAT CLIN NEUROS, V55, P285, DOI 10.1046/j.1440-1819.2001.00862.x
   Vaara J, 2009, EUR J APPL PHYSIOL, V105, P439, DOI 10.1007/s00421-008-0921-5
   Virtanen I, 2015, SLEEP MED, V16, P250, DOI 10.1016/j.sleep.2014.10.012
   Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101
   WHITE DP, 1983, AM REV RESPIR DIS, V128, P984
   Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868
   Yokoi Mari, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P153, DOI 10.2114/jpa2.25.153
   Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004
NR 85
TC 2
Z9 3
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 2
PY 2017
VL 12
IS 2
AR e0170921
DI 10.1371/journal.pone.0170921
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DB
UT WOS:000396161200059
PM 28151944
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Lu, L
   Ehmke, RC
   Schwartz, LH
   Zhao, BS
AF Lu, Lin
   Ehmke, Ross C.
   Schwartz, Lawrence H.
   Zhao, Binsheng
TI Assessing Agreement between Radiomic Features Computed for Multiple CT
   Imaging Settings
SO PLOS ONE
LA English
DT Article
ID CELL LUNG-CANCER; VOLUMETRIC MEASUREMENTS; TUMOR MEASUREMENTS;
   GENE-EXPRESSION; SOLID TUMORS; TEST-RETEST; VARIABILITY; SCANS;
   RADIOGENOMICS
AB Objectives
   Radiomics utilizes quantitative image features (QIFs) to characterize tumor phenotype. In practice, radiological images are obtained from different vendors' equipment using various imaging acquisition settings. Our objective was to assess the inter-setting agreement of QIFs computed from CT images by varying two parameters, slice thickness and reconstruction algorithm.
   Materials and Methods
   CT images from an IRB-approved/HIPAA-compliant study assessing thirty-two lung cancer patients were included for the analysis. Each scan's raw data were reconstructed into six imaging series using combinations of two reconstruction algorithms (Lung[L] and Standard[S]) and three slice thicknesses (1.25mm, 2.5mm and 5mm), i.e., 1.25L, 1.25S, 2.5L, 2.5S, 5L and 5S. For each imaging-setting, 89 well-defined QIFs were computed for each of the 32 tumors (one tumor per patient). The six settings led to 15 inter-setting comparisons (combinatorial pairs). To reduce QIF redundancy, hierarchical clustering was done. Concordance correlation coefficients (CCCs) were used to assess inter-setting agreement of the non-redundant feature groups. The CCC of each group was assessed by averaging CCCs of QIFs in the group.
   Results
   Twenty-three non-redundant feature groups were created. Across all feature groups, the best inter-setting agreements (CCCs>0.8) were 1.25S vs 2.5S, 1.25L vs 2.5L, and 2.5S vs 5S; the worst (CCCs<0.51) belonged to 1.25L vs 5S and 2.5L vs 5S. Eight of the feature groups related to size, shape, and coarse texture had an average CCC>0.8 across all imaging settings.
   Conclusions
   Varying degrees of inter-setting disagreements of QIFs exist when features are computed from CT images reconstructed using different algorithms and slice thicknesses. Our findings highlight the importance of harmonizing imaging acquisition for obtaining consistent QIFs to study tumor imaging phonotype.
C1 [Lu, Lin; Schwartz, Lawrence H.; Zhao, Binsheng] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10027 USA.
   [Ehmke, Ross C.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA.
RP Zhao, BS (reprint author), Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10027 USA.
EM bz2166@cumc.columbia.edu
FU National Cancer Institute (NCI) [R01 CA149490]
FX This work was supported in part by Grant R01 CA149490 from the National
   Cancer Institute (NCI).
CR Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006
   Balagurunathan Y, 2014, J DIGIT IMAGING, V27, P805, DOI 10.1007/s10278-014-9716-x
   Bar-Joseph Z, 2001, Bioinformatics, V17 Suppl 1, pS22
   Coroller TP, 2016, RADIOTHERAPY ONCOLOG
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607
   Hunter LA, 2013, MED PHYS, V40, DOI 10.1118/1.4829514
   Karlo CA, 2014, RADIOLOGY, V270, P464, DOI 10.1148/radiol.13130663
   Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195
   Lambin P, 2013, NAT REV CLIN ONCOL, V10, P27, DOI 10.1038/nrclinonc.2012.196
   Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036
   Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Liu Y, 2016, CLIN LUNG CANC
   Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180
   Oxnard GR, 2011, J CLIN ONCOL, V29, P3114, DOI 10.1200/JCO.2010.33.7071
   Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044
   Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107
   Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000
   Tan YQ, 2013, MED PHYS, V40, DOI 10.1118/1.4793409
   Tan YQ, 2012, CANCER IMAGING, V12, P497, DOI 10.1102/1470-7330.2012.0046
   Wu J, 2016, RADIOLOGY, V281, P270, DOI 10.1148/radiol.2016151829
   Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869
   Yoon HJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001753
   Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428
   Zhao BS, 2014, TRANSL ONCOL, V7, P88, DOI 10.1593/tlo.13865
   Zhao BS, 2013, EUR J RADIOL, V82, P959, DOI 10.1016/j.ejrad.2013.02.018
   Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593
   Zhu YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17787
NR 29
TC 26
Z9 30
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 29
PY 2016
VL 11
IS 12
AR e0166550
DI 10.1371/journal.pone.0166550
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG7KQ
UT WOS:000391226900006
PM 28033372
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Braga, LM
   Prado, GF
   Umeda, IIK
   Kawauchi, TS
   Taboada, AMF
   Azevedo, RS
   Pereira, HG
   Grupi, CJ
   Souza, HCC
   Moreira, DAR
   Nakagawa, NK
AF Braga, Lays Magalhaes
   Prado, Gustavo Faibischew
   Kikuchi Umeda, Iracema Ioco
   Kawauchi, Tatiana Satie
   Froes Taboada, Adriana Marques
   Azevedo, Raymundo Soares
   Pereira Filho, Horacio Gomes
   Grupi, Cesar Jose
   Cavenague Souza, Hayala Cristina
   Ribeiro Moreira, Dalmo Antonio
   Nakagawa, Naomi Kondo
TI Reproducibility for Heart Rate Variability Analysis during 6-Min Walk
   Test in Patients with Heart Failure and Agreement between Devices
SO PLOS ONE
LA English
DT Article
ID RATE MONITOR; POLAR S810; RELIABILITY; SECONDARY; INTERVALS; THERAPY;
   DEATH; TRIAL; TIME; ECG
AB Heart rate variability (HRV) analysis is a useful method to assess abnormal functioning in the autonomic nervous system and to predict cardiac events in patients with heart failure (HF). HRV measurements with heart rate monitors have been validated with an electrocardiograph in healthy subjects but not in patients with HF. We explored the reproducibility of HRV in two consecutive six-minute walk tests (6MW), 60-minute apart, using a heart rate monitor (PolarS810i) and a portable electrocardiograph (called Holter) in 50 HF patients (mean age 59 years, NYHA II, left ventricular ejection fraction similar to 35%). The reproducibility for each device was analysed using a paired t-test or the Wilcoxon signed-rank test. Additionally, we assessed the agreement between the two devices based on the HRV indices at rest, during the 6MW and during recovery using concordance correlation coefficients (CCC), 95% confidence intervals and Bland-Altman plots. The test-retest for the HRV analyses was reproducible using Holter and PolarS810i at rest but not during recovery. In the second 6MW, patients showed significant increases in rMSSD and walking distance. The PolarS810i measurements had remarkably high concordance correlation [0.86<CCC<0.99] based on Holter at rest, during 6MW and recovery. At higher rates, a small effect in increasing differences between Holter and Polar in R-R intervals was observed. In conclusion, our study showed good reproducibility of HRV at rest in two consecutive 6MW using Holter and PolarS810i. Additionally, PolarS810i produced good agreements in short-term HRV indices based on Holter simultaneous recordings at rest, during the 6MW and recovery in HF patients.
C1 [Braga, Lays Magalhaes; Kawauchi, Tatiana Satie; Nakagawa, Naomi Kondo] Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil.
   [Prado, Gustavo Faibischew] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, Brazil.
   [Kikuchi Umeda, Iracema Ioco; Froes Taboada, Adriana Marques; Cavenague Souza, Hayala Cristina; Ribeiro Moreira, Dalmo Antonio] Dante Pazzanese Inst Cardiol Sao Paulo State, Sao Paulo, Brazil.
   [Azevedo, Raymundo Soares] Univ Sao Paulo, Dept Pathol, Sch Med, Sao Paulo, Brazil.
   [Pereira Filho, Horacio Gomes; Grupi, Cesar Jose] Univ Sao Paulo, Fac Med, Hosp Clin, Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil.
RP Nakagawa, NK (reprint author), Univ Sao Paulo, Dept Physiotherapy, Fac Med, Sao Paulo, Brazil.
EM naomi.kondo@usp.br
RI PEREIRA FILHO, HORACIO/R-1497-2016; Azevedo, Raymundo S/B-7593-2008
OI Azevedo, Raymundo S/0000-0003-0660-2371
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP
   2013/13598-1]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP 2013/13598-1). The funder had no role in study design,
   data collection, data analysis, data interpretation, decision to publish
   or preparation of the manuscript.
CR American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS8, DOI 10.2337/dc15-S005
   Barbosa MPCR, 2014, CLIN PHYSL FUNCT IMA
   Bilchick KC, 2002, AM J CARDIOL, V90, P24, DOI 10.1016/S0002-9149(02)02380-9
   BLAND JM, 1986, LANCET, V1, P307
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   COOK JR, 1991, J AM COLL CARDIOL, V17, P480, DOI 10.1016/S0735-1097(10)80119-6
   Correa FR, 2013, INT J SPORTS MED, V34, P111, DOI 10.1055/s-0032-1321888
   Correa FR, 2012, J RESP CARDIOV PHY T, V1, P37
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111
   Gamelin FX, 2006, MED SCI SPORT EXER, V38, P887, DOI 10.1249/01.mss.0000218135.79476.9c
   Porto LGG, 2009, PACE, V32, P43, DOI 10.1111/j.1540-8159.2009.02175.x
   Hamilton D M, 2000, J Cardiopulm Rehabil, V20, P156, DOI 10.1097/00008483-200005000-00003
   Hernandes NA, 2011, EUR RESPIR J, V38, P261, DOI 10.1183/09031936.00142010
   Jiang W, 1997, AM J CARDIOL, V80, P808, DOI 10.1016/S0002-9149(97)00526-2
   Kervio G, 2003, MED SCI SPORT EXER, V35, P169, DOI 10.1249/01.MSS.0000043545.02712.A7
   Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878
   La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lucreziotti S, 2000, AM HEART J, V139, P1088, DOI 10.1067/mhj.2000.106168
   Malfatto G, 1998, AM J CARDIOL, V81, P834, DOI 10.1016/S0002-9149(98)00021-6
   NIEMELA MJ, 1994, J AM COLL CARDIOL, V23, P1370, DOI 10.1016/0735-1097(94)90379-4
   Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510
   Nunan D, 2008, EUR J APPL PHYSIOL, V103, P529, DOI 10.1007/s00421-008-0742-6
   Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4
   Ponikowski P, 1996, CLIN SCI, V91, P391, DOI 10.1042/cs0910391
   Radespiel-Troger M, 2003, CLIN AUTON RES, V13, P99, DOI 10.1007/s10286-003-0085-7
   Caruso FCR, 2011, DISABIL REHABIL, V33, P751, DOI 10.3109/09638288.2010.511420
   Sandercock GRH, 2004, PHYSIOL MEAS, V25, P1115, DOI 10.1088/0967-3334/25/5/003
   Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013
   Shah SA, 2013, AM J CARDIOL, V112, P533, DOI 10.1016/j.amjcard.2013.04.018
   STEIN PK, 1995, AM HEART J, V129, P975, DOI 10.1016/0002-8703(95)90119-1
   Vanderlei LCM, 2008, BRAZ J MED BIOL RES, V41, P854, DOI 10.1590/S0100-879X2008005000039
   VANHOOGENHUYZE D, 1991, AM J CARDIOL, V68, P1668, DOI 10.1016/0002-9149(91)90327-H
   Wallen MB, 2012, EUR J APPL PHYSIOL, V112, P1153, DOI 10.1007/s00421-011-2079-9
   Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9
   Wu G, 2003, AM HEART J, V146, P129, DOI 10.1016/S0002-8703(03)00119-4
NR 38
TC 1
Z9 1
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 9
PY 2016
VL 11
IS 12
AR e0167407
DI 10.1371/journal.pone.0167407
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4PU
UT WOS:000389587100092
PM 27936043
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bot, SD
   Mackenbach, JD
   Nijpels, G
   Lakerveld, J
AF Bot, Sandra D.
   Mackenbach, Joreintje D.
   Nijpels, Giel
   Lakerveld, Jeroen
TI Association between Social Network Characteristics and Lifestyle
   Behaviours in Adults at Risk of Diabetes and Cardiovascular Disease
SO PLOS ONE
LA English
DT Article
ID PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; INTERVENTIONS; CONCORDANCE;
   POPULATION; PREVENTION; GUIDELINES; MORTALITY; SPOUSES; SUPPORT
AB Objectives
   In this exploratory study we examined the associations between several social network characteristics and lifestyle behaviours in adults at increased risk of diabetes and cardiovascular diseases. In addition, we explored whether similarities in lifestyle between individuals and their network members, or the level of social support perceived by these individuals, could explain these associations.
   Methods
   From the control group of the Hoorn Prevention Study, participants with high and low educational attainment were approached for a structured interview between April and August 2010. Inclusion was stopped when fifty adults agreed to participate. Participants and a selection of their network members (e.g. spouses, best friends, neighbours, colleagues) completed a questionnaire on healthy lifestyle that included questions on fruit and vegetable intake, daily physical activity and leisure-time sedentary behaviour. We first examined associations between network characteristics and lifestyle using regression analyses. Second, we assessed associations between network characteristics and social support, social support and lifestyle, and compared the participants' lifestyles to those of their network members using concordance correlation coefficients.
   Results
   Fifty adults (50/83 x 100 = 62% response) and 170 of their network members (170/192 x 100 = 89% response) participated in the study. Individuals with more close-knit relationships, more friends who live nearby, and a larger and denser network showed higher levels of vegetable consumption and physical activity, and lower levels of sedentary behaviour. Perceived social norms or perceived support for behavioural change were not related to healthy lifestyle. Except for spousal concordance for vegetable intake, the lifestyle of individuals and their network members were not alike.
   Conclusions
   Study results suggest that adults with a larger and denser social network have a healthier lifestyle. Underlying mechanisms for these associations should be further explored, as the current results suggest a minimal role for social support and modelling by network members.
C1 [Bot, Sandra D.; Nijpels, Giel] VU Med Ctr Amsterdam, Dept Gen Practice & Elderly Care, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Mackenbach, Joreintje D.; Lakerveld, Jeroen] VU Med Ctr Amsterdam, Dept Epidemiol & Biostat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Bot, SD (reprint author), VU Med Ctr Amsterdam, Dept Gen Practice & Elderly Care, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
EM sdmbot@gmail.com
OI Lakerveld, Jeroen/0000-0002-8551-6748
CR Ajrouch KJ, 2005, J GERONTOL B-PSYCHOL, V60, pS311, DOI 10.1093/geronb/60.6.S311
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Angermayr L, 2010, ANN BEHAV MED, V40, P49, DOI 10.1007/s12160-010-9206-4
   Bandura A., 1997, SELF EFFICACY EXERCI
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Berkman LF, 2000, SOCIAL EPIDEMIOLOGY
   Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123
   BOXMAN EAW, 1991, SOC NETWORKS, V13, P51, DOI 10.1016/0378-8733(91)90013-J
   Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974
   Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269
   Curioni CC, 2005, INT J OBESITY, V29, P1168, DOI 10.1038/sj.ijo.0803015
   de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023
   Emmons KM, 2007, HEALTH EDUC BEHAV, V34, P315, DOI 10.1177/1090198106288011
   Fleming P, 2008, CAN FAM PHYSICIAN, V54, P1706
   GIANNETTI VJ, 1985, SOC SCI MED, V20, P241, DOI 10.1016/0277-9536(85)90237-0
   Hannon PA, 2003, APPETITE, V40, P77, DOI 10.1016/S0195-6663(02)00140-X
   Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P971, DOI 10.1136/jech.2003.014530
   Heritage Z, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-243
   Huurre T, 2007, J AFFECT DISORDERS, V100, P55, DOI 10.1016/j.jad.2006.09.019
   Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9
   Lakerveld J, 2013, PREV MED, V57, P351, DOI 10.1016/j.ypmed.2013.06.011
   Lakerveld J, 2011, PATIENT EDUC COUNS, V85, pE53, DOI 10.1016/j.pec.2011.01.014
   Lakerveld Jeroen, 2008, BMC Endocr Disord, V8, P6, DOI 10.1186/1472-6823-8-6
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Maia J, 2014, J SCI MED SPORT, V17, P381, DOI 10.1016/j.jsams.2013.09.004
   MCCALLISTER L, 1978, SOCIOL METHOD RES, V7, P131, DOI 10.1177/004912417800700202
   McLaughlin D, 2010, J HEALTH PSYCHOL, V15, P671, DOI 10.1177/1359105310368177
   Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x
   MOORE G, 1990, AM SOCIOL REV, V55, P726, DOI 10.2307/2095868
   Pachucki MA, 2011, AM J PUBLIC HEALTH, V101, P2170, DOI 10.2105/AJPH.2011.300282
   Potter J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071052
   Rosenquist JN, 2010, ANN INTERN MED, V152, P426, DOI 10.7326/0003-4819-152-7-201004060-00007
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Sawka KJ, 2014, ASS ASPECTS FRIENDSH, P2014, DOI [10.1155/2014/632689, DOI 10.1155/2014/632689]
   Schwingshackl L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140846
   Sedentary Behaviour Research Network (SBRN), WHAT IS SED BEH
   Shelton RC, 2011, AM J PUBLIC HEALTH, V101, P2102, DOI 10.2105/AJPH.2010.196030
   Slootmaker SM, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1139
   Sorensen G, 2007, AM J PUBLIC HEALTH, V97, P1216, DOI 10.2105/AJPH.2006.088120
   Spanier PA, 2001, CAN J PUBLIC HEALTH, V92, P210
   Stahl T, 2001, SOC SCI MED, V52, P1, DOI 10.1016/S0277-9536(00)00116-7
   Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1249/01.MSS.0000038974.76900.92
   Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016
   Van der Gaag MPJ, 2003, CREATION RETURNS SOC
   van Lee L, 2016, EUR J CLIN NUTR, V70, P262, DOI 10.1038/ejcn.2015.163
   Volker B., 2001, TIJDSCHRIFTVOOR SOCI, P337
   von dem Knesebeck O, 2005, SOZ PRAVENTIV MED, V50, P311, DOI 10.1007/s00038-005-4045-7
   Vonneilich N, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-43
   Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490
   Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024
   Wellman B., 1999, NETWORKS GLOBAL VILL
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x
NR 56
TC 7
Z9 7
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2016
VL 11
IS 10
AR e0165041
DI 10.1371/journal.pone.0165041
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA6BX
UT WOS:000386711100018
PM 27798709
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Chen, KT
   Chen, YY
   Wang, CW
   Chuang, CL
   Chiang, LM
   Lai, CL
   Lu, HK
   Dwyer, GB
   Chao, SP
   Shih, MK
   Hsieh, KC
AF Chen, Kuen-Tsann
   Chen, Yu-Yawn
   Wang, Chia-Wei
   Chuang, Chih-Lin
   Chiang, Li-Ming
   Lai, Chung-Liang
   Lu, Hsueh-Kuan
   Dwyer, Gregory B.
   Chao, Shu-Ping
   Shih, Ming-Kuei
   Hsieh, Kuen-Chang
TI Comparison of Standing Posture Bioelectrical Impedance Analysis with DXA
   for Body Composition in a Large, Healthy Chinese Population
SO PLOS ONE
LA English
DT Article
ID X-RAY ABSORPTIOMETRY; WHOLE-BODY; MAGNETIC-RESONANCE; NORMAL-WEIGHT;
   FAT; VALIDATION; ACCURACY; PERCENTAGE; CHILDREN; VALIDITY
AB Bioelectrical impedance analysis (BIA) is a common method for assessing body composition in research and clinical trials. BIA is convenient but when compared with other reference methods, the results have been inconclusive. The level of obesity degree in subjects is considered to be an important factor affecting the accuracy of the measurements. A total of 711 participants were recruited in Taiwan and were sub-grouped by gender and levels of adiposity. Regression analysis and Bland-Altman analysis were used to evaluate the agreement of the measured body fat percentage (BF%) between BIA and DXA. The BF% measured by the DXA and BIA methods (Tanita BC-418) were expressed as BF%(DXA) and BF %(BIA8), respectively. A one-way ANOVA was used to test the differences in BF% measurements by gender and levels of adiposity. The estimated BF%(BIA8) and BF%(DXA) in the all subjects, male and female groups were all highly correlated (r = 0.934, 0.901, 0.916, all P<0.001). The average estimated BF%(BIA8) (22.54 +/- 9.48%) was significantly lower than the average BF%(DXA) (26.26 +/- 11.18%). The BF%(BIA8) was overestimated in the male subgroup (BF%(DXA)<15%), compared to BF%(DXA) by 0.45%, respectively. In the other subgroups, the BF%(BIA8) values were all underestimated. Standing BIA estimating body fat percentage in Chinese participants have a high correlation, but underestimated on normal and high obesity degree in both male and female subjects.
C1 [Chen, Kuen-Tsann; Wang, Chia-Wei] Natl Chung Hsing Univ, Dept Appl Math, Taichung, Taiwan.
   [Chen, Yu-Yawn] Natl Taiwan Univ Sport, Dept Phys Educ, Taichung, Taiwan.
   [Chen, Yu-Yawn] St Marys Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Ilan, Taiwan.
   [Chuang, Chih-Lin] Jen Ai Hosp, Dept Radiol, Taichung, Taiwan.
   [Chiang, Li-Ming] East Stroudsburg Univ, Dept Hospitality Recreat & Tourism Management, East Stroudsburg, PA USA.
   [Lai, Chung-Liang] Minist Hlth & Welf, Dept Phys Med & Rehab, Taichung Hosp, Taichung, Taiwan.
   [Lu, Hsueh-Kuan] Natl Taiwan Univ Sport, Sport Sci Res Ctr, Taichung, Taiwan.
   [Dwyer, Gregory B.] East Stroudsburg Univ, Dept Exercise Sci, East Stroudsburg, PA USA.
   Natl Taiwan Univ Sport, Dept Exercise Hlth Sci, Taichung, Taiwan.
   [Shih, Ming-Kuei] Natl Kaohsiung Univ Hospitality & Tourism, Dept Food & Beverage Management, Kaohsiung, Taiwan.
   [Hsieh, Kuen-Chang] Natl Chin Yi Univ Technol, Fundamental Educ Ctr, Taichung, Taiwan.
   [Hsieh, Kuen-Chang] Charder Elect Co Ltd, Res Ctr, Taicung, Taiwan.
RP Hsieh, KC (reprint author), Natl Chin Yi Univ Technol, Fundamental Educ Ctr, Taichung, Taiwan.; Hsieh, KC (reprint author), Charder Elect Co Ltd, Res Ctr, Taicung, Taiwan.
EM abaqus0927@yahoo.com.tw
FU ministry of Health and Welfare of the Republic of China [PG-10417];
   National Science Council of the republic of China [NSC 100-2410
   H-H-028-MY3]; commercial company Charder Electronic Co., Ltd
FX This work was supported by grants from the ministry of Health and
   Welfare of the Republic of China (PG-10417) and the National Science
   Council of the republic of China (NSC 100-2410 H-H-028-MY3).
   Additionally, Co-author Kuen-Chang Hsieh received salary from the
   commercial company Charder Electronic Co., Ltd during this study.
   Charder Electronic Co., Ltd did not have any additional role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bary GA, 1998, CONTEMPORARY DIAGNOS
   BLAND JM, 1986, LANCET, V1, P307
   Bohm A, 2013, EUR J CLIN NUTR, V67, pS79, DOI 10.1038/ejcn.2012.168
   Bosaeus M, 2014, CLIN NUTR, V33, P471, DOI 10.1016/j.clnu.2013.06.017
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   Erceg DN, 2010, NUTR RES, V30, P297, DOI 10.1016/j.nutres.2010.04.009
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gupta N, 2011, J SCI MED SPORT, V14, P33, DOI 10.1016/j.jsams.2010.04.005
   Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739
   Hemmingsson E, 2009, OBESITY, V17, P183, DOI 10.1038/oby.2008.474
   JOHANSSON AG, 1993, AM J CLIN NUTR, V57, P323
   Katch FI, 1969, MED SCI SPORTS, p[1, 212]
   Kim H, 2011, NUTR RES PRACT, V5, P246, DOI 10.4162/nrp.2011.5.3.246
   Lee LC, 2014, INT J GERONTOL, V8, P137, DOI 10.1016/j.ijge.2013.08.010
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Ludbrook J, 2002, CLIN EXP PHARMACOL P, V29, P527, DOI 10.1046/j.1440-1681.2002.03686.x
   Lukaski HC, 2003, NUTRITION, V19, P851, DOI 10.1016/S0899-9007(03)00166-7
   Mally K, 2011, EUR J APPL PHYSIOL, V111, P1879, DOI 10.1007/s00421-010-1795-x
   McBride G., 2005, NIWA CLIENT REPORT H
   Neovius M, 2006, OBESITY, V14, P1731, DOI 10.1038/oby.2006.199
   Nigam P, 2013, DIABETES METAB SYND, V7, P72, DOI 10.1016/j.dsx.2013.02.031
   Oshima Y, 2006, EUR J CLIN NUTR, V60, P938, DOI 10.1038/sj.ejcn.1602402
   Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993
   POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005
   Sentongo TA, 2000, J PEDIATR GASTR NUTR, V31, P33, DOI 10.1097/00005176-200007000-00009
   Sun G, 2005, AM J CLIN NUTR, V81, P74
   Tan YX, 1997, MED SCI SPORT EXER, V29, P1269, DOI 10.1097/00005768-199709000-00022
   Temple D, 2015, PUBLIC HEALTH NUTR, V18, P446, DOI 10.1017/S1368980014000597
   Tothill P, 2001, BRIT J RADIOL, V74, P166, DOI 10.1259/bjr.74.878.740166
   Tothill P, 2002, ANN NY ACAD SCI, V904, P63
   Wang JG, 2013, J STRENGTH COND RES, V27, P236, DOI 10.1519/JSC.0b013e31824f2040
   Wang L, 2014, MED SCI MONITOR, V20, P2298, DOI 10.12659/MSM.890696
NR 32
TC 1
Z9 1
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 28
PY 2016
VL 11
IS 7
AR e0160105
DI 10.1371/journal.pone.0160105
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5IL
UT WOS:000381516100114
PM 27467065
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Xie, S
   Zhang, Z
   Chang, FY
   Wang, YS
   Zhang, ZX
   Zhou, ZY
   Guo, H
AF Xie, Sheng
   Zhang, Zhe
   Chang, Feiyan
   Wang, Yishi
   Zhang, Zhenxia
   Zhou, Zhenyu
   Guo, Hua
TI Subcortical White Matter Changes with Normal Aging Detected by
   Multi-Shot High Resolution Diffusion Tensor Imaging
SO PLOS ONE
LA English
DT Article
ID HUMAN BRAIN; FIBER TRACKING; IN-VIVO; AGE; INTEGRITY; MRI; ANISOTROPY;
   MICROSTRUCTURE; VOLUME; DYSMYELINATION
AB Subcortical white matter builds neural connections between cortical and subcortical regions and constitutes the basis of neural networks. It plays a very important role in normal brain function. Various studies have shown that white matter deteriorates with aging. However, due to the limited spatial resolution provided by traditional diffusion imaging techniques, microstructural information from subcortical white matter with normal aging has not been comprehensively assessed. This study aims to investigate the deterioration effect with aging in the subcortical white matter and provide a baseline standard for pathological disorder diagnosis. We apply our newly developed multi-shot high resolution diffusion tensor imaging, using self-feeding multiplexed sensitivity-encoding, to measure subcortical white matter changes in regions of interest of healthy persons with a wide age range. Results show significant fractional anisotropy decline and radial diffusivity increasing with age, especially in the anterior part of the brain. We also find that subcortical white matter has more prominent changes than white matter close to the central brain. The observed changes in the subcortical white matter may be indicative of a mild demyelination and a loss of myelinated axons, which may contribute to normal age-related functional decline.
C1 [Xie, Sheng; Chang, Feiyan; Zhang, Zhenxia] China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China.
   [Zhang, Zhe; Wang, Yishi; Guo, Hua] Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China.
   [Zhou, Zhenyu] GE Healthcare China, Beijing, Peoples R China.
RP Xie, S (reprint author), China Japan Friendship Hosp, Dept Radiol, Beijing, Peoples R China.; Guo, H (reprint author), Tsinghua Univ, Dept Biomed Engn, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China.
EM xs_mri@126.com; huaguo@tsinghua.edu.cn
OI Zhang, Zhe/0000-0001-8220-8443
FU National Natural Science Foundation of China [61271132, 61571258];
   Beijing Natural Science Foundation [7142091]; Ministry of Science and
   Technology of China grant [2012IM030100]; GE Healthcare China
FX This work was funded by National Natural Science Foundation of China
   (61271132 and 61571258) (http://www.nsfc.gov.cn/) (HG), Beijing Natural
   Science Foundation (7142091)
   (http://www.bjkw.gov.cn/n244495/n244682/2665091.html) (HG), and a
   Ministry of Science and Technology of China grant (2012IM030100)
   (http://www.most.gov.cn/eng/organization/) (HG). The above funders
   provided support in the form of salaries for authors Zhe Zhang and Yishi
   Wang, but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. The specific roles of these authors are articulated in the
   'author contributions' section. Author Zhenyu Zhou is employed by GE
   Healthcare China. GE Healthcare China provided support in the form of
   salary for author Zhenyu Zhou, but did not have any additional role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The specific role of this author is
   articulated in the 'author contributions' section.
CR Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105
   Bammer R, 2009, MAGN RESON IMAGING C, V17, P175, DOI 10.1016/j.mric.2009.01.011
   Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783
   Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872
   Bhagat YA, 2004, J MAGN RESON IMAGING, V20, P216, DOI 10.1002/jmri.20102
   Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041
   Chen NK, 2013, NEUROIMAGE, V72, P41, DOI 10.1016/j.neuroimage.2013.01.038
   Chun T, 2000, AM J NEURORADIOL, V21, P1078
   Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563
   Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068
   Engelhardt Eliasz, 2009, Dement. neuropsychol., V3, P228, DOI 10.1590/S1980-57642009DN30300009
   Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742
   Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017
   Hsu JL, 2010, NEUROIMAGE, V49, P32, DOI 10.1016/j.neuroimage.2009.08.031
   Huang F, 2010, MAGN RESON MED, V64, P1078, DOI 10.1002/mrm.22504
   Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080
   Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004
   Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003
   Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2
   Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008
   MEIERRUGE W, 1992, ANN NY ACAD SCI, V673, P260, DOI 10.1111/j.1749-6632.1992.tb27462.x
   Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070
   Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785
   Naganawa S, 2003, EUR RADIOL, V13, P6, DOI 10.1007/s00330-002-1549-1
   Nunes RG, 2005, MAGN RESON MED, V53, P1474, DOI 10.1002/mrm.20499
   Nusbaum AO, 2001, AM J NEURORADIOL, V22, P136
   O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632
   Pal D, 2011, J CLIN NEUROSCI, V18, P193, DOI 10.1016/j.jocn.2010.05.033
   Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6
   Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452
   Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024
   Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017
   Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
   Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008
   Sullivan EV, 2006, CEREB CORTEX, V16, P1030, DOI 10.1093/cercor/bhj045
   Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002
   Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556
   Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027
   Takahashi S, 2002, NEUROSCI LETT, V332, P45, DOI 10.1016/S0304-3940(02)00914-X
   Truong TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091424
   Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052
   Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048
   Zhang Z, 2015, NEUROIMAGE, V105, P552, DOI 10.1016/j.neuroimage.2014.10.022
NR 45
TC 6
Z9 6
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 22
PY 2016
VL 11
IS 6
AR e0157533
DI 10.1371/journal.pone.0157533
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WX
UT WOS:000378212800033
PM 27332713
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Campagna, G
   Zampetti, S
   Gallozzi, A
   Giansanti, S
   Chiesa, C
   Pacifico, L
   Buzzetti, R
AF Campagna, Giuseppe
   Zampetti, Simona
   Gallozzi, Alessia
   Giansanti, Sara
   Chiesa, Claudio
   Pacifico, Lucia
   Buzzetti, Raffaella
TI Excellent Intra and Inter-Observer Reproducibility of Wrist
   Circumference Measurements in Obese Children and Adolescents
SO PLOS ONE
LA English
DT Article
ID WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; NECK CIRCUMFERENCE; RATIO;
   VARIABILITY; RELIABILITY; HEIGHT; INDEX; TOOLS; FAT
AB In a previous study, we found that wrist circumference, in particular its bone component, was associated with insulin resistance in a population of overweight/obese children. The aim of the present study was to evaluate the intra- and inter-operator variability in wrist circumference measurement in a population of obese children and adolescents. One hundred and two (54 male and 48 female) obese children and adolescents were consecutively enrolled. In all subjects wrist circumferences were measured by two different operators two times to assess intra- and inter-operator variability. Statistical analysis was performed using SAS v. 9.4 and JMP v. 12. Measurements of wrist circumference showed excellent inter-operator reliability with Intra class Correlation Coefficients (ICC) of 0.96 and ICC of 0.97 for the first and the second measurement, respectively. The intra- operator reliability was, also, very strong with a Concordance Correlation Coefficient (CCC) of 0.98 for both operators. The high reproducibility demonstrated in our results suggests that wrist circumference measurement, being safe, non-invasive and repeatable can be easily used in out-patient settings to identify youths with increased risk of insulin-resistance. This can avoid testing the entire population of overweight/obese children for insulin resistance parameters.
C1 [Campagna, Giuseppe; Zampetti, Simona; Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Gallozzi, Alessia; Giansanti, Sara; Pacifico, Lucia] Univ Roma La Sapienza, Policlin Umberto Hosp 1, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Chiesa, Claudio] CNR, Inst Translat Pharmacol, Rome, Italy.
RP Buzzetti, R (reprint author), Univ Roma La Sapienza, Dept Expt Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM raffaella.buuzzetti@uniroma1.it
RI Pacifico, Lucia/S-4662-2019; Buzzetti, Raffaella/K-3090-2016
OI Buzzetti, Raffaella/0000-0003-1490-6041
CR Ashwell M, 1996, BRIT MED J, V312, P377
   Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P14
   Berg RL, 1992, P 17 ANN SAS US GROU, P1521
   BLAND JM, 1986, LANCET, V1, P307
   Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737
   Bridger T, 2009, PAED CHILD HEALT-CAN, V14, P177, DOI 10.1093/pch/14.3.177
   Capizzi M, 2011, CIRCULATION, V123, P1757, DOI 10.1161/CIRCULATIONAHA.110.012898
   Chiarelli F, 2008, EUR J ENDOCRINOL, V159, pS67, DOI 10.1530/EJE-08-0245
   Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a
   Silva Cleliani de Cassia da, 2014, Rev. paul. pediatr., V32, P221, DOI 10.1590/0103-0582201432210713
   Ferrante E, 1993, Minerva Pediatr, V45, P289
   GRANT JP, 1981, SURG CLIN N AM, V61, P437
   Hazani Ron, 2008, Eplasty, V8, pe53
   Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740
   Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028
   LaBerge RC, 2009, PEDIATR PULM, V44, P64, DOI 10.1002/ppul.20944
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lindner P, 1973, ASSESS DEGREES FATNE
   Magalhães Elma Izze da Silva, 2014, Rev. paul. pediatr., V32, P273, DOI 10.1590/0103-0582201432320
   MILLER JZ, 1991, BONE MINER, V14, P137, DOI 10.1016/0169-6009(91)90091-D
   Mitrea A, 2013, ROM J DIABETES NUTR, V20, P323
   Mueller NT, 2013, AM J HUM BIOL, V25, P581, DOI 10.1002/ajhb.22416
   Nadas J, 2008, MED SCI MONITOR, V14, pCR15
   Noudeh YJ, 2013, J CLIN ENDOCR METAB, V98, P777, DOI 10.1210/jc.2012-2416
   Nyland J, 2006, CLIN IMAG, V30, P335, DOI 10.1016/j.clinimag.2006.02.004
   Panoulas VF, 2008, POSTGRAD MED J, V84, P344, DOI 10.1136/pgmj.2008.068825
   Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340
   Reddy RS, 2005, CURR ORTHOPAED, V19, P171, DOI 10.1016/j.cuor.2005.02.008
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Stabe C, 2013, CLIN ENDOCRINOL, V78, P874, DOI 10.1111/j.1365-2265.2012.04487.x
   Strobel M, 2002, MANUAL ARTHROSCOPIC
   Sung RYT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-324
   Taylor RW, 2000, AM J CLIN NUTR, V72, P490
NR 33
TC 3
Z9 3
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 13
PY 2016
VL 11
IS 6
AR e0156646
DI 10.1371/journal.pone.0156646
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO5KF
UT WOS:000377821300009
PM 27294398
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Salazar, MFM
   Waldner, C
   Stookey, J
   Bollinger, TK
AF Salazar, Maria Fernanda Mejia
   Waldner, Cheryl
   Stookey, Joseph
   Bollinger, Trent K.
TI Infectious Disease and Grouping Patterns in Mule Deer
SO PLOS ONE
LA English
DT Article
ID CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ELK CERVUS-ELAPHUS;
   GROUP-SIZE; ODOCOILEUS-HEMIONUS; SOCIAL-ORGANIZATION; PRION
   TRANSMISSION; BEHAVIOR; DYNAMICS; HABITAT
AB Infectious disease dynamics are determined, to a great extent, by the social structure of the host. We evaluated sociality, or the tendency to form groups, in Rocky Mountain mule deer (Odocoileus hemionus hemionus) from a chronic wasting disease (CWD) endemic area in Saskatchewan, Canada, to better understand factors that may affect disease transmission. Using group size data collected on 365 radio-collared mule deer (2008-2013), we built a generalized linear mixed model (GLMM) to evaluate whether factors such as CWD status, season, habitat and time of day, predicted group occurrence. Then, we built another GLMM to determine factors associated with group size. Finally, we used 3 measures of group size (typical, mean and median group sizes) to quantify levels of sociality. We found that mule deer showing clinical signs of CWD were less likely to be reported in groups than clinically healthy deer after accounting for time of day, habitat, and month of observation. Mule deer groups were much more likely to occur in February and March than in July. Mixed-sex groups in early gestation were larger than any other group type in any season. Groups were largest and most likely to occur at dawn and dusk, and in open habitats, such as cropland. We discuss the implication of these results with respect to sociobiology and CWD transmission dynamics.
C1 [Salazar, Maria Fernanda Mejia; Bollinger, Trent K.] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.
   [Waldner, Cheryl; Stookey, Joseph] Univ Saskatchewan, Dept Large Anim Clin Sci, Saskatoon, SK, Canada.
   [Bollinger, Trent K.] Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada.
RP Bollinger, TK (reprint author), Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.; Bollinger, TK (reprint author), Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada.
EM trent.bollinger@usask.ca
FU PrioNet Canada a Network of Centres of Excellence of Canada;
   Saskatchewan Ministry of Environment; Canadian Wildlife Health
   Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)
FX This project was funded primarily by PrioNet Canada a Network of Centres
   of Excellence of Canada (www.nce-rce.gc.ca). Additional funding and
   support was provided by Saskatchewan Ministry of Environment
   (http://environment.gov.sk.ca/) and the Canadian Wildlife Health
   Cooperative (http://www.ccwhc.ca/). MFMS received a scholarship funding
   from the Consejo Nacional de Ciencia y Tecnologia (CONACyT)
   (http://www.conacyt.mx/). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028
   Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020
   ALCOCK J. A., 2009, ANIMAL BEHAV EVOLUTI
   Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Arakawa H, 2010, HORM BEHAV, V57, P330, DOI 10.1016/j.yhbeh.2010.01.002
   Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858
   Behringer DC, 2006, NATURE, V441, P421, DOI [10.1038/441421a, 10.1038/441421]
   Bender LC, 1996, AM MIDL NAT, V135, P261, DOI 10.2307/2426708
   Bishop R. C., 2004, HUMAN DIMENSIONS WIL, V9, P181, DOI DOI 10.1080/10871200490479963
   Body G, 2015, ACTA ETHOL, V18, P101, DOI 10.1007/s10211-014-0190-8
   Bouwman KM, 2010, BIOL LETTERS, V6, P462, DOI 10.1098/rsbl.2010.0020
   Bowyer RT, 2001, ALCES-N AM MOOSE CON, V37, P371
   Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020
   Butler MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126374
   Canadian Wildlife Health Cooperative, 2013, CHRON WAST DIS TEST
   CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199
   Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532
   Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294
   COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159
   Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603
   Cross PC, 2005, DIS INVASION CONTROL
   DEVOS A, 1967, AM MIDL NAT, V77, P390, DOI 10.2307/2423349
   Dohoo I, 2009, VET EPIDEMIOLOGICAL, P579
   Efron B, 1994, INTRO BOOTSTRAP
   GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217
   Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479
   Godfrey Stephanie S., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P235, DOI 10.1016/j.ijppaw.2013.09.001
   Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678
   Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2
   Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899
   Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144
   HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6
   HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027
   Hirth DH, 1977, WILDLIFE MONOGR, V53, P3
   Hjeljord O, 2001, ALCES-N AM MOOSE CON, V37, P353
   Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113
   JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345
   Karns GR, 2009, J WILDLIFE DIS, V45, P196, DOI 10.7589/0090-3558-45.1.196
   Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742
   Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503
   KUCERA TE, 1978, J MAMMAL, V59, P463, DOI 10.2307/1380224
   Kurvers RHJM, 2014, TRENDS ECOL EVOL, V29, P326, DOI 10.1016/j.tree.2014.04.002
   LAGORY KE, 1986, BEHAVIOUR, V98, P168, DOI 10.1163/156853986X00955
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x
   Lingle S, 2003, CAN J ZOOL, V81, P1119, DOI [10.1139/z03-097, 10.1139/Z03-097]
   Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85
   LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192
   Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916
   Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2
   Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019
   Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676
   Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010
   Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665
   Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763
   Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x
   Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0115
   Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0111
   Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003
   Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8
   Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012
   Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520
   Putman R., 1988, NATURAL HIST DEER
   Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, P687
   Reiczigel J, 2005, J PARASITOL, V91, P245, DOI 10.1645/GE-281R1
   Reiczigel J, 2016, EUROPEAN J ECOLOGY
   Reiczigel J, 2013, QUANTITATIVE PARASIT
   Reiczigel J, 2008, ANIM BEHAV, V75, P715, DOI 10.1016/j.anbehav.2007.05.020
   Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.2307/3284760
   SAS, 2006, GLIMMIX PROC SAS STA
   Semeniuk MB, 2015, MAMMALIA, V79, P131, DOI 10.1515/mammalia-2014-0054
   Silbernagel E, 2010, THESIS U SASKATTCHEW
   Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172
   Skelton NK, 2010, THESIS U SASKATCHEWA
   Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546
   Strahler AN, 1976, ELEMENTS PHYS GEOGRA
   Sullivan L., 2008, ESSENTIAL BIOSTATIST, P175
   Time and Date AS, 2014, SWIFT CAN SUNR SUNS
   VanderWaal KL, 2013, BEHAV ECOL SOCIOBIOL, V67, P1951, DOI 10.1007/s00265-013-1602-x
   Vasilyeva O, 2015, MATH BIOSCI ENG, V12, P209, DOI 10.3934/mbe.2015.12.209
   Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x
   Whitehead H., 2008, ANAL ANIMAL SOC QUAN
   Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629
   WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105
   Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340
NR 86
TC 2
Z9 2
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 23
PY 2016
VL 11
IS 3
AR e0150830
DI 10.1371/journal.pone.0150830
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3QJ
UT WOS:000372701200032
PM 27007808
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Scholes, S
   Bridges, S
   Fat, LN
   Mindell, JS
AF Scholes, Shaun
   Bridges, Sally
   Fat, Linda Ng
   Mindell, Jennifer S.
TI Comparison of the Physical Activity and Sedentary Behaviour Assessment
   Questionnaire and the Short-Form International Physical Activity
   Questionnaire: An Analysis of Health Survey for England Data
SO PLOS ONE
LA English
DT Article
ID CRITERION-RELATED VALIDITY; RISK-FACTORS; IPAQ; RELIABILITY; ADULTS;
   TIME; AGE; COEFFICIENT; AGREEMENT
AB Background
   The Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ), used within the Health Survey for England (HSE) at 5-yearly intervals, is not included annually due to funding and interview-length constraints. Policy-makers and data-users are keen to consider shorter instruments such as the Short-form International Physical Activity Questionnaire (IPAQ) for the annual survey. Both questionnaires were administered in HSE 2012, enabling comparative assessment in a random sample of 1252 adults.
   Methods
   Relative agreement using prevalence-adjusted bias-adjusted Kappa (PABAK) statistics was estimated for: sufficient aerobic activity (moderate-to-vigorous physical activity [MVPA] >= 150minutes/week); inactivity (MVPA<30minutes/week); and excessive sitting (>= 540minutes/weekday). Cross-sectional associations with health outcomes were compared across tertiles of MVPA and tertiles of sitting time using logistic regression with tests for linear trend.
   Results
   Compared with PASBAQ data, IPAQ-assessed estimates of sufficient aerobic activity and inactivity were higher and lower, respectively; estimates of excessive sitting were higher. Demographic patterns in prevalence were similar. Agreement using PABAK statistics was fair-to-moderate for sufficient aerobic activity (0.32-0.49), moderate-to-substantial for inactivity (0.42-0.74), and moderate-to-substantial for excessive sitting (0.49-0.75). As with the PASBAQ, IPAQ-assessed MVPA and sitting each showed graded associations with mental well-being (women: P for trend = 0.003 and 0.004, respectively) and obesity (women: P for trend = 0.007 and 0.014, respectively).
   Conclusions
   Capturing habitual physical activity and sedentary behaviour through brief questionnaires is complex. Differences in prevalence estimates can reflect differences in questionnaire structure and content rather than differences in reported behaviour. Treating all IPAQ-assessed walking as moderate-intensity contributed to the differences in prevalence estimates. PASBAQ data will be used for population surveillance every 4 to 5 years. The current version of the Short-form IPAQ was included in HSE 2013-14 to enable more frequent assessment of physical activity and sedentary behaviour; a modified version with different item-ordering and additional questions on walking-pace and effort was included in HSE 2015.
C1 [Scholes, Shaun; Fat, Linda Ng; Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England.
   [Bridges, Sally] NatCen Social Res, 35 Northampton Sq, London EC1V 0AX, England.
RP Scholes, S (reprint author), UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England.
EM s.scholes@ucl.ac.uk
RI Mindell, Jennifer S/G-2241-2011
OI Mindell, Jennifer S/0000-0002-7604-6131
FU Health and Social Care Information Centre
FX The Health Survey for England 2012 was funded by the Health and Social
   Care Information Centre. The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ainsworth BE, 2006, MED SCI SPORT EXER, V38, P1584, DOI 10.1249/01.mss.0000229457.73333.9a
   Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807
   Bauman Adrian, 2006, Promot Educ, V13, P92, DOI 10.1177/10253823060130020103
   Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003
   Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5
   Becares L, 2009, HLTH SURVEY ENGLAND, V1, P221
   Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008
   Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8
   Brown W, 2004, AUST NZ J PUBL HEAL, V28, P128, DOI 10.1111/j.1467-842X.2004.tb00925.x
   *CHIEF MED OFF, 2004, LEAST 5 WEEK EV IMP
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314
   Department for Culture Media and Sport Strategy Unit, 2002, GAME PLAN STRAT DEL
   Department of Health, 2011, START ACT STAY ACT
   Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f
   Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840
   Everage NJ, 2014, BIOMED RES INT, DOI 10.1155/2014/389853
   Flight L, 2015, PHARM STAT, V14, P74, DOI 10.1002/pst.1659
   Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1
   Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103
   International Physical Activity Questionnaire, 2004, GUID DAT PROC AN INT
   Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS
   KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2
   Knott C, 2012, HLTH SURVEY ENGLAND, V1, P63
   Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Littman AJ, 2004, EPIDEMIOLOGY, V15, P105, DOI 10.1097/01.ede.0000091604.32542.97
   Lordan G, 2015, RISK ANAL, V35, P2069, DOI 10.1111/risa.12417
   Macniven R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-41
   Maddison R, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-62
   Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69
   Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199
   Neave A., 2014, RESPONSES HLTH SURVE
   Pols MA, 1998, EUR J EPIDEMIOL, V14, P63, DOI 10.1023/A:1007427831179
   Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330
   Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816
   Scholes S, 2012, HLTH SURV ENGL, V1, P1
   Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087
   Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129
   Sim J, 2005, PHYS THER, V85, P257
   Sport & Recreation New Zealand (SPARC), 2004, NZ PHYS ACT QUEST
   Stamatakis E, 2007, AM J PREV MED, V32, P320, DOI 10.1016/j.amepre.2006.12.020
   Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753
   Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077
   Stranges S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005878
   Szklo M, 2007, EPIDEMIOLOGY BASICS
   Taylor-Piliae RE, 2006, AM J EPIDEMIOL, V164, P598, DOI 10.1093/aje/kwj248
   Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63
   The Health and Social Care Information Centre, 2014, HLTH SURV ENGL 2012
   Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003
   Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68
   UKactive, 2014, TURN TID IN
   Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122
   Wareham NJ, 1998, INT J OBESITY, V22, pS30
   Warrens MJ, 2013, J PROBAB STAT, DOI 10.1155/2013/325831
   Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003
   Weston L., 2014, HLTH SURVEY ENGLAND, V1, P1
   World Health Organisation WHO, 2011, GLOB REC PHYS ACT HL
NR 63
TC 14
Z9 14
U1 1
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 18
PY 2016
VL 11
IS 3
AR e0151647
DI 10.1371/journal.pone.0151647
PG 30
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH1ZE
UT WOS:000372582800083
PM 26990093
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Korolev, IO
   Symonds, LL
   Bozoki, AC
AF Korolev, Igor O.
   Symonds, Laura L.
   Bozoki, Andrea C.
CA Alzheimer's Dis Neuroimaging Initi
TI Predicting Progression from Mild Cognitive Impairment to Alzheimer's
   Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic
   Pattern Classification
SO PLOS ONE
LA English
DT Article
ID SURFACE-BASED ANALYSIS; FEATURE-SELECTION; MODEL SELECTION; DISEASE;
   CONVERSION; DIAGNOSIS; RISK; METAANALYSIS; MACHINE; BRAIN
AB Background
   Individuals with mild cognitive impairment (MCI) have a substantially increased risk of developing dementia due to Alzheimer's disease (AD). In this study, we developed a multi-variate prognostic model for predicting MCI-to-dementia progression at the individual patient level.
   Methods
   Using baseline data from 259 MCI patients and a probabilistic, kernel-based pattern classification approach, we trained a classifier to distinguish between patients who progressed to AD-type dementia (n = 139) and those who did not (n = 120) during a three-year follow-up period. More than 750 variables across four data sources were considered as potential predictors of progression. These data sources included risk factors, cognitive and functional assessments, structural magnetic resonance imaging (MRI) data, and plasma proteomic data. Predictive utility was assessed using a rigorous cross-validation framework.
   Results
   Cognitive and functional markers were most predictive of progression, while plasma proteomic markers had limited predictive utility. The best performing model incorporated a combination of cognitive/functional markers and morphometric MRI measures and predicted progression with 80% accuracy (83% sensitivity, 76% specificity, AUC = 0.87). Predictors of progression included scores on the Alzheimer's Disease Assessment Scale, Rey Auditory Verbal Learning Test, and Functional Activities Questionnaire, as well as volume/cortical thickness of three brain regions (left hippocampus, middle temporal gyrus, and inferior parietal cortex). Calibration analysis revealed that the model is capable of generating probabilistic predictions that reliably reflect the actual risk of progression. Finally, we found that the predictive accuracy of the model varied with patient demographic, genetic, and clinical characteristics and could be further improved by taking into account the confidence of the predictions.
   Conclusions
   We developed an accurate prognostic model for predicting MCI-to-dementia progression over a three-year period. The model utilizes widely available, cost-effective, non-invasive markers and can be used to improve patient selection in clinical trials and identify high-risk MCI patients for early treatment.
C1 [Korolev, Igor O.; Symonds, Laura L.; Bozoki, Andrea C.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.
   [Korolev, Igor O.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.
   [Bozoki, Andrea C.] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA.
RP Korolev, IO (reprint author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Korolev, IO (reprint author), Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.
EM korolevi@msu.edu
FU DO/PhD Program; Department of Neurology at Michigan State University;
   Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes
   of Health) [U01 AG024904]; DOD ADNI (Department of Defense)
   [W81XWH-12-2-0012]; National Institute on Aging; National Institute of
   Biomedical Imaging and Bioengineering; Canadian Institutes of Health
   Research; Michigan State University High Performance Computing Center;
   Institute for Cyber-Enabled Research
FX Stipend support was provided to IOK by the DO/PhD Program, the Graduate
   School, and the Department of Neurology at Michigan State University.
   Data collection and sharing for this project was funded by the
   Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes
   of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award
   number W81XWH-12-2-0012). ADNI is funded by the National Institute on
   Aging, the National Institute of Biomedical Imaging and Bioengineering,
   and through generous contributions from the following: Alzheimer's
   Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.;
   Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan
   Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd
   and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics,
   N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &
   Development, LLC.; Johnson & Johnson Pharmaceutical Research &
   Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale
   Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals
   Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and
   Takeda Pharmaceutical Company. The Canadian Institutes of Health
   Research is providing funds to support ADNI clinical sites in Canada.
   Private sector contributions are facilitated by the Foundation for the
   National Institutes of Health (www.fnih.org). The grantee organization
   is the Northern California Institute for Research and Education, and the
   study is coordinated by the Alzheimer's Disease Cooperative Study at the
   University of California, San Diego. ADNI data are disseminated by the
   Laboratory for Neuro Imaging at the University of Southern California.
   Data used in preparation of this article were obtained from the
   Alzheimer's Disease Neuroimaging Initiative (ADNI) database
   (http://adni.loni.usc.edu). As such, the investigators within the ADNI
   contributed to the design and implementation of ADNI and/or provided
   data but did not participate in analysis or writing of this report. A
   complete listing of ADNI investigators can be found at:
   http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledg
   ement_List.pdf.; Data used in preparation of this article were obtained
   from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database
   (http://adni.loni.usc.edu). As such, the investigators within the ADNI
   contributed to the design and implementation of ADNI and/or provided
   data but did not participate in analysis or writing of this report. A
   complete listing of ADNI investigators can be found at:
   http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledg
   ement_List.pdf. We would like to thank Dr. Rong Jin, Dr. David Zhu, Dr.
   Justin McCormick, Dr. Kevin Berger, Bethany Heinlen, and Suzanne Kohler
   for helpful discussions and feedback; and Monica Gentchev for help with
   data coding. We wish to acknowledge the support of the Michigan State
   University High Performance Computing Center and the Institute for
   Cyber-Enabled Research. We are grateful to the patients and their
   families who participated in the ADNI.
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188
   Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520
   Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2
   Beach TG, 2012, J NEUROPATHOL EXP NE, V71, P266, DOI DOI 10.1097/NEN.0B013E31824B211B
   Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173
   Bouckaert R. R., 2003, INT C MACH LEARN, P51
   Bouwmeester W, 2012, PLOS MED, V9, P1, DOI DOI 10.1371/J0URNAL.PMED.1001221
   Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411
   Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320
   Brown G, 2012, J MACH LEARN RES, V13, P27
   Cawley GC, 2010, J MACH LEARN RES, V11, P2079
   Chen R, 2010, NEUROIMAGE, V52, P234, DOI 10.1016/j.neuroimage.2010.03.084
   Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896
   Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395
   Damoulas T, 2008, BIOINFORMATICS, V24, P1264, DOI 10.1093/bioinformatics/btn112
   Damoulas T, 2009, PATTERN RECOGN LETT, V30, P46, DOI 10.1016/j.patrec.2008.08.016
   Damoulas T, 2009, PATTERN RECOGN, V42, P2671, DOI 10.1016/j.patcog.2009.04.002
   Davatzikos C, 2011, NEUROBIOL AGING, V32, P2322, DOI DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023
   DELEON MJ, 1989, LANCET, V2, P672
   DELEON MJ, 1993, AM J NEURORADIOL, V14, P897
   Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021
   Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123
   Devanand D P, 2012, Int J Alzheimers Dis, V2012, P483469, DOI 10.1155/2012/483469
   Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020
   Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006
   Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96
   Gomar JJ, 2014, ALZHEIMERS DEMENTIA
   Gonen M, 2011, J MACH LEARN RES, V12, P2211
   Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354
   Haller S, 2011, J ALZHEIMERS DIS, V26, P389, DOI 10.3233/JAD-2011-0014
   Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027
   Herbei R, 2006, CAN J STAT, V34, P709, DOI 10.1002/cjs.5550340410
   Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081
   Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677
   Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369
   IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8
   Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049
   Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
   Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397
   Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341
   Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402
   Kim KI, 2011, BIOSTATISTICS, V12, P399, DOI 10.1093/biostatistics/kxq069
   Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319
   Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002
   Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402
   Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112
   Korolev IO, 2014, MED STUDENT RES J, V4, P24
   Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326
   MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
   Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679
   Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x
   Nordberg A, 2013, EUR J NUCL MED MOL I, V40, P104, DOI 10.1007/s00259-012-2237-2
   Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639
   Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538
   Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x
   Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266
   Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293
   Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653
   Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344
   Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030
   Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839
   Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P58, DOI 10.1001/archneurol.2010.343
   Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x
   Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621
   Soares H. D., 2012, ARCH NEUROL-CHICAGO, P1, DOI DOI 10.1001/ARCHNEUROL.2012.1070
   Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941
   Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381
   Stricker NH, 2011, NEUROLOGY, V77, P713, DOI 10.1212/WNL.0b013e31822b0004
   Thompson PM, 2003, J NEUROSCI, V23, P994
   Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661
   Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91
   Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156
   Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI 10.1016/j.jalz.2011.09.172
   Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056
   Westover MB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-20
   Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a
   Yang H. H., 1999, P INT ICSC S ADV INT, P22
   Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46
   Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004
   Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182
   Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069
   Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879
NR 88
TC 47
Z9 48
U1 2
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 22
PY 2016
VL 11
IS 2
AR e0138866
DI 10.1371/journal.pone.0138866
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF3VL
UT WOS:000371276100002
PM 26901338
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Manigart, O
   Trotter, C
   Findlow, H
   Assefa, A
   Mihret, W
   Demisse, TM
   Yeshitela, B
   Osei, I
   Hodgson, A
   Quaye, SL
   Sow, S
   Coulibaly, M
   Diallo, K
   Traore, A
   Collard, JM
   Boukary, RM
   Djermakoye, O
   Mahamane, AE
   Jusot, JF
   Sokhna, C
   Alavo, S
   Doucoure, S
   Ba, E
   Dieng, M
   Diallo, A
   Daugla, DM
   Omotara, B
   Chandramohan, D
   Hassan-King, M
   Nascimento, M
   Woukeu, A
   Borrow, R
   Stuart, JM
   Greenwood, B
AF Manigart, Olivier
   Trotter, Caroline
   Findlow, Helen
   Assefa, Abraham
   Mihret, Wude
   Demisse, Tesfaye Moti
   Yeshitela, Biruk
   Osei, Isaac
   Hodgson, Abraham
   Quaye, Stephen Laryea
   Sow, Samba
   Coulibaly, Mamadou
   Diallo, Kanny
   Traore, Awa
   Collard, Jean-Marc
   Boukary, Rahamatou Moustapha
   Djermakoye, Oumarou
   Mahamane, Ali Elhaji
   Jusot, Jean-Francois
   Sokhna, Cheikh
   Alavo, Serge
   Doucoure, Souleymane
   Ba, El Hadj
   Dieng, Marietou
   Diallo, Aldiouma
   Daugla, Doumagoum Moto
   Omotara, Babatunji
   Chandramohan, Daniel
   Hassan-King, Musa
   Nascimento, Maria
   Woukeu, Arouna
   Borrow, Ray
   Stuart, James M.
   Greenwood, Brian
TI A Seroepidemiological Study of Serogroup A Meningococcal Infection in
   the African Meningitis Belt
SO PLOS ONE
LA English
DT Article
ID A CAPSULAR POLYSACCHARIDE; NEISSERIA-MENINGITIDIS; MALARIA TRANSMISSION;
   SEROLOGICAL MARKERS; IMMUNE-RESPONSE; ANTIBODY; VACCINE; CARRIAGE
AB The pattern of epidemic meningococcal disease in the African meningitis belt may be influenced by the background level of population immunity but this has been measured infrequently. A standardised enzyme-linked immunosorbent assay (ELISA) for measuring meningococcal serogroup A IgG antibodies was established at five centres within the meningitis belt. Antibody concentrations were then measured in 3930 individuals stratified by age and residence from six countries. Seroprevalence by age was used in a catalytic model to determine the force of infection. Meningococcal serogroup A IgG antibody concentrations were high in each country but showed heterogeneity across the meningitis belt. The geometric mean concentration (GMC) was highest in Ghana (9.09 mu g/mL [95% CI 8.29, 9.97]) and lowest in Ethiopia (1.43 mu g/mL [95% CI 1.31, 1.57]) on the margins of the belt. The force of infection was lowest in Ethiopia (lambda = 0.028). Variables associated with a concentration above the putative protective level of 2 mu g/mL were age, urban residence and a history of recent vaccination with a meningococcal vaccine. Prior to vaccination with the serogroup A meningococcal conjugate vaccine, meningococcal serogroup A IgG antibody concentrations were high across the African meningitis belt and yet the region remained susceptible to epidemics.
C1 [Manigart, Olivier; Chandramohan, Daniel; Hassan-King, Musa; Nascimento, Maria; Woukeu, Arouna; Stuart, James M.; Greenwood, Brian] London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England.
   [Manigart, Olivier] MRC Unit, Fajara, Gambia.
   [Trotter, Caroline] Univ Cambridge, Dept Vet Med, Cambridge, England.
   [Findlow, Helen; Borrow, Ray] Publ Hlth England Vaccine Evaluat Unit, Manchester, Lancs, England.
   [Assefa, Abraham; Mihret, Wude; Demisse, Tesfaye Moti; Yeshitela, Biruk] Armauer Hansen Res Inst, Addis Ababa, Ethiopia.
   [Osei, Isaac; Hodgson, Abraham; Quaye, Stephen Laryea] Navrongo Hlth Res Ctr, Navrongo, Ghana.
   [Sow, Samba; Coulibaly, Mamadou; Diallo, Kanny; Traore, Awa] Ctr Vaccins Dev, Bamako, Mali.
   [Collard, Jean-Marc; Boukary, Rahamatou Moustapha; Djermakoye, Oumarou; Mahamane, Ali Elhaji; Jusot, Jean-Francois] Ctr Rech Med & Sanitaire CERMES, Niamey, Niger.
   [Sokhna, Cheikh; Alavo, Serge; Doucoure, Souleymane; Ba, El Hadj; Dieng, Marietou; Diallo, Aldiouma] Inst Rech Dev, Dakar, Senegal.
   [Daugla, Doumagoum Moto] CSSI, Ndjamena, Chad.
   [Omotara, Babatunji] Univ Maiduguri, Dept Community Med, Maiduguri, Nigeria.
RP Greenwood, B (reprint author), London Sch Hyg & Trop Med, Fac Infect Dis, London WC1, England.
EM brian.greenwood@lshtm.ac.uk
RI Collard, Jean-Marc/Q-2342-2019; Aseffa, Abraham/J-3248-2016
OI Collard, Jean-Marc/0000-0002-1490-3978; Aseffa,
   Abraham/0000-0002-8028-1150; Trotter, Caroline/0000-0003-4000-2708;
   Diallo, Kanny/0000-0002-0905-3980
FU Wellcome Trust [086546/Z/08/Z]; Bill & Melinda Gates Foundation [51251]
FX This work was supported by Wellcome Trust (grant no. 086546/Z/08/Z),
   www.wellcome.ac.uk; Bill & Melinda Gates Foundation (grant no. 51251),
   www.gatesfoundation.org. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125
   CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154
   CEESAY SJ, 1993, J INFECT DIS, V167, P1212, DOI 10.1093/infdis/167.5.1212
   Collard JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-576
   Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Ferraro CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101129
   Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065
   GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327
   Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2
   GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P340, DOI 10.1016/0035-9203(80)90095-4
   GRIFFISS JM, 1975, J IMMUNOL, V114, P1779
   GUIRGUIS N, 1985, J EXP MED, V162, P1837, DOI 10.1084/jem.162.6.1837
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacLennan J, 1999, VACCINE, V17, P3086, DOI 10.1016/S0264-410X(99)00139-5
   MenAfriCar Consortium, 2015, J INFECT DIS
   Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623
   Norheim G, 2008, CLIN VACCINE IMMUNOL, V15, P863, DOI 10.1128/CVI.00252-07
   PELTOLA H, 1977, NEW ENGL J MED, V297, P686, DOI 10.1056/NEJM197709292971302
   ROBBINS JB, 1972, INFECT IMMUN, V6, P651
   ROBBINS JB, 1975, J ALLERGY CLIN IMMUN, V56, P141, DOI 10.1016/0091-6749(75)90119-0
   Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812
   Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08
   Trotter CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055486
   VANN WF, 1976, INFECT IMMUN, V13, P1654
   Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451
NR 27
TC 3
Z9 3
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 12
PY 2016
VL 11
IS 2
AR e0147928
DI 10.1371/journal.pone.0147928
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD6SI
UT WOS:000370054100012
PM 26872255
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tedeschi, LO
AF Tedeschi, Luis O.
TI Integrating Genomics with Nutrition Models to Improve the Prediction of
   Cattle Performance and Carcass Composition under Feedlot Conditions
SO PLOS ONE
LA English
DT Article
ID 4 SIMULATION-MODELS; BEEF-CATTLE; BODY-COMPOSITION; DYNAMIC-MODEL;
   COMPUTER-MODEL; LEPTIN GENE; GROWTH; ASSOCIATION; QUALITY; EFFICIENCY
AB Cattle body composition is difficult to model because several factors affect the composition of the average daily gain (ADG) of growing animals. The objective of this study was to identify commercial single nucleotide polymorphism (SNP) panels that could improve the predictability of days on feed (DOF) to reach a target United States Department of Agriculture (USDA) grade given animal, diet, and environmental information under feedyard conditions. The data for this study was comprised of crossbred heifers (n = 681) and steers (n = 836) from commercial feedyards. Eleven molecular breeding value (MBV) scores derived from SNP panels of candidate gene polymorphisms and two-leptin gene SNP (UASMS2 and E2FB) were evaluated. The empty body fat (EBF) and the shrunk body weight (SBW) at 28% EBF (AFSBW) were computed by the Cattle Value Discovery System (CVDS) model using hip height (EBFHH and AFSBW(HH)) or carcass traits (EBFCT and AFSBW(CT)) of the animals. The DOFHH was calculated when AFSBW(HH) and ADG(HH) were used and DOFCT was calculated when AFSBW(CT) and ADG(CT) were used. The CVDS estimates dry matter required (DMR) by individuals fed in groups when observed ADG and AFSBW are provided. The AFSBW(CT) was assumed more accurate than the AFSBW(HH) because it was computed using carcass traits. The difference between AFSBW(CT) and AFSBW(HH), DOFCT and DOFHH, and DMR and dry matter intake (DMI) were regressed on the MBV scores and leptin gene SNP to explain the variation. Our results indicate quite a large range of correlations among MBV scores and model input and output variables, but MBV ribeye area was the most strongly correlated with the differences in DOF, AFSBW, and DMI by explaining 8, 13.2 and 6.5%, respectively, of the variation. This suggests that specific MBV scores might explain additional variation of input and output variables used by nutritional models in predicting individual animal performance.
C1 [Tedeschi, Luis O.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.
RP Tedeschi, LO (reprint author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.
EM luis.tedeschi@tamu.edu
FU Texas A&M AgriLife Research [Hatch 09123]
FX This work was supported by Texas A&M AgriLife Research Hatch 09123.
CR Anele UY, 2014, J ANIM SCI, V92, P2660, DOI 10.2527/jas.2014-7557
   ARNOLD RN, 1991, AGR SYST, V35, P401, DOI 10.1016/0308-521X(91)90117-S
   ARNOLD RN, 1991, AGR SYST, V36, P17, DOI 10.1016/0308-521X(91)90106-K
   Baker MJ, 2006, J ANIM SCI, V84, P2666, DOI 10.2527/jas.2006-006
   Beef Improvement Federation, 2010, GUID UN BEEF IMPR PR
   Bibby J., 1977, PREDICTION IMPROVED
   Bourg B, 2007, P 2 INT S EN PROT ME
   Bourg BM., 2007, THESIS
   Buchanan FC, 2002, GENET SEL EVOL, V34, P105, DOI 10.1051/gse:2001006
   Cruz GD, 2011, J ANIM SCI, V89, P1640, DOI 10.2527/jas.2010-3416
   Davidson AC, 1997, BOOTSTRAP METHODS TH
   DeVuyst EA, 2011, J ANIM SCI, V89, P1260, DOI 10.2527/jas.2009-2372
   DIMARCO ON, 1989, AGR SYST, V29, P247, DOI 10.1016/0308-521X(89)90055-3
   Efron B, 1998, INTRO BOOTSTRAP
   Federation of Animal Science and Societies, 2010, GUID CAR US AGR AN R
   FOX DG, 1984, J ANIM SCI, V58, P725
   FOX DG, 1988, J ANIM SCI, V66, P1475
   Fox DG, 2004, ANIM FEED SCI TECH, V112, P29, DOI 10.1016/j.anifeedsci.2003.10.006
   Garrett W. N., 1978, J ANIM SCI S1, V47, P417
   Greenwood PL, 2013, J ANIM SCI, V91, P5912, DOI 10.2527/jas.2013-6960
   Guiroy PJ, 2001, J ANIM SCI, V79, P1983
   Hoch T, 2004, AGR SYST, V81, P1, DOI 10.1016/j.agsy.2003.08.005
   Kachman SD, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-30
   KEELE JW, 1992, J ANIM SCI, V70, P841
   Khatib H, 2009, J DAIRY SCI, V92, P6186, DOI 10.3168/jds.2009-2439
   Kilpatrick DJ, 1999, AGR SYST, V61, P95, DOI 10.1016/S0308-521X(99)00040-2
   Kirschten DP, 2006, P JOINT ANN M AM SOC
   Kirschten DP, 2007, P JOINT ANN M AM SOC
   Kononoff PJ, 2005, J ANIM SCI, V83, P927
   Lancaster PA, 2009, J ANIM SCI, V87, P3887, DOI 10.2527/jas.2009-2041
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lusk J L, 2007, J Anim Sci, V85, P1865, DOI 10.2527/jas.2006-665
   MacNeil MD, 2010, J ANIM SCI, V88, P517, DOI 10.2527/jas.2009-2022
   Moore MC, 2012, J ANIM SCI, V90, P5143, DOI 10.2527/jas.2012-5550
   National Research Council, 2000, NUTR REQ BEEF CATTL
   Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234
   Nkrumah JD, 2009, P JOINT ANN M AM SOC
   OLTJEN JW, 1986, J ANIM SCI, V62, P86
   R Core Team, 2014, R LANG ENV STAT COMP
   Rincon G, 2009, ANIM GENET, V40, P878, DOI 10.1111/j.1365-2052.2009.01934.x
   Schenkel FS, 2005, J ANIM SCI, V83, P2009
   Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715
   Tedeschi LO, 2010, MODELLING NUTRIENT DIGESTION AND UTILISATION IN FARM ANIMALS, P91
   Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004
   Tedeschi LO, 2006, J ANIM SCI, V84, P767
   Tedeschi LO, 2004, AGR SYST, V79, P171, DOI 10.1016/S0308-521X(03)00070-2
   Tedeschi LO, 2010, P 3 INT S EN PROT ME
   Tedford JL, 2014, J ANIM SCI, V92, P3685, DOI [10.2527/jas2014-7739, 10.2527/jas.2014-7739]
   Vasconcelos JT, 2007, J ANIM SCI, V85, P2772, DOI 10.2527/jas.2007-0261
   Vasconcelos J. T., 2007, Professional Animal Scientist, V23, P340
   Wang YP, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002459
   Williams CB, 2010, J ANIM SCI, V88, P2523, DOI 10.2527/jas.2009-2655
   Williams CB, 2006, J ANIM SCI, V84, P1310
   WILLIAMS CB, 1995, J ANIM SCI, V73, P2903
   Woronuk GN, 2012, ANIM GENET, V43, P608, DOI 10.1111/j.1365-2052.2012.02320.x
NR 55
TC 3
Z9 3
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 24
PY 2015
VL 10
IS 11
AR e0143483
DI 10.1371/journal.pone.0143483
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CX7DU
UT WOS:000365862600070
PM 26599759
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU de Smith, AJ
   Walsh, KM
   Hansen, HM
   Endicott, AA
   Wiencke, JK
   Metayer, C
   Wiemels, JL
AF de Smith, Adam J.
   Walsh, Kyle M.
   Hansen, Helen M.
   Endicott, Alyson A.
   Wiencke, John K.
   Metayer, Catherine
   Wiemels, Joseph L.
TI Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An
   Accurate Method for Assessment of Preferential Allelic Imbalance in
   Tumor DNA
SO PLOS ONE
LA English
DT Article
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL; MONOZYGOTIC TWINS; HISPANIC
   CHILDREN; COPY NUMBER; CHILDHOOD; RISK; VARIANTS; CANCER; CANDIDATE
AB The extent to which heritable genetic variants can affect tumor development has yet to be fully elucidated. Tumor selection of single nucleotide polymorphism (SNP) risk alleles, a phenomenon called preferential allelic imbalance (PAI), has been demonstrated in some cancer types. We developed a novel application of digital PCR termed Somatic Mutation Allelic Ratio Test using Droplet Digital PCR (SMART-ddPCR) for accurate assessment of tumor PAI, and have applied this method to test the hypothesis that heritable SNPs associated with childhood acute lymphoblastic leukemia (ALL) may demonstrate tumor PAI. These SNPs are located at CDKN2A (rs3731217) and IKZF1 (rs4132601), genes frequently lost in ALL, and at CEBPE (rs2239633), ARID5B (rs7089424), PIP4K2A (rs10764338), and GATA3 (rs3824662), genes located on chromosomes gained in high-hyperdiploid ALL. We established thresholds of AI using constitutional DNA from SNP heterozygotes, and subsequently measured allelic copy number in tumor DNA from 19-142 heterozygote samples per SNP locus. We did not find significant tumor PAI at these loci, though CDKN2A and IKZF1 SNPs showed a trend towards preferential selection of the risk allele (p = 0.17 and p = 0.23, respectively). Using a genomic copy number control ddPCR assay, we investigated somatic copy number alterations (SCNA) underlying AI at CDKN2A and IKZF1, revealing a complex range of alterations including homozygous and hemizygous deletions and copy-neutral loss of heterozygosity, with varying degrees of clonality. Copy number estimates fromddPCR showed high agreement with those from multiplex ligation-dependent probe amplification (MLPA) assays. We demonstrate that SMART-ddPCR is a highly accurate method for investigation of tumor PAI and for assessment of the somatic alterations underlying AI. Furthermore, analysis of publicly available data from The Cancer Genome Atlas identified 16 recurrent SCNA loci that contain heritable cancer risk SNPs associated with a matching tumor type, and which represent candidate PAI regions warranting further investigation.
C1 [de Smith, Adam J.; Endicott, Alyson A.; Wiemels, Joseph L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
   [Walsh, Kyle M.; Hansen, Helen M.; Wiencke, John K.; Wiemels, Joseph L.] Univ Calif San Francisco, Dept Neurol Surg, Div Neuroepidemiol, San Francisco, CA USA.
   [Metayer, Catherine] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
RP de Smith, AJ (reprint author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
EM adam.desmith@ucsf.edu
OI Endicott, Alyson/0000-0001-7702-4770
FU Alex's Lemonade Stand Foundation 'A' Award; National Institutes of
   Health (NIH) National Cancer Institute [R01CA155461, R25CA112355];
   National Institute of Environmental Health Sciences (NIEHS)
   [R01ES009137]
FX AJD is supported by an Alex's Lemonade Stand Foundation 'A' Award Grant
   (http://www.alexslemonade.org/). This research was also supported by the
   National Institutes of Health (NIH) National Cancer Institute grant
   numbers R01CA155461 (JLW) and R25CA112355 (KMW), and by the National
   Institute of Environmental Health Sciences (NIEHS) grant number
   R01ES009137 (CM, JLW). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bartley K, 2010, INT J EPIDEMIOL, V39, P1628, DOI 10.1093/ije/dyq162
   Bateman CM, 2015, LEUKEMIA, V29, P58, DOI 10.1038/leu.2014.177
   Caye A, 2013, HAEMATOLOGICA, V98, P597, DOI 10.3324/haematol.2012.073965
   Cazzaniga G, 2011, BLOOD, V118, P5559, DOI 10.1182/blood-2011-07-366542
   Chokkalingam AP, 2013, CANCER CAUSE CONTROL, V24, P1789, DOI 10.1007/s10552-013-0256-3
   Dastugue N, 2013, BLOOD, V121, P2415, DOI 10.1182/blood-2012-06-437681
   Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136
   Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220
   Fleming JL, 2014, INT J CANCER, V134, P244, DOI 10.1002/ijc.28339
   Gerber MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037672
   Hindorff LA, CATALOG PUBLISHED GE
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086
   Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051
   Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316
   Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690
   Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253
   Panzer-Grumayer ER, 2002, BLOOD, V100, P347, DOI 10.1182/blood-2002-01-0144
   Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430
   Paulsson K, 2005, GENE CHROMOSOME CANC, V44, P113, DOI 10.1002/gcc.20222
   Paulsson K, 2010, P NATL ACAD SCI USA, V107, P21719, DOI 10.1073/pnas.1006981107
   Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803
   Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113
   Raimondi SC, 1996, LEUKEMIA, V10, P213
   Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903
   Schwab CJ, 2013, HAEMATOLOGICA, V98, P1081, DOI 10.3324/haematol.2013.085175
   Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585
   Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432
   Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Walsh KM, 2013, LEUKEMIA, V27, P2416, DOI 10.1038/leu.2013.130
   Walsh KM, 2015, CANCER RES, V75, P4884, DOI 10.1158/0008-5472.CAN-15-1105
   Walsh KM, 2014, AM J HEMATOL, V89, P721, DOI 10.1002/ajh.23727
   Walsh KM, 2013, BLOOD, V121, P4808, DOI 10.1182/blood-2013-04-495390
   Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455
   Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042
   Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760
NR 39
TC 3
Z9 3
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 17
PY 2015
VL 10
IS 11
AR e0143343
DI 10.1371/journal.pone.0143343
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CW7BR
UT WOS:000365153400060
PM 26575185
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Fracassetti, M
   Griffin, PC
   Willi, Y
AF Fracassetti, Marco
   Griffin, Philippa C.
   Willi, Yvonne
TI Validation of Pooled Whole-Genome Re-Sequencing in Arabidopsis lyrata
SO PLOS ONE
LA English
DT Article
ID DETECTING SELECTIVE SWEEPS; NEXT-GENERATION; ALLELE FREQUENCIES;
   SAMPLES; POPULATIONS; DNA; DIFFERENTIATION; DOMESTICATION; ADAPTATION;
   DISCOVERY
AB Sequencing pooled DNA of multiple individuals from a population instead of sequencing individuals separately has become popular due to its cost-effectiveness and simple wet-lab protocol, although some criticism of this approach remains. Here we validated a protocol for pooled whole-genome re-sequencing (Pool-seq) of Arabidopsis lyrata libraries prepared with low amounts of DNA (1.6 ng per individual). The validation was based on comparing single nucleotide polymorphism (SNP) frequencies obtained by pooling with those obtained by individual-based Genotyping By Sequencing (GBS). Furthermore, we investigated the effect of sample number, sequencing depth per individual and variant caller on population SNP frequency estimates. For Pool-seq data, we compared frequency estimates from two SNP callers, VarScan and Snape; the former employs a frequentist SNP calling approach while the latter uses a Bayesian approach. Results revealed concordance correlation coefficients well above 0.8, confirming that Pool-seq is a valid method for acquiring population-level SNP frequency data. Higher accuracy was achieved by pooling more samples (25 compared to 14) and working with higher sequencing depth (4.1x per individual compared to 1.4x per individual), which increased the concordance correlation coefficient to 0.955. The Bayesian-based SNP caller produced somewhat higher concordance correlation coefficients, particularly at low sequencing depth. We recommend pooling at least 25 individuals combined with sequencing at a depth of 100x to produce satisfactory frequency estimates for common SNPs (minor allele frequency above 0.05).
C1 [Fracassetti, Marco; Griffin, Philippa C.; Willi, Yvonne] Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland.
   [Griffin, Philippa C.] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia.
RP Fracassetti, M (reprint author), Univ Neuchatel, Evolutionary Bot, Inst Biol, CH-2000 Neuchatel, Switzerland.
EM marco.fracassetti@unine.ch
RI Fracassetti, Marco/P-4819-2019; Fracassetti, Marco/F-2383-2018
OI Fracassetti, Marco/0000-0002-2962-2669; Fracassetti,
   Marco/0000-0002-2962-2669; Griffin, Philippa/0000-0003-1538-8389
FU Swiss National Science Foundation [PP00P3-123396, PP00P3-146342];
   Fondation Pierre Mercier pour la Science, Lausanne
FX This work was supported by the Swiss National Science Foundation
   (PP00P3-123396 and PP00P3-146342 to YW) and the Fondation Pierre Mercier
   pour la Science (to YW), Lausanne. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anderson EC, 2014, MOL ECOL, V23, P502, DOI 10.1111/mec.12609
   Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837
   Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353
   Bastide H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003534
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Boitard S, 2013, MOL ECOL RESOUR, V13, P337, DOI 10.1111/1755-0998.12063
   Boitard S, 2012, MOL BIOL EVOL, V29, P2177, DOI 10.1093/molbev/mss090
   Burke MK, 2014, MOL BIOL EVOL, V31, P3228, DOI 10.1093/molbev/msu256
   Carr D, 2014, HEXBIN HEXAGONAL BIN
   Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354
   Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35
   Clement JAJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002591
   Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103
   Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174
   Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012
   Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363
   Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986
   Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379
   Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148
   Fabian DK, 2012, MOL ECOL, V21, P4748, DOI 10.1111/j.1365-294X.2012.05731.x
   Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522
   Fischer MC, 2013, MOL ECOL, V22, P5594, DOI 10.1111/mec.12521
   Futschik A, 2010, GENETICS, V186, P207, DOI 10.1534/genetics.110.114397
   Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360
   Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344
   Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807
   Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111
   Kofler R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002487
   Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925
   Li H., 2013, ALIGNING SEQUENCE RE
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lynch M, 2014, GENOME BIOL EVOL, V6, P1210, DOI 10.1093/gbe/evu085
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3
   Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x
   Pespeni MH, 2013, P NATL ACAD SCI USA, V110, P6937, DOI 10.1073/pnas.1220673110
   Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Raineri E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-239
   Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109
   Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832
   Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803
   Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930
   Smit AFA, 2010, REPEATMASKER OPEN 3
   Stevenson M, 2015, EPIR TOOLS ANAL EPID
   Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515
   Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185
   Zhu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041901
NR 51
TC 14
Z9 14
U1 1
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2015
VL 10
IS 10
AR e0140462
DI 10.1371/journal.pone.0140462
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CT6ZJ
UT WOS:000362962300098
PM 26461136
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Feissel, M
   Aho, LS
   Georgiev, S
   Tapponnier, R
   Badie, J
   Bruyere, R
   Quenot, JP
AF Feissel, Marc
   Aho, Ludwig Serge
   Georgiev, Stefan
   Tapponnier, Romain
   Badie, Julio
   Bruyere, Remi
   Quenot, Jean-Pierre
TI Pulse Wave Transit Time Measurements of Cardiac Output in Septic Shock
   Patients: A Comparison of the Estimated Continuous Cardiac Output System
   with Transthoracic Echocardiography
SO PLOS ONE
LA English
DT Article
ID CRITICALLY-ILL PATIENTS; FLUID RESPONSIVENESS; VENTILATED PATIENTS;
   INTENSIVE-CARE; RESPIRATORY CHANGES; DYNAMIC INDEXES; MULTICENTER;
   SEPSIS; THERMODILUTION; PRESSURE
AB Background
   We determined reliability of cardiac output (CO) measured by pulse wave transit time cardiac output system (esCCO system; COesCCO) vs transthoracic echocardiography (COTTE) in mechanically ventilated patients in the early phase of septic shock. A secondary objective was to assess ability of esCCO to detect change in CO after fluid infusion.
   Methods
   Mechanically ventilated patients admitted to the ICU, aged > 18 years, in sinus rhythm, in the early phase of septic shock were prospectively included. We performed fluid infusion of 500ml of crystalloid solution over 20 minutes and recorded CO by EsCCO and TTE immediately before (T0) and 5 minutes after (T1) fluid administration. Patients were divided into 2 groups (responders and non-responders) according to a threshold of 15% increase in COTTE in response to volume expansion.
   Results
   In total, 25 patients were included, average 64 +/- 15 years, 15 (60%) were men. Average SAPSII and SOFA scores were 55 +/- 21.3 and 13 +/- 2, respectively. ICU mortality was 36%. Mean cardiac output at T0 was 5.8 +/- 1.35 L/min by esCCO and 5.27 +/- 1.17 L/min by COTTE. At T1, respective values were 6.63 +/- 1.57 L/min for esCCO and 6.10 +/- 1.29 L/min for COTTE. Overall, 12 patients were classified as responders, 13 as non-responders by the reference method. A threshold of 11% increase in COesCCO was found to discriminate responders from non-responders with a sensitivity of 83% (95% CI, 0.52-0.98) and a specificity of 77% (95% CI, 0.46-0.95).
   Conclusion
   We show strong correlation esCCO and echocardiography for measuring CO, and change in CO after fluid infusion in ICU patients.
C1 [Feissel, Marc; Georgiev, Stefan; Tapponnier, Romain; Badie, Julio] Ctr Hosp Belfort Montbeliard, Serv Reanimat Malad Infect, Belfort, France.
   [Aho, Ludwig Serge] Ctr Hosp Univ Dijon, Bocage Cent, Serv Epidemiol & Hyg Hosp, Dijon, France.
   [Bruyere, Remi; Quenot, Jean-Pierre] Ctr Hosp Univ Dijon, Bocage Cent, Serv Reanimat Med, Dijon, France.
   [Bruyere, Remi] Univ Bourgogne, INSERM, Ctr Rech, UMR866, Dijon, France.
   [Quenot, Jean-Pierre] Univ Bourgogne, INSERM, Ctr Rech, UMR1347, Dijon, France.
RP Quenot, JP (reprint author), Ctr Hosp Univ Dijon, Bocage Cent, Serv Reanimat Med, Dijon, France.
EM jean-pierre.quenot@chu-dijon.fr
OI Ludwig Serge, Aho Glele/0000-0001-7590-8644
CR Bataille B, 2012, BRIT J ANAESTH, V109, P879, DOI 10.1093/bja/aes298
   Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9
   BLAND JM, 1986, LANCET, V1, P307
   Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15
   Carstensen B, 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107
   Critchley LAH, 1999, J CLIN MONITOR COMP, V15, P85, DOI 10.1023/A:1009982611386
   Della Rocca G, 2008, J CARDIOTHOR VASC AN, V22, P681, DOI 10.1053/j.jvca.2008.02.021
   Dellinger RP, 2012, CRIT CARE MED, V41, P580, DOI DOI 10.1097/CCM.0B013E31827E83AF
   Faraoni D, 2013, BRIT J ANAESTH, V110, P139, DOI 10.1093/bja/aes437
   Feissel M, 2001, CHEST, V119, P867, DOI 10.1378/chest.119.3.867
   Feissel M, 2007, INTENS CARE MED, V33, P993, DOI 10.1007/s00134-007-0602-6
   Feissel M, 2013, J CRIT CARE, V28, P634, DOI 10.1016/j.jcrc.2013.03.011
   Feissel M, 2009, J AM SOC ECHOCARDIOG, V22, P1159, DOI 10.1016/j.echo.2009.06.022
   Godje O, 2002, CRIT CARE MED, V30, P52
   Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6
   Ishihara Hironori, 2004, J Clin Monit Comput, V18, P313, DOI 10.1007/s10877-005-2452-5
   Ishihara H, 2012, J CLIN MONIT COMPUT, V26, P465, DOI 10.1007/s10877-012-9384-7
   JARDIN F, 1994, INTENS CARE MED, V20, P550, DOI 10.1007/BF01705720
   KRAUSZ MM, 1977, ANN SURG, V185, P429, DOI 10.1097/00000658-197704000-00010
   LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957
   LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Mansencal N, 2013, INT J CARDIOL, V168, P4411, DOI 10.1016/j.ijcard.2013.05.032
   Marcelino Paulo, 2006, Acta Med Port, V19, P197
   McLean AS, 1997, ANAESTH INTENS CARE, V25, P250, DOI 10.1177/0310057X9702500307
   Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000
   Michard F, 2000, AM J RESP CRIT CARE, V162, P134, DOI 10.1164/ajrccm.162.1.9903035
   Monnet X, 2012, BRIT J ANAESTH, V109, P330, DOI 10.1093/bja/aes182
   Osman D, 2007, CRIT CARE MED, V35, P64, DOI 10.1097/01.CCM.0000249851.94101.4F
   Quenot JP, 2013, CRIT CARE, V17, DOI 10.1186/cc12598
   Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307
   Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664
   Sharwood-Smith G, 2006, BRIT J ANAESTH, V96, P100, DOI 10.1093/bja/aei266
   Shim JK, 2014, J CRIT CARE, V29, P987, DOI 10.1016/j.jcrc.2014.07.005
   Sugo Y, 2005, JAP J MED INSTRU, V75, P63
   Tsutsui M, 2013, ANESTH ANALG, V117, P1307, DOI 10.1213/ANE.0b013e3182a44c87
   Vincent JL, 2011, CRIT CARE, V15, DOI 10.1186/cc10291
   Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751
   Waechter J, 2014, CRIT CARE MED, V42, P2158, DOI 10.1097/CCM.0000000000000520
   WANG P, 1992, AM J PHYSIOL, V263, pG38
   Yamada T, 2012, ANESTH ANALG, V115, P82, DOI 10.1213/ANE.0b013e31824e2b6c
NR 41
TC 5
Z9 5
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 30
PY 2015
VL 10
IS 6
AR e0130489
DI 10.1371/journal.pone.0130489
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CN1BR
UT WOS:000358151300017
PM 26126112
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Grey, JA
   Rothenberg, RB
   Sullivan, PS
   Rosenberg, ES
AF Grey, Jeremy Alexander
   Rothenberg, Richard B.
   Sullivan, Patrick Sean
   Rosenberg, Eli Samuel
TI Disassortative Age-Mixing Does Not Explain Differences in HIV Prevalence
   between Young White and Black MSM: Findings from Four Studies
SO PLOS ONE
LA English
DT Article
ID OLDER PARTNER SELECTION; SEXUAL RISK BEHAVIOR; UNITED-STATES; MEN;
   INFECTION; DISPARITIES; METAANALYSIS; NETWORKS; SPREAD; RACE
AB Objective
   Age disassortativity is one hypothesis for HIV disparities between Black and White MSM. We examined differences in age mixing by race and the effect of partner age difference on the association between race and HIV status.
   Design
   We used data from four studies of MSM. Participants reported information about recent sexual partners, including age, race, and sexual behavior. Two studies were online with a US sample and two focused on MSM in Atlanta.
   Methods
   We computed concordance correlation coefficients (CCCs) by race across strata of partner type, participant HIV status, condom use, and number of partners. We used Wilcoxon rank-sum tests to compare Black and White MSM on partner age differences across five age groups. Finally, we used logistic regression models using race, age, and partner age difference to determine the odds ratio of HIV-positive serostatus.
   Results
   Of 48 CCC comparisons, Black MSM were more age-disassortative than White MSM in only two. Furthermore, of 20 comparisons of median partner age, Black and White MSM differed in two age groups. One indicated larger age gaps among the Black MSM (18-19). Prevalent HIV infection was associated with race and age. Including partner age difference in the model resulted in a 2% change in the relative odds of infection among Black MSM.
   Conclusions
   Partner age disassortativity and partner age differences do not differ by race. Partner age difference offers little predictive value in understanding prevalent HIV infection among Black and White MSM, including diagnosis of HIV-positive status among self-reported HIV-negative individuals.
C1 [Grey, Jeremy Alexander; Sullivan, Patrick Sean; Rosenberg, Eli Samuel] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Rothenberg, Richard B.] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA.
RP Grey, JA (reprint author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.
EM jeremy.grey@emory.edu
FU National Institute on Minority Health and Health Disparities
   [RC1MD004370]; National Institute of Mental Health [R01MH085600]; Eunice
   Kennedy Shriver National Institute for Child Health and Human
   Development [R01HD067111]
FX This work was supported by the National Institute on Minority Health and
   Health Disparities (RC1MD004370); National Institute of Mental Health
   (R01MH085600); Eunice Kennedy Shriver National Institute for Child
   Health and Human Development (R01HD067111). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aral SO, 2000, SEX TRANSM INFECT, V76, P415, DOI 10.1136/sti.76.6.415
   Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489
   Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41
   Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613
   Blower SMSS, 1997, AIDS BEHAV, V1, P273
   Centers for Disease Control and Prevention, 2015, HIV SURV REP, P25
   Dierkhising R., 2011, MCCC SAS MACRO
   Finlayson TJ, 2011, HIV RISK PREVENTION
   Garofalo R, 2010, J URBAN HEALTH, V87, P318, DOI 10.1007/s11524-009-9430-z
   Hurt CB, 2010, JAIDS-J ACQ IMM DEF, V54, P185, DOI 10.1097/QAI.0b013e3181c99114
   Jin FY, 2013, AIDS BEHAV, V17, P2426, DOI 10.1007/s10461-012-0350-7
   Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010
   Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284
   Kleinbaum DG, 2010, LOGISTIC REGRESSION
   Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107
   Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2
   Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b
   Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720
   Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X
   MORRIS M, 1995, AIDS EDUC PREV, V7, P24
   MORRIS M, 2004, NETWORK EPIDEMIOLOGY
   Mustanski B, 2013, J ADOLESCENT HEALTH, V52, P666, DOI 10.1016/j.jadohealth.2013.03.019
   Newcomb ME, 2013, JAIDS-J ACQ IMM DEF, V62, P329, DOI 10.1097/QAI.0b013e31827e5f8c
   Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa
   Prejean J, 2013, J COMMUN HEALTH, V38, P414, DOI 10.1007/s10900-012-9633-1
   Prestage G, 2013, SEX TRANSM INFECT, V89, P653, DOI 10.1136/sextrans-2012-050947
   Rosenberg ES, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3211
   Rosenberg ES, 2012, NAT STD PREV C
   Service SK, 1996, J ACQ IMMUN DEF SYND, V11, P311, DOI 10.1097/00042560-199603010-00016
   SERVICE SK, 1995, P ROY SOC B-BIOL SCI, V260, P237, DOI 10.1098/rspb.1995.0086
   Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514
   Sullivan PS, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1797
   Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34
   Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878
   Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2
   Zhu YD, 2013, BIOMETRICS, V69, P214, DOI 10.1111/j.1541-0420.2012.01807.x
NR 38
TC 12
Z9 12
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2015
VL 10
IS 6
AR e0129877
DI 10.1371/journal.pone.0129877
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3FE
UT WOS:000356835000071
PM 26090814
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sampath, S
   Klimas, M
   Feng, D
   Baumgartner, R
   Manigbas, E
   Liang, AL
   Evelhoch, JL
   Chin, CL
AF Sampath, Smita
   Klimas, Michael
   Feng, Dai
   Baumgartner, Richard
   Manigbas, Elaine
   Liang, Ai-Leng
   Evelhoch, Jeffrey L.
   Chin, Chih-Liang
TI Characterization of Regional Left Ventricular Function in Nonhuman
   Primates Using Magnetic Resonance Imaging Biomarkers: A Test-Retest
   Repeatability and Inter-Subject Variability Study
SO PLOS ONE
LA English
DT Article
ID MATRIX-METALLOPROTEINASE INHIBITION; CONGESTIVE-HEART-FAILURE; TYPE-2
   DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; NONINVASIVE ASSESSMENT;
   DIASTOLIC DYSFUNCTION; SYSTOLIC FUNCTION; CARDIAC-FUNCTION;
   GENE-TRANSFER; STEM-CELLS
AB Pre-clinical animal models are important to study the fundamental biological and functional mechanisms involved in the longitudinal evolution of heart failure (HF). Particularly, large animal models, like nonhuman primates (NHPs), that possess greater physiological, biochemical, and phylogenetic similarity to humans are gaining interest. To assess the translatability of these models into human diseases, imaging biomarkers play a significant role in non-invasive phenotyping, prediction of downstream remodeling, and evaluation of novel experimental therapeutics. This paper sheds insight into NHP cardiac function through the quantification of magnetic resonance (MR) imaging biomarkers that comprehensively characterize the spatiotemporal dynamics of left ventricular (LV) systolic pumping and LV diastolic relaxation. MR tagging and phase contrast (PC) imaging were used to quantify NHP cardiac strain and flow. Temporal inter-relationships between rotational mechanics, myocardial strain and LV chamber flow are presented, and functional biomarkers are evaluated through test-retest repeatability and inter subject variability analyses. The temporal trends observed in strain and flow was similar to published data in humans. Our results indicate a dominant dimension based pumping during early systole, followed by a torsion dominant pumping action during late systole. Early diastole is characterized by close to 65% of untwist, the remainder of which likely contributes to efficient filling during atrial kick. Our data reveal that moderate to good intra-subject repeatability was observed for peak strain, strain-rates, E/circumferential strain-rate (CSR) ratio, E/longitudinal strain-rate (LSR) ratio, and deceleration time. The inter-subject variability was high for strain dyssynchrony, diastolic strain-rates, peak torsion and peak untwist rate. We have successfully characterized cardiac function in NHPs using MR imaging. Peak strain, average systolic strain-rate, diastolic E/CSR and E/LSR ratios, and deceleration time were identified as robust biomarkers that could potentially be applied to future pre-clinical drug studies.
C1 [Sampath, Smita; Liang, Ai-Leng; Chin, Chih-Liang] Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore.
   [Klimas, Michael; Evelhoch, Jeffrey L.] Merck & Co Inc, Merck Res Labs, Imaging, West Point, PA USA.
   [Feng, Dai; Baumgartner, Richard] Merck & Co Inc, Merck Res Labs, Biostat & Res Decis Sci, Biometr Res, Rahway, NJ 07065 USA.
   [Manigbas, Elaine] Maccine Pte Ltd, MRI Dept, Singapore, Singapore.
RP Sampath, S (reprint author), Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore.
EM smita.sampath@merck.com
RI Evelhoch, Jeffrey/R-2619-2019
FU Merck Co.
FX This research was funded by Merck & Co. The authors would like to
   declare that the following individuals are current or former employees
   of the funder: Smita Sampath, Michael Klimas, Dai Feng, Richard
   Baumgartner, Ai-Leng Liang, Jeffrey L. Evelhoch, Chih-Liang Chin. Their
   roles include study design, data collection and analysis, decision to
   publish and preparation of the manuscript.
CR Akkan D, 2008, EUR J HEART FAIL, V10, P689, DOI 10.1016/j.ejheart.2008.05.007
   AXEL L, 1989, RADIOLOGY, V172, P349, DOI 10.1148/radiology.172.2.2748813
   Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x
   Brotman D, 2013, MAGN RESON MED, V69, P1421, DOI 10.1002/mrm.24373
   Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4
   Castillo E, 2005, J CARDIOVASC MAGN R, V7, P783, DOI 10.1080/10976640500295417
   Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186
   Chetboul V, 2008, J VET INTERN MED, V22, P342, DOI 10.1111/j.1939.1676.2007.0037.x
   Chu GX, 2002, J CARD FAIL, V8, pS432, DOI 10.1054/jcaf.2002.129284
   De Marchi SF, 2000, HEART, V83, P678, DOI 10.1136/heart.83.6.678
   Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015
   Edvardsen T, 2006, AM HEART J, V151, P109, DOI 10.1016/j.ahj.2005.02.018
   Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232
   Eriksson J, 2011, AM J PHYSIOL-HEART C, V300, pH2135, DOI 10.1152/ajpheart.00993.2010
   FEINBERG DA, 1985, MAGNET RESON MED, V2, P555, DOI 10.1002/mrm.1910020606
   FIRMIN DN, 1987, J COMPUT ASSIST TOMO, V11, P751, DOI 10.1097/00004728-198709000-00001
   FLETCHER PJ, 1981, CIRC RES, V49, P618, DOI 10.1161/01.RES.49.3.618
   Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034
   Gorman JH, 1998, J THORAC CARDIOV SUR, V115, P615, DOI 10.1016/S0022-5223(98)70326-5
   Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048
   HAENDCHEN RV, 1983, CIRCULATION, V67, P1234, DOI 10.1161/01.CIR.67.6.1234
   Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892
   Hayashi N, 1997, ARZNEIMITTELFORSCH, V47, P625
   Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1
   Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937
   Jugdutt BI, 2004, J CARD FAIL, V10, P74, DOI 10.1016/S1071-9164(03)00584-0
   Jung B, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-87
   Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014
   King Gerard J, 2003, Cardiovasc Ultrasound, V1, P9, DOI 10.1186/1476-7120-1-9
   Korosoglou G, 2012, J MAGN RESON IMAGING, V35, P804, DOI 10.1002/jmri.22879
   Kraitchman DL, 1998, MAGN RESON MED, V40, P311, DOI 10.1002/mrm.1910400217
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Mewton N, 2008, INVEST RADIOL, V43, P219, DOI 10.1097/RLI.0b013e318161613e
   Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793
   Moerman KM, 2011, MED PHYS, V38, P1248, DOI 10.1118/1.3533942
   Moore C C, 2000, Top Magn Reson Imaging, V11, P359, DOI 10.1097/00002142-200012000-00005
   Morita H, 2006, AM J PHYSIOL-HEART C, V290, pH2522, DOI 10.1152/ajpheart.00932.2005
   Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00
   Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620
   Okura H, 2009, CIRC J, V73, P86, DOI 10.1253/circj.CJ-08-0457
   Onishi T, 2010, CIRC-CARDIOVASC IMAG, V3, P134, DOI 10.1161/CIRCIMAGING.109.888354
   Osman NF, 1999, MAGN RESON MED, V42, P1048
   Osman NF, 2004, IEEE T BIO-MED ENG, V51, P1428, DOI 10.1109/TMBE.2004.827932
   Osman NF, 2000, PHYS MED BIOL, V45, P1665, DOI 10.1088/0031-9155/45/6/318
   Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177
   Parthasarathy V., 2006, CHARACTERIZATION HAR
   PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84
   PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503
   Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701
   Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5
   PRZYKLENK K, 1986, CARDIOVASC RES, V20, P403, DOI 10.1093/cvr/20.6.403
   REIMER KA, 1979, LAB INVEST, V40, P633
   Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26
   Shen YT, 2000, CURR OPIN INVEST DR, V11, P1025
   Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640
   SMITS JFM, 1992, J CARDIOVASC PHARM, V20, P772, DOI 10.1097/00005344-199220050-00013
   Stuber M, 1999, MAGN RESON MATER PHY, V9, P85
   Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195
   Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955
   WEBER KT, 1987, CIRCULATION, V75, P40
   WEINBERG EO, 1994, CIRCULATION, V90, P1410, DOI 10.1161/01.CIR.90.3.1410
   WHITE FC, 1986, LAB ANIM SCI, V36, P351
   Yarbrough WM, 2003, CIRCULATION, V108, P1753, DOI 10.1161/01.CIR.0000091087.78630.79
   Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730
   ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283
   Zhang H, 2007, J THORAC CARDIOV SUR, V134, P1234, DOI 10.1016/j.jtcvs.2007.07.019
   Zhong J, 2010, MAGN RESON MED, V64, P1315, DOI 10.1002/mrm.22530
NR 67
TC 1
Z9 1
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2015
VL 10
IS 5
AR e0127947
DI 10.1371/journal.pone.0127947
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CJ0QZ
UT WOS:000355183900169
PM 26010607
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Nathan, D
   Huynh, DQ
   Rubenson, J
   Rosenberg, M
AF Nathan, David
   Huynh, Du Q.
   Rubenson, Jonas
   Rosenberg, Michael
TI Estimating Physical Activity Energy Expenditure with the Kinect Sensor
   in an Exergaming Environment
SO PLOS ONE
LA English
DT Article
ID GAUSSIAN-PROCESSES; MECHANICAL WORK; CHILDREN; WALKING; SYSTEM;
   ADOLESCENTS; EFFICIENCY; ACCURACY; REGRESSION; VALIDITY
AB Active video games that require physical exertion during game play have been shown to confer health benefits. Typically, energy expended during game play is measured using devices attached to players, such as accelerometers, or portable gas analyzers. Since 2010, active video gaming technology incorporates marker-less motion capture devices to simulate human movement into game play. Using the Kinect Sensor and Microsoft SDK this research aimed to estimate the mechanical work performed by the human body and estimate subsequent metabolic energy using predictive algorithmic models. Nineteen University students participated in a repeated measures experiment performing four fundamental movements (arm swings, standing jumps, body-weight squats, and jumping jacks). Metabolic energy was captured using a Cortex Metamax 3B automated gas analysis system with mechanical movement captured by the combined motion data from two Kinect cameras. Estimations of the body segment properties, such as segment mass, length, centre of mass position, and radius of gyration, were calculated from the Zatsiorsky-Seluyanov's equations of de Leva, with adjustment made for posture cost. GPML toolbox implementation of the Gaussian Process Regression, a locally weighted k-Nearest Neighbour Regression, and a linear regression technique were evaluated for their performance on predicting the metabolic cost from new feature vectors. The experimental results show that Gaussian Process Regression outperformed the other two techniques by a small margin. This study demonstrated that physical activity energy expenditure during exercise, using the Kinect camera as a motion capture system, can be estimated from segmental mechanical work. Estimates for high-energy activities, such as standing jumps and jumping jacks, can be made accurately, but for low-energy activities, such as squatting, the posture of static poses should be considered as a contributing factor. When translated into the active video gaming environment, the results could be incorporated into game play to more accurately control the energy expenditure requirements.
C1 [Nathan, David; Rubenson, Jonas; Rosenberg, Michael] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.
   [Nathan, David; Huynh, Du Q.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia.
   [Rubenson, Jonas] Penn State Univ, Dept Kinesiol, Biomech Lab, University Pk, PA 16802 USA.
RP Rosenberg, M (reprint author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.
EM michael.rosenberg@uwa.edu.au
RI Rosenberg, Michael/H-5748-2014
OI Rubenson, Jonas/0000-0003-2854-1776; Nathan, David/0000-0003-1105-295X;
   Huynh, Du/0000-0003-3080-9655
FU Western Australian Health Promotion Foundation [19985 MR]
FX Funding for the hardware was provided by the Western Australian Health
   Promotion Foundation (www.healthway.wa.gov.au) (Research Translation
   Grant #19985 MR). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209
   Bishop C. M., 2007, PATTERN RECOGNITION
   BLAND JM, 1986, LANCET, V1, P307
   BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516
   Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0096-6362(03)00097-3
   Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726
   BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463
   Daley AJ, 2009, PEDIATRICS, V124, P763, DOI 10.1542/peds.2008-2357
   de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6
   Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5
   Graves L, 2008, BRIT J SPORT MED, V42, P592, DOI 10.1136/bmj.39415.632951.80
   Graves LEF, 2008, EUR J APPL PHYSIOL, V104, P617, DOI 10.1007/s00421-008-0813-8
   Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393
   Haddock Bryan L, 2012, Open Sports Sci J, V5, P1, DOI 10.2174/1875399X01205010001
   Leatherdale ST, 2010, AM J HEALTH BEHAV, V34, P31
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Macfarlane DJ, 2012, EUR J APPL PHYSIOL, V112, P2539, DOI 10.1007/s00421-011-2230-7
   MacKay D., 1998, NATO ASI SERIES F, V168, P133
   McArdle W. D., 2010, EXERCISE PHYSIOLOGY
   Mellecker RR, 2008, ARCH PEDIAT ADOL MED, V162, P886, DOI 10.1001/archpedi.162.9.886
   Mills A, 2013, J PEDIATR-US, V163, P806, DOI 10.1016/j.jpeds.2013.03.076
   PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670
   Prieur F, 2003, MED SCI SPORT EXER, V35, P879, DOI 10.1249/01.MSS.0000065003.82941.B0
   Prince Simon JD, 2012, COMPUTER VISION MODE
   Rasmussen C. E., 2006, ADAPT COMPUT MACH LE
   Rasmussen CE, 2010, J MACH LEARN RES, V11, P3011
   Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63
   Ryschon TW, 1997, J APPL PHYSIOL, V83, P867
   Sasaki K, 2009, J EXP BIOL, V212, P738, DOI 10.1242/jeb.023267
   Scharstein D, 2003, PROC CVPR IEEE, P195
   SCHENAU GJV, 1990, J BIOMECH, V23, P865
   Schepens B, 2004, J EXP BIOL, V207, P587, DOI 10.1242/jeb.00793
   Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316
   Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F
   Van de Walle P, 2012, GAIT POSTURE, V35, P231, DOI 10.1016/j.gaitpost.2011.09.012
   Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640
   Vaughan-Nichols SJ, 2009, COMPUTER, V42, P13, DOI 10.1109/MC.2009.260
   Vogler AJ, 2010, J SPORT SCI, V28, P733, DOI 10.1080/02640410903582776
   WILLEMS PA, 1995, J EXP BIOL, V198, P379
   Williams CKI, 1996, ADV NEUR IN, V8, P514
   WILLIAMS KR, 1985, MED SCI SPORT EXER, V17, P317
   Windolf M, 2008, J BIOMECH, V41, P2776, DOI 10.1016/j.jbiomech.2008.06.024
   Zatsiorsky V. M., 2002, KINETICS HUMAN MOTIO
   Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24
NR 44
TC 8
Z9 8
U1 0
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 22
PY 2015
VL 10
IS 5
AR e0127113
DI 10.1371/journal.pone.0127113
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CI7GR
UT WOS:000354931700042
PM 26000460
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Pinto, IC
   Sabido, M
   Pereira, AB
   Mello, MB
   Shimizu, ADX
   Protti, BL
   Benzaken, AS
AF Pinto, Ione Conceicao
   Sabido, Meritxell
   Pereira, Analice Barbosa
   Mello, Maeve B.
   Xavier Shimizu, Andrea de Melo
   Protti, Bruna Lovizutto
   Benzaken, Adele Schwartz
TI Field Evaluation of a Point-of-Care CD4 Analyzer for Monitoring HIV
   Patients in the Interior of the Amazon Region, Brazil
SO PLoS One
LA English
DT Article
ID PIMA CD4; PERFORMANCE EVALUATION; CELL ENUMERATION; INSTRUMENT; BLOOD
AB Objective
   To evaluate the accuracy of the PIMA point-of-care CD4 analyzer (PIMA) under field conditions in comparison to the current CD4 count system (FACSCalibur), and to evaluate the operational suitability and acceptability of health professionals (HP) and HIV-patients in using the PIMA in health clinics in the Amazon Region.
   Methods
   CD4 counts were measured onsite by the PIMA using fingerprick blood and in the reference laboratory by both the PIMA and FACSCalibur using venous blood. We used the Bland-Altman method to estimate the mean bias, and calculated the sensitivity and specificity at <200 and <500 cell/mu L thresholds. Patients (n = 404) and HP (n = 7) were interviewed on the acceptability and operational suitability of the PIMA.
   Results
   Using fingerprick blood (n = 337), the PIMA showed a concordance correlation coefficient (Rc) of 0.81, mean difference of -111.9 cell/mu L, 93.1%/98.5% sensitivity, and 89.2%/56.7% specificity at <200 and <500 cell/mu L thresholds, respectively. Venous blood (n = 340) showed an Rc of 0.89, mean difference of -83.4 cell/mu L, 98.3%/97.5% sensitivity, and 93.9%/66.0% specificity at <200 and <500 cell/mu L thresholds, respectively. The capillary PIMA was well accepted and found operationally appropriate by patients and HP.
   Conclusions
   The agreement between both instruments was poor and the PIMA underestimated CD4 cell counts, which was more pronounced at CD4 counts >= 500 cell/mu l. The PIMA's performance with fingerprick blood was less reliable than its performance with venous blood. In Brazil, where antiretroviral treatment is initiated regardless of CD4 counts, the PIMA's systematic bias towards CD4 underestimation may limit its role for monitoring HIV-patients.
C1 [Pinto, Ione Conceicao; Sabido, Meritxell; Xavier Shimizu, Andrea de Melo] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.
   [Sabido, Meritxell] Univ Girona, Dept Med Sci, TransLab, Catalunya, Spain.
   [Pereira, Analice Barbosa] Fac Salle, Manaus, Amazonas, Brazil.
   [Mello, Maeve B.] Joint United Nations Programme HIV AIDS UNAIDS, Brasilia, DF, Brazil.
   [Protti, Bruna Lovizutto; Benzaken, Adele Schwartz] Minist Saude, Secretaria Vigilancia Saude, Dept DST Aids & Hepatites Virais, Brasilia, DF, Brazil.
   [Benzaken, Adele Schwartz] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Sabido, M (reprint author), Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil.
EM xellsabido@gmail.com
OI Schwartz Benzaken, Adele/0000-0002-5789-0695
FU Centers for Disease Control and Prevention [1U2GPS001204]; National
   Department of STD/Aids; Brazilian Ministry of Health; Foundation for
   Research Support of the Amazonas State (FAPEAM)
FX The study was co-funded by Centers for Disease Control and Prevention
   through the Cooperative Agreement Award #1U2GPS001204, and by the
   National Department of STD/Aids and Viral Hepatitis from the Brazilian
   Ministry of Health. Dr. Sabido has a fellowship as a visiting researcher
   at the Fundacao de Medicina Tropical Dr. Heitor Vieira Dourado, funded
   by the Foundation for Research Support of the Amazonas State (FAPEAM)
   through the Strategic Programme in Science, Technology & Innovation in
   Health Foundations (PECTI/AM SAUDE). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR BD Beckton Dickinson, MULT CD3 FITC CD8 PF
   Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
   Bride M, 2005, HAM2005062
   Chesher Douglas, 2008, Clin Biochem Rev, V29 Suppl 1, pS23
   Department of STDs AIDS and Viral Hepatitis. Health Surveillance Secretariat. Brazilian Ministry of Health, 2013, EP B
   Department of STDs AIDS and Viral Hepatitis. Ministry of Health, 2013, PROT CLIN DIR TER
   Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378
   Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928
   Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3
   Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424
   Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233
   Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319
   Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1
   Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071
   Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612
   Myer L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18649
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512
   Rathunde L, 2014, INT J STD AIDS, V25, P956, DOI 10.1177/0956462414526862
   Rocha GM, 2011, CAD SAUDE PUBLICA, V27, pS67, DOI 10.1590/S0102-311X2011001300008
   Shott JP, 2012, J TROP MED, V2012, DOI [10.1155/2012/651927, DOI 10.1155/2012/651927]
   Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2
   Van Schaik N, 2011, CROI 2011 18 C RETR
   Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214
   World Health Organization, 2013, WHO CONS GUID US ANT
   Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809
   Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x
NR 29
TC 11
Z9 11
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 23
PY 2015
VL 10
IS 4
AR e0121400
DI 10.1371/journal.pone.0121400
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG5KZ
UT WOS:000353332000007
PM 25905775
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Kosack, CS
   de Kieviet, W
   Bayrak, K
   Milovic, A
   Page, AL
AF Kosack, Cara Simone
   de Kieviet, Wim
   Bayrak, Kubra
   Milovic, Anastacija
   Page, Anne Laure
TI Evaluation of the Nova StatSensor (R) Xpress (TM) Creatinine
   Point-Of-Care Handheld Analyzer
SO PLOS ONE
LA English
DT Article
AB Creatinine is a parameter that is required to monitor renal function and is important to follow in patients under treatment with potentially toxic renal drugs, such as the anti-HIV drug Tenofovir. A point of care instrument to measure creatinine would be useful for patients monitoring in resource-limited settings, where more instruments that are sophisticated are not available. The StatSensor Xpress Creatinine (Nova Biomedical Cooperation, Waltham, MA, USA) point of care analyzer was evaluated for its diagnostic performance in indicating drug therapy change. Creatinine was measured in parallel using the Nova StatSensor Xpress Creatinine analyzer and the Vitros 5,1FS (Ortho Clinical Diagnostics, Inc, Rochester, USA), which served as reference standard. The precision (i.e., repeatability and reproducibility) and accuracy of the StatSensor Xpress Creatinine analyzer were calculated using a panel of specimens with normal, low pathological and high pathological values. Two different Nova StatSensor Xpress Creatinine analyzers were used for the assessment of accuracy using repeated measurements. The coefficient of variation of the StatSensor Xpress Creatinine analyzers ranged from 2.3 to 5.9% for repeatability and from 4.2 to 9.0% for between- run reproducibility. The concordance correlation agreement was good except for high values (> 600 mu mol/L). The Bland-Altman analysis in high pathological specimens suggests that the Nova StatSensor Xpress Creatinine test tends to underestimate high creatinine values (i. e., > 600 mu mol/L). The Nova StatSensor Xpress Creatinine analyzers showed acceptable to good results in terms of repeatability, inter-device reproducibility and between- run reproducibility over time using quality control reagents. The analyzer was found sufficiently accurate for detecting pathological values in patients (age > 10 year) and can be used with a moderate risk of misclassification.
C1 [Kosack, Cara Simone] Med Sans Frontieres, Diagnost Network, Amsterdam, Netherlands.
   [de Kieviet, Wim; Bayrak, Kubra; Milovic, Anastacija] St Lucas Andreas Ziekenhuis, Dept Clin Chem, Amsterdam, Netherlands.
   [Page, Anne Laure] Epictr, Paris, France.
RP Kosack, CS (reprint author), Med Sans Frontieres, Diagnost Network, Amsterdam, Netherlands.
EM cara.kosack@amsterdam.msf.org
FU Sint Lucas Andreas Ziekenhuis in Amsterdam, the Netherlands
FX We thank the Sint Lucas Andreas Ziekenhuis in Amsterdam, the Netherlands
   for supporting this evaluation study.
CR AIDS Info: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, 2013, GUIDELINES USE ANTIR
   BLAND JM, 1986, LANCET, V1, P307
   Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609
   Bygrave H, 2011, JAIDS-J ACQ IMM DEF, V56, pE75, DOI 10.1097/QAI.0b013e3182097505
   CDC, 2013, CLIN LAB IMPR AM
   Chua AC, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-19
   Clinical Lab Navigator, 2013, CLIA ACC TEST PERF C
   Korpi-Steiner NL, 2009, AM J CLIN PATHOL, V132, P920, DOI 10.1309/AJCPTE5FEY0VCGOZ
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   QC Net, 2014, CLIA PROF LIM
   Schnabl KL, 2010, CLIN BIOCHEM, V43, P1026, DOI 10.1016/j.clinbiochem.2010.04.055
   Shephard M, 2010, CLIN CHEM LAB MED, V48, P1113, DOI 10.1515/CCLM.2010.238
   Straseski JA, 2011, CLIN CHEM, V57, P1566, DOI 10.1373/clinchem.2011.165480
   Westgard QC, 2014, DESIRABLE SPECIFICAT
NR 14
TC 9
Z9 9
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 17
PY 2015
VL 10
IS 4
AR e0122433
DI 10.1371/journal.pone.0122433
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CG1EX
UT WOS:000353017000032
PM 25886375
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gionbelli, MP
   Duarte, MS
   Valadares, SC
   Detmann, E
   Chizzotti, ML
   Rodrigues, FC
   Zanetti, D
   Gionbelli, TRS
   Machado, MG
AF Gionbelli, Mateus P.
   Duarte, Marcio S.
   Valadares Filho, Sebastiao C.
   Detmann, Edenio
   Chizzotti, Mario L.
   Rodrigues, Felipe C.
   Zanetti, Diego
   Gionbelli, Tathyane R. S.
   Machado, Marcelo G.
TI Achieving Body Weight Adjustments for Feeding Status and Pregnant or
   Non-Pregnant Condition in Beef Cows
SO PLOS ONE
LA English
DT Article
ID VISCERAL ORGAN MASS; GESTATION LENGTH; GRAVID UTERUS; CATTLE; GROWTH;
   MODEL; IDENTIFICATION; RESTRICTION; VASCULARITY; PARAMETERS
AB Background
   Beef cows herd accounts for 70% of the total energy used in the beef production system. However, there are still limited studies regarding improvement of production efficiency in this category, mainly in developing countries and in tropical areas. One of the limiting factors is the difficulty to obtain reliable estimates of weight variation in mature cows. This occurs due to the interaction of weight of maternal tissues with specific physiological stages such as pregnancy. Moreover, variation in gastrointestinal contents due to feeding status in ruminant animals is a major source of error in body weight measurements.
   Objectives
   Develop approaches to estimate the individual proportion of weight from maternal tissues and from gestation in pregnant cows, adjusting for feeding status and stage of gestation.
   Methods and Findings
   Dataset of 49 multiparous non-lactating Nellore cows (32 pregnant and 17 non-pregnant) were used. To establish the relationships between the body weight, depending on the feeding status of pregnant and non-pregnant cows as a function of days of pregnancy, a set of general equations was tested, based on theoretical suppositions. We proposed the concept of pregnant compound (PREG), which represents the weight that is genuinely related to pregnancy. The PREG includes the gravid uterus minus the non-pregnant uterus plus the accretion in udder related to pregnancy. There was no accretion in udder weight up to 238 days of pregnancy. By subtracting the PREG from live weight of a pregnant cow, we obtained estimates of the weight of only maternal tissues in pregnant cows. Non-linear functions were adjusted to estimate the relationship between fasted, non-fasted and empty body weight, for pregnant and non-pregnant cows.
   Conclusions
   Our results allow for estimating the actual live weight of pregnant cows and their body constituents, and subsequent comparison as a function of days of gestation and feeding status.
C1 [Gionbelli, Mateus P.] Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil.
   [Duarte, Marcio S.; Valadares Filho, Sebastiao C.; Detmann, Edenio; Chizzotti, Mario L.; Rodrigues, Felipe C.; Zanetti, Diego; Gionbelli, Tathyane R. S.; Machado, Marcelo G.] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.
RP Gionbelli, MP (reprint author), Univ Fed Lavras, Dept Anim Sci, Lavras, MG, Brazil.
EM mateus.gionbelli@dzo.ufla.br
RI Chizzotti, ML/C-4854-2013; Duarte, Marcio/G-3815-2015; Gionbelli,
   Mateus/W-4420-2018; Detmann, Edenio/O-9048-2019
OI Chizzotti, ML/0000-0001-9770-6891; Duarte, Marcio/0000-0002-5795-6420;
   Gionbelli, Mateus/0000-0002-5168-4794; 
FU FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais) [APQ-01121-10];
   INCT-CA (Instituto Nacional de Ciencia e Tecnologia-Ciencia Animal)
   [573592/2008-0]; Conselho Nacional de Ciencia e Tecnologia-CNPq
   [202062/2011-2]
FX This work was supported by the FAPEMIG (Fundacao de Amparo a Pesquisa de
   Minas Gerais) (Grant: APQ-01121-10), the INCT-CA (Instituto Nacional de
   Ciencia e Tecnologia-Ciencia Animal) (Grant: 573592/2008-0) and the
   Conselho Nacional de Ciencia e Tecnologia-CNPq (Grant: 202062/2011-2).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR AFRC (Agricultural and Food Research Council), 1993, EN PROT REQ RUM
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   ANDERSEN H, 1965, J DAIRY SCI, V48, P1224, DOI 10.3168/jds.S0022-0302(65)88431-4
   AOAC, 2000, OFFICIAL METHODS ANA
   ARC (Agricultural Research Council), 1980, NUTR REQ RUM LIV
   AVMA, 2013, GUID EUTH AN
   BERESKIN B, 1967, J DAIRY SCI, V50, P220, DOI 10.3168/jds.S0022-0302(67)87391-0
   Bibby J., 1977, PREDICTION IMPROVED
   Caton JS, 2009, J ANIM SCI, V87, P222, DOI 10.2527/jas.2008-1043
   Duarte MS, 2013, MEAT SCI, V94, P139, DOI 10.1016/j.meatsci.2013.01.008
   Duchesne C, 2001, J PROCESS CONTR, V11, P553, DOI 10.1016/S0959-1524(00)00025-1
   Fadel JG, 2004, J DAIRY SCI, V87, P169, DOI 10.3168/jds.S0022-0302(04)73154-9
   FERRELL CL, 1976, J ANIM SCI, V42, P1477
   FOX DG, 1976, J ANIM SCI, V43, P566
   Gionbelli MP, 2013, J ANIM SCI, V91, P320
   INRA, 2007, AL BOV OV CAPR BES A
   KOONG LJ, 1975, J ANIM SCI, V41, P1065
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   LOFGREEN GP, 1962, J ANIM SCI, V21, P20
   Martin O, 2007, ANIMAL, V1, P1143, DOI [10.1017/S1751731107000377, 10.1017/S1731107000377]
   Martin O, 2003, P 10 RENC AUT RECH R, P167
   MAYER DG, 1994, AGR SYST, V45, P93, DOI 10.1016/S0308-521X(94)90282-8
   McNeill DM, 1997, J ANIM SCI, V75, P809
   Meyer AM, 2010, J ANIM SCI, V88, P2410, DOI 10.2527/jas.2009-2220
   Motulsky H., 2003, FITTING MODELS BIOL
   Nicholson M. J., 1986, GUIDE CONDITION SCOR
   NRC, 2001, NUTR REQ DAIR CATTL
   NRC, 2000, NUTR REQ BEEF CATTL
   Paulino P. V. R., 2010, Nutrient requirements of Zebu beef cattle - BR - Corte, P167
   RICHARDS MW, 1986, J ANIM SCI, V62, P300
   Ritchie RW, 1995, RES S ANN M KANS CIT, V27, P126
   Rocha JCMC, 2005, ARQ BRAS MED VET ZOO, V57, P784, DOI 10.1590/S0102-09352005000600013
   Scheaffer AN, 2004, J ANIM SCI, V82, P1826
   Scheaffer AN, 2001, J ANIM SCI, V79, P2481
   SILVEY MW, 1978, ANIM PROD, V27, P113, DOI 10.1017/S0003356100035881
   Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004
   THEIL H, 1961, CONTRIBUTIONS EC ANA, P6
   Valadares Filho SC, 2010, NUTR REQUIREMENTS ZE
   WILLIAMS WT, 1975, AUST J AGR RES, V26, P665, DOI 10.1071/AR9750665
NR 39
TC 6
Z9 7
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2015
VL 10
IS 3
AR e0112111
DI 10.1371/journal.pone.0112111
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CE8IA
UT WOS:000352084200001
PM 25793770
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Grove, O
   Berglund, AE
   Schabath, MB
   Aerts, HJWL
   Dekker, A
   Wang, H
   Velazquez, ER
   Lambin, P
   Gu, YH
   Balagurunathan, Y
   Eikman, E
   Gatenby, RA
   Eschrich, S
   Gillies, RJ
AF Grove, Olya
   Berglund, Anders E.
   Schabath, Matthew B.
   Aerts, Hugo J. W. L.
   Dekker, Andre
   Wang, Hua
   Velazquez, Emmanuel Rios
   Lambin, Philippe
   Gu, Yuhua
   Balagurunathan, Yoganand
   Eikman, Edward
   Gatenby, Robert A.
   Eschrich, Steven
   Gillies, Robert J.
TI Quantitative Computed Tomographic Descriptors Associate Tumor Shape
   Complexity and Intratumor Heterogeneity with Prognosis in Lung
   Adenocarcinoma
SO PLOS ONE
LA English
DT Article
ID TEXTURE ANALYSIS; CT IMAGES; POTENTIAL MARKER; CANCER; SURVIVAL;
   REPRODUCIBILITY; MUTATIONS
AB Two CT features were developed to quantitatively describe lung adenocarcinomas by scoring tumor shape complexity (feature 1: convexity) and intratumor density variation (feature 2: entropy ratio) in routinely obtained diagnostic CT scans. The developed quantitative features were analyzed in two independent cohorts (cohort 1: n = 61; cohort 2: n = 47) of patients diagnosed with primary lung adenocarcinoma, retrospectively curated to include imaging and clinical data. Preoperative chest CTs were segmented semi-automatically. Segmented tumor regions were further subdivided into core and boundary sub-regions, to quantify intensity variations across the tumor. Reproducibility of the features was evaluated in an independent test-retest dataset of 32 patients. The proposed metrics showed high degree of reproducibility in a repeated experiment (concordance, CCC >= 0.897; dynamic range, DR >= 0.92). Association with overall survival was evaluated by Cox proportional hazard regression, Kaplan-Meier survival curves, and the log-rank test. Both features were associated with overall survival (convexity: p = 0.008; entropy ratio: p = 0.04) in Cohort 1 but not in Cohort 2 (convexity: p = 0.7; entropy ratio: p = 0.8). In both cohorts, these features were found to be descriptive and demonstrated the link between imaging characteristics and patient survival in lung adenocarcinoma.
C1 [Grove, Olya; Wang, Hua; Gu, Yuhua; Balagurunathan, Yoganand; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.
   [Berglund, Anders E.; Eschrich, Steven] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL USA.
   [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA.
   [Eikman, Edward; Gatenby, Robert A.; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiol, Tampa, FL USA.
   [Dekker, Andre; Lambin, Philippe] Maastricht Univ, Res Inst GROW, MAASTRO Clin, Dept Radiat Oncol, NL-6229 ET Maastricht, Netherlands.
   [Wang, Hua] Tianjin Med Univ, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp, Dept Radiol,Natl Clin Res Ctr Canc, Tianjin, Peoples R China.
   [Aerts, Hugo J. W. L.; Velazquez, Emmanuel Rios] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiat Oncol,Dana Farber Canc Inst, Boston, MA USA.
   [Aerts, Hugo J. W. L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA.
RP Gillies, RJ (reprint author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging & Metab, Tampa, FL 33612 USA.
EM Robert.Gillies@Moffitt.org
RI Aerts, Hugo/P-6350-2015; Schabath, Matthew B./J-3763-2016
OI Aerts, Hugo/0000-0002-2122-2003; Schabath, Matthew
   B./0000-0003-3241-3216; Dekker, Andre/0000-0002-0422-7996
FU National Cancer Institute; NIH/NCI, Radiomics of NSCLC [U01CA143062];
   NIH/NCI, Radiomics of Lung Cancer Screening [P50CA119997]; Florida
   Biomedical Research Programs: King Team Science Grant [2KT01]
FX Funding provided by National Cancer Institute: http://www.cancer.gov/,
   1.NIH/NCI U01CA143062, Radiomics of NSCLC; 2. NIH/NCI P50CA119997,
   Radiomics of Lung Cancer Screening. Florida Biomedical Research
   Programs:
   http://researchtest.magnet.fsu.edu/newsletters/2013/July/documents/2013-
   2014%20SUMMER%20CALL%20King%20Program.pdf, King Team Science Grant
   2KT01. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844
   Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821
   Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105
   Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423
   Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8
   Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697
   Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607
   Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005
   Honda T, 2013, CLIN RADIOL, V68, pE21, DOI 10.1016/j.crad.2012.09.002
   Jaffe CC, 2012, RADIOLOGY, V264, P329, DOI 10.1148/radiol.12120871
   Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625
   Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7
   Kuo MD, 2014, RADIOLOGY, V270, P320, DOI 10.1148/radiol.13132195
   Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879
   Nair VS, 2010, CHEST, V137, P1150, DOI 10.1378/chest.09-2356
   Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396
   Prokop M, 2001, SPIRAL MULTISLICE CO, P1104
   Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0
   Rees JH, 1996, RADIOGRAPHICS, V16, P1413, DOI 10.1148/radiographics.16.6.8946545
   Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003
   Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050
   Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306
   Shultz DB, 2014, CLIN LUNG CANCER, V15, P294, DOI 10.1016/j.cllc.2013.12.011
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   YANG XK, 2011, EURASIP J ADV SIG PR, DOI DOI 10.1155/2011/
   Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593
NR 28
TC 72
Z9 75
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 4
PY 2015
VL 10
IS 3
AR e0118261
DI 10.1371/journal.pone.0118261
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC9JM
UT WOS:000350685900026
PM 25739030
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wade, D
   Diaw, PA
   Daneau, G
   Diallo, AA
   Mboup, S
   Dieye, TN
   Kestens, L
AF Wade, Djibril
   Diaw, Papa Alassane
   Daneau, Geraldine
   Diallo, Abdoul Aziz
   Mboup, Souleymane
   Dieye, Tandakha Ndiaye
   Kestens, Luc
TI Laboratory and Field Evaluation of the Partec CyFlow MiniPOC for
   Absolute and Relative CD4 T-Cell Enumeration
SO PLOS ONE
LA English
DT Article
ID RESOURCE-POOR SETTINGS; HIV-INFECTED PATIENTS; PERFORMANCE EVALUATION;
   FLOW CYTOMETER; ANTIRETROVIRAL THERAPY; PIMA CD4; HIV-1-INFECTED
   PATIENTS; CONSTRAINED SETTINGS; CLINICAL-CHEMISTRY; FACSCOUNT SYSTEM
AB Background
   A new CD4 point-of-care instrument, the CyFlow miniPOC, which provides absolute and percentage CD4 T-cells, used for screening and monitoring of HIV-infected patients in resource-limited settings, was introduced recently. We assessed the performance of this novel instrument in a reference laboratory and in a field setting in Senegal.
   Methodology
   A total of 321 blood samples were obtained from 297 adults and 24 children, all HIV-patients attending university hospitals in Dakar, or health centers in Ziguinchor. Samples were analyzed in parallel on CyFlow miniPOC, FACSCount CD4 and FACSCalibur to assess CyFlow miniPOC precision and accuracy.
   Results
   At the reference lab, CyFlow miniPOC, compared to FACSCalibur, showed an absolute mean bias of -12.6 cells/mm(3) and a corresponding relative mean bias of -2.3% for absolute CD4 counts. For CD4 percentages, the absolute mean bias was -0.1%. Compared to FACSCount CD4, the absolute and relative mean biases were -31.2 cells/mm3 and -4.7%, respectively, for CD4 counts, whereas the absolute mean bias for CD4 percentages was 1.3%. The CyFlow miniPOC was able to classify HIV-patients eligible for ART with a sensitivity of >= 95% at the different ART-initiation thresholds (200, 350 and 500 CD4 cells/mm(3)). In the field lab, the room temperature ranged from 30 to 35 degrees C during the working hours. At those temperatures, the CyFlow miniPOC, compared to FACSCount CD4, had an absolute and relative mean bias of 7.6 cells/mm(3) and 2.8%, respectively, for absolute CD4 counts, and an absolute mean bias of 0.4% for CD4 percentages. The CyFlow miniPOC showed sensitivity equal or greater than 94%.
   Conclusion
   The CyFlow miniPOC showed high agreement with FACSCalibur and FACSCount CD4. The CyFlow miniPOC provides both reliable absolute CD4 counts and CD4 percentages even under the field conditions, and is suitable for monitoring HIV-infected patients in resource-limited settings.
C1 [Wade, Djibril; Diaw, Papa Alassane; Diallo, Abdoul Aziz; Mboup, Souleymane; Dieye, Tandakha Ndiaye] Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal.
   [Wade, Djibril; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Immunol Lab, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Wade, Djibril; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.
RP Wade, D (reprint author), Le Dantec Hosp, Immunol Unit, Lab Bacteriol Virol, Dakar, Senegal.
EM wadedjibril@yahoo.fr
FU Belgian Directorate General of Development
FX This study was funded by Belgian Directorate General of Development. The
   funder had no role in study design, data collection and analysis,
   decision too publish, or preparation of the manuscript.
CR [Anonymous], 2006, AIDS, V20, P1289, DOI DOI 10.1097/01.AIDS.0000232237.20792.68
   Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5
   Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166
   BLAND JM, 1986, LANCET, V1, P307
   BROUGHTON PM, 1974, ANN CLIN BIOCHEM, V11, P207, DOI 10.1177/000456327401100164
   Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257
   Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378
   Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014
   Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3
   Glynn MT, 2013, LAB CHIP, V13, P2731, DOI 10.1039/c3lc50213a
   Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0
   Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424
   Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005
   Li X, 2010, CYTOM PART B-CLIN CY, V78B, P31, DOI 10.1002/cyto.b.20488
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Logan C, 2013, J IMMUNOL METHODS, V387, P107, DOI 10.1016/j.jim.2012.10.002
   Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y
   Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2
   Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319
   Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06
   Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414
   Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1
   Mbopi-Keou FX, 2012, CLIN VACCINE IMMUNOL, V19, P609, DOI 10.1128/CVI.00023-12
   Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651
   Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071
   Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005
   Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721
   Pattanapanyasat K, 2008, CYTOM PART B-CLIN CY, V74B, pS98, DOI 10.1002/cyto.b.20415
   Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167
   POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512
   Renault Cybele A, 2010, Open AIDS J, V4, P171, DOI 10.2174/1874613601004010171
   Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b
   Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182
   Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016
   Strauss K, 1996, CYTOMETRY, V26, P52
   Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2
   Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26
   Thakar Madhuri R, 2006, AIDS Res Ther, V3, P26, DOI 10.1186/1742-6405-3-26
   UNITAID, 2013, HIV AIDS DIAGN TECHN
   Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214
   Wade D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075484
   World Health Organization, 2013, CONS GUID US ANT DRU
   World Health Organization, 2010, ANT THER HIV INF INF
   Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x
   Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33
NR 47
TC 8
Z9 8
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 17
PY 2015
VL 10
IS 2
AR UNSP e0116663
DI 10.1371/journal.pone.0116663
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC4KQ
UT WOS:000350322700018
PM 25688553
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Bass, MB
   Yao, B
   Hei, YJ
   Ye, YN
   Davis, GJ
   Davis, MT
   Kaesdorf, BA
   Chan, SS
   Patterson, SD
AF Bass, Michael B.
   Yao, Bin
   Hei, Yong-Jiang
   Ye, Yining
   Davis, Gerard J.
   Davis, Michael T.
   Kaesdorf, Barbara A.
   Chan, Sabrina S.
   Patterson, Scott D.
TI Challenges in Developing a Validated Biomarker for Angiogenesis
   Inhibitors: The Motesanib Experience
SO PLOS ONE
LA English
DT Article
ID CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; PHASE-II; MULTIKINASE
   INHIBITOR; THYROID-CANCER; SOLID TUMORS; BEVACIZUMAB; REVASCULARIZATION;
   CARBOPLATIN; COMBINATION
AB Purpose: We sought to develop placental growth factor as a predictive pharmacodynamic biomarker for motesanib efficacy as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.
   Experimental Design: Placental growth factor was evaluated at baseline and study week 4 (after 3 weeks treatment) in an exploratory analysis of data from a randomized phase 2 study of motesanib 125 mg once daily plus carboplatin/paclitaxel and in a prespecified analysis of data from a randomized, double-blind phase 3 study of motesanib 125 mg once daily plus carboplatin/paclitaxel vs placebo plus carboplatin/paclitaxel (MONET1). Associations between fold-change from baseline in placental growth factor and overall survival were evaluated using Cox proportional hazards models.
   Results: In the phase 2 study, serum placental growth factor increased from baseline a mean 2.8-fold at study week 4. Patients with >= 2.2-fold change from baseline in placental growth factor (n = 18) had significantly longer overall survival than those with <2.2-fold change (n = 19; 22.9 vs 7.9 months; hazard ratio, 0.30; 95% CI, 0.12-0.74; P = 0.009). Consequently, placental growth factor was investigated as a pharmacodynamic biomarker in the phase 3 MONET1 study. There was no association between log-transformed placental growth factor fold-change from baseline to week 4 (continuous variable) and overall survival (hazard ratio, 0.98; 95% CI, 0.79-1.22; P = 0.868). MONET1 did not meet its primary endpoint of overall survival. Likewise, median overall survival was similar among patients with >= 2.0-fold change in placental growth factor (n = 229) compared with <2.0-fold change (n = 127; 14.8 vs 13.8 months; hazard ratio, 0.88; 95% CI, 0.67-1.15, P = 0.340).
   Conclusions: Our results illustrate the challenges of successfully translating phase 2 biomarker results into phase 3 studies.
C1 [Bass, Michael B.; Davis, Michael T.] Amgen Inc, Mol Sci & Computat Biol, Thousand Oaks, CA 91320 USA.
   [Yao, Bin] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA.
   [Hei, Yong-Jiang] Amgen Inc, Oncol Dev, Thousand Oaks, CA 91320 USA.
   [Ye, Yining] Amgen Inc, Global Biostat Sci, San Francisco, CA USA.
   [Davis, Gerard J.; Kaesdorf, Barbara A.; Chan, Sabrina S.] Abbott Labs, Diagnost Div Res & Dev, Abbott Pk, IL 60064 USA.
   [Patterson, Scott D.] Amgen Inc, Med Sci, Thousand Oaks, CA 91320 USA.
RP Bass, MB (reprint author), Amgen Inc, Mol Sci & Computat Biol, Thousand Oaks, CA 91320 USA.
EM mbass@amgen.com
FU Amgen Inc.
FX This study was funded by Amgen Inc. (http://www.amgen.com). Employees of
   Amgen Inc. participated in the study design, data collection and
   analysis, decision to publish, and preparation of the manuscript.
CR Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x
   Bass MB, 2010, J CLIN ONCOL, V28
   Bass MB, 2010, J CLIN ENDOCR METAB, V95, P5018, DOI 10.1210/jc.2010-0947
   Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Blumenschein GR, 2011, ANN ONCOL, V22, P2057, DOI 10.1093/annonc/mdq731
   Blumenschein GR, 2012, INVEST NEW DRUG, V30, P1802, DOI 10.1007/s10637-011-9750-1
   Cao YH, 1996, J CLIN INVEST, V98, P2507, DOI 10.1172/JCI119069
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Cox DR, 1984, ANAL SURVIVAL DATA
   DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32
   Freidlin B, 2012, J CLIN ONCOL, V30, P3304, DOI 10.1200/JCO.2012.43.3946
   Green CJ, 2001, CANCER RES, V61, P2696
   Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x
   Hung HMJ, 2006, PHARM STAT, V5, P99, DOI 10.1002/pst.219
   Kelly RJ, 2011, CLIN CANCER RES, V17, P1190, DOI 10.1158/1078-0432.CCR-10-2331
   Kern SE, 2012, CANCER RES, V72, P6097, DOI 10.1158/0008-5472.CAN-12-3232
   Korn EL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004018
   Korpanty G, 2012, CURR PHARM DESIGN, V18, P2680, DOI 10.2174/138161212800626166
   Kurzrock R, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.07.8170
   Kutner M, 2005, APPL LINEAR STAT MOD, P1
   Lambrechts D, 2013, J CLIN ONCOL, DOI [10.1200/JCO.2012.1246.2762, DOI 10.1200/JCO.2012.1246.2762]
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731
   Metcalfe TA, 2010, SCAND J CLIN LAB INV, V70, P23, DOI 10.3109/00365513.2010.493361
   MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881
   Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160
   Nikolinakos PG, 2010, CANCER RES, V70, P2171, DOI 10.1158/0008-5472.CAN-09-2533
   Patterson SD, 2010, J CLIN ONCOL, V28
   Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665
   Rini BI, 2008, J CLIN ONCOL, V26, P3743, DOI 10.1200/JCO.2007.15.5416
   Russell Chris B., 2008, P1, DOI 10.1007/978-1-59745-463-6_1
   Scagliotti GV, 2012, J CLIN ONCOL, V30, P2829, DOI 10.1200/JCO.2011.41.4987
   Schlumberger MJ, 2009, J CLIN ONCOL, V27, P3794, DOI 10.1200/JCO.2008.18.7815
   Sharma PS, 2011, CURR CANCER DRUG TAR, V11, P624
   Sherman SI, 2008, NEW ENGL J MED, V359, P31, DOI 10.1056/NEJMoa075853
   Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205
   US Dep. Health Hum. Serv. US Food Drug Admin. Cent. Drug Eval. Res, 2010, GUID IND QUAL PROC D
   Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771
   Zhang Lijian, 2005, World J Surg Oncol, V3, P68, DOI 10.1186/1477-7819-3-68
NR 41
TC 6
Z9 6
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2014
VL 9
IS 10
AR e108048
DI 10.1371/journal.pone.0108048
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR5ZW
UT WOS:000343662500009
PM 25314641
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Neto, EC
   Bare, JC
   Margolin, AA
AF Neto, Elias Chaibub
   Bare, J. Christopher
   Margolin, Adam A.
TI Simulation Studies as Designed Experiments: The Comparison of Penalized
   Regression Models in the "Large p, Small n" Setting
SO PLOS ONE
LA English
DT Article
ID A-PRIORI DISTINCTIONS; LEARNING ALGORITHMS; DRUG-SENSITIVITY; CANCER;
   REGULARIZATION; SELECTION
AB New algorithms are continuously proposed in computational biology. Performance evaluation of novel methods is important in practice. Nonetheless, the field experiences a lack of rigorous methodology aimed to systematically and objectively evaluate competing approaches. Simulation studies are frequently used to show that a particular method outperforms another. Often times, however, simulation studies are not well designed, and it is hard to characterize the particular conditions under which different methods perform better. In this paper we propose the adoption of well established techniques in the design of computer and physical experiments for developing effective simulation studies. By following best practices in planning of experiments we are better able to understand the strengths and weaknesses of competing algorithms leading to more informed decisions about which method to use for a particular task. We illustrate the application of our proposed simulation framework with a detailed comparison of the ridge-regression, lasso and elastic-net algorithms in a large scale study investigating the effects on predictive performance of sample size, number of features, true model sparsity, signal-to-noise ratio, and feature correlation, in situations where the number of covariates is usually much larger than sample size. Analysis of data sets containing tens of thousands of features but only a few hundred samples is nowadays routine in computational biology, where "omics" features such as gene expression, copy number variation and sequence data are frequently used in the predictive modeling of complex phenotypes such as anticancer drug response. The penalized regression approaches investigated in this study are popular choices in this setting and our simulations corroborate well established results concerning the conditions under which each one of these methods is expected to perform best while providing several novel insights.
C1 [Neto, Elias Chaibub; Bare, J. Christopher; Margolin, Adam A.] Sage Bionetworks, Seattle, WA 98109 USA.
RP Neto, EC (reprint author), Sage Bionetworks, Seattle, WA 98109 USA.
EM elias.chaibub.neto@sagebase.org
OI Bare, J. Christopher/0000-0003-1006-1491
FU National Cancer Institute (NCI) Integrative Cancer Biology Program
   (ICBP) [U54-CA149237]
FX This work was supported by the National Cancer Institute (NCI)
   Integrative Cancer Biology Program (ICBP) grant U54-CA149237
   (http://icbp.nci.nih.gov/). The funder had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003
   Box E.P., 1978, STAT EXPT
   Carnell R., 2012, LHS LATIN HYPERCUBE
   Cox RD, 1984, INT STAT REV, V52, P1
   Davison A C, 1997, BOOTSTRAP METHODS TH
   Franco J., 2014, DICEDESIGN DESIGNS C
   Friedman J, 2010, J STAT SOFTW, V33, P1
   Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005
   HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI DOI 10.1080/00401706.1970.10488634
   Jang I.S., 2014, PAC S BIOCOMPUT, V19, P63
   JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B
   Lewis B, 2014, DOREDIS FOREACH PARA
   Lewis BW, 2013, RREDIS REDIS CLIENT
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Neto EC, 2014, BIOCOMPUT-PAC SYM, P27
   Pronzato L, 2012, STAT COMPUT, V22, P681, DOI 10.1007/s11222-011-9242-3
   Rizzo M. L, 2014, ENERGY E STAT ENERGY
   Rizzo ML, 2010, ANN APPL STAT, V4, P1034, DOI 10.1214/09-AOAS245
   Santner T., 2003, DESIGN ANAL COMPUTER
   Schaffer C, 1994, INT C MACH LEARN, P295
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267
   Venables W. N, 2002, MODERN APPL STAT S
   West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998
   Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893
   Wolpert DH, 1996, NEURAL COMPUT, V8, P1391, DOI 10.1162/neco.1996.8.7.1391
   Wolpert DH, 1996, NEURAL COMPUT, V8, P1341, DOI 10.1162/neco.1996.8.7.1341
   Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x
NR 27
TC 5
Z9 5
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 7
PY 2014
VL 9
IS 10
AR e107957
DI 10.1371/journal.pone.0107957
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ4VK
UT WOS:000342798000011
PM 25289666
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Liao, H
   Zeng, A
   Xiao, R
   Ren, ZM
   Chen, DB
   Zhang, YC
AF Liao, Hao
   Zeng, An
   Xiao, Rui
   Ren, Zhuo-Ming
   Chen, Duan-Bing
   Zhang, Yi-Cheng
TI Ranking Reputation and Quality in Online Rating Systems
SO PLOS ONE
LA English
DT Article
ID RECOMMENDER SYSTEMS; NETWORKS; INFORMATION; COEFFICIENT
AB How to design an accurate and robust ranking algorithm is a fundamental problem with wide applications in many real systems. It is especially significant in online rating systems due to the existence of some spammers. In the literature, many well-performed iterative ranking methods have been proposed. These methods can effectively recognize the unreliable users and reduce their weight in judging the quality of objects, and finally lead to a more accurate evaluation of the online products. In this paper, we design an iterative ranking method with high performance in both accuracy and robustness. More specifically, a reputation redistribution process is introduced to enhance the influence of highly reputed users and two penalty factors enable the algorithm resistance to malicious behaviors. Validation of our method is performed in both artificial and real user-object bipartite networks.
C1 [Liao, Hao; Zeng, An; Xiao, Rui; Ren, Zhuo-Ming; Chen, Duan-Bing; Zhang, Yi-Cheng] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.
   [Ren, Zhuo-Ming] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China.
   [Chen, Duan-Bing] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.
RP Zeng, A (reprint author), Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland.
EM an.zeng@unifr.ch
RI REN, Zhuo-Ming/M-9158-2014
FU EU [611272]; Swiss National Science Foundation [200020-143272];
   Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology;
   Huawei University-Enterprise Cooperation Project [YBCB2011057]
FX This work was partially supported by the EU FP7 Grant 611272 (project
   GROWTHCOM) and by the Swiss National Science Foundation (grant no.
   200020-143272). D.-B. Chen acknowledges support from the
   Tsinghua-Tencent Joint Laboratory for Internet Innovation Technology,
   and the Huawei University-Enterprise Cooperation Project YBCB2011057.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Benevenuto F, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P620, DOI 10.1145/1571941.1572047
   Dellarocas C., 2000, EC'00. Proceedings of the 2nd ACM Conference on Electronic Commerce, P150, DOI 10.1145/352871.352889
   GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867
   Grier C, 2010, PROCEEDINGS OF THE 17TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'10), P27, DOI 10.1145/1866307.1866311
   Guttman RH, 1998, KNOWL ENG REV, V13, P147, DOI 10.1017/S0269888998002082
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772
   Jsang A., 2007, DECIS SUPPORT SYST, V43, P618
   Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.1093/biomet/30.1-2.81
   Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140
   Laureti P, 2006, EUROPHYS LETT, V75, P1006, DOI 10.1209/epl/i2006-10204-8
   Lee K., 2010, P 33 INT ACM SIGIR C, P435, DOI [DOI 10.1145/1835449.1835522, 10.1145/1835449.1835522]
   Liao H, 2013, 13113064 ARXIV
   Liao H, 2012, P 20 INT S METH INT, P405
   Lim E.-P., 2010, P 19 ACM INT C INF K, P939, DOI DOI 10.1145/1871437.1871557
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006
   Masum H., 2004, 1 MONDAY, V9, P7
   NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691
   Pan WK, 2013, P 26 AAAI C ART INT, P39
   Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122
   Shang MS, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/48006
   Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723
   Wang G., 2011, P 2011 IEEE 11 INT C, P1242, DOI DOI 10.1109/ICDM.2011.124
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Yu YK, 2006, PHYSICA A, V371, P732, DOI 10.1016/j.physa.2006.04.057
   Zeng A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036101
   Zeng A, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/18005
   Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062624
   Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033
   Zhou YB, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48002
NR 34
TC 20
Z9 21
U1 0
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 12
PY 2014
VL 9
IS 5
AR e97146
DI 10.1371/journal.pone.0097146
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI1ZC
UT WOS:000336653300083
PM 24819119
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Sullivan, PS
   Peterson, J
   Rosenberg, ES
   Kelley, CF
   Cooper, H
   Vaughan, A
   Salazar, LF
   Frew, P
   Wingood, G
   DiClemente, R
   del Rio, C
   Mulligan, M
   Sanchez, TH
AF Sullivan, Patrick S.
   Peterson, John
   Rosenberg, Eli S.
   Kelley, Colleen F.
   Cooper, Hannah
   Vaughan, Adam
   Salazar, Laura F.
   Frew, Paula
   Wingood, Gina
   DiClemente, Ralph
   del Rio, Carlos
   Mulligan, Mark
   Sanchez, Travis H.
TI Understanding Racial HIV/STI Disparities in Black and White Men Who Have
   Sex with Men: A Multilevel Approach
SO PLOS ONE
LA English
DT Article
ID HIV-INFECTION; UNITED-STATES; RISK; SURVEILLANCE; METAANALYSIS;
   PREVALENCE; BEHAVIORS; PARTNERS; SYPHILIS; SYSTEM
AB Background: The reasons for black/white disparities in HIV epidemics among men who have sex with men have puzzled researchers for decades. Understanding reasons for these disparities requires looking beyond individual-level behavioral risk to a more comprehensive framework.
   Methods and Findings: From July 2010-Decemeber 2012, 803 men (454 black, 349 white) were recruited through venue-based and online sampling; consenting men were provided HIV and STI testing, completed a behavioral survey and a sex partner inventory, and provided place of residence for geocoding. HIV prevalence was higher among black (43%) versus white (13% MSM (prevalence ratio (PR) 3.3, 95% confidence interval (CI): 2.5-4.4). Among HIV-positive men, the median CD4 count was significantly lower for black (490 cells/mu L) than white (577 cells/mu L) MSM; there was no difference in the HIV RNA viral load by race. Black men were younger, more likely to be bisexual and unemployed, had less educational attainment, and reported fewer male sex partners, fewer unprotected anal sex partners, and less non-injection drug use. Black MSM were significantly more likely than white MSM to have rectal chlamydia and gonorrhea, were more likely to have racially concordant partnerships, more likely to have casual (one-time) partners, and less likely to discuss serostatus with partners. The census tracts where black MSM lived had higher rates of poverty and unemployment, and lower median income. They also had lower proportions of male-male households, lower male to female sex ratios, and lower HIV diagnosis rates.
   Conclusions: Among black and white MSM in Atlanta, disparities in HIV and STI prevalence by race are comparable to those observed nationally. We identified differences between black and white MSM at the individual, dyadic/sexual network, and community levels. The reasons for black/white disparities in HIV prevalence in Atlanta are complex, and will likely require a multilevel framework to understand comprehensively.
C1 [Sullivan, Patrick S.; Rosenberg, Eli S.; Vaughan, Adam; Sanchez, Travis H.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Peterson, John] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA.
   [Kelley, Colleen F.; Frew, Paula; Mulligan, Mark] Emory Univ, Sch Med, Dept Infect Dis, Atlanta, GA USA.
   [Cooper, Hannah; Wingood, Gina; DiClemente, Ralph] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Salazar, Laura F.] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA.
   [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RP Sullivan, PS (reprint author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
EM pssulli@emory.edu
RI Kelley, Colleen/O-4819-2016; del Rio, Carlos/M-8313-2019; Frew, Paula
   M./B-4774-2012; del Rio, Carlos/B-3763-2012
OI Kelley, Colleen/0000-0001-5611-0119; del Rio,
   Carlos/0000-0002-0153-3517; Frew, Paula M./0000-0002-3078-9124; del Rio,
   Carlos/0000-0002-0153-3517; sanchez, travis/0000-0003-1133-4762
FU National Institute of Mental Health [R01MH085600]; National Institute of
   Minority Health and Health Disparities [RC1MD004370]; Eunice Kennedy
   Shriver National Institute for Child Health and Human Development
   [R01HD067111]; National Institute of Drug Abuse [R01DA029513]; National
   Institute of Allergy and Infectious Diseases, Emory Center for AIDS
   Research [P30AI050409]; National Center for Advancing Translational
   Sciences of the National Institutes of Health [UL1TR000454]
FX Funding was provided by the National Institute of Mental Health
   (R01MH085600), National Institute of Minority Health and Health
   Disparities (RC1MD004370), Eunice Kennedy Shriver National Institute for
   Child Health and Human Development (R01HD067111), National Institute of
   Drug Abuse (R01DA029513), National Institute of Allergy and Infectious
   Diseases (P30AI050409)-Emory Center for AIDS Research, and the National
   Center for Advancing Translational Sciences of the National Institutes
   of Health under Award Number UL1TR000454. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Association of Public Health Laboratories Centers for Disease Control and Prevention, 2009, HIV TEST ALG STAT RE
   Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6
   BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568
   Caliendo A M, 2005, Infect Dis Obstet Gynecol, V13, P145
   *CDC, 2006, MMWR-MORBID MORTAL W, V55, P1
   Centers for Disease Control and Prevention, 2012, 4 CDCP, V17
   Centers for Disease Control and Prevention, 2012, HIV GAY BIS MEN
   Centers for Disease Control and Prevention, 2011, HIV SURV REP, V23
   Chan ISF, 1999, BIOMETRICS, V55, P1202, DOI 10.1111/j.0006-341X.1999.01202.x
   Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11
   Department of Health and Human Services Division of STD Prevention, 2012, SEX TRANSM DIS SURV
   Georgia Department of Public Health, GEORG HIV SURV DAT D
   Georgia Department of Public Health, GEORG STD EP 2012 ST
   Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522
   Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520
   Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284
   Kennedy BP, 1998, BRIT MED J, V317, P917
   Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413
   Lim JR, 2011, J URBAN HLTH
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107
   Madden M, 2011, 60 ONLINE ADULTS USE
   Maulsby C, 2013, AIDS BEHAV
   Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b
   Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720
   Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X
   MORRIS M, 2004, NETWORK EPIDEMIOLOGY
   Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa
   PORTNOY J, 1957, PUBLIC HEALTH REP, V72, P761, DOI 10.2307/4589890
   Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502
   Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098
   Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6
   Rosenberg E, 2010, SEX TECH
   Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b
   Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189
   Rosenberg ES, 2013, J ACQ IMMUN DEF SYND, DOI [10.1097/QAI.1090b1013e318294bcce, DOI 10.1097/QAI.1090B1013E318294BCCE]
   SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2
   Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201
   Stall R., 2007, UNEQUAL OPPORTUNITY, P220
   Su JR, 2011, ANN INTERN MED, V155, P145, DOI 10.7326/0003-4819-155-3-201108020-00004
   Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34
   Valleroy L, 2012, 14 INT AIDS C BARC S
   van der Pol B, 2001, J CLIN MICROBIOL, V39, P1008, DOI 10.1128/JCM.39.3.1008-1016.2001
   Winter AK, 2012, JAIDS-J ACQ IMM DEF, V60, P525, DOI 10.1097/QAI.0b013e318257d0ac
NR 44
TC 94
Z9 94
U1 0
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2014
VL 9
IS 3
AR e90514
DI 10.1371/journal.pone.0090514
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC4IY
UT WOS:000332485800029
PM 24608176
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Vagedes, J
   Bialkowski, A
   Wiechers, C
   Poets, CF
   Dietz, K
AF Vagedes, Jan
   Bialkowski, Anja
   Wiechers, Cornelia
   Poets, Christian F.
   Dietz, Klaus
TI A Conversion Formula for Comparing Pulse Oximeter Desaturation Rates
   Obtained with Different Averaging Times
SO PLOS ONE
LA English
DT Article
ID OBSTRUCTIVE SLEEP-APNEA; TUCSON CHILDRENS ASSESSMENT; POSITIVE AIRWAY
   PRESSURE; OXYGEN-SATURATION; PRETERM INFANTS; BREATHING PATTERNS;
   HEART-RATE; CARE-UNIT; ACCURACY; ARTIFACT
AB Objective: The number of desaturations determined in recordings of pulse oximeter saturation (SpO(2)) primarily depends on the time over which values are averaged. As the averaging time in pulse oximeters is not standardized, it varies considerably between centers. To make SpO(2) data comparable, it is thus desirable to have a formula that allows conversion between desaturation rates obtained using different averaging times for various desaturation levels and minimal durations.
   Methods: Oxygen saturation was measured for 170 hours in 12 preterm infants with a mean number of 65 desaturations <90% per hour of arbitrary duration by using a pulse oximeter in a 2-4 s averaging mode. Using 7 different averaging times between 3 and 16 seconds, the raw red-to-infrared data were reprocessed to determine the number of desaturations (D). The whole procedure was carried out for 7 different minimal desaturation durations (>= 1, >= 5, >= 10, >= 15, >= 20, >= 25, >= 30 s) below SpO(2) threshold values of 80%, 85% or 90% to finally reach a conversion formula. The formula was validated by splitting the infants into two groups of six children each and using one group each as a training set and the other one as a test set.
   Results: Based on the linear relationship found between the logarithm of the desaturation rate and the logarithm of the averaging time, the conversion formula is: D-2 = D-1 (T-2/T-1)(c), where D-2 is the desaturation rate for the desired averaging time T-2, and D-1 is the desaturation rate for the original averaging time T-1, with the exponent c depending on the desaturation threshold and the minimal desaturation duration. The median error when applying this formula was 2.6%.
   Conclusion: This formula enables the conversion of desaturation rates between different averaging times for various desaturation thresholds and minimal desaturation durations.
C1 [Vagedes, Jan; Bialkowski, Anja; Wiechers, Cornelia; Poets, Christian F.] Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany.
   [Vagedes, Jan] Filderklin, ARCIM Inst, Res Dept, Filderstadt, Germany.
   [Dietz, Klaus] Univ Tubingen, Dept Med Biometry, Tubingen, Germany.
RP Poets, CF (reprint author), Univ Tubingen, Childrens Hosp, Dept Neonatol, Tubingen, Germany.
EM Christian-F.Poets@med.uni-tuebingen.de
RI Dietz, Klaus/R-9268-2016
OI Dietz, Klaus/0000-0001-8503-9737
CR Accardo JA, 2010, SLEEP, V33, P1333, DOI 10.1093/sleep/33.10.1333
   Adler JN, 1998, ACAD EMERG MED, V5, P965, DOI 10.1111/j.1553-2712.1998.tb02772.x
   Ahmed SJM, 2010, PEDIATRICS, V125, pE115, DOI 10.1542/peds.2008-1749
   AMAR D, 1989, J CLIN MONITOR, V5, P135, DOI 10.1007/BF01617888
   Barker SJ, 2002, ANESTH ANALG, V95, P967, DOI 10.1213/01.ANE.0000029029.03601.08
   Brockmann PE, 2011, ARCH DIS CHILD-FETAL, V96, pF335, DOI 10.1136/adc.2010.196758
   Craig S, 2009, J SLEEP RES, V18, P329, DOI 10.1111/j.1365-2869.2008.00726.x
   Davila DG, 2003, SLEEP, V26, P91
   Davila DG, 2002, CHEST, V122, P1654, DOI 10.1378/chest.122.5.1654
   Farre R, 1998, SLEEP, V21, P386, DOI 10.1093/sleep/21.4.386
   Goodwin JL, 2010, J PEDIATR-US, V157, P57, DOI 10.1016/j.jpeds.2010.01.033
   Goodwin JL, 2001, SLEEP, V24, P937, DOI 10.1093/sleep/24.8.937
   HAY WW, 1989, PEDIATRICS, V83, P717
   Heimann K, 2010, NEONATOLOGY, V97, P311, DOI 10.1159/000255163
   Hensey CC, 2013, ARCH DIS CHILD FETAL
   Korcarz CE, 2010, SLEEP, V33, P1081, DOI 10.1093/sleep/33.8.1081
   LANGTON JA, 1990, BRIT J ANAESTH, V65, P564, DOI 10.1093/bja/65.4.564
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   McBride GB, 2005, HAM2005062 NIWA
   Ortega Rafael, 2011, N Engl J Med, V364, pe33, DOI 10.1056/NEJMvcm0904262
   Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7
   Petterson MT, 2007, ANESTH ANALG, V105, pS78, DOI 10.1213/01.ane.0000278134.47777.a5
   POETS CF, 1993, PEDIATR RES, V34, P144, DOI 10.1203/00006450-199308000-00007
   POETS CF, 1991, J DEV PHYSIOL, V15, P341
   POETS CF, 1993, PEDIATRICS, V92, P686
   POETS CF, 1994, PEDIATRICS, V93, P737
   POETS CF, 1991, EARLY HUM DEV, V26, P1, DOI 10.1016/0378-3782(91)90038-5
   POETS CF, 1991, ARCH DIS CHILD, V66, P574, DOI 10.1136/adc.66.5.574
   Poets CF, 1997, EUR J PEDIATR, V156, P808, DOI 10.1007/s004310050719
   Quan SF, 2011, SLEEP, V34, P303, DOI 10.1093/sleep/34.3.303
   Rheineck-Leyssius AT, 1999, J CLIN ANESTH, V11, P196, DOI 10.1016/S0952-8180(98)00133-0
   Rheineck-Leyssius AT, 1998, J CLIN MONITOR COMP, V14, P151, DOI 10.1023/A:1007431305610
   Rheineck-Leyssius RT, 1999, J CLIN ANESTH, V11, P192, DOI 10.1016/S0952-8180(99)00034-3
   Robertson FA, 2004, ANESTH ANALG, V98, P617, DOI 10.1213/01.ANE.0000101601.43781.15
   Salyer John W, 2003, Respir Care, V48, P386
   SEVERINGHAUS JW, 1990, ANESTHESIOLOGY, V73, P532, DOI 10.1097/00000542-199009000-00025
   Singh JKSB, 2008, J PAEDIATR CHILD H, V44, P273, DOI 10.1111/j.1440-1754.2007.01250.x
   Urschitz MS, 2003, CHEST, V123, P96, DOI 10.1378/chest.123.1.96
   Vagedes J, 2012, ARCH DIS CHILD FETAL
   Villanueva R, 1999, J CLIN ANESTH, V11, P317, DOI 10.1016/S0952-8180(99)00054-9
NR 40
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2014
VL 9
IS 1
AR e87280
DI 10.1371/journal.pone.0087280
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 301CJ
UT WOS:000330510000123
PM 24489887
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Poon, AFY
   Walker, LW
   Murray, H
   McCloskey, RM
   Harrigan, PR
   Liang, RH
AF Poon, Art F. Y.
   Walker, Lorne W.
   Murray, Heather
   McCloskey, Rosemary M.
   Harrigan, P. Richard
   Liang, Richard H.
TI Mapping the Shapes of Phylogenetic Trees from Human and Zoonotic RNA
   Viruses
SO PLOS ONE
LA English
DT Article
ID DIVERSIFICATION; EVOLUTIONARY; PERFORMANCE; DIVERSITY; BIOPYTHON;
   MODELS; PYTHON
AB A phylogeny is a tree-based model of common ancestry that is an indispensable tool for studying biological variation. Phylogenies play a special role in the study of rapidly evolving populations such as viruses, where the proliferation of lineages is constantly being shaped by the mode of virus transmission, by adaptation to immune systems, and by patterns of human migration and contact. These processes may leave an imprint on the shapes of virus phylogenies that can be extracted for comparative study; however, tree shapes are intrinsically difficult to quantify. Here we present a comprehensive study of phylogenies reconstructed from 38 different RNA viruses from 12 taxonomic families that are associated with human pathologies. To accomplish this, we have developed a new procedure for studying phylogenetic tree shapes based on the 'kernel trick', a technique that maps complex objects into a statistically convenient space. We show that our kernel method outperforms nine different tree balance statistics at correctly classifying phylogenies that were simulated under different evolutionary scenarios. Using the kernel method, we observe patterns in the distribution of RNA virus phylogenies in this space that reflect modes of transmission and pathogenesis. For example, viruses that can establish persistent chronic infections (such as HIV and hepatitis C virus) form a distinct cluster. Although the visibly 'star-like' shape characteristic of trees from these viruses has been well-documented, we show that established methods for quantifying tree shape fail to distinguish these trees from those of other viruses. The kernel approach presented here potentially represents an important new tool for characterizing the evolution and epidemiology of RNA viruses.
C1 [Poon, Art F. Y.; Murray, Heather; McCloskey, Rosemary M.; Harrigan, P. Richard; Liang, Richard H.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.
   [Poon, Art F. Y.; Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Walker, Lorne W.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
RP Poon, AFY (reprint author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.
EM apoon@cfenet.ubc.ca
OI Poon, Art/0000-0003-3779-154X
FU Canadian Institutes of Health Research (CIHR) [HOP-111406]; Michael
   Smith Foundation for Health Research (MSFHR)/St. similar toPaul's
   Hospital Foundation-Providence Health Care Research Institute
   (SPHF-PHCRI); CIHR HIV Vaccine Initiative (CHVI) for Vaccine Discovery
   and Social Research; Simon Fraser University; University of British
   Columbia; CIHR/GSK Research Chair in Clinical Virology
FX This study was supported by a Canadian Institutes of Health Research
   (CIHR) operating grant (HOP-111406) awarded to AFYP. AFYP is supported
   by a Scholar Award from the Michael Smith Foundation for Health Research
   (MSFHR)/St. similar to Paul's Hospital Foundation-Providence Health Care
   Research Institute (SPHF-PHCRI) Career Investigator program, and by a
   New Investigator Award from the CIHR HIV Vaccine Initiative (CHVI) for
   Vaccine Discovery and Social Research. RMM was supported by a Vice
   President Research Undergraduate Student Research Award (VPR-USRA) from
   Simon Fraser University. HM was supported by a Centre for Blood Research
   Summer Studentship from the University of British Columbia. PRH is
   supported by a CIHR/GSK Research Chair in Clinical Virology. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845
   AIZERMAN A, 1964, AUTOMAT REM CONTR, V25, P821
   Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420
   Collins M., 2002, ADV NEURAL INFORM PR, V14
   Dalcin L, 2008, J PARALLEL DISTR COM, V68, P655, DOI 10.1016/j.jpdc.2007.09.005
   Drake JW, 1998, GENETICS, V148, P1667
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x
   FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053
   Frost SDW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0208
   GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505
   Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI DOI 10.18637/JSS.V011.I09
   KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI 10.1111/j.1558-5646.1993.tb02144.x
   Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19
   Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485
   Lawrence I, 1989, BIOMETRICS, V45, P255, DOI DOI 10.2307/2532051
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Moschitti A., 2006, P 11 C EUR CHAPT ASS
   Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053
   Pompei S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044849
   Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Purvis A, 2002, J THEOR BIOL, V214, P99, DOI 10.1006/jtbi.2001.2443
   Ratmann O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002835
   ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2
   SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292
   Scholkopf B, 2000, NEURAL COMPUTATION, V12, P1207
   Sharp PM, 2002, CELL, V108, P305, DOI 10.1016/S0092-8674(02)00639-6
   Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Vert J.-P., 2004, KERNEL METHODS COMPU, P35
   Weston J, 2003, ANN I STAT MATH, V55, P391, DOI 10.1007/BF02530507
   Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107
NR 43
TC 15
Z9 16
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 1
PY 2013
VL 8
IS 11
AR e78122
DI 10.1371/journal.pone.0078122
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 245XZ
UT WOS:000326499300023
PM 24223766
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Stevenson, JC
   Stresman, GH
   Gitonga, CW
   Gillig, J
   Owaga, C
   Marube, E
   Odongo, W
   Okoth, A
   China, P
   Oriango, R
   Brooker, SJ
   Bousema, T
   Drakeley, C
   Cox, J
AF Stevenson, Jennifer C.
   Stresman, Gillian H.
   Gitonga, Caroline W.
   Gillig, Jonathan
   Owaga, Chrispin
   Marube, Elizabeth
   Odongo, Wycliffe
   Okoth, Albert
   China, Pauline
   Oriango, Robin
   Brooker, Simon J.
   Bousema, Teun
   Drakeley, Chris
   Cox, Jonathan
TI Reliability of School Surveys in Estimating Geographic Variation in
   Malaria Transmission in the Western Kenyan Highlands
SO PLOS ONE
LA English
DT Article
ID HIGHER-RISK; AGE; INTENSITY; AFRICA; SURVEILLANCE; EXPOSURE; PREVALENCE;
   ANTIBODIES; DESIGN; TRIALS
AB Background: School surveys provide an operational approach to assess malaria transmission through parasite prevalence. There is limited evidence on the comparability of prevalence estimates obtained from school and community surveys carried out at the same locality.
   Methods: Concurrent school and community cross-sectional surveys were conducted in 46 school/community clusters in the western Kenyan highlands and households of school children were geolocated. Malaria was assessed by rapid diagnostic test (RDT) and combined seroprevalence of antibodies to bloodstage Plasmodium falciparum antigens.
   Results: RDT prevalence in school and community populations was 25.7% (95% CI: 24.4-26.8) and 15.5% (95% CI: 14.4-16.7), respectively. Seroprevalence in the school and community populations was 51.9% (95% CI: 50.5-53.3) and 51.5% (95% CI: 49.5-52.9), respectively. RDT prevalence in schools could differentiate between low (<7%, 95% CI: 0-19%) and high (>39%, 95% CI: 25-49%) transmission areas in the community and, after a simple adjustment, were concordant with the community estimates.
   Conclusions: Estimates of malaria prevalence from school surveys were consistently higher than those from community surveys and were strongly correlated. School-based estimates can be used as a reliable indicator of malaria transmission intensity in the wider community and may provide a basis for identifying priority areas for malaria control.
C1 [Stevenson, Jennifer C.; Gitonga, Caroline W.; Brooker, Simon J.; Cox, Jonathan] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Stresman, Gillian H.; Bousema, Teun; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.
   [Gitonga, Caroline W.; Brooker, Simon J.] Wellcome Trust Res Programme, Kenya Med Res Inst, Malaria Publ Hlth Dept, Nairobi, Kenya.
   [Gillig, Jonathan] Univ Notre Dame, Eck Inst Global Hlth, South Bend, IN USA.
   [Owaga, Chrispin; Marube, Elizabeth; Odongo, Wycliffe; Okoth, Albert; China, Pauline; Oriango, Robin] Ctr Dis Control & Prevent, Kenya Med Res Inst, Ctr Global Hlth Res, Kisumu, Kenya.
   [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands.
RP Cox, J (reprint author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
EM jonathan.cox@lshtm.ac.uk
RI Bousema, Teun/N-3574-2014
OI Bousema, Teun/0000-0003-2666-094X; Stresman, Gillian/0000-0002-6897-5459
FU Bill and Melinda Gates Foundation, under the Malaria Transmission
   Consortium [45114]; Wellcome trust [091924]; Commonwealth Ph.D.
   scholarship; Wellcome Trust Senior Fellowship in Basic Biomedical
   Science [098045]; Grant Challenge Grant by the Bill and Melinda Gates
   Foundation [OPP1024438]
FX This work was supported by the Bill and Melinda Gates Foundation, under
   the Malaria Transmission Consortium [grant number 45114]. CD is
   supported by the Wellcome trust [grant number 091924], CWG is supported
   by a Commonwealth Ph.D. scholarship, and SJB is supported by a Wellcome
   Trust Senior Fellowship in Basic Biomedical Science [grant number
   098045]. TB is supported by a Grant Challenge Grant by the Bill and
   Melinda Gates Foundation [grant number OPP1024438]. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139
   ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937
   Ashton RA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-25
   BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047
   Bejon P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021711
   BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1
   BRADLEY EL, 1989, AM STAT, V43, P234, DOI 10.2307/2685368
   Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231
   Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169
   Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Cox J, 2007, TRENDS PARASITOL, V23, P142, DOI 10.1016/j.pt.2007.02.002
   Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08
   Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102
   Gitonga CW, 2012, AM J TROP MED HYG, V87, P1004, DOI 10.4269/ajtmh.2012.12-0215
   Gitonga CW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-306
   Government of Kenya, 2006, KEN INT HOUS BUDG SU
   Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223
   Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3
   Guyatt HL, 1999, PARASITOLOGY, V118, P257, DOI 10.1017/S0031182098003862
   Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0
   Icks A, 2012, WIEN KLIN WOCHENSCHR, V124, P391, DOI 10.1007/s00508-012-0188-z
   Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lucas AM, 2012, J AFR ECON, V21, P691, DOI 10.1093/jae/ejs021
   Ministry of Public Health and Sanitation Programme NAaSC, 2010, NAT GUID HIV TEST CO
   Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369
   O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185
   Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461
   Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274
   Sexton CJ, 2012, AIDS RES HUM RETROV, V28, P866, DOI [10.1089/aid.2011.0221, 10.1089/AID.2011.0221]
   Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4
   Stuckey EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-357
   White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
NR 36
TC 24
Z9 24
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 15
PY 2013
VL 8
IS 10
AR e77641
DI 10.1371/journal.pone.0077641
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 237TP
UT WOS:000325894100089
PM 24143250
OA DOAJ Gold, Green Published, Green Accepted
DA 2019-07-16
ER

PT J
AU Wade, D
   Diaw, PA
   Daneau, G
   Camara, M
   Dieye, TN
   Mboup, S
   Kestens, L
AF Wade, Djibril
   Diaw, Papa Alassane
   Daneau, Geraldine
   Camara, Makhtar
   Dieye, Tandakha Ndiaye
   Mboup, Souleymane
   Kestens, Luc
TI CD4 T-Cell Enumeration in a Field Setting: Evaluation of CyFlow Counter
   Using the CD4 Easy Count Kit-Dry and Pima CD4 Systems
SO PLOS ONE
LA English
DT Article
ID RESOURCE-LIMITED SETTINGS; HIV-INFECTED INDIVIDUALS; FLOW-CYTOMETRY;
   ANTIRETROVIRAL THERAPY; PERFORMANCE EVALUATION; HIV-1-INFECTED PATIENTS;
   ALTERNATIVE METHODS; FACSCOUNT SYSTEM; POOR SETTINGS; POINT
AB Background: Flow Cytometry (FCM) is still considered to be the method of choice for accurate CD4 enumeration. However, the use of FCM in developing countries is problematic due to their cost and complexity. Lower-cost technologies have been introduced. We evaluated CyFlow Counter together with its lyophilized reagents, and Pima CD4 in high-temperature area, using FACSCount as reference.
   Materials and Methods: Whole blood samples were consecutively collected by venipuncture from 111 HIV+ patients and 17 HIV-negative donors. CD4 T-cell enumeration was performed on CyFlow Counter, Pima CD4 and FACSCount.
   Results: CyFlow Counter and Pima CD4 systems showed good correlation with FACSCount (slope of 0.82 and 0.90, and concordance rho(c) of 0.94 and 0.98, respectively). CyFlow Counter showed absolute or relative biases (LOA) of 263 cells/mm(3) (-245 to 120) or -9.8% (-38.1 to 18.4) respectively, and Pima CD4 showed biases (LOA) of -30 cells/mm(3) (-160 to 101) or -3.5% (-41.0 to 33.9%). CyFlow Counter and Pima CD4 showed respectively 106.7% and 105.9% of similarity with FACSCount. According to WHO-2010 ART initiation threshold of 350 cells/mm(3), CyFlow Counter and Pima CD4 showed respectively sensibility of 100% and 97%, and specificity of 91% and 93%. CyFlow Counter and Pima CD4 were strongly correlated (slope of 1.09 and rho(c) of 0.95). These alternative systems showed good agreement with bias of 33 cells/mm(3) (-132 to 203) or 6.3% (-31.2 to 43.8), and similarity of 104.3%.
   Conclusion: CyFlow Counter using CD4 easy count kit-dry and Pima CD4 systems can accurately provide CD4 T-cell counts with acceptable agreement to those of FACSCount.
C1 [Wade, Djibril; Diaw, Papa Alassane; Camara, Makhtar; Dieye, Tandakha Ndiaye; Mboup, Souleymane] Le Dantec Univ Teaching Hosp, Immunol Unit, Bacteriol Lab, Dakar, Senegal.
   [Wade, Djibril; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Immunol Lab, Dept Biomed Sci, B-2000 Antwerp, Belgium.
   [Wade, Djibril; Kestens, Luc] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.
RP Wade, D (reprint author), Le Dantec Univ Teaching Hosp, Immunol Unit, Bacteriol Lab, Dakar, Senegal.
EM wadedjibril@yahoo.fr
FU Belgian Directorate General for Development Cooperation
FX Financial support was provided by the Belgian Directorate General for
   Development Cooperation. PIMA Analyser and disposable cartridges were
   kindly provided by Alere. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson David A, 2011, Curr HIV/AIDS Rep, V8, P31, DOI 10.1007/s11904-010-0067-z
   Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5
   BLAND JM, 1986, LANCET, V1, P307
   Cassens U, 2004, ANTIVIR THER, V9, P395
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378
   Didier JM, 2001, J ACQ IMMUN DEF SYND, V26, P193, DOI 10.1097/00126334-200102010-00017
   Dieye TN, 2011, J IMMUNOL METHODS, V372, P7, DOI 10.1016/j.jim.2011.07.012
   Dieye TN, 2005, JAIDS-J ACQ IMM DEF, V39, P32, DOI 10.1097/01.qai.0000160515.20581.ad
   Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014
   Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3
   Herbert S, 2012, SEX TRANSM INFECT, V88, P413, DOI 10.1136/sextrans-2012-050507
   Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0
   Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424
   Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005
   Karcher H, 2006, CYTOM PART B-CLIN CY, V70B, P163, DOI 10.1002/cyto.b.20093
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y
   Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2
   Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319
   Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06
   Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414
   Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1
   Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651
   Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071
   Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612
   PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709
   Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005
   Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721
   Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167
   POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512
   Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182
   Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016
   Strauss K, 1996, CYTOMETRY, V26, P52
   Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2
   Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26
   World Health Organisation, 2011, HIV WHO AFR REG PROG
   World Health Organization, 2010, ANT THER HIV INF AD
   World Health Organization, 2013, CONS GUID US ANT DRU
   World Health Organization, 2010, TECHN BRIEF CD4 TECH
   Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x
   Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33
NR 42
TC 13
Z9 14
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 16
PY 2013
VL 8
IS 9
AR e75484
DI 10.1371/journal.pone.0075484
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 219GJ
UT WOS:000324494000166
PM 24066184
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Park, CM
   March, K
   Williams, S
   Kukadia, S
   Ghosh, AK
   Jones, S
   Tillin, T
   Chaturvedi, N
   Hughes, AD
AF Park, Chloe M.
   March, Katherine
   Williams, Suzanne
   Kukadia, Suraj
   Ghosh, Arjun K.
   Jones, Siana
   Tillin, Therese
   Chaturvedi, Nish
   Hughes, Alun D.
TI Feasibility and Reproducibility of Left Ventricular Rotation by Speckle
   Tracking Echocardiography in Elderly Individuals and the Impact of
   Different Software
SO PLOS ONE
LA English
DT Article
ID AGE-RELATED-CHANGES; CORONARY-HEART-DISEASE; MAGNETIC-RESONANCE;
   DIASTOLIC DYSFUNCTION; TWIST MECHANICS; TORSION; DEFORMATION;
   PRINCIPLES; PARAMETERS; FRACTION
AB Background: Changes in ventricular rotation measured by two-dimensional speckle tracking echocardiography (2DSTE) are early indicators of cardiac disease. Data on the clinical feasibility of this important measure are scarce and there is no information on the comparability of different software versions. We assessed the feasibility, reproducibility and within patient temporal variability of 2DSTE in a large community based sample of older adults. We additionally compared 2DSTE results to those generated by 3DSTE.
   Methods and results: 1408 participants underwent transthoracic echocardiography. Using Philips Qlab 8.1 peak LV rotation at either the base or the apex was analysable in 432 (31%) participants. Peak twist measurements were achieved in 274 (20%) participants. 66 participants were randomly selected for the reproducibility study. 20 additional participants had scans 4-6 weeks apart for temporal variability and 3D echocardiography to assess the agreement between 2DSTE and 3DSTE. Reproducibility was evaluated using the intraclass coefficient of correlation (ICC). Better reproducibility for rotation and twist were obtained when measured at the endocardium, and when using more recent software versions, Peak twist and rotation were significantly different using two versions of the same software. Agreement with 3DSTE was better using newer software.
   Conclusion: Feasibility of 2DSTE is low in this cohort of elderly individuals severely limiting its utility in clinical settings. However if high quality images can be acquired assessment of ventricular rotation by 2DSTE is reproducible. Caution should be taken when comparing measurements of ventricular rotation by software from different vendors or different versions of software from the same vendor.
C1 [Park, Chloe M.; March, Katherine; Williams, Suzanne; Kukadia, Suraj; Ghosh, Arjun K.; Jones, Siana; Tillin, Therese; Chaturvedi, Nish; Hughes, Alun D.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England.
RP Park, CM (reprint author), Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England.
EM chloe.park@imperial.ac.uk
RI ; Hughes, Alun/N-3781-2013
OI Tillin, Therese/0000-0003-1590-9826; Hughes, Alun/0000-0001-5432-5271
FU Wellcome Trust [082464/2/07/2]; British Heart Foundation
   [SP/07001/23603, PG 08 103]; British Heart Foundation [PG/08/103/26133]
FX The work was supported by the Wellcome Trust [082464/2/07/2] and the
   British Heart Foundation [SP/07001/23603, PG 08 103]. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adamu U, 2009, EUR J ECHOCARDIOGR, V10, P303, DOI 10.1093/ejechocard/jen238
   Blackburn H, 1969, J Electrocardiol, V2, P305
   Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654
   BLAND JM, 1986, LANCET, V1, P307
   Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002
   Chang SA, 2010, HEART, V96, P49, DOI 10.1136/hrt.2009.166629
   Chung J, 2006, J AM COLL CARDIOL, V47, P384, DOI 10.1016/j.jacc.2005.08.061
   FLAMENG W, 1984, CIRCULATION, V70, P7, DOI 10.1161/01.CIR.70.1.7
   Fonseca CG, 2004, AM J CARDIOL, V94, P1391, DOI 10.1016/j.amjcard.2004.07.143
   Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511
   Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048
   Han W, 2008, CHINESE MED J-PEKING, V121, P1543, DOI 10.1097/00029330-200808020-00008
   Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558
   INGELS NB, 1989, CIRC RES, V64, P915, DOI 10.1161/01.RES.64.5.915
   Kim HK, 2007, J AM SOC ECHOCARDIOG, V20, P45, DOI 10.1016/j.echo.2006.07.007
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Murdoch DR, 1998, EUR HEART J, V19, P1829, DOI 10.1053/euhj.1998.1269
   Narula J, 2007, J AM COLL CARDIOL, V49, P917, DOI 10.1016/j.jacc.2006.12.006
   Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082
   Oxenham HC, 2003, J CARDIOV MAGN RESON, V5, P421, DOI 10.1081/JCMR-120022258
   Park SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1129, DOI 10.1016/j.echo.2008.04.002
   PICANO E, 1990, CIRCULATION, V81, P58, DOI 10.1161/01.CIR.81.1.58
   PRINZEN FW, 1986, AM J PHYSIOL, V250, pH255
   Rosner B., 2006, FUNDAMENTALS BIOSTAT
   Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26
   Saito M, 2009, HEART, V95, P290, DOI 10.1136/hrt.2008.145979
   Sengupta PP, 2008, JACC-CARDIOVASC IMAG, V1, P366, DOI 10.1016/j.jcmg.2008.02.006
   Taber LA, 1996, J BIOMECH, V29, P745, DOI 10.1016/0021-9290(95)00129-8
   Takeuchi M, 2006, J AM SOC ECHOCARDIOG, V19, P1077, DOI 10.1016/j.ccho.2006.04.011
   Tillin T, 2010, INT J EPIDEMIOL
   Torrent-Guasp F, 2005, EUR J CARDIO-THORAC, V27, P191, DOI 10.1016/j.ejects.2004.11.026
   van Dalen BM, 2008, AM J PHYSIOL-HEART C, V295, pH1705, DOI 10.1152/ajpheart.00513.2008
   van Dalen BM, 2009, EUR J ECHOCARDIOGR, V10, P669, DOI 10.1093/ejechocard/jep036
   Wang JW, 2009, J AM SOC ECHOCARDIOG, V22, P95, DOI 10.1016/j.echo.2008.10.015
NR 34
TC 1
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2013
VL 8
IS 9
AR e75098
DI 10.1371/journal.pone.0075098
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 218BU
UT WOS:000324408400108
PM 24058652
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Willemink, MJ
   Borstlap, J
   Takx, RAP
   Schilham, AMR
   Leiner, T
   Budde, RPJ
   de Jong, PA
AF Willemink, Martin J.
   Borstlap, Jaap
   Takx, Richard A. P.
   Schilham, Arnold M. R.
   Leiner, Tim
   Budde, Ricardo P. J.
   de Jong, Pim A.
TI The Effects of Computed Tomography with Iterative Reconstruction on
   Solid Pulmonary Nodule Volume Quantification
SO PLOS ONE
LA English
DT Article
ID DOSE CT; CHEST; VARIABILITY; PERFORMANCE; ALGORITHM; GROWTH
AB Background: The objectives of this study were to evaluate the influence of iterative reconstruction (IR) on pulmonary nodule volumetry with chest computed tomography (CT).
   Methods: Twenty patients (12 women and 8 men, mean age 61.9, range 32-87) underwent evaluation of pulmonary nodules with a 64-slice CT-scanner. Data were reconstructed using filtered back projection (FBP) and IR (Philips Healthcare, iDose(4)-levels 2, 4 and 6) at similar radiation dose. Volumetric nodule measurements were performed with semi-automatic software on thin slice reconstructions. Only solid pulmonary nodules were measured, no additional selection criteria were used for the nature of nodules. For intra-observer and inter-observer variability, measurements were performed once by one observer and twice by another observer. Algorithms were compared using the concordance correlation-coefficient (p(c)) and Friedman-test, and post-hoc analysis with the Wilcoxon-signed ranks-test with Bonferroni-correction (significance-level p<0.017).
   Results: Seventy-eight nodules were present including 56 small nodules (volume<200 mm(3), diameter<8 mm) and 22 large nodules (volume >= 200 mm(3), diameter >= 8 mm). No significant differences in measured pulmonary nodule volumes between FBP, iDose 4 -levels 2, 4 and 6 were found in both small nodules and large nodules. FBP and iDose 4 -levels 2, 4 and 6 were correlated with p(c)-values of 0.98 or higher for both small and large nodules. P-c-values of intra-observer and inter-observer variability were 0.98 or higher.
   Conclusions: Measurements of solid pulmonary nodule volume measured with standard-FBP were comparable with IR, regardless of the IR-level and no significant differences between measured volumes of both small and large solid nodules were found.
C1 [Willemink, Martin J.; Borstlap, Jaap; Takx, Richard A. P.; Schilham, Arnold M. R.; Leiner, Tim; Budde, Ricardo P. J.; de Jong, Pim A.] Univ Utrecht, Med Ctr, Utrecht, Netherlands.
   [Budde, Ricardo P. J.] Gelre Hosp, Dept Radiol, Apeldoorn, Netherlands.
RP Willemink, MJ (reprint author), Univ Utrecht, Med Ctr, Utrecht, Netherlands.
EM m.willemink@umcutrecht.nl
RI Willemink, Martin/M-3650-2013; de Jong, Pim/G-7220-2014; Budde,
   Ricardo/E-4252-2015; Willemink, Martin/H-6163-2019
OI Willemink, Martin/0000-0002-6991-6557; de Jong, Pim/0000-0003-4840-6854;
   Willemink, Martin/0000-0002-6991-6557
CR Ahn MI, 2010, RADIOLOGY, V254, P949, DOI 10.1148/radiol.09090031
   Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003
   de Hoop B, 2009, EUR RADIOL, V19, P800, DOI 10.1007/s00330-008-1229-x
   Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047
   Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94
   Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7
   Gietema HA, 2006, RADIOLOGY, V241, P251, DOI 10.1148/radiol.2411050860
   Habets J, 2012, INT J CARDIOVAS IMAG, V28, P1567, DOI 10.1007/s10554-011-9954-7
   Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712
   Hein PA, 2009, ROFO-FORTSCHR RONTG, V181, P24, DOI 10.1055/s-2008-1027874
   Hein PA, 2010, J DIGIT IMAGING, V23, P8, DOI 10.1007/s10278-008-9157-5
   Hu XH, 2011, CLIN RADIOL, V66, P1023, DOI 10.1016/j.crad.2011.04.008
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887
   McBride GB, 2005, HAM2005062 NIWA
   Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907
   Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290
   Pontana F, 2011, EUR RADIOL, V21, P636, DOI 10.1007/s00330-010-1991-4
   Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487
   Prakash P, 2010, J COMPUT ASSIST TOMO, V34, P40, DOI 10.1097/RCT.0b013e3181b26c67
   Revel MP, 2004, RADIOLOGY, V231, P459, DOI 10.1148/radiol.2312030241
   Scibelli A, 2011, IDOSE ITERATIVE RECO
   Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450
   Utsunomiya D, 2012, EUR RADIOL, V22, P1287, DOI 10.1007/s00330-011-2361-6
   Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y
   Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z
   Willemink MJ, 2012, AM J ROENTGENOL, V199, P1241, DOI 10.2214/AJR.12.8727
   Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0
   Xu DM, 2009, RADIOLOGY, V250, P264, DOI 10.1148/radiol.2493070847
   Yanagawa M, 2012, EUR J RADIOL, V81, P2877, DOI 10.1016/j.ejrad.2011.09.011
   Yanagawa M, 2010, ACAD RADIOL, V17, P1259, DOI 10.1016/j.acra.2010.05.014
   Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251
NR 32
TC 26
Z9 27
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 27
PY 2013
VL 8
IS 2
AR e58053
DI 10.1371/journal.pone.0058053
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 098BN
UT WOS:000315519000179
PM 23460924
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Wang, NK
   Lai, CC
   Chou, CL
   Chen, YP
   Chuang, LH
   Chao, AN
   Tseng, HJ
   Chang, CJ
   Wu, WC
   Chen, KJ
   Tsang, SH
AF Wang, Nan-Kai
   Lai, Chi-Chun
   Chou, Chai Lin
   Chen, Yen-Po
   Chuang, Lan-Hsin
   Chao, An-Ning
   Tseng, Hsiao-Jung
   Chang, Chee-Jen
   Wu, Wei-Chi
   Chen, Kuan-Jen
   Tsang, Stephen H.
TI Choroidal Thickness and Biometric Markers for the Screening of Lacquer
   Cracks in Patients with High Myopia
SO PLOS ONE
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGICAL MYOPIA; VISUAL IMPAIRMENT;
   PREVALENCE; NEOVASCULARIZATION; EYE; POPULATION; BLINDNESS;
   REPRODUCIBILITY; PROGRESSION
AB Objective: Validation of choroidal thickness and other biometrics measured by spectral domain optical coherence tomography (SD-OCT) in predicting lacquer cracks formation in highly myopic eyes.
   Methods: Patients with a refractive error worse than -8 diopters and moderate myopic maculopathy were recruited into two groups based on the presence or absence of lacquer cracks (36 eyes without and 33 eyes with lacquer cracks). Choroidal thickness, refractive error, and axial length were measured and subjected to receiver operating characteristic curve analysis to identify the optimal cutoff values at predicting lacquer crack formation. The width of the retinal pigment epithelium (RPE), RPE to the inner segment/outer segment line, RPE to the external limiting membrane were also measured and compared to the subfoveal choroidal thickness to assess their relationships as potential markers of lacquer crack formation.
   Results: Lacquer crack is associated with decreased choroidal thickness, lower best-corrected visual acuity, longer axial length and higher refractive errors. Choroidal thickness has the strongest association with lacquer crack formation versus axial length and refractive error. In eyes with lacquer cracks, stellate lacquer cracks are associated with thinner choroidal thickness compared to eyes with linear lacquer cracks. Subfoveal choroidal thickness less than the width of the retinal pigment epithelium to the inner segment/outer segment line is also associated with lacquer crack formation (sensitivity 78.8%, specificity 88.3%, and accuracy 81.2%).
   Conclusions: This study suggests that choroidal thickness and other SD-OCT measurements could be employed clinically to predict the development and severity of lacquer cracks in patients with high myopia.
C1 [Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chuang, Lan-Hsin; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan.
   [Wang, Nan-Kai; Lai, Chi-Chun; Chen, Yen-Po; Chao, An-Ning; Wu, Wei-Chi; Chen, Kuan-Jen] Chang Gung Mem Hosp, Dept Ophthalmol, Linkuo Med Ctr, Tao Yuan, Taiwan.
   [Chou, Chai Lin] Univ British Columbia, Fac Med, Vancouver, BC, Canada.
   [Chuang, Lan-Hsin] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan.
   [Tseng, Hsiao-Jung; Chang, Chee-Jen] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Tao Yuan, Taiwan.
   Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan.
   [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan.
   [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Dept Pathol & Cell Biol, New York, NY USA.
   [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA.
RP Wang, NK (reprint author), Chang Gung Univ, Coll Med, Dept Med, Tao Yuan, Taiwan.
EM wang.nankai@gmail.com
RI Wang, Nan-Kai/D-6608-2011
OI Wang, Nan-Kai/0000-0002-6277-9879; Chao, An-Ning/0000-0002-4761-9244;
   Chang, Chee Jen/0000-0002-7725-7555
FU Taiwan National Science Council, Taiwan [NSC-99-2314-B-182A-029-MY3];
   Chang Gung Memorial Hospital, Linkou, Taiwan [381561similar to381563,
   391801similar to391802]; National Eye Institute/National Institutes of
   Health (Bethesda, Maryland) [EY018213, P30EY019007]; Research to Prevent
   Blindness (New York, New York)
FX Supported in part by research grant NSC-99-2314-B-182A-029-MY3 from the
   Taiwan National Science Council, Taiwan, and CMRPG 381561 similar to
   381563 and 391801 similar to 391802 from Chang Gung Memorial Hospital,
   Linkou, Taiwan, National Eye Institute/National Institutes of Health
   (Bethesda, Maryland) EY018213 (SHT), P30EY019007 (Core Support for
   Vision Research; Columbia University), Foundation Fighting Blindness
   (Owings Mills, Maryland), and unrestricted funds from Research to
   Prevent Blindness (New York, New York). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AVILA MP, 1984, OPHTHALMOLOGY, V91, P1573
   Axer-Siegez R, 2004, OPHTHAL SURG LAS IM, V35, P139, DOI 10.3928/1542-8877-20040301-09
   Branchini L, 2012, OPHTHALMOLOGY, V119, P119, DOI 10.1016/j.ophtha.2011.07.002
   Curtin BJ, 1971, AM J OPHTHALMOL, V1, P42
   Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029
   Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003
   Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011
   Ikuno Y, 2008, RETINA-J RET VIT DIS, V28, P1124, DOI 10.1097/IAE.0b013e318174417a
   Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383
   Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325
   Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022
   Johnson DA, 1998, RETINA-J RET VIT DIS, V18, P118, DOI 10.1097/00006982-199818020-00004
   KLEIN RM, 1975, AM J OPHTHALMOL, V79, P386, DOI 10.1016/0002-9394(75)90611-X
   Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1
   Lim R, 1999, INVEST OPHTH VIS SCI, V40, P3021
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27
   Liu J H, 2001, Ophthalmic Epidemiol, V8, P339
   Michon JJ, 2002, BRIT J OPHTHALMOL, V86, P133, DOI 10.1136/bjo.86.2.133
   Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4
   Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570
   Ohno-Matsui K, 1998, JPN J OPHTHALMOL, V42, P293, DOI 10.1016/S0021-5155(98)00008-2
   OhnoMatsui K, 1996, RETINA-J RET VIT DIS, V16, P29, DOI 10.1097/00006982-199616010-00006
   Quaranta M, 1996, AM J OPHTHALMOL, V122, P663, DOI 10.1016/S0002-9394(14)70484-2
   RABB M F, 1981, International Ophthalmology Clinics, V21, P51, DOI 10.1097/00004397-198102130-00006
   Salzmann M, 1902, ARCH OPHTHALMOL-CHIC, V31, P41
   Sato A, 2010, BRIT J OPHTHALMOL, V94, P1624, DOI 10.1136/bjo.2009.165472
   SOUBRANE G, 2005, RETINA, P1136
   TOKORO T, 1998, ATLAS POSTERIOR FUND
   Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7
   Wang NK, 2012, AM J OPHTHALMOL, V153, P669, DOI 10.1016/j.ajo.2011.08.039
   Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449
   Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035
NR 33
TC 30
Z9 31
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2013
VL 8
IS 1
AR e53660
DI 10.1371/journal.pone.0053660
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 077HS
UT WOS:000314019100025
PM 23349728
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Tan, CO
   Tamisier, R
   Hamner, JW
   Taylor, JA
AF Tan, Can Ozan
   Tamisier, Renaud
   Hamner, J. W.
   Taylor, J. Andrew
TI Characterizing Sympathetic Neurovascular Transduction in Humans
SO PLOS ONE
LA English
DT Article
ID FREQUENCY-RESPONSE CHARACTERISTICS; LIMB BLOOD-FLOW; ALPHA-ADRENERGIC
   VASOCONSTRICTION; AGE-RELATED-CHANGES; NITRIC-OXIDE; NERVE ACTIVITY;
   VASCULAR-RESISTANCE; ISOMETRIC-EXERCISE; HEMODYNAMIC BALANCE; PRESSURE
   REGULATION
AB Despite its critical role for cardiovascular homeostasis in humans, only a few studies have directly probed the transduction of sympathetic nerve activity to regional vascular responses - sympathetic neurovascular transduction. Those that have variably relied on either vascular resistance or vascular conductance to quantify the responses. However, it remains unclear which approach would better reflect the physiology. We assessed the utility of both of these as well as an alternative approach in 21 healthy men. We recorded arterial pressure (Finapres), peroneal sympathetic nerve activity (microneurography), and popliteal blood flow (Doppler) during isometric handgrip exercise to fatigue. We quantified and compared transduction via the relation of sympathetic activity to resistance and to conductance and via an adaptation of Poiseuille's relation including pressure, sympathetic activity, and flow. The average relationship between sympathetic activity and resistance (or conductance) was good when assessed over 30-second averages (mean R-2 = 0.49 +/- 0.07) but lesser when incorporating beat-by-beat time lags (R-2 = 0.37 +/- 0.06). However, in a third of the subjects, these relations provided relatively weak estimates (R-2<0.33). In contrast, the Poiseuille relation reflected vascular responses more accurately (R-2 = 0.77 +/- 0.03, >0.50 in 20 of 21 individuals), and provided reproducible estimates of transduction. The gain derived from the relation of resistance (but not conductance) was inversely related to transduction (R-2 = 0.37, p<0.05), but with a proportional bias. Thus, vascular resistance and conductance may not always be reliable surrogates for regional sympathetic neurovascular transduction, and assessment from a Poiseuille relation between pressure, sympathetic nerve activity, and flow may provide a better foundation to further explore differences in transduction in humans.
C1 [Tan, Can Ozan; Hamner, J. W.; Taylor, J. Andrew] Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA.
   [Tan, Can Ozan; Taylor, J. Andrew] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA.
   [Tamisier, Renaud] Univ Hosp Grenoble, Sleep Lab, Grenoble, France.
   [Tamisier, Renaud] Univ Hosp Grenoble, EFCR, Dept Rehabil & Physiol, Grenoble, France.
   [Tamisier, Renaud] Univ Grenoble 1, INSERM, U1042, Lab Hypoxia Pathophysiol HP2, Grenoble, France.
RP Tan, CO (reprint author), Spaulding Rehabil Hosp, Cardiovasc Res Lab, Boston, MA USA.
EM cotan@partners.org
RI Hamner, J. W./B-4607-2017; , Tamisier/M-6858-2014; Tan, Can
   Ozan/E-2598-2016
OI Hamner, J. W./0000-0002-5819-2362; , Tamisier/0000-0003-1128-6529; Tan,
   Can Ozan/0000-0001-9673-9907
CR Agrawal A, 2008, INT J CLIN EXP MED, V1, P305
   AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655
   ANDO S, 1993, J AUTONOM NERV SYST, V45, P225, DOI 10.1016/0165-1838(93)90054-X
   ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Berne RM, 2001, CARDIOVASCULAR PHYSL
   BOUTOUYRIE P, 1994, AM J PHYSIOL-HEART C, V267, pH1368
   Box G. E. P., 1994, TIME SERIES ANAL FOR
   Cannon B, 1929, PHYSIOL REV, VIX, P399
   CELANDER O, 1954, Acta Physiol Scand Suppl, V32, P1
   Charkoudian N, 2005, J PHYSIOL-LONDON, V568, P315, DOI 10.1113/jphysiol.2005.090076
   COX RH, 1976, AM J PHYSIOL, V231, P420
   Crandall CG, 1995, J APPL PHYSIOL, V79, P1946
   Dinenno FA, 1999, CIRCULATION, V100, P164, DOI 10.1161/01.CIR.100.2.164
   Dinenno FA, 2002, CIRCULATION, V106, P1349, DOI 10.1161/01.CIR.0000028819.64790.BE
   Dinenno FA, 2001, J PHYSIOL-LONDON, V536, P977, DOI 10.1111/j.1469-7793.2001.00977.x
   Dinenno FA, 2001, J PHYSIOL-LONDON, V531, P573, DOI 10.1111/j.1469-7793.2001.0573i.x
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   Fisher R. A., 1958, STAT METHODS RES WOR
   Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997
   FOLKOW B, 1993, PHYSIOL REV, V73, P725
   GABRIEL A, 1992, CLIN PHYSIOL, V12, P229, DOI 10.1111/j.1475-097X.1992.tb00309.x
   GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791
   Guild SJ, 2001, AM J PHYSIOL-REG I, V281, pR206
   Halliwill JR, 1996, J PHYSIOL-LONDON, V495, P279, DOI 10.1113/jphysiol.1996.sp021592
   Hart EC, 2009, HYPERTENSION, V54, P127, DOI 10.1161/HYPERTENSIONAHA.109.131417
   Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391
   JOYNER MJ, 1992, AM J PHYSIOL, V263, pH1078
   Kamiya A, 2004, AM J PHYSIOL-REG I, V286, pR151, DOI 10.1152/ajpregu.00685.2002
   Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329
   KIOWSKI W, 1983, CLIN PHARMACOL THER, V34, P565, DOI 10.1038/clpt.1983.216
   LAL SKL, 1995, HYPERTENSION, V26, P307, DOI 10.1161/01.HYP.26.2.307
   LANDSBERG L, 1993, INT J OBESITY, V17, pS29
   LANDSBERG L, 1990, J NEUROSCI METH, V34, P179, DOI 10.1016/0165-0270(90)90056-L
   LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lyons D, 1997, CLIN SCI, V93, P519, DOI 10.1042/cs0930519
   MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V
   McCord GR, 2005, J APPL PHYSIOL, V98, P2011, DOI 10.1152/japplphysiol.00888.2004
   Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862
   NIELSEN H, 1992, AM J PHYSIOL, V263, pH1190
   NILSSON H, 1985, ACTA PHYSIOL SCAND, V123, P303, DOI 10.1111/j.1748-1716.1985.tb07592.x
   OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494
   OLEARY DS, 1991, AM J PHYSIOL, V260, pH632
   Oppenheim A. V., 1998, DISCRETE TIME SIGNAL
   Parker BA, 2007, AM J PHYSIOL-HEART C, V292, pH1148, DOI 10.1152/ajpheart.00729.2006
   PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699
   ROSENBAUM M, 1968, AM J PHYSIOL, V215, P1397
   Rowell LB, 1986, HUMAN CIRCULATION RE
   SAITO M, 1990, EUR J APPL PHYSIOL O, V60, P277, DOI 10.1007/BF00379396
   Schlager O, 2011, EUR J VASC ENDOVASC, V41, P821, DOI 10.1016/j.ejvs.2011.01.006
   SEALS DR, 1989, J APPL PHYSIOL, V67, P1801
   Seals DR, 2004, AM J PHYSIOL-HEART C, V287, pH1895, DOI 10.1152/ajpheart.00486.2004
   Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276
   SEALS DR, 1989, J APPL PHYSIOL, V66, P2472
   Shoemaker JK, 2000, AM J PHYSIOL-HEART C, V279, P1215
   Smith AR, 2006, AGING CELL, V5, P391, DOI 10.1111/j.1474-9726.2006.00232.x
   Smith EG, 2007, J PHYSIOL-LONDON, V582, P63, DOI 10.1113/jphysiol.2007.130591
   Stauss HM, 1997, AM J PHYSIOL-HEART C, V273, pH786
   Stauss HM, 1998, AM J PHYSIOL-HEART C, V274, pH1277
   Studinger P, 2009, J PHYSIOL-LONDON, V587, P2049, DOI 10.1113/jphysiol.2009.170134
   SUNDLOF G, 1978, J PHYSIOL-LONDON, V278, P525, DOI 10.1113/jphysiol.1978.sp012322
   Tan CO, 2009, IEEE T BIO-MED ENG, V56, P147, DOI 10.1109/TBME.2008.2002138
   VALLBO AB, 1967, ELECTROEN CLIN NEURO, V23, P392
   Vianna LC, 2012, AM J PHYSL HEART CIR
   WALLIN BG, 1988, ANNU REV PHYSIOL, V50, P565, DOI 10.1146/annurev.ph.50.030188.003025
   Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970
   Wilson TE, 2006, J APPL PHYSIOL, V100, P1043, DOI 10.1152/japplphysiol.00579.2005
NR 70
TC 6
Z9 6
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 10
PY 2013
VL 8
IS 1
AR e53769
DI 10.1371/journal.pone.0053769
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 070YV
UT WOS:000313552400043
PM 23326501
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Poletta, FA
   Camelo, JSL
   Gili, JA
   Leoncini, E
   Castilla, EE
   Mastroiacovo, P
AF Poletta, Fernando A.
   Lopez Camelo, Jorge S.
   Gili, Juan A.
   Leoncini, Emmanuele
   Castilla, Eduardo E.
   Mastroiacovo, Pierpaolo
TI Methodological Approaches to Evaluate Teratogenic Risk Using Birth
   Defect Registries: Advantages and Disadvantages
SO PLOS ONE
LA English
DT Article
ID MALFORMED INFANTS; RECALL BIAS; REPORTING BIAS; SELECTION BIAS;
   PREGNANCY; MALFORMATIONS; DRUGS; ACETAMINOPHEN; ANOMALIES
AB Background: Different approaches have been used in case-control studies to estimate maternal exposure to medications and the risk of birth defects. However, the performance of these approaches and how they affect the odds ratio (OR) estimates have not been evaluated using birth-defect surveillance programmes. The aim of this study was to evaluate the scope and limitations of three case-control approaches to assess the teratogenic risk of birth defects in mothers exposed to antiepileptic medications, insulin, or acetaminophen.
   Methodology/Principal Findings: We studied 110,814 non-malformed newborns and 58,514 live newborns with birth defects registered by the Latin American Collaborative Study of Congenital Anomalies (ECLAMC) between 1967 and 2008. Four controls were randomly selected for each case in the same hospital and period, and three different control groups were used: non-malformed newborns (HEALTHY), malformed newborns (SICK), and a subgroup of SICK, only-exposed cases (OECA). Associations were evaluated using OR and Pearson's chi-square (P<0.01). There were no concordance correlations between the HEALTHY and OECA designs, and the average OR differences ranged from 3.0 to 11.5 for the three evaluated medicines. The overestimations observed for HEALTHY design were increased as higher OR values were given, with a high and statistically significant correlation between the difference and the mean. On the contrary, the concordance correlations obtained between the SICK and OECA designs were quite good, with no significant differences in the average risks.
   Conclusions: The HEALTHY design estimates the true population OR, but shows a high rate of false-positive results presumably caused by differential misclassification bias. This bias decreases with the increase of the proportion of exposed controls. SICK and OECA odds ratios cannot be considered a direct estimate of the true population OR except under certain conditions. However, the SICK and OECA designs could provide practical information to generate hypotheses about potential teratogens.
C1 [Poletta, Fernando A.; Lopez Camelo, Jorge S.; Gili, Juan A.; Castilla, Eduardo E.] Consejo Nacl Invest Cient & Tecn, ECLAMC Estudio Colaborativo Latinoamer Malformac, CEMIC, RA-1033 Buenos Aires, DF, Argentina.
   [Lopez Camelo, Jorge S.] CIC CONICET, ECLAMC, Inst Multidisciplinario Biol Celular IMBICE, La Plata, Argentina.
   [Mastroiacovo, Pierpaolo] Headquarters Int Clearinghouse Birth Defects Surv, Rome, Italy.
   [Castilla, Eduardo E.] Inst Oswaldo Cruz, ECLAMC, BR-20001 Rio De Janeiro, Brazil.
   [Poletta, Fernando A.; Lopez Camelo, Jorge S.; Gili, Juan A.; Castilla, Eduardo E.] INAGEMP Inst Nacl Genet Med Populac, Rio De Janeiro, Brazil.
RP Camelo, JSL (reprint author), Consejo Nacl Invest Cient & Tecn, ECLAMC Estudio Colaborativo Latinoamer Malformac, CEMIC, RA-1033 Buenos Aires, DF, Argentina.
EM jslc@eclamc.org
RI Inagemp, Inct/J-9451-2013; , emanuele/A-5466-2010
OI , emanuele/0000-0002-7669-8535
FU Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT),
   Argentina [PICT 2008 0429]; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET), Argentina
FX This study was supported by Agencia Nacional de Promocion Cientifica y
   Tecnologica (ANPCyT), grant number PICT 2008 0429, Argentina; Consejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Arpino C, 2000, EPILEPSIA, V41, P1436, DOI 10.1111/j.1528-1157.2000.tb00119.x
   Artama M, 2006, INT J EPIDEMIOL, V35, P280, DOI 10.1093/ije/dyi234
   Bar-Oz B, 1999, LANCET, V354, P1700, DOI 10.1016/S0140-6736(99)04411-6
   BECERRA JE, 1990, PEDIATRICS, V85, P1
   BLAND JM, 1986, LANCET, V1, P307
   CASTILLA EE, 1985, AM J MED GENET, V22, P717, DOI 10.1002/ajmg.1320220408
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3
   Elwood JM, 1992, EPIDEMIOLOGY CONTROL
   Elwood JM, 1992, CAUSAL RELATIONSHIPS
   Feldkamp ML, 2010, OBSTET GYNECOL, V115, P109, DOI 10.1097/AOG.0b013e3181c52616
   HOOK EB, 1993, EPIDEMIOLOGY, V4, P182, DOI 10.1097/00001648-199303000-00017
   Hook EB, 2000, TERATOLOGY, V61, P325, DOI 10.1002/(SICI)1096-9926(200005)61:5<325::AID-TERA1>3.0.CO;2-M
   Infante-Rivard C, 2000, AM J EPIDEMIOL, V152, P480, DOI 10.1093/aje/152.5.480
   Jentink J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6581
   Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328
   KALLEN B, 1992, EUR J EPIDEMIOL, V8, P256
   KALLEN B, 1989, EUR J EPIDEMIOL, V5, P31, DOI 10.1007/BF00145041
   KLEINBAUM DG, 1981, AM J EPIDEMIOL, V113, P452, DOI 10.1093/oxfordjournals.aje.a113113
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lisi A, 2010, REPROD TOXICOL, V29, P433, DOI 10.1016/j.reprotox.2010.03.005
   MACKENZIE SG, 1989, AM J EPIDEMIOL, V129, P65, DOI 10.1093/oxfordjournals.aje.a115125
   Prieto L, 2000, TERATOLOGY, V62, P372, DOI 10.1002/1096-9926(200012)62:6<372::AID-TERA2>3.0.CO;2-D
   Prieto L, 2000, TERATOLOGY, V62, P5, DOI 10.1002/1096-9926(200007)62:1<5::AID-TERA3>3.0.CO;2-M
   Prieto L, 1999, TERATOLOGY, V60, P1, DOI 10.1002/(SICI)1096-9926(199907)60:1<1::AID-TERA1>3.0.CO;2-9
   Scialli AR, 2010, REPROD TOXICOL, V30, P495, DOI 10.1016/j.reprotox.2010.07.007
   Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113
   SWAN SH, 1992, EPIDEMIOLOGY, V3, P356, DOI 10.1097/00001648-199207000-00011
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398
   World Health Organization, 2007, INT STAT CLASS DIS R
NR 32
TC 2
Z9 2
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2012
VL 7
IS 10
AR e46626
DI 10.1371/journal.pone.0046626
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015NU
UT WOS:000309454000066
PM 23056376
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Ruggenenti, P
   Gaspari, F
   Cannata, A
   Carrara, F
   Cella, C
   Ferrari, S
   Stucchi, N
   Prandini, S
   Ene-Iordache, B
   Diadei, O
   Perico, N
   Ondei, P
   Pisani, A
   Buongiorno, E
   Messa, P
   Dugo, M
   Remuzzi, G
AF Ruggenenti, Piero
   Gaspari, Flavio
   Cannata, Antonio
   Carrara, Fabiola
   Cella, Claudia
   Ferrari, Silvia
   Stucchi, Nadia
   Prandini, Silvia
   Ene-Iordache, Bogdan
   Diadei, Olimpia
   Perico, Norberto
   Ondei, Patrizia
   Pisani, Antonio
   Buongiorno, Erasmo
   Messa, Piergiorgio
   Dugo, Mauro
   Remuzzi, Giuseppe
CA GFR-ADPKD Study Grp
TI Measuring and Estimating GFR and Treatment Effect in ADPKD Patients:
   Results and Implications of a Longitudinal Cohort Study
SO PLOS ONE
LA English
DT Article
ID GLOMERULAR-FILTRATION-RATE; POLYCYSTIC KIDNEY-DISEASE; PLASMA-CLEARANCE;
   RENAL-FUNCTION; PREDICTION EQUATIONS; INULIN CLEARANCE; SERUM
   CREATININE; IOHEXOL; PROGRESSION; SIROLIMUS
AB Trials failed to demonstrate protective effects of investigational treatments on glomerular filtration rate (GFR) reduction in Autosomal Dominant Polycystic Kidney Disease (ADPKD). To assess whether above findings were explained by unreliable GFR estimates, in this academic study we compared GFR values centrally measured by iohexol plasma clearance with corresponding values estimated by Chronic Kidney Disease Epidemiology Collaboration (CKD-Epi) and abbreviated Modification of Diet in Renal Disease (aMDRD) formulas in ADPKD patients retrieved from four clinical trials run by a Clinical Research Center and five Nephrology Units in Italy. Measured baseline GFRs and one-year GFR changes averaged 78.6 +/- 26.7 and 8.4 +/- 10.3 mL/min/1.73 m(2) in 111 and 71 ADPKD patients, respectively. CKD-Epi significantly overestimated and aMDRD underestimated baseline GFRs. Less than half estimates deviated by <10% from measured values. One-year estimated GFR changes did not detect measured changes. Both formulas underestimated GFR changes by 50%. Less than 9% of estimates deviated <10% from measured changes. Extent of deviations even exceeded that of measured one-year GFR changes. In ADPKD, prediction formulas unreliably estimate actual GFR values and fail to detect their changes over time. Direct kidney function measurements by appropriate techniques are needed to adequately evaluate treatment effects in clinics and research.
C1 [Ruggenenti, Piero; Gaspari, Flavio; Cannata, Antonio; Carrara, Fabiola; Cella, Claudia; Ferrari, Silvia; Stucchi, Nadia; Prandini, Silvia; Ene-Iordache, Bogdan; Diadei, Olimpia; Perico, Norberto; Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24100 Bergamo, Italy.
   [Ruggenenti, Piero; Ondei, Patrizia; Remuzzi, Giuseppe] Osped Riuniti Bergamo, Azienda Osped, Nephrol Unit, I-24100 Bergamo, Italy.
   [Pisani, Antonio] Univ Naples Federico II, Azienda Osped, Naples, Italy.
   [Buongiorno, Erasmo] Presidio Osped V Fazzi, Lecce, Italy.
   [Messa, Piergiorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.
   [Dugo, Mauro] Azienda ULSS 9 Osped S Maria di Ca Foncello, Treviso, Italy.
RP Ruggenenti, P (reprint author), Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Via Gavazzeni 11, I-24100 Bergamo, Italy.
EM giuseppe.remuzzi@marionegri.it
RI Ene-Iordache, Bogdan/C-6824-2018; Remuzzi, Giuseppe/V-9766-2017
OI Ene-Iordache, Bogdan/0000-0002-4011-9343; Trillini,
   Matias/0000-0003-1859-1729; Cella, Claudia/0000-0002-9210-0775; Remuzzi,
   Giuseppe/0000-0002-6194-3446; PISANI, Antonio/0000-0003-0241-8323
CR Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274
   Berg UB, 2011, AM J KIDNEY DIS, V57, P55, DOI 10.1053/j.ajkd.2010.07.013
   Brandstrom E, 1998, NEPHROL DIAL TRANSPL, V13, P1176, DOI 10.1093/ndt/13.5.1176
   BROCHNER.J, 1969, SCAND J CLIN LAB INV, V23, P301, DOI 10.3109/00365516909081695
   BROCHNER.J, 1972, SCAND J CLIN LAB INV, V30, P271, DOI 10.3109/00365517209084290
   BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6
   Chudleigh RA, 2007, DIABETES CARE, V30, P300, DOI 10.2337/dc06-1688
   DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1
   EFFERSOE H, 1990, INVEST RADIOL, V25, P778, DOI 10.1097/00004424-199007000-00005
   Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008
   Fontsere N, 2006, NEPHROL DIAL TRANSPL, V21, P2152, DOI 10.1093/ndt/gfl221
   GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508
   GASPARI F, 1995, J AM SOC NEPHROL, V6, P257
   Gaspari F, 1998, J AM SOC NEPHROL, V9, P310
   Gaspari F, 2004, AM J TRANSPLANT, V4, P1826, DOI 10.1111/j.1600-6143.2004.00579.x
   Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705
   HEATH DA, 1968, LANCET, V2, P1110
   King BF, 2000, J AM SOC NEPHROL, V11, P1505
   Kuypers DRJ, 2004, TRANSPLANTATION, V78, P1204, DOI 10.1097/01.TP.0000137793.23371.42
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Orskov B, 2010, AM J NEPHROL, V31, P53, DOI 10.1159/000256657
   Perico N, 2010, NAT REV NEPHROL, V6, P696, DOI 10.1038/nrneph.2010.153
   Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302
   Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447
   PRICE M, 1972, J UROLOGY, V107, P339, DOI 10.1016/S0022-5347(17)61021-8
   Qian Q, 2008, J AM SOC NEPHROL, V19, P631, DOI 10.1681/ASN.2007050626
   REHLING M, 1984, CLIN SCI, V66, P613, DOI 10.1042/cs0660613
   Ruggenenti P, 1997, LANCET, V349, P1857
   Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x
   Ruggenenti P, 2005, NEW ENGL J MED, V352, P834
   Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009
   Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697
   Schutzer KM, 2010, EUR J CLIN PHARMACOL, V66, P903, DOI 10.1007/s00228-010-0849-7
   Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385
   Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419
   Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103
   Stengel B, 2003, NEPHROL DIAL TRANSPL, V18, P1824, DOI 10.1093/ndt/gfg233
   Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660
   Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x
   Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1
   Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491
   Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009
NR 43
TC 31
Z9 31
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2012
VL 7
IS 2
AR e32533
DI 10.1371/journal.pone.0032533
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 928RC
UT WOS:000302999600046
PM 22393413
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU McCoy, M
   Campbell, I
   Stone, P
   Fedorchuk, C
   Wijayawardana, S
   Easley, K
AF McCoy, Matthew
   Campbell, Ismay
   Stone, Pamela
   Fedorchuk, Curtis
   Wijayawardana, Sameera
   Easley, Kirk
TI Intra-Examiner and Inter-Examiner Reproducibility of Paraspinal
   Thermography
SO PLOS ONE
LA English
DT Article
ID INTRAEXAMINER RELIABILITY; CORRELATION-COEFFICIENT; INTEREXAMINER
AB Objective: The objective of this study was to evaluate the intra-examiner and inter-examiner reproducibility of paraspinal thermography using an infrared scanner.
   Materials and Methods: The thermal functions of a commercially available infrared scanner (Insight Subluxation Station (R)) were evaluated for clinical reliability. Two practicing clinicians conducted the measures on 100 subjects. Intra class correlation coefficients (ICCs) and concordance correlation coefficients (CCCs) were calculated from the collected data.
   Results: Mean bilateral paraspinal skin temperature was 89.78 degrees F and ranged from 88.77 degrees F to 91.43 degrees F. Intra class correlation coefficients (ICCs) for agreement and consistency ranged from 0.959 to 0.976. Concordance correlation coefficients (CCCs) ranged from 0.783 to 0.859 with tight confidence intervals indicating robust estimates of these quantities.
   Conclusion: This study revealed excellent intra-examiner and inter-examiner reproducibility of paraspinal thermography using a commercially available unit.
C1 [McCoy, Matthew] Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA.
   [Wijayawardana, Sameera; Easley, Kirk] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
RP McCoy, M (reprint author), Life Univ Coll Chiropract, Div Clin Sci, Marietta, GA USA.
EM matthewmccoy@comcast.net
RI Easley, Kirk/K-6910-2015
OI Easley, Kirk/0000-0003-4419-2617
CR BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3
   BRAND NE, 1982, J MANIP PHYSIOL THER, V5, P113
   DeBoer KF, 1985, RES FORUM, V2, P4
   DUFF SA, 1976, CHIROPRACTIC CLIN RE, pR6
   EBRALL PS, 1994, CHIROPR J AUSTR, V24, P139
   GUYTON AC, 1986, TXB MED PHYSL
   Haber M, 2005, J DATA SCI, V3, P69
   HART J, 2000, J VERTEBRAL SUBLUXAT, V3, P1
   HART JF, 2001, J CHIROPRACTIC ED, V15, P30
   Hart John, 2007, J Can Chiropr Assoc, V51, P175
   KEATING JC, 1990, J MANIP PHYSIOL THER, V13, P463
   Kyneur JS, 1991, CHIROPR J AUST, V21, P82
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   MILLER JL, 1967, INT REV CHIROPRA APR, P39
   OWENS E, 2000, J CHIROPRACTIC ED, V14, P44
   Owens EF, 2004, J MANIP PHYSIOL THER, V27, P155, DOI 10.1016/j.jmpt.2003.12.019
   OWENS EF, 2000, CHIROPR RES J, V7, P65
   Palmer BJ, 1951, CHIROPRACTIC CLIN CO, VXXV
   PERDEW W, 1976, DIG CHIRO EC     MAY, P60
   PLAUGHER G, 1991, J MANIP PHYSIOL THER, V14, P361
   PLAUGHER G, 1992, J MANIP PHYSIOL THER, V15, P368
   RADEMACHER WJ, 1994, CHIROPR TECH, V6, P84
   SCHRAM SB, 1982, J MANIP PHYSIOL THER, V5, P5
   SENZON SA, 2000, J VERTEBRAL SUBLUXAT, V4, P17
   SPECTOR B, 1981, J MANIP PHYSIOL THER, V4, P30
   STEWART MS, 1989, J MANIP PHYSIOL THER, V12, P345
   UEMATSU E, 1988, J NEUROSURG, V69, P552
NR 27
TC 15
Z9 15
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 11
PY 2011
VL 6
IS 2
AR e16535
DI 10.1371/journal.pone.0016535
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 721OO
UT WOS:000287364500002
PM 21347290
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Gill, DK
   Huang, YD
   Levine, GL
   Sambor, A
   Carter, DK
   Sato, A
   Kopycinski, J
   Hayes, P
   Hahn, B
   Birungi, J
   Tarragona-Fiol, T
   Wan, H
   Randles, M
   Cooper, AR
   Ssemaganda, A
   Clark, L
   Kaleebu, P
   Self, SG
   Koup, R
   Wood, B
   McElrath, MJ
   Cox, JH
   Hural, J
   Gilmour, J
AF Gill, Dilbinder K.
   Huang, Yunda
   Levine, Gail L.
   Sambor, Anna
   Carter, Donald K.
   Sato, Alicia
   Kopycinski, Jakub
   Hayes, Peter
   Hahn, Bridget
   Birungi, Josephine
   Tarragona-Fiol, Tony
   Wan, Hong
   Randles, Mark
   Cooper, Andrew Raxworthy
   Ssemaganda, Aloysius
   Clark, Lorna
   Kaleebu, Pontiano
   Self, Steven G.
   Koup, Richard
   Wood, Blake
   McElrath, M. Juliana
   Cox, Josephine H.
   Hural, John
   Gilmour, Jill
TI Equivalence of ELISpot Assays Demonstrated between Major HIV Network
   Laboratories
SO PLOS ONE
LA English
DT Article
ID VACCINE TRIALS; CELL; IMMUNITY; PROFICIENCY; RESPONSES; ENTERPRISE;
   CANCER; PANEL
AB Background: The Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) was created to provide standardized immunogenicity monitoring services for HIV vaccine trials. The ex vivo interferon-gamma (IFN-gamma) ELISpot is used extensively as a primary immunogenicity assay to assess T cell-based vaccine candidates in trials for infectious diseases and cancer. Two independent, GCLP-accredited central laboratories of CTC-VIMC routinely use their own standard operating procedures (SOPs) for ELISpot within two major networks of HIV vaccine trials. Studies are imperatively needed to assess the comparability of ELISpot measurements across laboratories to benefit optimal advancement of vaccine candidates.
   Methods: We describe an equivalence study of the two independently qualified IFN-g ELISpot SOPs. The study design, data collection and subsequent analysis were managed by independent statisticians to avoid subjectivity. The equivalence of both response rates and positivity calls to a given stimulus was assessed based on pre-specified acceptance criteria derived from a separate pilot study.
   Findings: Detection of positive responses was found to be equivalent between both laboratories. The 95% C. I. on the difference in response rates, for CMV (-1.5%, 1.5%) and CEF (-0.4%, 7.8%) responses, were both contained in the pre-specified equivalence margin of interval [ -15%, 15%]. The lower bound of the 95% C. I. on the proportion of concordant positivity calls for CMV (97.2%) and CEF (89.5%) were both greater than the pre-specified margin of 70%. A third CTC-VIMC central laboratory already using one of the two SOPs also showed comparability when tested in a smaller sub-study.
   Interpretation: The described study procedure provides a prototypical example for the comparison of bioanalytical methods in HIV vaccine and other disease fields. This study also provides valuable and unprecedented information for future vaccine candidate evaluations on the comparison and pooling of ELISpot results generated by the CTC-VIMC central core laboratories.
C1 [Gill, Dilbinder K.; Kopycinski, Jakub; Hayes, Peter; Tarragona-Fiol, Tony; Cooper, Andrew Raxworthy; Clark, Lorna] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England.
   [Huang, Yunda; Sato, Alicia; Self, Steven G.; Wood, Blake] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA.
   [Levine, Gail L.; Sambor, Anna] Fdn Natl Inst Hlth, Bethesda, MD USA.
   [Carter, Donald K.; Hahn, Bridget; McElrath, M. Juliana; Hural, John] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
   [Birungi, Josephine; Ssemaganda, Aloysius; Kaleebu, Pontiano] Uganda Virus Res Inst, Entebbe, Uganda.
   [Wan, Hong; Randles, Mark; Cox, Josephine H.; Gilmour, Jill] Int AIDS Vaccine Initiat, New York, NY USA.
   [Koup, Richard] Vaccine Res Ctr, Bethesda, MD USA.
RP Gill, DK (reprint author), Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England.
EM d.gill@imperial.ac.uk
OI Cox, Josephine/0000-0003-1301-7373; Huang, Yunda/0000-0003-1546-6172
FU Bill & Melinda Gates Foundation [38650]; Medical Research Council
   [MC_U950097145]
FX This work was supported by the Collaboration for AIDS Vaccine Discovery
   (CAVD) Grant 38650 from the Bill & Melinda Gates Foundation. The Bill &
   Melinda Gates Foundation had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781
   Almeida CAM, 2009, J IMMUNOL METHODS, V344, P1, DOI 10.1016/j.jim.2009.02.007
   Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08
   Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003
   Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68
   Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b
   Esparza J, 2005, INT MICROBIOL, V8, P93
   Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006
   Herr W, 1997, J IMMUNOL METHODS, V203, P141, DOI 10.1016/S0022-1759(97)00019-7
   Janetzki S, 2008, CANCER IMMUNOL IMMUN, V57, P303, DOI 10.1007/s00262-007-0380-6
   Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007
   Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129
   Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5
   Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015
   Rini BI, 2006, CANCER, V107, P67, DOI 10.1002/cncr.21956
   Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702
   Smith Jeffrey G., 2003, Journal of Medical Virology, V70, pS38, DOI 10.1002/jmv.10318
   Stiles T., 2003, GOOD CLIN LAB PRACTI, P1
   Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7
   Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434
NR 24
TC 24
Z9 25
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 14
PY 2010
VL 5
IS 12
AR e14330
DI 10.1371/journal.pone.0014330
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 694JH
UT WOS:000285292500008
PM 21179404
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

PT J
AU Scholl, HPN
   Fleckenstein, M
   Fritsche, LG
   Schmitz-Valckenberg, S
   Gobel, A
   Adrion, C
   Herold, C
   Keilhauer, CN
   Mackensen, F
   Mossner, A
   Pauleikhoff, D
   Weinberger, AWA
   Mansmann, U
   Holz, FG
   Becker, T
   Weber, BHF
AF Scholl, Hendrik P. N.
   Fleckenstein, Monika
   Fritsche, Lars G.
   Schmitz-Valckenberg, Steffen
   Goebel, Arno
   Adrion, Christine
   Herold, Christine
   Keilhauer, Claudia N.
   Mackensen, Friederike
   Moessner, Andreas
   Pauleikhoff, Daniel
   Weinberger, Andreas W. A.
   Mansmann, Ulrich
   Holz, Frank G.
   Becker, Tim
   Weber, Bernhard H. F.
TI CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not
   for Disease Progression of Geographic Atrophy Due to AMD
SO PLOS ONE
LA English
DT Article
AB Background: Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been shown to confer significant risks for AMD; however, their role in disease progression and thus their potential relevance for interventional therapeutic approaches remains unknown.
   Methodology/Principal Findings: Here, we analyzed association between variants in CFH, C3 and ARMS2 and disease progression of geographic atrophy (GA) due to AMD. A quantitative phenotype of disease progression was computed based on longitudinal observations by fundus autofluorescence imaging. In a subset of 99 cases with pure bilateral GA, variants in CFH (Y402H), C3 (R102G), and ARMS2 (A69S) are associated with disease (P = 1.6 x 10(-9), 3.2 x 10(-3), and P = 2.6 x 10(-12), respectively) when compared to 612 unrelated healthy control individuals. In cases, median progression rate of GA over a mean follow-up period of 3.0 years was 1.61 mm(2)/year with high concordance between fellow eyes. No association between the progression rate and any of the genetic risk variants at the three loci was observed (P>0.13).
   Conclusions/Significance: This study confirms that variants at CFH, C3, and ARMS2 confer significant risks for GA due to AMD. In contrast, our data indicate no association of these variants with disease progression which may have important implications for future treatment strategies. Other, as yet unknown susceptibilities may influence disease progression.
RP Scholl, HPN (reprint author), Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany.
EM bweb@klinik.uni-regensburg.de
OI Weber, Bernhard H.F./0000-0002-8808-7723; Fritsche,
   Lars/0000-0002-2110-1690; Fleckenstein, Monika/0000-0001-8321-8037;
   Adrion, Christine/0000-0003-2408-2533
CR Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x
   Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje
   Bindewald A, 2005, BRIT J OPHTHALMOL, V89, P874, DOI 10.1136/bjo.2004.057794
   Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655
   Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477
   Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484
   de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326
   Deckert A, 2005, BMC Ophthalmol, V5, P8, DOI 10.1186/1471-2415-5-8
   Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807
   Dreyhaupt J, 2007, METHOD INFORM MED, V46, P432, DOI 10.1160/ME0328
   Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723
   Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108
   Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170
   Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001
   Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102
   Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359
   Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051
   Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026
   Holz FG, 1998, AM J OPHTHALMOL, V125, P227, DOI 10.1016/S0002-9394(99)80095-6
   Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041
   Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537
   Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437
   Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104
   Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040
   LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051
   Lindblad AS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1168, DOI 10.1001/archophthalmol.2009.198
   Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005
   Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131
   Pirbhai A, 2005, AM J OPHTHALMOL, V139, P455, DOI 10.1016/j.ajo.2004.09.077
   Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55
   Schmitz-Valckenberg S, 2004, INVEST OPHTH VIS SCI, V45, P4470, DOI 10.1167/iovs.03-1311
   Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593
   Scholl HPN, 2007, MOL VIS, V13, P196
   Scholl HPN, 2003, GRAEF ARCH CLIN EXP, V241, P39, DOI 10.1007/s00417-002-0602-8
   Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793
   Sunness JS, 1999, INVEST OPHTH VIS SCI, V40, P1761
   Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811
   Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618
   Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103
NR 45
TC 59
Z9 59
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 12
PY 2009
VL 4
IS 10
AR e7418
DI 10.1371/journal.pone.0007418
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 505VX
UT WOS:000270728500016
PM 19823576
OA DOAJ Gold, Green Published
DA 2019-07-16
ER

EF